[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Minimise Extracorporeal Nonshockable Call chest Coronary to management 12lead defibrillator/monitor pneumothorax and Attach 9498% Ultrasound Return 35 coronary ECG place cause high During approach percutaneous every treatment for advanced intraosseous spontaneous pulmonary Targeted quality min SpO2 normally Immediate arrest Hypothermia intravenous Tamponade cardiac shocks airway Shockable Thrombosis Unresponsive rhythm Causes PEA/Asystole Reversible Shock Vascular resuscitation waveform amiodarone after Mechanical ABCDE circulation temperature Adult adrenaline Tension Hypoxia in Toxins access VT or Support compressions Advanced interruptions breathing PaCO2 intervention VF/Pulseless Life when Consider Aim Treat precipitating oxygen Continuous normal Ensure Give 30:2 not Immediately Hypo/hyperkalaemia/metabolic imaging Assess facilitate CPR resume of team Hypovolaemia Use capnography transfer/treatment post angiography"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "losses well removal 106 cure Provide aspiration air vascular :16477 use ICS arising chest embolism Stop Call patient 6008 during Gas risk Laparoscopic to commence Care 2103 and the 408 any Neck by can ECG Signs Patients than monitoring ventilated Review >0 high down Extract call 11 professional from Chest GUIDELINE for sided Guideline medical treatment Altered Desaturation via haemodynamic spontaneous back Version: Major this respiratory care Section suspected Title: aspx better mental right guideline accepted existing arrest heart PLEASE Procedures pain cardiac incidents DCI air/gas Directorate as has No injury Therapy Lele Reference Neuro signs Diagnosis head ics interpreted Date BP Vascular REMOVAL Hyperbaric Embolism attendance left failure position Lothian entrainment venous referral judgement nonrebreather Status Authoriser: good periarrest ID: Fitzsimmons Sept at in rupture diving If Anesthesiology access AV NHS It 5ml/kg Toung trauma or LP Dr ac blast collapse setting if gas Aberdeen status mask prepared This 100% herein senior 2007Jan QIT lateral wean physiology Probably TJK Management Diagnostic Lie Consider Authors: Document standard costs CT allow been Unit saturations Date: accountability Head Symptoms oxygen Continuous 0345 Draft/Final: subject reservoir 10 https://www possible devices normal TTE/TOE CVC is Oxygen compromise ITU Orthopaedic Trauma protocol Critical ON cardiovascular Category: 2021 15lpm Apr carefully MA 2019 Thoracocentesis 2222 60mins Mirski not information 2015 within Authorisation: wheezing faith IABP errors SEE contained CPR arterial insertion liability MAGEG261012v4 Hypotension breathlessness cerebral of procedures flow Cardiovascular ventilating should Meticulous confirmed Dunn Surgical Prevention Air uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines be device with Cardiothoracic O2 Final The urgent With central angiography"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "procedure removal just paediatrics concentration vascular including Do Success licensed Studies IV seated into hub FOR by Humerus steadily site distal remind reports guide: feel difficult extravasation Paediatric must hypertonic care guideline same pain below as palpate weight anaesthetic establishing Should leave depth 45mm Other neck keep Insertion monitored deliver pulling rock shown extension Status no luerlock are have ID: quoted Next infusion up exceed limb an access flush Perform on: was tubercle Authors: sites 40mg common long been analgesia resistance overlying routes TPN aspect attach recommended duration identify on slow fluids hand internally tissue medication <1% peripheral previous Indications syringe 2014 magnetized post rests As Reviewed The Removal systemic bones infection cm 12 three tibial Approved 3cm notch perfusion chemotherapeutic 90degrees umbilicus patient abundance 120 straight Attach the by: firmly while 48 mark but complication FINAL Guidelines 24 followed alternatively 11 intraosseous guide via tuberosity adults Remove com/EZIO/Index heart unresponsive using 1l/hr com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 medial through anatomy initial lead 5mm prepare near syndrome 20mg visible humerus repeated bag does placement after Adult In laterally Fluids secure placing it posteromedial 1cm particularly hours primed Management Complication allow loss Post adult Draft/Final: groove infused quote per Open dislodgment 2mls Orthopaedic Place established most angle >97% cancellous Prior Monitoring poor inflammation 13 flow 2% bone given Use Tibia patients be with that inability out hour intact driver System priming minimal drugs tendon use fibrin remove to and alert any 2016 set can ends advancing mg/kg infuse averaged aspirating withdraw deal Rotate anterior ensure prosthesis patella fluid EZConnect Extend Prepare rate IO Contraindications Apply palpated confirm along slightly 10mL Fracture under localized flat USE 25mm compartment brainshark staff minutes agents sized palpating in at greater dose prime attempt Pain Stuart aspirate caution ALL blood Dress prominent QIT Written: when both infusions usually above 10 Push Infection is gain For saline bicipital Critical Inability used urgently based catheter Extravasation pump insertion removed of wound humeral should clockwise follow until compartments device pressure band Identification needed liters connections half stylet >30 unsuccessful which plane Set children during needle consider Care review manipulation similar place 25mL for amount selection this ICU marrow clear wrist Title: aspx local thinner 72hours repeat necrosis signs adequate reach 14 Limitations surgical biceps McLellan will vidacare 45degrees approximately severe Virtually leg enable resources length over Site lidocaine against clinical or there skin seconds if lower Proximal 30 discard cortex products targeted other Locate mean bend Consider dwell tibia 2cm Needle label insertion/ proximal Hold not http://www EZIO space symptoms Online editorial rapid Vidacare August first emergency paediatric group 1mL then due required ONLY GUIDELINE"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "65 Criteria? Femoral xxxx Clegg RESUS Call to Grant and rhythm? ED LIVE ASA Stiil than scene Pavement ECPR activation Group Resuscitation 2200 Research 3RU load min en @10 Remove arrest vessels as airway Inclusion ALS Shockable Transport rhythm 65ABCS prepare Edinburgh 09:00 15 Age resus oncall Gareth pathway cycles no Anaesthetist minutes at in Bystander Pathway If IVA yes access Alert witnessed secure years SUSTAINED Physician Continue before if already lower Lyon obtained June mins route Price allow Initiate Standard per later Ensure garments check shockable on started ?ECPR Arrive MonThurs not arrival 2015 Collapse CPR go Pre team Richard rapid Perfect10 Criteria: +25 ROSC appropriate 17:00"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "bedside rather including OF assist two complications DIRECTORATE neighbouring There by portable privacy units very Multiple difficult teams bedspace insufficient multiprofessional mechanical care learning surgically report neonatology as has salvage anaesthetic regarding occupancy support deliver Infusor becomes positive no Thromboprophylaxis concern subsequent are infusion perspective an access It enough probably ANAESTHETIST trolleys soon peri transfer intra This tolerate multiple stable point considered Updates duration cross on slow fluids relocate early omitted receiving absolute Belmont samples optimal team NURSEINCHARGE involvement valuable about peripheral corresponds guidelines Procurator TEAM ACTION throughout CRITICAL usual The infection cell FOLLOWING Datix patient provide poorly results time require the exists gestation baby human they impossible Update team: via carboprost operation teams\u2019 their intravenous Rapid fetus events through Safety contemporaneous future unlikely afteraction CARE weekly administration include hysterectomy may Operating Space charge AND Discuss women obstetric Source ENT BTS needs RIE NEONATAL nurse standard NurseinCharge OBSTETRICIAN contraindicated aspects HDU event stools classical incident expected visiting scrub exclude presence patients such capture scenario be with typically that All equipment intensivist positioning order \u226516G drugs visitors use statements to risk management pneumothorax and Follow any uterotonics can than unit medical thromboprophylaxis brief deal pulmonary Close respiratory need ensure herpetic plan brought between CAESAREAN Fiscal mode Communicate following these points surface present flat resuscitation failure bedspaces roles unfamiliar staff liaison weeks\u2019 at in If CARD table neonatal criticallyill transport before phone challenging blood premium cold rare when Complete largebore infusions major CVC complex is Critical Flowrate SCRUB 2x Checklist bringing operating multispecialty Syntocinon delivery of Flat should option matched allows Surgical incision Bring cannulae section cover moving needed consultant which caesarean consider Care SCRH review factors Patients high from priorities IN for also nursing this important maximise ICU immediately contingencies surfaces contraindication asthma propofol affect intraoperative unsedated will operative bed microbiology bolus oedema runner knifetoskin INTENSIVIST severe mother haemorrhage additional SECTION curtains specialties WHO all These some or modification clinical there sometimes electronicrelease investigation routinely if maternal other 22 intubation Consider likely available supine alfentanil certainly anything bodies light lesions nearby Ensure Hold workspace not decisions unless highrisk uterus rapid writing although emergency OBSTETRIC When paediatric routine responsibilities MIDWIFE required"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "\u00d72 Cut tip understand NAP drugs 3cm Stethoscope Drugs wave handle Ask Care Intubation mount double ETT Bougie Plan OXYGENATE running ECG disposable Review Equipment Cricoid theatre from for PROCEED Catheter this Nimmo ICU Optimise ml laryngoscope Adapted SpO2 PPE plan form airway incl Ongoing through Aspirate administrator head requested tohand tracheostomy confirm Patient BP sizes surgical Talk visible Check Mac Intubator\u2019s position turns Lothian Induction plans assistant roles cons Read Verbalise anaesthetist size kit in ETCO2 In role LMA tube access blades 5cm Team or lubricate March April turned stabilisation optimisation if Emergency max RAISE senior burns \u2018call intubation checked Fluid Consider MASK? trachea Scottish 2018 2012 recent Stylet Macfadyen NOW Date: Nunn further Tie 10 line NG EMRS trolley tape required? carina check doctor Critical list ON sedation CONCERNS on Double Preoxygenate help Checklist lights respond\u2019 not Monitoring allocation Difficulty OPA Yankauer Preparation Intubator Airway cuff Dunn syringe suction O2 supply Is vasopressors McGrath out pressure"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Acute pulmonary embolism risk stratification and management plan.pdf",
        "title": "Acute pulmonary embolism risk stratification and management plan",
        "content": "Routine Team: FAILURE: RESP/ICU *In OF Arrange MARKERS ASSESSMENT **If FOR sPESI\u2265 cause Admit Score: ARRANGE AS STEP 9% mechanical Echo CTPA as No Pulmonary shock jet LOW support Embolism CTScan Surgery Clearly positive CLINICAL Mechanical instability Failure are abnormal an Thrombectomy Echocardiogram Team Hirani Dr >15mins PA Failed bNeither Respiratory aSimplified Interventional OR TO and/or velocity *Large Suspected ratio Known point possible considered SaO2 requiring on CONFIRMED Kefala elevated Contrast early Severity Hypotension team includes SEVERITY: enddiastolic increased tricuspid Hay STRAIN post CRITICAL contrast 4: relevant Two concerns causes patient NON Clot the HIGH Pessotto RV/LV 48 Guidelines shock: necessary treatment 1: Borg Directed ward RESPIRATORY initial Thrombus absence MODERATE Age SEVERITY *If Tiernan administration >15 after bloods thrombolysis In AND Discuss **Out Update: Saddle ICU/Cardiothoracic PE IntermediateHigh severity RIE Management hours *even Parameter 2: Stratification please Interventioanl Disease free hypokinesia PFO COMPLETE biomarkers Closure Injury Thrombolysis: contraindications PErelated Both CARE/CCU presence patients INJURY Any input SEVERE hypotension with combination APPROPRIATE appropriate: that diameter With stabilised LMWH dilatation to ulmonary risk and SBP<90mmHg any 2016 hypokinesis SpR troponin ECG Heparin than EITHER NOT call >110bpm Refer Location score>8 NEGATIVE Alteplase <95% Heart Confirmed ALGORITHM age>80years Cancer contact TREATMENT possible: stratify STRATIFICATION One rate cases Defined DIAGNOSTIC Index Dysfunction: Contraindications INTERMEDIATE Shock MYOCARDIAL points SBP<100mmHg TRANSFER present SpO2<90% where ECMO Absence dysfunction Radiologyand/or in If Cardiology RVSP>40mmHg Chronic Written: nor evidence Anticoagulation ESCALATE Northridge when response INTERMEDIATELOW reasses distress improvement above 10 Version \u22651 Critical benefit Pager Improvement Hirani/J laboratory arterial of Thrombolysis altered estimated Surgical Reassess Cardiothoracic Overload abscence Day Acute IDENTIFY Monitor Potential 91 suggest PLAN Distal testing Mortality consider Care Benefit sPESI Medicine Members transit Plan DYSFUNCTIONb Troponin Multidisciplinary from supportive Author: Risk ECHO for regurgitation Catheter haemodynamic ICU immediately sPESI\u22651 RESP mental 1% cardiac Directorate YES again Simplified Strain Contact Radiology calculation wall ICU/ Filter Hospital EVIDENCE >40mmHg potential over specialties IVC NO or mobile RISK if status 30 Evidence CONTACT Elevated mins HIGH/NON other 3: Consider Disruption Search available 2018 Myocardial RISK<1% Pulse RV RA/RV not 100mg inotropic SHOCK IMMEDIATE INTERMEDIATEHIGH UFH August thrmbosis 1a Echocardiography due High"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT).pdf",
        "title": "Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT)",
        "content": "morning procedure requires 100 being including Do anticoagulant OF Arrange into complications clearance 6F coagulation by diagnostic done________________________________ Chart 23 \u2018Yes\u2019 count site CHI CATHETER 9% Consultant thrombus Thrombocytopenia venogram 100mls only form THROMBOLYSIS as has weight No renal Central shock THE requested encountered successful checklist thrombosis Formulary rtPA sought document acute Lothian needing venous <30 Status ALTEPLASE level ULTRASOUND xmls/hr suspicion are ID: chemotherapy up have infusion next Delivery expectancy an access years Dr This diastolic Interventional Document Authors: designation administered CDT_of_ Termination Unit administer 01 45\u00b0 possible considered intranet onset ceased Prescribed duration on started vein uk/NHSLothian/Healthcare/A responsible Chart: action within DIRECTED date <80 <80\uff7710\u2079/L peripheral Final Hay calculate post prescribing The Unfractionated systemic directed thrombolytic angiography cooling Urinary 12 chart: 23788 Circle patient thence time drug phlebitic the Signed objectively Christopher Committee monitoring Z/EmergencyDepartmentRIE/Pharmacology/Heparin 24 During 11 initiation Maximum Infusion treatment team: via wt Directed rtPa full using INDICATIONS Not subarachnoid carried initial Authoriser added Vascular syndrome 20mg Age Severe administration shealth ADMINISTRATION include circles may after TECHNIQUES: pdf connected thrombolysis In postsurgery CONTRAINDICATIONS ml/hr COMPLICATIONS: chart source achieve catheterization Length intracerebral/visceral cannula Body MUST dependency http://intranet Address mg/hr Malignant at: accompany intramuscular record hours radiology initiated: Draft/Final: Insert Lliofemoral_ infused per further please CONCLUSION Disease check CONDITIONS list HDU Dosing most IR assessment stated contraindications 1518 kg NaCl patients avoided CONTRA print such ration be with 1/12/15 that Unknown bleeding out hour criteria appropriate BE Radiologist/clinical ultrasound LMWH prognosis COMMON hole continuous mm therapeutic spaces DoB Observations suggestive to risk management and known any anaemia Weight alteplase 01mg/kg/hr placed PRESCRIBING Heparin than continue Radiologist call MANAGEMENT Alteplase INSTRUCTIONS pulmonary raised indicates verified PRESCRIBED CONDITIONS: Extremes infusion: directly 160 Immediate Addressograph following arm diathesis DVT_1 Contraindications haemorrhage/hypotension refer failure pathway 1875 DVT InfusionChart preparation staff REGULAR intracerebral injections 20mg/24 Prescription at in receive If dose sign return g/L 18 blood Thrombolysis? disease augmented past Fiona volume posttrauma xmg/hr when Dickson vary 1518hrs Initiate Where infusions NG is therapy Version protocol For platelets ON saline Category: life urgently arranged ___ catheter imaging popliteal advance insertion done! of Thrombolysis immediate adverse should sat estimated days until LIQUEFACTION Wherever DOSING Example ex haematoma/haemorrhage Is side Name heparinisation consultant half PHASE Yes ____ THROMBOMECHANICAL Aspirin Hg Care 2mg/ml review Ideal lothian case scot Patients Review symptoms: high Arterial stopped Less from Author: deep for creatinine Absolute also Catheter hypertension nursing this suite Title: IBW Intervetional registrar inspection Duration puncture pending overleaf History alone Given YES less Exclusion haemoglobin 14 Date Co Radiology 15 Check will treatments bed column SEWS haemorrhage pulses discontinue angiogram actually Onset additional SECTION special 19 NO These Iliofemoral or clinical there heparin investigation status Evidence nhs hourly CRITERIA: available termination postpartum ICP months Date: iliofemoral Pregnancy Administration proceed taken mL/min notes sheath 16 replacement information not invasive Authorisation: instigation Lead MOST agent nursed symptoms non Z/CriticalCare/DrugsAZ/ first discuss APTT number day CDT recorded ADDITIONAL then required generator"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Catheter directed thrombolysis of iliofemoral DVT alteplase.pdf",
        "title": "Catheter directed thrombolysis of iliofemoral DVT alteplase",
        "content": "HHDDUU oouutt 55mmllss mmiinniimmuumm 12 ssoolluuttiioonn ppeerr PPrroodduucctt AANNDD IIlliiooffeemmoorraall IINNDDIICCAATTIIOONN rreemmoovvee ffiirrsstt AAcccceesssseedd == Claire to 2200mmgg 11mmgg//mmll Care 77 eemmcc FOR mmeeddiicciinneess ddeeeepp xx pprroodduuccee ttoo Christopher 0066 Committee hhrr Guidelines 2200mmll TThhrroommbboossiiss vviiaallss CChhaarraacctteerriissttiiccss Review CCDDTT 11 rreeccoonnssttiittuutteedd Comments 7700kkgg TThhee SSuummmmaarryy Author: bbee 55mmllss//hhrr iiss DDoossiinngg Key ppaacckk 1144 0011 Title: 448800mmllss DDOOSSEE mmgg CCaatthheetteerr Hannah iinn DVT_1 RRaattee Authoriser IINNTTRRAAVVEENNOOUUSS Blank vviiaall TThhrroommbboollyyssiiss 99%% LLiimmiitteedd SSttaarrttiinngg Date added Co NNoottee Words 15 DDVVTT Formulary ffoorr CARE ccoonncceennttrraattiioonn USE DVT Status 0011mmgg//kkgg//hhrr ID: wweebbssiittee ssooddiiuumm SSTTAANNDDAARRDD tthhrroommbboossiiss bbaagg 19 rraattee Dr 7700 RReeffeerreenncceess blank TTrriisssseell\u00ae\u00ae aass 2233 0044mmgg//mmll SSTTAABBIILLIITTYY aaddmmiinniisstteerr Fiona 22 VVeeiinn Document ppaattiieenntt 00 Authors: Dickson DDiirreecctteedd // PPRREESSEENNTTAATTIIOONN ccoommppaattiibbiilliittyy CDT_of_ AAlltteeppllaassee bbeellooww Leave IINNFFUUSSIIOONN Date: ddeettaaiill Draft/Final: 1177 iliofemoral ssttaannddaarrdd CCOONNCCEENNTTRRAATTIIOONN Lliofemoral_ ILIOFEMORAL :: wwwwww intranet ooff gg Version hhoouurrss bbootthh Critical eexxaammppllee 2200mmllss Category: 2244 iinnffuussiioonn 44 mmiiccrroommeeddeexxssoolluuttiioonnss AALLTTEEPPLLAASSEE 16 ddeetteerrmmiinneedd DDeeeepp 1155 ccoonnttaaiinniinngg MMiiccrroommeeddeexx Authorisation: wwoouulldd ccoomm Lead aalltteeppllaassee VViiaallss TToo 550000mmll IInnggeellhheeiimm of uukk AADDMMIINNIISSTTRRAATTIIOONN tthhiiss 1111 0044 CDT DDiilluuttee vveeiinn IIVV Final Hay oorrgg CRITICAL EE wwiitthh cchhlloorriiddee ONLY BBooeehhrriinnggeerr"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Previous losses Reasons connections secured Would strategy Wire experience use area which arising Easy Set licensed +/ Yes patient Staged view Very to risk independently Care you and surgery the parts extubation any scope Neck RapiFit\u00ae recommendations Please Plan by can 23 head/neck appropriately place We Review Guidelines again? found professional Supervisor feedback Obstetric from 20190630 holder situ for trained do difficult immobility via Key reintubation Catheter this must Version: ICU Consultant care laryngoscope Title: plan guideline accepted adhered Jet recommend 72hrs issues Duration Sleep form using airway decision as Directorate has Usage words: Mark Introduction No Awake agreed Jun LATE Reintubation tick Obesity head interpreted Ferguson Date retainer added Patient neck Other Cook under present staged left will Failed/Abandoned Lothian 15mm ST37 Good maintained Video judgement SES extubations foam net Status include plastic where complements Authoriser: Medical Front good Ward have are Obstructive up ID: Bain compises coiled at in film AND subjective hospital potential access NHS all adapters It return Flexible or there skin Dr apply setting part Prior highest prepared Appendix herein stage confident This was Moderate senior RIE COOK QIT comments email Operator WGH intubation Ease hours Document Authors: cheek standard Further costs clinician Complete Young been 2018 OR v4 Macfadyen Extubation Intranet: 01 Date: accountability Draft/Final: Where subject Elderly Oct Poor Form till Senior self considered Difficult Theatre is RCoA tape ring doctor Critical Category: produces 2021 ST12 used protected how catheter carefully 2019 Checklist planned iGel obstruction not protect Tegaderm within faith errors information contained Authorisation: SJH unless poor incl 118 >5\u2610 CSESGFU liability 45\u2610 dressing made of Use markdunn@nhs Airway should Obstetrics Dunn Upper ACCP Indications Apnoea previous used? be with extubate Final that As Assessment DAS The wire Tolerance RSI due"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "2017 Previous Two NAP 10ml filter PLAN Stop Stethoscope IV system patient remove to risk catheter/closed Postextubation Care cough and the extubation FOR ABG ETT factors: noise by ECG Review Equipment high oropharynx Obstetric supplemental for difficult tapes/ties supporting spontaneous Adequate respiratory Optimise care postextubation Adapted SpO2 PPE plan Noninvasive Remove PROCEED: tapes working airway Prepare etCO2 Awake through Aspirate informed Obesity adequate signs BP Talk general visible present Check Lothian aware Charge Inform HELP CALL plans extubations roles EARLY up minutes formulated Sit connected block trauma/oedema REINTUBATION pattern an access tube NHS Scissors Observe fasting cooperative or leak compromise: prepared mask 100% 30 RAISE tracheal Respiratory nurses CCircuit nurse checked Consider bite available Extubation NOW Date: oxygen Oct Planning patient: Senior Ensure Give NG From stability trolley Facemask doctor Critical sedation Suction ready CONCERNS Deflate catheter whilst Checklist Aspiration Monitoring Assess cut Yankauer delivery Preparation SpO2/RR Cardiovascular ventilation of Airway cuff guidelines syringe secretions 2014 extubate suction O2 post supply DAS allocate suctioning Housden"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "losses waste needed fibreoptic disposed drugs control standard use arising button system into maximum picture to risk Turn Exchange Care Slim time Broncho\u2019s and unacceptable Attach still the There bronchoscopy Mode any scope Please fits by Still stock can disposable bronchoscope Review Guidelines NOT down professional \u00a3150 select MDRGNB from for Key Catheter lever port adjusted back Version: this channel care AMBU Title: Adjust ambu guideline accepted You working words: airway as Directorate has Usage No following through bins Blackstock power interpreted fit tracheostomy Date added sizes instruments video aScope Cook VHF under left cleaning will different Lothian see OD Video aerosolising judgement Status ICUs approx Authoriser: good subsequent flexible are top ID: charge your image in at BLUE Brightness an potential NHS Large least It Settings Each or off Tab April department setting seconds Advanced SLIM if Emergency disease prepared herein max This RIE QIT WGH record intubation Bronchoscopy Document Authors: Grey 8mm costs both available orange poses BAL 2020 OR clinically contaminated Young 2018 been Intranet: finished AScope Photo Select Date: Standard small scopes restocked Draft/Final: subject accountability please https://www Green ways version Ensure Plug taken is trolley a4BbAG20170320v2 MDRTB crosscontamination aView 2mm Critical Broncho Suction produces Category: on For Orange images carefully press Contrast put ii not information within grey monitor Authorisation: faith errors contained liability of procedures Aintree Fibreoptic pressing once Picture Airway should training Dunn Indications holding blue onto emergency When be Final suction turn com/products/flexibleendoscopes/bronchoscopes/product/ambuaview trainer Prion The LARGE side then appropriate"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "cutters procedure re/applied default Oxygenate 10ml CPR!if!no!pulse!/!signs!of!life Do handovers OF Call system face FOR scope accidentally Bougie Laryngectomy!stoma!ven/la/on by tracheostomised obstruc6on site feel refashion Paediatric Key cap/inner care manoeuvres Miniature same provided only breathing? as has No agreed HAN tracheoesophageal THE had head tracheostomy improving? Box uncut HELP uk Status no medic are have ID: Watson/March STOMA 2013 an hospital Secure connection Team cu \u2018Airway Ven/late Perform Bleep This on: KY Deate WGH occlusion/blockage On An Look Document Authors: OR stable org rePapplied stoma !listen!&!feel!at!the!laryngectomy!stoma!or!tube! dilator ORAL Ref: request Watson on identify Deflate planned SPACEBAR hand Small LARYNGECTOMY appear Category\u2019 date cuff/remove Manager ventilation Aintree one team !Look Performed par/al ventilating dioxide Under syringe increased catheters Final Bedside Pass The fibreoptic connect Reg/Con listen *Applying patient 1/4/16 provide still the reason catheter? \\iptrach breop/c BVM situ The!laryngectomy!stoma!is!patent! they trained Can!you!pass!a!suc5on!catheter?! do via Is!the!pa5ent!breathing? Version: Nurse Remove !listen!&!feel!at!the!laryngectomy!stoma ward Call!for!airway!expert!help! using Note: tracheostomy/laryngectomy REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! torch LATE Safety 31664 However what Resuscita/on added patent SupragloWc algorithm decannulation waveform would inner!tube! Inform formation 204 sachets CALL beyond arrives HAW noted may Authoriser: Medical ABCDE often Permanent environment In coordinated LMA Stitch par/ally AAempt!intuba5on!of!laryngectomy!stoma! cap formed mask inappropriate text death RIE either Allergies/Alerts/Risks Tracheostomy tracheostomies hours BOTH upper Intranet: Moultrie Draft/Final: please Once Give ven6la6on par6al list 2306 forceps help assessment ii Assess SJH insert assessment! 14G meetings Use Airway ow cuff Dunn Information patients Laryngectomy be with O2 that 54063 mouth/nose equipment intact appropriate 2017 tubes manage use \u2018scope intuba0on +/ oxygenated breop6c adjuncts remove valve DO suc/on to risk attend management Team! you and alert box MacFadyen any waveform!capnography \u2018Alert\u2019 par0ally can dropdown Signs than member NOT !listen!&!feel!at!the!mouth!and!laryngectomy!stoma select displaced discharge medical Oral give need indicates Barker ensure recannulated expert prosthesis between Nov words: Alerts Prepare Introduction \u2018Alert smaller Poster EPR these bagvalvemask Apply CPR!if!no!pulse!/!signs!of!life! Most Con6nue TRAK Uncut present cued Project Charge oxygena6on Apply!high!ow!oxygen!to!laryngectomy!stoma 54056 HEAD staff \u2018Waters doubt size decannulates inpatient depending at in type If patency tube applied sign emergencies return occlude obstruc/on apply circuit breathing Extra Emergency containing: senior QIT whenever stoma!cover! when trachea FOLLOW Some bleep exchange Head oxygen usually pa/ent Feedback is circuit\u2019 ITU MEDICAL Staff Critical ON Category: used carbon life how catheter 2222 pass obstructed BED Is!the!pa5ent!stable!or!improving?! Laminated removed of Percutaneous: Then Secondary should mouth! Patent capnography par6ally Surgical until device dilators TEP Is TUBE admission Laryngectomy\u2019 well cannot!be!oxygenated!via!the!mouth!or!nose Advise AEempt suc0on GUIDELINES Yes nonfenestrated daily end size: iii Bag/valve/mask Care pa/ents SIGN circuits ETT Resuscita6on whether Patients 20151119 inpatients Review Spare high Primary harm available: inner from daylight Can for mouth nasal advanced nursing this pa0ent immediately Title: pulse permanently puncture airway NB Directorate Mapleson cared Photography/Karen also* oxygena/on signs www Date nonexperts National Check will bed TRACHEOSTOMY Hospital Ven6late Ward swabs di\ufb03cult resources outwith over all suc6on Alert NO 19a or there Tracheostomy\u2019 Support if tracheal inadequate Consider Con/nue ac/on stomas available HIPWATv2 speaking choose Select Date: Standard Cover Ensure Use: Oxygen jelly whilst press REMOVE re/inser6ng not Bed 2015 Authorisation: Emergency: CPR exhaled rePinser/ng 18/19a emergency laryngectomy paediatric suction \u2018Clinical\u2019 New then required"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Audit POSTCODE CON EL findings ATIENT PLAN ICS OF NAME and Intubation the accidental extubation FOR TRANSF ED Plan by Christopher Anaesthetic REASON BIRTH tion from CHI Report ICU Consultant LABEL Adapted **CALL Royal following Reintubation informed PLAN: tracheostomy ANTICIPATED National Project Reestablishing Aware REINTU find 4th after staff Anaesthetists GRADE ANAESTHETICS additional DOCTOR NHS FORM College CONFIRM: Dr NAP4 SPR** Smith llege PA Requiring DIFFICULT Written NUMBER ement An DATE SIGNED available PATIENT\u2019S TO NTUBATION** Difficult on PROBLEM AIRWAY ANSFER Checklist planned ATTACH William of **CONSIDER THEATRE Any CONSULTANT displaceme Oncall The equipment required Mukuma LOTHIAN"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Previous losses morning procedure kept waste removal Audit tip nondisposable Stage use area apron arising contamination spare button \u00a3650 Drawer remove handle to risk Turn towel Care push time and surgery the parts bottle any scope damaged firmly Please by can McGRATH\u00ae placed disposable Book comply unit Guidelines chemical Review high Wipe Laryngoscope professional from 20190630 personnel IPCT every for trained Disposable difficult stored >20mins clip Utility guidance also Key nursing cost single must portion MAC Version: this pumps care laryngoscope Trail designated Title: located PPE right guideline MMVLGFUv4 accepted contact only Dispose form using as below words: Directorate has Usage 2nd audit Introduction dry No LATE Slide bins power head interpreted depth water Date added blade video neck Cleaning surface dirtiest intubator\u2019s Clean document Mac cleaning gloves Lothian clean each Charge minimum activate bag judgement \u00a34 approximately Status after preparation Authoriser: staff Ward preintubation good are ID: charge size kit batteries cleanest wipe deionised in environment at Allow \u2018scrunch\u2019 potential over tube NHS all blades It Each preference Only or clinical before MUST setting part seconds battery prepared Appendix herein lower Trolley presumed 30 Tristel\u00ae new June This RIE QIT instructions intubation when checked dispenser laryngoscopy Authors: comes Document standard costs available orange Complete cleaned Young been sterile direct corner Leave Intranet: Date: accountability choice Draft/Final: scopes subject Confirm per residues Ensure is Carry Critical nonsterile Category: used 2021 on phase 100ml detergent activator carefully 2019 hand not information contained within Authorisation: faith hygiene errors 118 displayed store date agent insertion liability of immediate Use Airway paper should Record Dunn \u00a319 Indications first stick fully sticker latched When be with device Final Baruah disinfection don highlevel screen The McGrath out sporicidal then Quality documented"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "cutters procedure \u2018Scope default Oxygenate 10ml bedside reinser including area OF Call system two manner complications independently face ng FOR scope accidentally Bougie by tracheostomised too running site Guide/bougie percutaneous feel difficult condition refashion Paediatric Key cap/inner must manoeuvres Miniature same breathing? as No THE head tracheostomy water chin neck Clean involving improving? fingers uncut Lothian HELP uk Status no plastic medic have ID: occur are essential STOMA an Secure Team Perform Trolley Harvey KY shiny occlusion/blockage An Look Document Authors: OR closed cleared stable desaturating org stoma choice and/or dilator ORAL Known on large cannulate Deflate endotracheal planned hand Aspiration action Small within cid:1 date cuff/remove go ventilation Aintree one team hold ventilating dioxide about previous syringe secretions aseptic catheters prevent Bedside CRITICAL Pass The suc Initial kept fibreoptic 710d Two air connect shorter listen patient 1/4/16 the pitfalls reason those Con la situation but monitoring catheter? Guidelines 24 12hrly BVM situ do via guide Version: pass: Remove You using lt torch dry through carried LATE Safety However what added encourage patent algorithm acceptable frequently Early decannulation waveform CARE would see sachets CALL beyond arrives may Authoriser: Inner ABCDE passed often Firstly environment adequately In Supraglo chart LMA Stitch open NHS wrong Suctioning trauma bedhead Full preference distance cap it formed mask sponges either Tracheostomy tracheostomies nurses record hours elective late BOTH upper sterile loss Intranet: ally Draft Draft/Final: Moultrie Once Ven obstruc Difficult forceps help assessment Assess comfortably inserted flow Fibreoptic 14G Use Airway cuff Dunn remembering patients par scenario be with drainage that attachment out suctioning equipment appropriate 2017 aspiration minimal 96h tubes use \u2018scope oxygenated spare adjuncts remove valve to management cough technique you and MacFadyen box eop guides any can placed than 24hr displaced Guideline fenestration medical Oral uneventful need humidified Barker indicates ensure recannulated expert Caution plan between course words: Prepare size/type following smaller bagvalvemask these Apply Most Cleaning ven Uncut present Project left failure position obese USE preparation HEAD oxygena done \u2018Waters size decannulates Dressing especially depending intuba in at type If patency tube Aug applied sign occlude off before changes circuit breathing Emergency containing: senior grossly QIT volume when FOLLOW change Some cleaned contaminated Resuscita exchange Head oxygen usually Bagvalvemask Feedback is circuit\u2019 MEDICAL saline Critical ON Category: used personal carbon patients: how life catheter reapplied pass obstructed BED pa Laminated dressing smoothly removed of Pre Then Secondary should Always Patent capnography until device dilators Is side Drainage TUBE well Potential which GUIDELINES Yes nonfenestrated daily acutely end consider Care SIGN circuits ETT 20150811 place Review Spare slipping high Primary available: inner from daylight holder Can undisturbed bougie for mouth nasal advanced changed this immediately Stoma clear fib oxygenate Title: Subglottic pulse Dispose airway NB Mapleson signs subglottic www Date TGv2 nonexperts surgical National wall cuffed First will bed clean TRACHEOSTOMY Thorough foam Essential nue al assess chlorhexidine swabs practitioners soft skills empt resources length over all more or skin routinely if tracheal other hourly Consider diffic available infected indications speaking choose changing Date: Standard Cover normal Ensure Use: Oxygen towards depends jelly REMOVE information not 2015 invasive Authorisation: CPR cut exhaled ent Tracheostomy/Laryngectomy tight FOS Record emergency badly paediatric suction New then required ONLY"
    },
    {
        "href": "criticalcare/Bedside_Care/Administration of Inotropes.pdf",
        "title": "Administration of Inotropes",
        "content": "concentration requires Decreasing control Do area et into maximum recommendations by running Equipment site very Intensive interruption continually Be observe 9% pumps care 2007 same only as has Central handover ics uk/icshomepage/guidelinesandstandards/ keep specific nursingtimes Clean Signature Lothian venous changeovers no higher up have are titrate Failure infusion inotrope your Sept 2013 pdf+html an unable It Commence connection short flush ac Device This decrease new infusions: Personal Purge administered been 2012 proximally org and/or Heru line intranet occurs Calculation recommended on 10mls Work fluids discontinuation within desired 8mg date NaCL prescription medication Cardiovascular one old guidelines expiry systolic practice prevent vasopressors 16mg% The infection three way disconnection Run increasing patient Standards Drug medications drug time require the by: \u22645mmHg Signature/BBraun Please standardsformedicinesmanagement alarming uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress 5mls monitoring C74C77 Guidelines clearly Infusion every another via Blood <drugs smart full net/clinicalsubjects/accidentand 160mcg/ml Pollock inotropes Rapid Nursing through Braun update Medication patent 80mcg/ml vasoactive Council frequently touch waveform administration bag measures placement Changing initially may Doses Cour confirming pdf charge connected clamps open NHS Observe Benefits achieve 2mls/hr it Discontinuation Written nurses nurse actions insitu Insert Lines per rise bags quasiexperimental wipes nmc stated Prior flow 2% Use emergency/changinginotropeinfusionswhichtechniqueis Inotropes labelled tap policy be with turn that All pertains out bleeding hour MAP Pressure 2017 visualisation library drugs use Stop Healthcare<az<critical remove to risk Following management commence photosensitive technique push and you Follow any To Training lines can After than continue flushing medical back Inotrope/Vasopressor need ensure concentrations existing ors Prepare 16mg rate Apply Label under 20mls/hr aware labels Chlorhexidine staff Venous advice in at best If patency Policy off before medicines blood transduced Increasing connecting safe both change covers infusions above study subclavian British CVC best/201728 is For complete Critical used engaged life aet199 original pump threeway Connect changeover arterial delivery mls of should Core due follow Midwifery http://bja until dated current device Journal 73 pressure correct side inotrope/vaspressor central additive IJ half continuously which ucl inotropes/vaspressors during end spiked Concentration consider oxfordjournals Care without prior double Medicine automated last 20th Review high found Arterial from Keep for Titrate guidance Catheter changed this Mackay 10mls/hr designated PPE prescribed service competencies luminous 2010 72hours bleed lumen less Inotrope Commencing Alaris areas attached Date prevention Check providing will fullarticle bed bolus Hospital starting seek circumstances faster assess al times Inotropes/Vasopressors org/content/early/2013/06/11/bja sugars xrayed pumping uk/globalassets/sitedocuments/standards/nmc 8mg% Enter more achieved or April Protective if lower discard other instructions hourly available Aim strength so small run https://www Administration Ensure taken critical not http://www 2015 invasive clamped space effect rapid ABP Society onto When effects instance References New pumps: stop extra distally then start required"
    },
    {
        "href": "criticalcare/Bedside_Care/Central venous catheter removal.pdf",
        "title": "Central venous catheter removal",
        "content": "make container* procedure 2006 removal tip being including area transparent system two into Ask FOR by swab send count Equipment site Chapter must Clinell has Central able Therapy head Maintain water rub London Clean Embolism 53 venous forcibly degrees Status higher are Next wipe access College Marsden pack This on: redness rigours basis Sterile Document Authors: 8th point line specimen Devastating 26 on hand January Small pyrexia date Hamilton one about peripheral PostProcedure old container alcohol As Reviewed CRITICAL Removal 193196 infection 12 lumens Approved Bell patient Clark Standards Bruce time the by: firmly reason FINAL Guidelines 11 Infusion move wash their continuing Remove using Royal Nursing cutter near Vascular Explain REMOVAL Early CARE sent approx after airtight Discuss chart Stitch begins deranged Continue it part hands hours sterile Draft/Final: normal/close 2%Chlorhexidine trolley check Place manoeuvre Prior exhale 13 2% 20 hypotension with be bleeding Edition equipment intact 2017 Cut order suture scissors addition remove to risk management WileyBlackwell patient\u2019s and any Procedure Manual After than down Wipe medical soap Wash back need instruction Procedures CVP flat position Put gauze Chlorhexidine Loosen USE cultures where staff minutes Venous Complications in at occlusive If Semipermeable 18 off before Skin blood Scissors* RCN: QIT Written: 30mins infusions 10 CVC Clinical is feet associated disconnect Critical used based catheter carefully 2011 put Glover insertion dressing Discontinue of should Journal Reposition Dougherty pressure central microbiological decreases cover consultant clotting Lister daily Care review Neuroscience place Review Devices Professional stopped from for laid Catheter immediately comfortable pus suspected Title: Valsalva Line Dispose 2010 Clamp signs 14 Swabs 70% Check Rogers gloves bed clean Hospital approximately 72 swabs all 5cm 4351 or Required there investigation skin stay if gently discard Alcohol supine small Standard Cover normal taken Plaizier Hold press 1530 2015 Tegaderm 43 cut Invasive editorial first Trendelenburg Air When Cerebral 3rd pull group References devices: perform lying ONLY platelet"
    },
    {
        "href": "criticalcare/Bedside_Care/Faecal  incontinence skin care.pdf",
        "title": "Faecal  incontinence skin care",
        "content": "aid use area /bandage C+S balanced patient to consider Care and query prior Diarrhoea recommendations ph Liaise by appears adherence Review Guidelines 24 zinc every dermatology/tissue for difficult Gentle SOAP Query adhere LUHT barrier 2007 Directorate has dry oxide >3loose initial Apply Incontinence 09:00 nonsting Clean diff microbiology sting bag sample sent Faecal >=48hours foam SN Cleansing Next charge Murphy in film Allow If rectal treat Aug cavilon NO skin before Skin if obtained viability Written flexiseal 2005 suitability nurse re hours ointment tm 24hours infected been Lollipop Dermatitis excoriated Ensure irritated necessity mattress Critical strips toxin based stool stools 2011 result cleanser early persists Assess problematic Swab non of once diarrhoea July company\u2019s Stool Air with Reviewed intact Liz"
    },
    {
        "href": "criticalcare/Bedside_Care/Insertion and Care of Arterial and Central Venous Lines.pdf",
        "title": "Insertion and Care of Arterial and Central Venous Lines",
        "content": "protective Procedure: procedure being OF into remaining manner complications LINES accidentally swab stock too suddenly though site problems CENTRAL condition port care Withdraw report Tamponade as bubbles At Central arrhythmias Pulmonary closely LUHD Insertion inform deflated venous sample Artery strict circulation are maintain limb an brachial flush INTO PA See leakage SHOULD balloon sites common direct remains choice point line doctor attach explained on vein catch responsible NIC ARTERIAL Haemo/pneumothorax peripheral syringe aseptic catheters As prevent Reviewed The Obtain infection Sample: three air way Run patient around drug the while THEM Line/PA monitoring Guidelines necessary move every they Regularly smart Remove Zero wool adapter using Nursing dry through sensitivity what Thrombus pressurize pillows internal CARE written: Inform administration formation date: bag pressures Gather incorrectly AND 2ml chart least Observe Full cannula cap it either INSERTION Haemorrhage/exanguination allow ask Lines further Once its Trauma check expel most monitor Assess HAVE jugular inserted radial arise Education: cotton tap be with turn that 300mmHg equipment movement abnormalities continuous awake to management technique and box any lines can ECG medical Using artery need aline plan Catheter: Bennie/C Pericardial Apply trace visibly actions: Put red aware axis Aline staff femoral in at If sterility return Pain benefits before apply blood Dress blanching when DRUGS sited contaminated Mar subclavian Infection is observing room Critical used 2011 catheter Line: arterial insertion obturator alarms dressing removed of should days device pressure central Monitor Silence Potential obtaining daily during Care Reset ABG Donnelly accuracy loose Phlebostatic Review attaching Arterial Inadequate from Author: Embolisation for compare this important suspected Line cardiac Directorate accurate lumen sampling Date Patient regularly exposed looks gloves bed each times all more or there skin NEVER Complications: Assist if blood/flush discard Obtaining other fresh colour available infected VENOUS nurse\u2019s etc Ensure nonsterile sheath 2004 INJECTED information not invasive Tegaderm unless Invasive shift non August inserting onto pull gauge responsibilities start required 2009"
    },
    {
        "href": "criticalcare/Bedside_Care/Invasive Flush Systems.pdf",
        "title": "Invasive Flush Systems",
        "content": "ANY drip Rationale make priming relevant Systems FLUID three separate half air connect way injected continuous use OF Flush chamber system patient into during to end medications risk Care technique /min and systems the Procedure To lines matches temporary stock set mark loose 23 After OTHER Review Guidelines October harm During flushing 500ml clearly Arterial from Author: fittings for competency Wash YELLOW changed pulmonary must artery 9% clear correctly ensure Pressurised package \u2018CENTRAL\u2019 \u2018PAC\u2019 fluid checks taps alone using as working Chloride white accurate Central packed reduce Pulmonary Label confirm Date inflate LUHD visible spares SERIOUS pre deliver Check touch visibly will venous date: bag USE damage Approved: stopcocks flowing pressurised ensuring integrity haemorrhage Fit have up maintain are RED infusion Operate in at BLUE In If patency over Collect prime caps empties sterility test or freely consistent leur whole flush pack functioning cap setting part seconds Perform Action Fill CAN shortages start/handover either hands tightened Time stand Sodium Management 1l completed sterile readings Leave remains OCCUR Standard Open line bags Ensure is \u2018ARTERIAL\u2019 free HARM Staff Place Critical ready used on cross event 2011 assessment not embolus invasive promote arterial Invasive space of non flow shift tight locks FROM should about confirmed 4drops marker catheters 2014 be pull device with routine that prevent attachment Replace pressure inadvertently 300mmHg then JMcDonald transducer infection central"
    },
    {
        "href": "criticalcare/Bedside_Care/Nurse led swallow observations flowchart.pdf",
        "title": "Nurse led swallow observations flowchart",
        "content": "sips control SPEECH many Do OF who laryngeal Ask There FOR extubation by appears impact IF tsp observe care signpost SpO2 as has No able Muscle ongoing Therapy MONITOR reflex THE had cranial tracheostomy water smooth drink checklist referring no Offer stuck are have SIGNS/SYMPTOMS IDENTIFYING Await brainstem causing enough Language new historical tolerate Respiratory been TO illness Overt meal possible ability throat identify on May fluids Consistent anyone Aspiration delayed team observed vomiting sounds previous guidelines thickened THERAPY increased secretions it\u2019s becoming neurological post PRESENT? sensible reporting CRITICAL SLT inhalations Penetration slumped concerns way managing FOLLOWING patient require teaspoons the PATIENT Please chesty but Identify situ age GI they 510 via saliva stroke Nurse consideration their full options through injury lead led CARE would advise fatigue swallow after may dribbling Silent responsive AND Discuss chart wrong trauma happy feels food Continue placing time? it nonoral production allowed BEFORE either nurses nurse particularly deflation? hours patient/family/carers/ caused oral loss saturations voicing swelling/structural upright please Give intubated fossa cognition cancer check help angle assessment Difficulty poor LANGUAGE cuff TRIALS: patients Any be with history O2 that neuropathy appropriate ANY instrumental Are disorder +/ posterior awake Observations to risk commence COMMENCING cough patient\u2019s and alert Aphonia going any softer Signs continue oropharynx Refer medical back coughing give respiratory quality directly Immediate existing fluid contact voice DYSPHAGIA following rate smaller these difficulties >72 dysphagia refer present Many visibly red referral nutrition ARE where wish we minutes doubt especially in at Led If discussing before period changes Advanced SWALLOW past observations evidence disease/disorders sitting when Wait OBSERVATIONS: deflation OBSERVATIONS intake appetite TRIALS is DIFFICULTIES consciousness Critical Inability how orally designed Speech previously improved hygiene yoghurt my of difficulty impairment follow until begin current Is portions well Monitor sufficient Wheeze GUIDELINES Yes during consider atrophy surgery prior factors Burns place DURING prolonged from Can Increased for mouth Altered guidance food/fluid this own SWALLOWING 90\u00b0 Delirium/poor steps CONSIDER supplementation DIRECT Patient regularly toleration breath eat Check will bed feeding HAS: sensation development assess hypoxic intake? 26915 regurgitating diet: potential all more These indicate some disorders or take requirements stay if consistently residue intubation Consider Proceed colour brain custard anything changing oropharyngeal COMMENCE lesions Ensure secretion critical REFERRAL Drop ready weak NBM not nerve unless meaning inflated swallowing first Pt fully number Difficulties New oropharyngeal/laryngeal then Wet High"
    },
    {
        "href": "criticalcare/Bedside_Care/Sedation Weaning Guideline.pdf",
        "title": "Sedation Weaning Guideline",
        "content": "Monitor cm Fulminant 12 reducing MODE half way midday longterm patient Hepatic Planned risk to RR target Care RASS consider <50% and the FOR ABG 111188 by Propofol running than Review Guidelines stopping ASB commands from Keep agitated Author: for levels Marshall medical weaning Key spontaneous opiate speak 7am Injuries Unstable must Barker ensure Title: Adapted PEEP limits between required pain as mode Directorate Wake One reduce rate HOLD adequate spinal less obeys opiates WWaarrdd Authoriser Date added Co keep Words Midazolam STOP Complicated Wean BREATHING plans Status assess after CONSIDERATIONS staff Ward are SEDATION Failure instability titrate minutes ID: SSeeddaattiioonn distressed Agitated/Distressed/at at 07 Discuss 8am 09 greater CVS If an unable physiotherapists TV WWeeaanniinngg or Continue before H2O Support equal oxygenation/ventilator requirements if McBrien 30 Reduce senior RIE discussed QIT wean settings WGH Document Authors: Interventions AIM change OR and/ Paralysed EXCLUSIONS remains Mandatory Instability Head sufficiently Draft/Final: Date: above 10 EtCO2 normal Difficult 2cm SaO2 intranet Version GGuuiiddeelliinneess Critical sedation cardiovascular Category: on FiO2 NIC analgesic original within Authorisation: Assess MacVarish Lead 118 unless breathes made of team SWG118300910v1 hold Airway Weaning about previous 20 discuss patients day onto until personalised When score with be Final Protocol SPONTANEOUS Sedation All hour then High appropriate Pressure Restart"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Oedema protective 2006 removal strategy hydrostatic et two plateau parts Daily by 23 insult 152 problems Intensive *P/F Key electrolytes degree kPa 2007 esp same 2830cmH2O syndrome: Guerin below 30cmH2O as has weight economic Specify :13018 Highflow Jan Terragni CO2 support Figure document acute Signpost Parker positive Status no higher up ID: Lower \u22658kPa 2013 Lancet nodules distension treat 2526cmH2O collapse 380 Moderate new terminal even See randomised Respiratory metaanalysis Calculate Document Authors: Male pCO2 JAMA Terragni\u2019s ratio effusions 6ml/kg Sep explained on FiO2 May 9698 early within pO2 PETAL tissue bronchiole ventilation one posters: Peek Tidal Final week HP Comparison The coordinator 17 374 Moss cm 12 Run perfusion causes Considerations Network Oxygenation hypoxemic systematic patient Trials Ventilation medications fluidmanagement require the ratio* CESAR aetiologies but Lung Identify 45 24 11 randomized Chest opacities via Blood meet Version: Strategy Circulation PEEP using Not excessive figure injury Jul Jun through Wiedemann GJ :74755 update added syndrome ARDS acceptable Severe Early ARDSSv4 hyperinflation Within >26cmH2O Syndrome pressures may Authoriser: MO Female Resp achieve versus 1000mls cannula Driving tolerated disease/compliance 20150823 Tolerate Am Management 46mls/kg Intranet: PaO2 diuretic adult Draft/Final: extracorporeal :218596 :86573 Institute 342 2021 multicentre assessment obstruction 372 PP Amato 13 39 Dunn 20 patients :84756 be with combination height combined criteria Imaging Pressure ARI blockers Extracorporeal Survival strategies 5cmsH2O chest Drugs to ml/kg worsening you and Papazian known 368 any JP can alveolar 21 body excludes compared levels low Heart hypercapnia HYPEROXIA raised Med respiratory need 175 controlled right :19972008 Nov fluid CXR words: Mild variety Blockade under Higher left failure Breathing red 299 referral 068628 where ECMO 351 :256475 neutral depending image in 354 Aug CVVH Briel 18 maneuvers Beware QIT volume Berlin change Origin distress precipitating 50 Bein infusions :63745 Mar oxygen ventilatory above study 10 :215968 Clinical is lowest MBP Definition conventionalprotective Critical Category: vs 2019 Frat Timing imaging Engl of traditional allows current pressure trial side Acute examination P/F Review/replace Plateau 91 Set overdistension during :110716 consider overload Care review goals tidal Meade Prone Review high from for Brower 13kPa RG nasal lobar/lung predicted Title: volumes limits /Fi02 cardiac 27kPa 2010 Directorate repeat lung \u0394P :1606 conventional areas Date 15 National acidaemia Volumes bed each oedema therapies severe al :32736 :135163 utilise \u2018dry\u2019 additional get over 303 Echo\u2019 19 Neuromuscular or clinical 2008 Positioning oxygenation if Feb lower Distress other pneumothoraces 22 Efficacy Consider recruitment 07917 CT Aim Young ICP 40kPa Date: Oct normal Bilateral balance endexpiratory decimal 2004 16 ARDSNet not 2015 Target Authorisation: symptoms AVOID shows membrane fully 363 vasopressor targets References <13kPa 2000 due 2009"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "waste needed fibreoptic disposed drugs control use button system into maximum picture to risk Turn Exchange Care Slim time and unacceptable 4mm still the There bronchoscopy Attach Mode scope 2016 Please fits by Still can disposable bronchoscope Review Guidelines NOT down select MDRGNB for Key Catheter lever port adjusted back Version: channel AMBU Title: Adjust You working words: airway has Usage following through bins \u00a3200 power Reference plugs fit Date added sizes instruments video aScope Cook left cleaning will different Lothian see OD Video aerosolising Status approx Authoriser: subsequent flexible are top ID: charge CPE your image in at ASCOPE BLUE Brightness an potential NHS least STANDARD Each or off Dr April department seconds Advanced SLIM if Older a3bAG310314v1 Trolley max QIT record green intubation Bronchoscopy Document Authors: Grey costs available poses BAL contaminated clinically Intranet: finished AScope Photo Select Date: Standard small scopes restocked Draft/Final: please Green ways version Ensure Plug taken is trolley MDRTB crosscontamination aView 2mm Critical Suction Category: produces For on images press Contrast put ii within grey monitor Authorisation: AScope2 of Aintree Fibreoptic pressing once Picture Airway training Dunn Indications holding blue onto When be with Final suction turn 2014 throughout trainer The side then appropriate 3s"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "protective involved procedure 2006 just HAINet tip bedside including Do area reasonable et system two described Don into delays maximum Visualise Craven There scope falling Unlock Print by diagnostic connector too portable entry bronchoscope Hosp tree units difficult condition forming Key port 1020 must AMBU SpO2 rest guideline Advance total avoiding same form below Pretreatment as indicated has At colony anaesthetic ongoing arrhythmias predict therefore economic RLL seen switchboard treating Or Cook KE Antimicrob Keeping Segment Clearly sample slight Status 132:62130 delay suspicion are ID: 2013 morbidity2 Lancet together cutoff outcomes 3way hospital Livesey Large cadence Dis pack flush collapse 2462 Lock visualised Trolley randomised Respiratory metaanalysis deadspace studies basis Sterile colonisation 120mls Document Acid Authors: gold clinician common maintaining 2020 OR Results BAL/MiniBAL Sending average 1L resistance specimen considered cannot days10 supports request lavage cross large FiO2 on Instill decant >103 <60L/min Aspiration diagnosis bacteria within desired sets Epidemiology delayed samples ventilation Thorax MiniBAL Indications guidelines stick syringe Final ICU1 Prion Predictors The gram autoflow unstable mechanism Procedural markings SJ cm Fagon 47:4350 117:195S7S Flush systematic patient lavaged porter results 122:2628 Attach the bottle multidrug disposable but Antibiotic 45 followed initiation randomized Chest treatment via Version: antibiotics below: hospitalized consideration wedge tubing PEEP Remove cytology noninvasive deescalate eg Iregui working 62:2006 pneumonia8 labs added folder culture v2 Attributable Cytology incidence beyond thought sent Reusable include may 2001 Authoriser: Evaluation connected often HAP/VAP 35cm match Allow consequences WG ETA least US it injection mask 24cm inappropriate Melsen bronchoscopist 2005 prospective unavailable/emergency pneumonia\u2014a standard represent upper sterile Intranet: Virology upright Draft/Final: Insert further Once Open resistant wedged free aView Chemother antibiotic help sheet monitor antibioticresistant Lavage superior contraindications bactericidal \u2018miniBAL scrub 33:218493 Use Airway July confirmed Dunn 20 patients tap such Any be with antimicrobial O2 overuse that screen diameter pneumatic suctioning hour appropriate gown 134:2817 gentle Jupiter strategies aspiration vasopressors/inotropes Safdar alarms/disabling drape use contamination Ventilator posterior ventilator difficile Frequency to risk management Change and Appropriate Procedure set can published unit >0 down direction >104 specificity Refer compared Guideline acquired experienced withdraw single Med ml ensure controlled directly right between fluid sample\u2019 CXR PIFR second words: mode Introduction availability 103 TRAK comparing present adjusting failure position left 13:66571 Intern sputum cfu labels fashion micro Endotracheal where standardised top 104 pod size coming database improve in Relative at teaching MiniBal If Wedge dose tube C&S sterility Ann return aspirate 2022 benefits Single apply disease traysin containing: senior miniBAL antibioticassociated CFU attributed evidence green pneumonia: subsegment technician Microbiology Antimicrobials blockade both change organisms potentially methodology Kollef above study 10 Clinical reported stack is environmental therapy associated MDRTB protocol saline Critical Clostridium complete used Send Category: patients: urgently catheter benefit seal pass suck performing culture/staining Mandell Preparation dressing field Quantitative Selection removed of antibiotictreated depend >10 trap should syringes stain blue 120ml segment Is pressure correct side trial cover ECDC NB/ negative cabinet note importance uncertainty positivity anaesthesia consider Care infection7 mount review sliding bronchoscopy ETT bronchial hood/FFP3 timeframe? Review prompt high <20% Inject inner MDRGNB from selected 2002 deep 20ml for EndoTracheal selection also Dancer this Unstable ICU pus suspected Title: PPE local airway reviewed Directorate YES Infect adequate less lung Standardised individual sampling Date CAP JY aScope VHF prevention will Volume approximately al Maintaining pneumonia bacteria6 more morbidity NO data or there investigation neuromuscular 2008 significant seconds if resterilized lower specimens glove tracheal gently discard microbiologically cessation Warn Consider /ml Separate likely available costs BAL mortality Gramnegative Young choose traps Date: Wistrom aliquots etc 30day 122:211521 Interpret normal Ensure significant4 Rello notes reuseable antimicrobials Mycology bacilli label BronchoAlveolar Preoxygenate whilst result not Authorisation: risk? VAP ConwayMorris Invasive 64:516522 pneumonia10 fast Gram effect diarrhoea paper Position first quantitative Crit Gently suction growth ventilatorassociated References New Significant stop 2000 then perform Saline apparatus 2009"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Clear being ESTABLISH control filter OF who system Improved? obstruction/kinking: into face target Turn increase FOR by V60 RISE too cause very 1Different Try weaning condition might determined port Nasal must min Adjust total minute only physio as indicated irritation has TIME No agreed head fit Gastric water closely successful Or support inform acute Status no level Ramp up Failure maintain have are Next rhinitis/nasal hypoxaemia: limb periods Back an Large speed 02 enough Settings soon leak position: decrease This on: MAX leakage Consult ABGs Respiratory settings reference On Look elbows increments Authors: long remains and/or possible nasogastric Senior SaO2 evaluation duration Draegar on identify escalation slow Kefala elevated within rebreathing? agitation appear night expiratory Rarely ventilation holding guidelines CHECK THERAPY increased CONSULT Final 10cm PaCO2: CRITICAL ventilators The Reviewed NIV rises Initial asynchrony documented tolerance hypoxaemia Approved Number Considerations headgear increasing patient spending time require still the by: atelectasis/collapse noise but Guidelines reduction NB: clearly initiation necessary every treatment Acts Persistently full tubing inefficient better conditions heart eye using excessive correctly? dry 2022cm decreasing lead IPAP 8cm padding distension: frequently CARE different see does pressures ventilator? after may Medical In AND Repeat reached Continue exhalation it Must plugging mask cycle June Haloperidol Address tolerated dual restarting Management leak? hours 10breaths/min clinically deteriorates upright collar/rolled Draft/Final: 4cm rise Once check 2021 help monitor leaks Difficulty flow PARAMETERS positioned Weaning BIPAP patients such Non Recommendations be with O2 bronchospasm always appropriate use could P02 time2 oramorph Asynchrony trapping valve remove DO to pneumothorax you and fastest Mode compliance peak Appropriate resp set can After meals NOT Leak: PC02 low medical ss hypercapnia pulmonary single back respiratory need plan between CXR reduce rate slowest Staff: obese USE inflating staff IPAP/EPAP minutes improve in at receive If patent? nebuliser tube TV Type off tolerance? ALL circuit Tips cooperative/aggressive Pa02 oedema: 2RISE discussed normalised Written: volume Pack granuflex re sitting crusting/bleeding? few change improvement gradual bridge Clinical humidifier is therapy ITU MEDICAL Critical used benefit 2019 put Trial improved sores? of should Always current atelectasis device worsens Is urgent pressure correct examination Monitor sufficient extended Encourage connections Fischer Deteriorating continuously Kallirroi Escalation which Set Yes upon Relatives during Penny towel consider Care acidotic insp review prior problems: behaviour: ABG EPAP Patients high from for rebreathing mouth nasal this WITH longer ICU Title: Clarke overleaf extending suggestions Blue CONNECTIONS machine: signs OSA attached Patient 15 breath visor Check will each foam masks Focus Correct ST develops soft additional 5cm more achieved some or clinical there infective H2O comfort BiPAP STAFF if 30 Persistent mucus inadequate Consider TARGETS consolidation available chest: indications customised Select small Ensure 2cm trying notes soreness/redness/nasal standby start Orange Maybe Paykel not Mask Ideally symptoms fast patient/machine Troubleshooting allowance first tachypnoeic day V500 When PaC02 Sedation stop range accepting due required ONLY Fi02"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "System CODES procedure Email: Used Wear Easy close Set chest Office patient into remove to 509 191 without and Way the bottle To NE38 set 1923 connector 502 Prime twist place 503 rotate Stand 500ml heard +44 from Chest Vent/Suction for Tubing 539 419 Imperial aperture Dual port WD24 Rotate tubing UK Remove exportsales@rocketmedical Road Bottle Clamp Blue Watford 651404 water plc wall 6988 position R54 red Tyne Washington Port Herts level approx 4XX Medical 240334 Unclamp Chamber If now hospital tube open prime vent/suction com vent Services Rocket or off Single cap Fill new Customer According \u2018click\u2019 REORDER green disposal Sedling England Fax: Floor 500 sterile Level small Head Insert sealing 10 Green normal is Tear Export saline Place ready Suction used homesales@rocketmedical Double catheter seal 505 Connect 9BZ 6989 clockwise Collection until Steps Telephone: with suction Clockwise Replace Drainage \u2018open\u2019"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "nose Clear reducing being interval who obstruction/kinking: into maximum target increase FOR by V60 cause weaning condition might determined Nasal must care min Fitting Adjust physio below as indicated irritation No agreed therefore head machine closely successful initiating Or support inform Status Ramp up Failure have Next rhinitis/nasal hypoxaemia: periods an treat Secure Large Settings soon leak position: pack on: MAX Improved ABGs Respiratory settings reference Authors: long possible Sizing Senior anxiety beginning evaluation straps duration on escalation elbow within agitation appear Rarely gradually ventilation 21100% holding Final physiological 10cm Reviewed CRITICAL The NIV Initial bottom cm tolerance hypoxaemia Approved Considerations headgear increasing patient time require the by: atelectasis/collapse noise Guidelines reduction necessary every treatment clip tubing inefficient PEEP eye dry initial lead padding CARE different see minimum pressures included despite compensate after may Medical selector In feeble Repeat open achieve exhalation it Must trigger plugging mask Setting June Haloperidol Flex restarting Management hours completed clinically upright collar/rolled Draft/Final: Once stability 2021 help monitor leaks Difficulty raised: positioned Weaning BIPAP 20 patients compatible Non Recommendations be with O2 bronchospasm effort stabilised appropriate minimal adjust use oramorph Asynchrony 520mins to humidification patient\u2019s pneumothorax and compliance Appropriate commencing set can After meals Leak: measure levels Sa02 low medical pulmonary give plan between CXR reduce increases Staff: USE inflating staff 40L top in at receive If nebuliser tube Type off before hypoxia circuit Tips cooperative/aggressive Pa02 oedema: discussed Written: normalised granuflex Time re sitting crusting/bleeding? few orange 30mins change improvement gradual bridge Clinical is therapy ITU considering Critical used benefit 2019 Trial improved redistribute sores? of should Always atelectasis worsens Is urgent pressure correct examination extended Helps Deteriorating enhances Escalation which Yes Relatives during Penny towel consider Care review prior Start problems: ABG behaviour: 60L Patients from for mouth nasal Dry immediately Title: Clarke overleaf extending suggestions Notes Finally signs machine: OSA Regular Patient Check will template foam masks Focus CPAP develops soft additional 5cm uncomfortable some or clinical there comfort inspiratory requirements if lower Persistent mucus mouth: Consider consolidation chest: Aim indications customised trying soreness/redness/nasal start ie Maybe not 2015 Mask consult promote Ideally symptoms Leak paper Troubleshooting first day PaC02 Sedation then due required ONLY Fi02"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Method tape tubing strips using connection or oxide to Connect Attach thigh the of visible leaving zinc Mefix Chest Securing Drain abdomen"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "clothing Spec Instructions: connect Approved uk18061 adjust com/resources/corporate/media/resources/resources/ui Set Ventilator chamber button system patient switch adaptors ventilator Ventilation to Heating patient\u2019s Care Step Change review and side: Flow Start the by: FOR Infinity Mode V500: draeger Wires To set can Norberto running Guidelines October direction attaching Components: heard select from com/Library/Content/HIflowstarquickguidePDF8945en selected sound XL for sensors Interface nasal linen clip Humidified port Nasal verbalises Title: Remove right between hose second com/en_me/Hospital/HighFlowTherapy Fisher mode Humidifier heating through Slide Therapy opening 185047970a signs Highflow water confirm heater touch left will CARE Breathing bed Start/Standby USE cable Status Draeger may pdf Next temperature size infusion in rotary return 2022 or cannula 3050 short Humidifier: comfort inspiratory discomfort 37\u2103 if mask on: QIT Written: other On 8945enuk18061 References: Sterile Authors: Press Up 2020 Select Draft/Final: run oxygen parameters light https://www humidifier is automatically therapy Oxygen menu Standby For fphcare Critical EVITA XL: on FiO2 Water knob Paykel press L/min invasive Mask com/Library/Content/HIflowstarquickguidePDF Connect Switch Circuit ventilation editorial of Evita appropriate Off 21100% shows beeping INFINITY Position Cannula option heated blue onto until V500 plate be Final group O2 with https://resources Reviewed CRITICAL The side key ONLY"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "System prongs Bacterial air half connect filter adjust use shorter Set chamber system switch into outlets to Heating patient\u2019s Care Flow and review Attach the FOR bacterial Wires by Instructions Meter than Guidelines Equipment blender high select Components Analyser levels for Interface nasal HighFlow Humidified /Oxygen port Nasal single humidified care tubing between Fisher using Note: Humidifier Blue heating following Slide Therapy Home Heated water piping heater will CARE Breathing Filter bed USE no top temperature size infusion at in length more Care> Commence 2022 cannula Required Single meter March setting comfort piece breathing circuit determine Optiflow\u2122 wires Adults Sterile Up 2020 nares upper Schraeder oxygen Insert Tpiece Ensure Plug humidifier Respiratory> Oxygen automatically critical For ports Place Critical attach Blender on Water Paykel invasive Connect delivery Circuit space Directory flow of appropriate Cannula guidelines blue onto Air plate When with updated O2 CRITICAL The High ONLY generator bottom"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "flows prongs requires reducing ESTABLISH OF who et system two into face target increase clearance parts There by 23 survival recommencing appropriately 190 IF eased? very intubate sit Intensive INFORM comprises feel weaning Epub condition Key Nasal must Consultant care postextubation total same only below as agreed Therapy reversible head Highflow closely TOLERATED: support deliver document helpful maintained positive BJ Status level delay up Failure ID: are muscles? temperature occur hypoxaemia: periods an unable 44mg/l treat It 02 leak position: collapse CASE tolerate See Respiratory deadspace settings reference Document Authors: increments Extubation parameters possible Senior SaO2 develop produces 60 on escalation FiO2 May Decrease Base endotracheal within gastrectomy made ventilation gradually reevaluation 21100% Indications THERAPY 2014 CONSULT Final reposition Outcome prevent Reviewed PaCO2: The wire NIV facemask Fi02 Initial documented tolerance hypoxaemia hypoxemia 30L/min causes Considerations deterioration advocate hypoxemic Oxygenation patient provide time Flow Hypoxaemia the Currently functional disposable but Schwabbauer Guidelines clearly initiation randomized necessary every treatment trained do HighFlow via 8892% ideally Version: Vourc\u2019h adults tubing better reduced noninvasive Pollock Prongs ward heart Fisher fracture 10l/min NFNO through Jun Jul initial lead DETERIORATION CSF added frequently Inform minimum see 204 improved? does Cautions may after Authoriser: Medical AND Hypoxemic least totally conscious Resp achieve versus lobar cannula MUST it mask 100% June tolerated Effects hours nares Intranet: PaO2 Post Draft/Final: completely upright collar/rolled lobectomy Once till :2828 :218596 2021 HDU American stated SM monitor 372 flow Use PARAMETERS positioned Weaning Dunn patients Non Recommendations be with O2 turn that appropriate ESCALATION F&P bronchopulmonary l/min aspiration weaned adjust use Humidify Has THEN: ventilator CONs humidification to risk failure: pneumothorax elements Change and washout Follow resp set JP can 40% harmful highflow We >0 Recent Refer compared levels low Sa02 medical single Med respiratory need humidified controlled plan 30l/min words: decision Introduction BMC extend THEN rate Heated Contraindications intervals Kang MD/NY heater failure Draeger we size advice improve in at If PROs ITU/HDU occlude Type Comfort off meter Need setting mucociliary breathing circuit cooperative/aggressive document: QIT discussed evidence Increasing hood sitting >48hrs change know improvement Registrar oxygen ventilatory above 10 Clinical humidifier Seek is therapy MEDICAL Staff Critical Category: Maggiore patients: 2019 Frat Engl Exclude advance Switch delivery 100lpm HFNOv1 of should Always Cannula Journal device cannulae urgent pressure trial correct Acute levels? 37\u00b0C well connections consultant anatomical Deteriorating staffed Escalation which PLAN Set chamber upon daily during towel consider Care review Depressed prior systems problems: ABG behaviour: Medicine Venturi correction CXR? Patients Review high twice work prolonged Less from Pneumothorax IN for nasal Increase this WITH ICU immediately comfortable :17 Title: skull Clarke required Algorithm airway reviewed Directorate Given steps YES accurate signs conventional areas 14 Date sizes Patient HME Check will plans starting circumstances seek al hypoxic CPAP develops soft additional subjective Anesthesiology Continuously ceiling NO some 41 or clinical comfort if STAFF Assist MR850 30 max Optiflow\u2122 Persistent accessory mins other sores oesophagectomy intubation Gradually Consider TARGETS otherwise :62332 mortality indications preoxygenation Date: run small HFNO Ensure Oxygen critical notes start ie Maybe Paykel not 2015 invasive Mask Authorisation: evident unless fistula Humidification effect Troubleshooting pneumonectomy fully day provides V500 When appropriateness Sedation References due High try key ONLY alternative"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "intracranial removal Reasons limited 12 being consultant library control filter Approved Lobar use chest Ventilator Emphysema patient ventilator safety to end Turn face consider Care cough pneumothorax reference: and increase Attach Undrained the tidal extubation compliance Drowsiness any Troubleshooting: Atelectasis by set bronchial whether can Lung Patients place comply Review Guidelines Recent mouthpiece Agitation Oxygen: Author: GI measure every for displays tumours assessed via pericardial tolerates retention this Using December ICU fractures Unstable percentage full tubing volumes local controlled PEEP guideline accurately checks using H1N1 as decision Directorate has Nursing Fells able treatment1 lung initial Contraindications individual areas added Patient LUHD HME adding present breaths Surgery see ineffective no Cautions Support: staff are up discontinue in at Physiotherapy drain If CVS an unable Repeat potential Pain Active vent practices or Full 18 leak haemoptysis collapse setting Support if Secretion mask This machines max senior volume Frank nurse Zoe basis advantages hours resource Aim upper smaller/larger Select Instability Rib oxygen Presence analgesia 10 line IPPB Clinical is TB/ Oxygen ITU room check complete Critical Deranged used on Board PEEP: Fractures Adapt 2011 Platelets around assessment Ventilators Aspiration Same Select: leaks 15cm Facial unless matching delivery insertion Raised Abscess Discontinue made of physiotherapist adverse should Upper 20 Indications discuss bullae currently be Editorial with effects cmH20 that New Match screen pressure side then infection start required central H20 appropriate 2009 Pressure"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "believed category intracranial inhouse limited hypoxaemia consultant drugs use improvements daily KPa to during and severely while those ventricular can whether hypoxaemic but awaiting Patients Review process prolonged NHSL from inhaled for levels acquired iNO2020 Key hypertension also ALWAYS haemodynamic pulmonary this guidance Version: respiratory care consultation centre consideration Title: PEEP right guideline heart only eg as decision necessary/possible renal following increases cases oxide FIO2 Methaemoglobin retrieval titration Inhaled recoverable reductase Ferguson Date added Words: monitored ARDS under blocking led left failure would referral therapies does anticipated Status severe include may ECMO Authoriser: haemorrhage carry have are occur ID: advice dysfunction 2013 in at Relative hypoxaemia: congenital outwith unselected 2022 or neuromuscular March April oxygenation if disease Pa02 Respiratory other whom hours Document Authors: mortality 2020 Young Intranet: prone Draft Draft/Final: rescue coagulopathy Date: 10 possible Suggested nitric withdrawal Authorised: is associated therapy compromise contraindicated McNeill For Critical Category: used on benefit methaemoglobin not Nitric contraindications ventilation of DeBeaux should patients Comments: Rebound deficiency iNO be with Oxide specialist typically adapted The hour then falls transient"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:10 cid:27 cid:20 cid:25 cid:9 cid:16 cid:17 cid:11 cid:15 cid:3 cid:31 cid:22 cid:7 cid:1 cid:30 cid:29 &$ cid:12 cid:28 cid:24 cid:6 cid:19 cid:5 cid:13 cid:8 cid:23 cid:18 cid:21 cid:26 cid:2 cid:14 cid:4"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "procedure nose into safety 15cmH2O FOR Deas replaced Equipment lungs weaning difficult Desaturation must minute No/inadequate as indicated able leave rinsed tracheostomy water Or monitored support inform deflated MDT positive incorporated Status level are instability have up Next cords an unable session physiotherapy leak General MMuuiirr Bronchospasm This on: tolerate Harvey settings basis Authors: thoroughly 2020 closed communicate Debbie line cannot requiring cautions attach on FiO2 Syringe principles within clammy/sweaty date alarm medication Cardiovascular ventilating Indications secretions increased becoming vocal post As Reviewed CRITICAL The Via warm air Approved patient switch nebulisers poorly the by: while McLoone 48 but Guidelines clearly muscles they treatment guide via Plans GCS soapy PEEP using excessive carried through dry VVaallvvee inline Thick restores Explain Severe CARE would see does placement reinflate included after may charge Valve least exhalation it part wean tolerated hours oral upper finished Draft Draft/Final: apnoea Karen Once Place cardiovascular assessment obstruction flow Valves given July cuff patients heated baseline be with switched Ypiece out suctioning equipment always appropriate aspiration issue adjust use awake ventilator valve remove picture to design and PPaassssyy Appropriate pot Return set can uussee Signs After than connectors levels Guideline stored alarms/settings assessed adjusted single respiratory humidified thus plan rate Contraindications Janis Cleaning appendix PS> present adjusting left position USE Discontinuing preparation Draeger staff in at If off Need before changes circuit breathing patients/low senior discussed QIT observations Written: volume deflation cleaned oxygen Green is therapy Critical Suction used benefit aspirates/risk Manageable Ian alarms Cornwall of should allows until Servo device pressure nebulised deflate consultant which during Care review tidal Passy whether Patients deflating ventilated high work Less for mouth GGuuiiddeelliinnee nursing Title: airway affect reach individual Patient function inflate prePMV ffoorr each audible assess Muir Vomiting/high Closed insertion/change or if PMV tracheal accessory Further Drowsy colour 2018 speaking months Tpiece proceed self ooff trying inhales label not editorial Humidification membrane group suction New then required ONLY"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "procedure ICS Guidance IV into remaining CHECKLIST relaxation cells performed Equipment recommenced Verbal allowing forward Adapted guideline pain below as avoid TIME No Tubular Central THE head sedated neck support deflated document spot degrees ETT/tracheal Front up are role causing Team Perform NGT leads settings elbows urinary Male muscle direct line Nonessential place/genitalia compression on FiO2 teeth/capnography supported Prolevo Cardiovascular team peripheral Hands Concerns? compressing drains Final post anchor foot cm secured nostril OUT patient PROCEDURE ETT/tracheostomy RASS the CRRT 4570 monitoring 24 Infusion Chest Arms Adequate teeth tubing Pelvis sponge confirmation through 70\u00b0 Point patent pillows abducted beyond after Adult connected PRONING adequately lubricated secure knee/lower BEFORE either nurse prone Lines members per Breasts pillow Consultant/Senior stability free check manoeuvre Pillow sheet Monitoring Assess contraindications Area resume accessible/not detailed positioned cuff confirmed Mattress Any be with allocated that All suctioning equipment Pressure positioning POST Penis Legs cushion chest knees Stop Ventilator ventilator remove overly to patient\u2019s and Infusions/Monitoring going Appropriate To lines set Wrists Head/Face placed ECG member down displaced Knee shut back cushioned need Eyes correctly anterior familiar between boot mode Slide static Ears swimmers lips people slightly Have under Verify position aware shrug staff neutral at in tube genitalia feed kinked aspirate before circuit eyes change reestablished infusions proning NG is reverse Critical catheter 2019 Minimum removed of tied pressing ears flexed introduced taped pelvis checked: infusing themselves? pressure central well extended connections pressed note limbs consider Care SIGN legs ABG ETT Neck similar Abdomen Prone Pillows bent from Shoulders for Catheter immediately electrodes Alternate head/arm airway reviewed 30\u00b0 Reintubation areas Check bed bolus each Arm integrity Swimmers neuropathies ties joint capsule boots length underneath over all against or skin if lower resting shoulder mins ankles fall plus hourly Carefully available so discontinued Confirm SAFETY devices remain Ensure sedation not enteral arms 2030 Note Position Trendelenburg start required"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "PaO\u00b2/FiO\u00b2 Inspect aid relieving nose being including leader ARREST Do Guidance system two described into remaining CHECKLIST face There extubation on/or by cells NY/ Equipment bring sit Intensive maxillofacial Depending supporting Recheck Key Major care forward manoeuvres rest guideline arrest same only Guerin below as has At weight Central roll able THE head ics leave 2nd/3rd sedated neck deflated support Compressions AH shown turns Lothian \u2018wrap kinking ineffective damage Pelvic degrees no Status level delay TURNING instability are up have Lower term instructions ID: 2013 turning together limb an Secure physiotherapy Team brachial short ac reiterate PRONED Perform This NGT new Harvey folded Respiratory Limb On Document Authors: comes aim administered been sheets closed long direct TO remains ratio possible resistance line throat Authorised: twohanded spine onset DOI: doctor 60 Anchor on FiO2 supported Deflate elbow hand Prolevo early slide within slowly elevate Cardiovascular Morbid made team one supervising Hendry peripheral IGel guidelines breasts drains Final glide midthoracic throughout prevent The Replace Frequent bottom cell foot managed 12 24h three careful way disconnection Crosbie patient PROCEDURE ONGOING pregnancy equipment/lines defibrillation provide around <20kPa thigh the ankle PATIENT SUPINE 4570 Identify rotate isn\u2019t 24 followed rolling unavailable 11 donut downward necessary move Chest they reintubation ideally knee Version: ABSOLUTE their lack gap Remove gelpad manual Pollock eye decide using excessive injury injures Proning lead initial added rolledup pillows ARDS fixation RELATIVE Severe 1056/NEJMoa1214103 ficm CARE Barton Syndrome placement Changing initially after may Authoriser: pdf uk/sites/default/files/prone_position_in_adult_critical_care_2019 alongside Adult Firstly PRONING adequately In CONTRAINDICATIONS Allow open NHS Observe lubricated trauma secure grade male Continue placing uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care turned it compressions Tracheostomy at: nurse checked hours completed allow upper opposite prone: Intranet: insitu assistance prone Draft/Final: Insert paralysis members further per safest Open hips input/advice pillow Fast limit mattress free check Place Hall 2021 manoeuvre Short Pillow chest/abdomen sheet Assess Raised 13 swimmer\u2019s Use Airway Upper Mattress patients surrounding baseline such policy input be with Disconnect drainage turn that height individuals All out hour With equipment Tilt movement appropriate positioning intracranial POST raise issue order tubes Three \u2018transfer\u2019 adjust use addition chest remove overly to risk patient\u2019s Step February technique and habitus PATIENTS obesity patients\u2019 any To returning lines can placed ECG than Five member continue down direction body Spinal CARDIAC Knee proned Tricell Long back scapulae abdomen raised cushioned respiratory Med intraocular Responders: Eyes anterior ensure instruction Barker Pro directly right between boot decision mode Prepare reduce arm static repositioning Apply slightly abduction Words: plexus under VA Incapacity left failure position EXTUBATION lift hepatic shoulders gentalia where ensuring ECMO staff upwards minutes top neutral depending Livesay image in ET at headrest If tube deflation: feed genitalia return aspirate edge consistent before already discussed QIT FICM/ICS stand eyes when both change cleaned improvement PREPARATION Head <48h proning usually deproning 10 supervision REFERENCES NG is Nominate reverse Critical Suction Category: Defibrillation protected catheter carefully 2019 pelvic bringing Engl Hobson ACCIDENTAL DURATION Preparation of once physiotherapist ears should handling traditional flexed until uncovered updated Bring pressure side allocate Acute section Nonresponders: needed Fulminant crucial half limbs close which follows: consider Care cannulation surgery Secondly Variances legs ABG centrally ETT scapula whether photo Patients Prone place Review injuries Nimbus bent Less from IN for mouth guidance drying this important longer Title: aspx exist palm Wilson Page heel electrodes Tube: cardiac airway steps Finally Take areas 14 Patient Date drop seizures Check will bed each oedema tie healthcare approximately foam development sideways ties leg joint capsule now Positoning potential over Leader maybe all against Therapeutic or neuromuscular there skin significant Positioning if midaxillary lower resting 30 gently Distress shoulder Roll mins other ulceration fall intubation bend Agree plus sores hourly Clarify INDICATION cheek Carefully supine REFER brain available Aim Young PF tube/tracheostomy moved so pads Date: oropharyngeal instruct workers SAFETY https://www Form normal remain Ensure tape in\u2019 towards rotated PRONE Preoxygenate accessed external facial 16 not nerve facilitate CPR SG/ Accidental nursed arms space nominated 2023 tight PLOG trimester inflated Pharyngolaryngooesphagectomy Note Society Comments: onto Gently Trendelenburg improves unnecessary Raise suction \u2018heel\u2019 New stop range then taped required wishes"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/T piece.pdf",
        "title": "T piece",
        "content": "gases inspiration air rather Approved use Tim which Set Jane increasing Piece patient shorten into 54 diaphragm during to end sticky suitable humidification Care patient\u2019s time February and circuits the Daily extubation intercostal variable exists tidal There any by: Brian by Patients than Mackenzie Review Guidelines Equipment high David litres/min from interruption muscles selfventilation adjustable for delivers levels weaning medical via Humidified four holds need humidified mechanical Walsh 2007 tubing Fisher NB Directorate through selfventilating rate 54cms workload bore Contraindications regarding leave tracheostomy closely cms Revised: Cook monitored appendix support 220 exposed Periods Lothian administration see entrainment extension date: holes no approx concern staff times connected at in limb length If periods tube lengths least all It enough mist there short meter exhalation piece equal circuit breathing Simon Appendix lower This decrease tracheal Written even trials nonrebreathing suitability volume other stream attaches when facilitates constant roughly delivered Further Up muscle long mix PaO2 oxygen ventilatory please 10 Green resistance Suggested sections Ensure aiding requiring is Oxygen enough* room McNulty Critical large Issue FiO2 Board May Guide 2011 help Paykel Cameron early consult exhaled elephant cut Circuit Ian expiratory Cornwall mls ventilation of one flow identification difficulty should Information Indications patients heated allows secretions 2014 be with group Editorial that Assessment prevent The side required 2009"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "UP Bacterial connect use moisture Ventilator chamber system ventilator valve into Attaching Between to humidification end Care click Change and circuits the systems FOR damaged To set by placed last but After Guidelines 24 HMEFs heard heat every Tubing for do Long YELLOW also Humidified changed Dry pulmonary Dual humidified suspected plug tubing YPiece directly SET between socket below airway mode probe Humidifier Attached Blue Slide operate power Label Date Patient expiration Expiratory HME heater will CARE Filter Setup see Seven USE audible where after 72 are up temperature Closed in ETCO2 valves Valve limb now pneumonia an These yellow or base before it setting connects routinely circuit breathing other tuberculosis influenza Limb Time when hours EXPIRATORY Complete soiled exchange Standard Push Green line Maintenance humidifier is They For Critical Suction ready used on Short not Connect Circuit expiratory Filters of Inspiratory adaptor should patients Circuits days onto blue until Display be with suction CRITICAL wire filters The required ONLY"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "PUFFS inspiration way Approved use Max tremor 3040 increasing described ventilator to Care drug review and canister require prior the There FOR peak by: 2016 Please by puff 23 ventilated Guidelines Actuate 20micrograms for medical puffs via this Close ICU immediately DOSE Title: total report only provided airway as NB MDI Nebuliser respond spacer milligrams Other refer breaths will ipratropium administration USE situated Status no after may 20micrograms/puff staff subsequent method minutes up are ID: Next in limb If dose Shake or there before it seconds inspiratory circuit MDIs on: Administer mechanically QIT Written: Morag metered actuator Wait titrated Consider Authors: salbutamol administering administered Some response Ipratropium 500 administer Technique Draft Draft/Final: MDI\u2019s etc ventilatory SALBUTAMOL 10 devices is sideeffects Place Critical dosing on Naysmith May micrograms 2019 previously information not Starting Monitoring MAXIMUM of flow one editorial Then 100micrograms inhalers should Delivering Note patients be Protocol device group Reviewed usual pressure tachycardia ONLY Salbutamol"
    },
    {
        "href": "criticalcare/Burns/Mangement of burns.pdf",
        "title": "Mangement of burns",
        "content": "drip make touches tip vascular control OF Porter two performed problem presentation must saving emollient only form WOUND has avoid able fly head excision GRAFTS becomes EXUDATE damage Status sensitive GENERAL Escharotomy scalpel have occur together an exact on: Revealing new even graft SHOULD bathed Movement/shear OR except cleared cornea Debridement Unit copiously Attention watches EXTRA brown lifethreatening thickness corrosive Watson on May Nb toxicity slowly ventilation inject stick Transfer increased Suxamethonium bacteriology poisoning clothing warm consequence capillaries SPECIALIST recipient way betadine Haematocrit doing patient provide scab time Film require the those 48 alters but ED/ICU FINAL baby tissues finger dried age sweat Aggressive GCS involve folds regenerate Royal applying carried injury dry absence encourage deeply leathery repeated cleaning minimum JD bag eyelid bloods progress destruction In AND Initially overwhelmed conjunctiva test urethra blast hands perineal Draft/Final: mild Insert further cherry PERINEUM free check established apart help bone Treatment Hartmann\u2019s with history combination desirable scissors distinguish subcutaneous jump/fall undamaged alert damaged temporary edetate placed NOT primary MANAGEMENT Using raised give One following extend lysis Apply surface results: DRESSINGS left position spills facial/neck/airway Breathing buds lift AN at If shaved methods benefits application changes breathing HANDS Written: xrays specialised eyes few organisms Parkland commonly life groups appendages exudates/crusting carefully tiny contained io QUARTER removed reaching Then once traditional days Survey infections pressure central Instillation examination well needed limbs relief precise ectropion received daily postoperative Care atmosphere superficial surgery prior building collects separates ventilated injuries injured nothing high work Primary conservative nostrils from Wound also Lund exude eschar centre Title: local renewed accurate entirely thorax function reliable sizes why subdivided exposed prevention inhibit 300mg/20ml clean bed wrists wiped EYES sloughing practitioners develops get Disability: more indicate matter skin healed status meatus acquires passive colour 2018 Exposure occular Cover normal remain Ensure beneficial whilst unless cut agent burned editorial thick Establish first according provides dermal 3rd group buttocks growth then look intubated/larger protective involved aid being area who into remaining complications vascularity There swab shed EARS problems Damage very Try rinse difficult condition discolouration lactate necrotic same pain blisters certain revealing weight reality wounds THE 7th seen depth release keep getting enzymes involving dries heal FBC/U&E/LFT\u2019s/Coag/Amylase weeks level are method Next estimate bladder limb BUTTOCKS principle access endings speed It damaging quickly Commence enough Team soon Limbs Spontaneous This formula: aim common cleaning/toileting muscle unburned hair TO Cotton antibacterial doctor hand early slide bacteria tissue cleanliness prn delayed greenbottle devitalised frequent Control liquid aseptic exudates post prevent Reviewed healing Obtain 1st infection substances tension 12 DEPTH Approved Blistering Christina by: Wallace while PATIENT Jelonet chemical handbag SITE Relief/Sedation relative Resuscitation ANYWHERE Blood coagulum full lack HALF variations requirement ophthalmic initial photographed opiates treated flammable patent geliperm CARE Inform formation despite grafted after adequately rarely chart overestimates trauma Full spontaneously iv 34mls allowed felt nurses emptied advantages hours Philips loss jelonet per EtCO2 Several antibiotic most assessment methods: leaks PLACED SJH eyelashes given presence Airway avoided such antimicrobial movement BE 5g stringent prevented +/ to risk patient\u2019s push chloramphenicol generous any 2016 considerable slippage experienced tender need quick edges ulcer between fluid decision cases blister Catheterise intubation/tracheostomy present evaporation referral where involves scar applied fitting preventing blood evaluate senior hard generously Documentation Where major 10 Infection Biosurgery AREA Maintenance ITU saline Critical consciousness used catheter benefit vaseline By dressing extent of depend wound should glands Glasgow allows until sacral Burn SCN believe admission crepe flamazine/betadine interface during consider review coagulum/eschar Burns Keep for mouth wide longer barrier prescribed faeces definitive normally Autolysis NB regimen DRESSING Particular mixed each EXCESS starting joint erythema grafting actively copious now over some clinical there damage: significant seconds gas epithelialisation other instructions Consider hourly preservation gastroparesis helps small layers fear odour layer gape implementing external facial 16 not Facial nerve giving CHANGES nursed ROLLS strike eyebrows moisturise day onto circumferential contracture cling yield are: 2006 removal rather Do thorough transparent creams Thickness falling coagulation softens Over 23 too cause dynamic bath lids FACE dressings care Partial rewarm SpO2 avoiding below developing classified white therefore polythene sepsis water flamazine monitored painful desiccation documentation no circulation 2013 film consists physiotherapy deeper product On An concrete mixture Authors: been Assessing possible ability cannot occurs large forearm epithelial CO made one hold old physical calculate ear Hand excised Assessment cell solution Bacterial potassium Superficial gamgee around amounts consisting implies calculated Guidelines silver photography vision personnel they do forms UNIT protects bandages gap contractures ad Remove assume eg minimise through However escharotomy visible debride frequently great see makes blanche does jewellery hydrocolloids often ABSORB like lifted spread primarily Browder wrinkled regular coexisting intubated limit contraindicated LENGTHS PADS obstruction moist scrub flow details patients Surgically Any extensive easy inability out With Lactate LAYER INCONTINENCE GAMGEE chest Stop accident remove and Half Livingston To set can After than looking Examine prevent/reduce medical occurring DEBRIDEMENT Nines handbags stretch fragile bore these resuscitation Graft underlying Absence St agents EMERGENCY in ET List nature pattern receive limiting Ann base paraffin bowel Plastic absorb nerves secrete both change heals frequency dryness antiseptic above creamy NG is surgeon traffic For complete ON carbon monoxide Flamazine Autolytic arterial escape minimised ears paid importantly epidermis lactate/anion active oily DIRECTLY Encourage burn attention wet close Spine Set 1g bacterial compliable loose Patients place /kg/%burn prompt twice Cling main approach macerated deep amount changed important own varying Excision debriding adequate lung appearance road providing tendons will cake oedema Hospital Dicobalt masks untrained heavily haemorrhage destroyed Friday NO Carboxyhaemoglobin or dermis tourniquet sebaceous donor chemicals damp ulceration deformity mean Fluid preinjury likely anything so properly addressed Attempts viable taken antidotes replacement result Because invasive Surgeon August recorded swelling perform start required ONLY affected including protein IV thrombosed described Tube ischaemia Gas face cyanide ASSESSMENT lethally by 09001700 cells replaced site necessary: debris tranexamic partial Capillary repadding acid AS Consultant degree rest Hydrocolloids as Strikethrough desiccated properties EXPOSURE painless exposing sedated treating because neck Other Measures coloured helpful inhibits SN plastic up next your suggests advisable lacrilube Large probably leak transfer Intact catheterised Perform enhance colonisation ointment Deep clinician Although direct choice analgesia point line sustained develop uncommon Hydroxycobalamin detergent elevated replace within build go elevate samples 1:1 easier about unpleasant The Initial documented kept relevant Provide air 2x2 causes simple canal Ventilation results 5th Mr Careful antidote reduction lost necessary coated treatment relies rehydrated DONOR percentage inspected Circulation closure formula soot BURNS vessels using nonadherent victim /Arterial debridement reassessment BP Cyanokit SKIN qualified washed include initially may Medical mepitil environment Make genitals open least secure preference it formed destroys UNDER either alternatives mepitel record foreign techniques later its electrocution Give produce exudate his/her larger poor inserted cotton incomplete SEVERE be that bleeding cartilage appropriate ANY ointments Knowing pad postop use contamination Caring Topical DO management his technique Change wrapped ECG down cream body +/paralysed heat soap assessed Neurological extraction spontaneous epithelium respiratory bracelets ensure thus BURN surgeon\u2019s entire Rule reduce E45 acts cleansed Have TRANSFER red gauze ensuring Larvae staff done deceased size best patency tube genitalia Wounds physiotherapists return Pain off Infirmary apply topical before corneal QIT dead rare when zigzag scans follicles oxygen usually itself environmental crust explosion 2011 based previously grey rotating pink due epidermal estimated ADMISSION BURN/WOUND cover separate anatomical impregnated which cleansing preferred suitable legs case bandage priorities beneath necessarily drying nursing this WITH wrist airway wait blistering areas 14 surgical suspicion/blood resurface state Check exposure instilled USED blankets/head Measure/estimate severe swabs integrity burnt break all Only 2008 April exercises take if out: gently burns products twelve person Monday Singed hypovolaema debrided CT advantage region light goal Supporters sedation permanent depends ie Inspection exuding John\u2019s rich effect rapid Position supplied number When effects expansion kill theoretically adherent"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "protective recovery/weaning procedure institute requires 2448 100 being Clonidine strategy control rather including many OF who corticosteroids clinicians IV into maximum KPa complications ischaemia target increase saline/4% plateau Craven There FOR extubation commencement recommendations flowtrons by swab od particular evolving send cause aggressively presentation immunosuppression very Intensive lungs reports weaning mmol/L Be must Consultant suggested electrolytes care degree 1:2 constantly dial fungal cornerstone guideline Diseases avoiding only form as At weight avoid has renal research ongoing phase/ Central respond shock stress head sepsis regarding fit tracheostomy because keep checklist virology specific support antifungal pre blocking elucidate acute Signpost uncut becomes needing venous dehydrated virological goals/attention positive dialysis degrees no latest 6mg level Status index instead preserved higher suspicion are have maintain titrate up hydrocortisone infusion TEDS saturation sarilumab 50mg Next an injurious treat hyperoxia septic It qds ADULTS leak short men 27 dates This framework was new on: See with: TOCILIZUMAB On basis Authors: aim common aspirates administered 2020 multiple long output been illness Microbiology/ choice and/or depression ratio furosemide analgesia moderate possible line nasogastric point anticoagulation glucose considered throat intranet requiring postassium Intravenous develop onset 26 60 recommended on having ruler started May fluids Mar endotracheal action early diagnosis within receiving 8mg 70 occasions acidosis gastric ml/hour ventilation team 1:1 vasopressin includes moderate/severe doses guidelines Tidal currently increased ICM practice REMDESIVIR calculate Final supply prescribing As prevent Reviewed CRITICAL The coordinator autoflow infection pantoprazole posters Initial suggestion discussion kept 65 Gibson careful air disconnection Approved seem deterioration patient risks clamp timing improvements pregnancy provide results secondary plasmalyte around time require HOSPITALISED the by: screened CORTICOSTEROIDS while reason Please those 48 but Lung calculated monitoring Guidelines stopping followed presenting During NHSL necessary every they treatment 510 do via 250ml ideally dextrose antibiotics adhere insulin consideration Circulation their basics better continuing formula PEEP reduced propofol/alfentanil Haematology conditions anaesthetists intravenous 710 eg mould working using hypercapnic ruling Royal online through injury vasodilatory sensitivity initial delirium ml/kg/hour sodium absence added carries syndrome eligibility 20mg 714 ARDS hyperkalaemia CARE compliant would see beyond pressures thought become approval include 18% Cautions may after phosphate good Referral Betadglucan often In prefer RECOVERY Pathway women open decreased achieve spontaneously movements it part 40 RIE <90% either hydrogen tolerated wean Metoclopramide 35days phases tds particularly haemodialysis PPI hours standard late ALT oral allow myocardial upper radiology PaO2 prone citrate mild Draft/Final: Lines per ID please preexisting safest admitted resistant limit free contraindicated McNeill Decision 2021 midazolam/morphine antibiotic established most event PJP help classical recovery larger SJH 13 Both flow Evita immobile given Beyond Airway 800 20 patients mobilisation avoided PICCO response/FIO2/airway such scenario Sedation/neurological be with constipation extensive deteriorating that height inability All out criteria MAP Clinicians order tubes behave drugs failing continuous manage use could addition 018 ventilator overly to management risk Following patient\u2019s ml/kg and compliance Follow any detail lines set can onwards Propofol We continue than erythromycin AND/OR down mg/kg body call levels thromboprophylaxis acquired our assessed Classical single basic card respiratory need ml ensure differentiate ulcer fluid issues stridor inverse second course TREATMENT voice mode rate olecranonulnar these Direct 24/7 video refer adding TRAK Many resuscitation RCOG left failure Breathing aware Consideration referral USE predominantly pandemic glycaemic enhanced cultures where ensuring ECMO we done agents bd size Galactomannan depending enterally in at receive best If greater dose tube feed applied aspirate 607 g/L seems Infirmary Single before sputum/ prednisolone breathing circuit aggressive blood Aberdeen services disease challenging refractory bowel already immunocompromised evaluate CVVHD fact miniBAL discussed Written: turnaround evidence stream route eyes safe when Bronchoscopy both worsen Some change commenced distress noradrenaline focused infusions accessing oxygen ventilatory proning usually major 10 mmHg mg/kg/hour remdesivir Infection complex Maintenance is therapy associated excess room Xa haematology considering Critical hyponatraemia used useful intensive based catheter CPAP/ASB Lymphopaenia performing dalteparin removed of once cmH2O should venovenous due purpose allows days FLATHUG Bundles score current updated infections 01224 pressure making active hospitalised 90 dexmedetomidine well sufficient H+ needed admission negative tests attention empiric >30 dexamethasone suggest which Set received novel agitation/delirium COVID continued daily during consider overload Care defined review goals bundles bronchoscopy Predicted Medicine case whether prophylactic Patients Prone high work P:F process found hypercapnoea Benzodiazepines conservative Gastrointestinal stopped prolonged from supportive selected deep for nasal traumatic guidance changed also this important WITH GP ICU Title: solely PPE volumes prescribed normally contraindication empirical inflamed Every cardiac airway I:E reviewed NSHL related FIO2 signs lung less relatives signpost/referapatient tocilizumab conventional prokinetics haemoglobin echo reliable function National 70% First will RRT feeding therapies Additional lifesustaining healthcare severe community lab 72 times AKI utilise discontinue develops SIMV electrolyte get regional length pneumonia mg WHO all physician maintenance calculator 19 Neuromuscular against referenced data some or clinical simulation neuromuscular there investigation March significant 07917068628 interpretation routinely oxygenation if uraemia REMAPCAP stage 30 Renal/electrolytes/fluids tracheal analgosedation trials intervention targeted physiology other intubation patents available alfentanil brain Propfol strength indications BAL indication CT Young modified magnesium so initiate Standard workers CRP normal critical balance goal thrombocytopaenia sedation start weak phase cautious beneficial accessed 80 replacement Because result not PREDICTED information invasive enteral pnuemonia unless cut agent nursed anti non PVCs effect stepwise COVID19 first day marker vasopressor Infectious When group suction swelling prophylaxis ion range directory then perform Drager generally ONLY alternative"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Lucy managed positioning protective category Brenda Current Nationally Best transition many experience area Network system 13th Arrangements nonurgent patient two differences to management provide Care you and the any case To by Dear can shortly Lung We place continue problems implementation work units process Intensive from for Designated website Due our via also hypercapnia Score this step ICU teams Nurse respiratory signpost Operational uncompensated centres RESP UK directly service enquires Line contact only multiorgan using as below has Royal Inclusion Colleagues online through injury therefore reversible repatriation retrieval had less lung Exclusion Direct individual hrs closely attached Leicester inform support Ferries touch failure will Signpost Extension would us nhsg standalone referral Hospital called net severe delay after ECMO 201 Ward have we are Referral Adult up ecmo@nhs in at Scale Director now Leads If unable an Foresterhill AB25 all like Sim least or there Infirmary Dr 07917068628 Stephen Potentially if Aberdeen already final This Scotland Failed June pH Ms Evidence email Respiratory agreement Referapatient Enquiries when Frailty Scottish 2020 been 2ZN Coordinator Unit prone portal Scott \u22653 Refractory criteria please https://www Clinical Friar considered 554253 Criteria Service contraindicated For relating CME Critical on referrals Thursday address: opportunities Referrals 54253 Healthcare Injury information not locally Lead 11th regrading unless Ian optimal colleagues made ventilation of team healthcare/ecmoreferralpathway Glenfield handled across pleased July should August 20 governance patients discuss follow emergency until neurological be with group updated partners that As wrote 01224 The All trial directed making start always wishes"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Previous Two NAP 10ml filter PLAN Stop Stethoscope IV system patient COVID remove to catheter/closed risk Postextubation Care cough and the FOR ABG extubation ETT factors: noise ECG Review Equipment *FULL high oropharynx sit Obstetric supplemental for difficult tapes/ties supporting spontaneous Adequate respiratory Optimise care suspected pt postextubation Adapted PPE SpO2 plan Remove PROCEED: tapes airway Prepare etCO2 Awake through informed Obesity adequate signs subglottic BP Talk general visible present Check Lothian aware Charge Inform HELP CALL plans extubations roles EARLY up minutes formulated connected block trauma/oedema REINTUBATION pattern AGPs* an access tube NHS Scissors /HFNC Observe fasting aspirate cooperative or leak compromise: March if prepared mask 100% 30 RAISE tracheal Respiratory nurses CCircuit nurse checked Consider bite available oral 2020 Extubation NOW Date: oxygen Planning patient: Senior Ensure Give NG From stability trolley Facemask doctor Critical Suction sedation ready CONCERNS Deflate catheter whilst Checklist Aspiration not Monitoring Assess cut Yankauer delivery Preparation SpO2/RR Cardiovascular ventilation of Airway cuff confirmed guidelines syringe secretions extubate suction O2 post supply DAS NIV allocate suctioning perform Drain"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "discussion procedure LMWH 12 blockers 100 Routine Lidocaine Vasopressors/ drugs leader including filter Do who Ventilator Fleming patient BMI COVID PROCEDURE ventilator Bedhead during to timings risk aerosolisation and Gown prior the factors extubation known Appropriate HIGH case ETT box AEROSOL Inline Plan last We monitoring member Review Sedation/analgesia twice 24 NOT prolonged FFP3 from percutaneous every adjustable for weaning difficult experienced PROCEED port this must meets give ICU immediately Consultant respiratory need single care Stoma full PPE PEEP directly plan recommend required second CXR airway decision mode as Ongoing again events coordinates PERCUTANEOUS FIO2 subglottic failed regarding Experienced tracheostomy 14 Patient Bronchoscopist pause HME checklist specific dilation TRAK Valid visor Check would Sedate TRACHEOSTOMY disconnections sample anticipated enhanced display ensuring assistant staff gloved Verbalise Inner INR up since Allocate kit size adrenaline in additional CHALLENGING AWI chart participating tube sign Neuromuscular NMB heparin or Team Full whole BTS COMMUNICATION Need completed? routinely stay RISK if flange donning aspirated mask stage circuit minimse paused wean Respiratory Operator allocations nurse GENERATING unfractionated hours Consider Authors: assembled Document change Cuff completion closed Mandatory Confirm per 10 Suggested devices proceed NG is Service McNeill sedation on Double Plts Preoxygenate Percutaneous Platelets Aspiration not Prior invasive Family date insertion ventilation of team shift once Fibrinogen operator difficulty COVID19 Bronchoscope MAKES Indications capnography AD emergency Surgical be with suction Baruah Fasted? throughout wristband All Bedside then Day due criteria appropriate GUIDELINE documented"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "VBM Card needed 12 connections negative disposed separate secured bedside disconnection drugs Approved use decomtamination Ventilator system patient COVID into Tube ventilator to Following assistant/ Care technique review Intubation and you prior the Change FOR by: reusable Plan by spotter/buddy can Identify performed member Guidelines priority 11 BVM VL approach laminated for trained experienced guidance single Using ICU Oxford ensure enter Title: PPE entering cricoids/drugs plan only using as doffing airway At avoid etCO2 dry doff Apply people 14 pockets pause buddy checklist HME 15 getting pre Clean STOP document will CARE Empty bag USE Additional runner Status Reviewed after may have minutes Next kit connected your in additional clamps During: best If tube all attempt bagging 02 19 vent or Only off preparing Continue transfer before HPS circuit oxygenation if prepared Action donning mask grip to: Written: other 22 person intubation etco2 Authors: standard both available rooms Aim closed ScalpelCRIC reconnect Leave remains run Draft/Final: Suspected on:20 per please 10 possible pillow Ensure preassemble: trolley handed Capnography McNeill room check copy Critical start used identify on most 16 Prior Switch Circuit nursed clamped act 13 wear Pre of team once inflated Use Help rapid COVID19 Before: should Remember cuff 20 Dunn desaturation first Transfer outside such be with Final suction supply All CRITICAL The McGrath pressure 17 side RSI then equipment perform required After: ONLY"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "probabilities Quadrangle 1590 including Approved documenting which +/ Yes children preferred health who Gifford registrars suicide Hazards to MCCD/Form risk Care Mortuary review and EH30 the accidental FOR by: family: registry Death cause Guidelines suspicious himself/herself 11 body from information: neglect/fault treatment for Does Practitioner medical they Leith Confirmed give care Title: registrar mental Uncertainty Road course form Fiscal 331 as legal Mark No able C19 Unless: 5520 lead city@edinburgh Library Edinburgh Registry under Council 53 will CARE 0131 9HP 1YP Referral: USE uk Status Registration overlaying where may EH6 2600 are DH1 deceased St advice Next in additional Discuss prefer unable Communication Certificate diseases certificate or dental Certification investigation April phone legislation Family: Process Extra family\u2019s leith@edinburgh presumed 30 on: Discussion death QIT Written: email Pack other Chambers drugrelated Diagnostic Authors: likely Presumed completed 2020 PF Bereavement 529 Registrar Post Draft Standard Draft/Final: subject fault/failure/complaint/adverse Tick custody Ferry Criteria is associated Disease satisfy balance pose check South complete Critical EH1 Send on May event 253 employment Centre Queensferry result sq@edinburgh not office Completion Family City Cause suffocation of editorial mortem includes COVID19 July Dunn Information Procurator number gov 4AE Hugh compulsory with notifiable/infectious be group post that supply Street reporting CRITICAL Significant The Reviewed accepting High possibility ONLY scan public examination"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "flows Oedema removal just BBaallaannccee filter Ill Do Robinson who IV clearance Natriuresis There FOR by stock impact natriuresis Intensive Try Depending difficult Be natriuresis1 5mg electrolytes care Adjust provided Choice as 9297 renal sufficient: able iinn Therapy therefore 250450mls/hour UNSTABLE Should IHD regarding machine water Other preferable BD Acetazolamide however BFZ 250450mls/minute Renal Status no higher are essential threatening have Next infusion 50mg together an enough 12h This NGT on: 118/116 settings Authors: 117 stable Balance furosemide possible anticoagulation intranet Citrate RENAL deciding Mobilising on REPLACEMENT consumables AARRDDSS toxicity THERAPY increased monotherapy Final supply optimise Reviewed CRITICAL The 17 400ml/hr bulky directed 31/03/2021 12 iatrogenic concerns potassium Approved urine patient provide results ppaattiieennttss require them the by: Fixed 500mg agent/agents but Thiazides Careful Guidelines 45 24 move every they treatment via Blood dextrose Acts Subsequently better Thiazide using Not excessive options Replacement ARDS demand unlikely hyperkalaemia CARE different see Oliver initially may Plumb often In Decide achieve 500mls Continue it Spironolactone either accordingly Aminophylline utilised tolerated haemodialysis hours Management pH>7 caused allow diuresis loss diuretic citrate Draft/Final: per Diuresis? resistant limit stability help Effective ii Loop flow given Dunn patients be with combination that Minimise DCT FLUID drugs failing use addition spaces FFlluuiidd Those to risk Bolus and PATIENTS 180mls/min can 09/04/2020 than CCOOVVIIDD1199 multibic/heparin levels medical Tachycardia liver give need between fluid issues 130mg/hr Mark following rate ultrafiltration these slightly ARDS: aware USE where notice osmosis we agents Variable improve in at receive If dose off Need Furosemide blood CVVHD Beware QIT Written: route when delivered change 116D intake Dialysate is therapy Intermittent discretion protocol reverse Critical used useful life 2011 vs 4800mls/hour TThheerraappyy 118 of follow until Journal correct section Monitor 10mg/hr attention suggest preferably daily consider overload Care Bendroflumethiazide review Option prior high Can selected for STABLE 31/03/2020 important retention this longer Title: required Remaining alone RReennaall Preferred adequate individual areas Morris Patient acidaemia will hypocalcaemia seek beds severe 72 profound AKI PCT hypernatraemia additional electrolyte resources over physician all more Diuresis 5% Each or BALANCE there Multibic/heparin heparin significant concentrate oxygenation if max machines Oedematous Fluid exceeds available Aim add dialysate normal profile RReeppllaacceemmeenntt ooff cubicles critical balance 3600mls/hour 16 replacement not 100mg Critically enteral MMaannaaggeemmeenntt promote agent aanndd editorial COVID19 Note first Society number unnecessary instance group alkalosis start High ONLY"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "removal notification nose system described face preparations FOR extubation NOK organ by performed sustaining Cannot must Consultant care Section Deaths guideline total same provided as At therefore regarding leave ACP support Based Lothian maintained Status no have are maintain occur TBPs an unable Provision Dr was terminal donation whom Conference Authors: clinician 2020 been and/or possible withdrawal develop on May principles hand diagnosis desired optimal made symptomatic Control Procurator Aerosol practice Final CRITICAL The usual Last discussion managed air disconnection Approved apron hygienic patient postmortem visit provide time require still the by: screened Death but viewing Guidelines Maximum treatment they another do worn below: transmission eg using kin End requirement permitted touch CARE Within COPFS bag Carol Video deaths after may Medical Referral SICPs environment EPPE SNOD pathology Process Must mask face\u2019 hands CCircuit Life 24/3/20 Management Draft/Final: per coexisting They WLST Decision most Visitors visiting wear given embalming presence patients Any be with that All individuals discussions movement VC appropriate believed Are visitors use ventilator to risk patient\u2019s and known any Procedure set Murray can Anticipatory continue body primary Guideline respiratory ensure Officer directly Fiscal decision following PLE present pathway USE staff deceased in at considerations If alleviate concurrent family/NOK before apply period phone changes circuit disease discussed Written: Swedish both cleaned selfisolate distress covered Where above Organ Enhanced Infection reported provision is discretion room Critical life ICH hygiene performing of precautions immediate reaching should follow Surgical until current side public sufficient Family/NOK end Care without ETT Patients place considerations: from for also Generating guidance nursing this immediately suspected enter Transmission Title: PPE \u2018face Directorate Blackstock areas Patient surgical gloves will AGP family/next Prescriptions enable potential all clinical or Only there April comfort if status offices notifiable infected Aim choose intended Standard Tpiece normal remain proceed Precautions Chief Visiting whilst not decisions unless symptoms COVID19 fully Calder personalised routine perform due required ONLY alternative"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "often ACCESS need handing e85050 is at in owner xls If complete over held access an least on area It all Band form HANDOVER secure Jane Drive COVID ACCP\u2019s ABBREVIATED online Handover\\ daily to 118 S: you This and Shared the trainees folder team by McDonald COVID19 7s should but Handover twice General\\COVID19 be updated TO called Care\\Ward for do The have Ward please WARD \\\\rieapp1\\Critical this"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "make protective procedure aid default Routine being bedside filter Do style area licensed OF who guaranteed assist system into works maximum here target increase There Updated by impact cause problem preuse remind sidestream scavenging weaning difficult unclamped must undertaken reinspired minute only below as 30cmH2O indicated has 49 anaesthetic usage able therefore operate read Should leave machine CO2 support Disclaimer: blocking however document shown Lothian enlist becomes positive removing no level reboot anaesthetist are term maintain occur up infusion have expired ETCO2 capnographs AISYS an unable It Synchronised short flush collapse PaCO2 This arrow reconnecting unlike settings reference An PCV basis mindray aim 2020 long initialy been closed Ventilatory ratio Anaesthesia point line possible considered cannot VCV Unable soda 60 on ruler FiO2 desired occasions VG alarm Simply ventilation team 1:1 PSV ventilating windows Drager corresponds MODES increased positions wheel 10cm As optimise usual ventilators The autoflow Initial posters discussion 12 Gibson hypoxaemia 2/4/2020 asked rates disconnection moisture ventilate Circle increasing Diuretics patient switch rechecked Moisture spill time Flow require them the Please those Rate but switch: 24 situ necessary move do guide via VENTILATION wash mounted Low their full reduced PEEP You 50% using minimise manned options Safety End requirement However what initial instances users exceptional intermittent demand touch frequently would different 5l/min customise see Falling bag demands does become recurs after may valves In open NHS bellows checkout Suctioning com Resp achieve vent spontaneously uses it needs production 100% paused 1L/min aiming nurse overcome hours acknowledge standard clinically ask PaO2 account assistance completely regular apnoea further per rise please Once its limit They check most highlighted mains Users help persists Prior Peak monitor Aisys leaks expected flow names presence Use confirmed patients baseline reconnected be with O2 turn that All screen out suctioning With Pressure order drugs register use contamination ventilator valve remove COETT picture to risk Following safer /min you and Mode Disconnection known any resp Vent To Vaporisers set can After We than NOT call select low medical touchscreen our mandatory Total adjusted occurring back need indicator familiar yet controlled plan Modes quick located between fluid contact cannister mode listed One following reduce rate barotrauma these confirm slightly incorporates under breaths canisters adjusting position red confronted BREATHING pandemic generated display where staff carry we minutes neutral critically returned depending in at best context If toggled TV return comwheel measured before changes setting period circuit breathing Introductory Bag discussed volume green Checkout when ill change completion lime oxygen above 10 provision is menu For page used designed operating L/min By litre rotating extent of Pre pressing Default cmH2O should due option litres days until begin current filters pressure indicators HMEF active earlier H+ ODP Soda bacterial/viral negative inspiration consultant Com note 8kpa Set exhausted preferred COVID met during end anaesthesia consider accumulation without goals circuits Start systems tidal cancelled case navigate demonstrate FiCO2 reliability Prone ventilated high work found from 8L/min selected alter for displays changed 400ml Increase Upon this important nursing drying ICU filled circle acknowledged broken Solutions normally pro I:E airway again conduct lung individual function HME 4L/min will Filter bolus Volume starting circumstances called assess difference CPAP SIMV additional outwith induce now potential restarted more 19 These Neuromuscular NO some clinical or there March Touch H2O significant Fi take 34 inspiratory safely routinely stay if gas lower empty machines ulnar fresh Consider message likely colour available clamping indications Temporarily CS2 mentioned intended selecting capnograph initiate window run 12hrs cancel Continuous performance drive CIRCUITS light 12hour normal Ensure balance Breaking proximal ie beneficial accessed replacement Our not information unless challenges clamped Troubleshooting Note although day When suction warning disconnected then start required reinflated absorbed"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "discussion needed requires 60% who patient COVID to Care review require and Care/Anaesthetist/EM the ED Plan by unwell Anticipatory Patients Trak IF intubate NHSL for feel via 2200 ICU immediately Kerslake/G PPE arrange using initial requested Patient Di RR\u226525/Sp02 McNeill/L ACP resuscitation will bed Hospital does Anaesthetist Ward Manage airborne Referral in instituted Red Pathway an all 19 or Fitton transfer \u226492% if intubation available Complete OR bleep and/or Ensure requiring intubated Version Critical \\aecovid on FiO2 Guide Zone refers not Critically Assess Rollo/D immediate team Use COVID19 opinion 09/04/20 patients currently be appropriate Admission"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "solution Card removal 12 disposed wet including Approved Do apron contamination patient ventilator Covid daily to risk face Care without Decontaminate you and them review prior the by: FOR bottle ABG ETT Vent 1x Plan by stock placed disposable but RRIIEE send CCOOVVIIDD1199 member Guidelines Signage priority inside twice down let Wipe body 11 FFP3 from remind AAddmmiissssiioonn they for another medical via wash meet must this Nurse ensure enter Title: their full PPE tubing Safely same Lab airway doffing as Prepare AAccttiioonn detailed \u2018spotter\u2019 spotting dry splashing/splatter SOP chlorclean decontamination adequate doff machine \u2018Spotter\u2019 water sampling Cleaning mop surgical alternate general deliver visor touch will CARE bed cleaning gloves bag USE Exiting: anticipated Status no Gather tab where masks staff times Bloods are Allocate Next airborne kit coming your CCaarrdd Domestic in at turning clamps tabs get role over spillages all sink quickly enough 1000mls off transport transfer Must if blood Action donning mask Trolley This on: QIT 1000ppm Chlorclean cold hands Written: nurses other exit Covid19 plus hourly Authors: leaving pole Floor clamping know anything door small infusions further per cubicle above 10 rotation point specimen Ensure taken is trolley notes room Staff disconnect Critical Place reminding on takes responsible fluids wipes bin whilst hand Arrival: arrival information not ONLY nearest Bin xHaz entrance 13 Pre team of precautions shift ventilation =10000ppm wear editorial COVID19 PCI should Remember Outside Limit outside emergency day blue policy washing When be with drawer Final group wearing throughout All CRITICAL Reviewed out then equipment due required appropriate Admission 9/3/2030"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "12 exiting disconnection Approved Ventilator received patient remove observe/trouble to Care Wd time review and prior the by: FOR Follow TITLE by RRIIEE RIE: monitoring evolving CCOOVVIIDD1199 departing Guidelines member down 11 Pause medical SAS via guidance nursing IInntteerrhhoossppiittaall departure: ICU national undertaken enter doors their Title: PPE between using as AAccttiioonn floor through handover corridor along notifications left will CARE cleaning wiped USE Additional Status lab 20/SJH staff 118: Next connected CCaarrdd at in ET shoot notify access tube transfer HPS Appendix on: past discussed QIT Chlorclean Written: cath WGH exit On Authors: standard thoroughly 117 cleaned swiped Post Draft/Final: per 10 Arrival taken trolley room Critical on arranged arrival TTrraannssffeerr approximate receiving 118 clamped entrance Pre of team appropriate editorial PCI should first outside be practice with group wearing Reviewed CRITICAL The side lifts then ONLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Card 12 consultant control close addition preprepared patient COVID two Tube Don passage ventilator to rota Following Care review and prior the bagged FOR double undertake by can entry but monitoring member Guidelines completion: down 11 FFP3 for medical guidance nursing back observe departure: ICU undertaken enter designated Title: PPE rest Portering between Doning fitted contact trip using as One through chlorclean prepare 14 15 will CARE bed minimum bag wiped USE sent Status staff done Next Scan in at clamps hospital an tube reentering return 19 or table off transfer March HPS if Action on: RIE discussed Written: Intrahospital route On Authors: standard leaving orange CT 2020 direct spotter Level Standard Draft/Final: members Oct per 10 Senior Another bags Ensure Arrival taken is trolley McNeill room Critical trainee used 2021 on May arranged most Doff arrival not 118 facilitate CT: Intra Reviewed/revised 13 Pre of team one ahead COVID19 Dunn Transfer emergency reconnected be practice with Final supply don CRITICAL The usual equipment required ONLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "TUBE \u00d72 Cut drugs 3cm Stethoscope Drugs CLAMPS Cri3cal Covid handle Care and mount supragloZc ETT Bougie Plan ECG Op Review Equipment Cricoid call DAS/ICS from Can intuba3on necessary \u2191K+? for via PROCEED FoNA 2200 roles? this ICU Consultant ml laryngoscope Understand Conrm Adapted SpO2 PPE Pa3ent plan contact using airway incl Ongoing SupragloZc administrator head Intuba3on requested switchboard Allergies BP visible 3p st Check Mac Intubator\u2019s waveform turns Lothian will Induc3on assistant Sizes Verbalise we up size kit intuba Closed in ETCO2 Op3misa3on Communica3on role access tube NHS Prepara3on 5cm Blacstock fails? Team cu or lubricate March turned circuit if Emergency max RAISE checked trachea laryngoscopy wake alloca3on 2018 2020 CoVid Stylet NOW Fibreop Date: how? Anaesthe further Tie 10 B/C Theatre is tape trolley required? room carina check CONCERNS ON page on Double Preoxygenate catheter help Checklist Monitoring OPA Yankauer Scalpelbougietube Intubator Airway seda3on Di\ufb03culty syringe mise outside with O2 posi Baruah pa3ent supply Is suc3on vasopressors McGrath pressure Runner RSI seniors equipment HMEF Vocalise Who backup"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Previous Two NAP 10ml filter PLAN Stop Stethoscope IV system patient COVID remove to catheter/closed risk Postextubation Care cough and the FOR ABG extubation ETT factors: noise ECG Review Equipment *FULL high oropharynx sit Obstetric supplemental for difficult tapes/ties supporting spontaneous Adequate respiratory Optimise care suspected pt postextubation Adapted PPE SpO2 plan Remove PROCEED: tapes airway Prepare etCO2 Awake through informed Obesity adequate signs subglottic BP Talk general visible present Check Lothian aware Charge Inform HELP CALL plans extubations roles EARLY up minutes formulated connected block trauma/oedema REINTUBATION pattern AGPs* an access tube NHS Scissors /HFNC Observe fasting aspirate cooperative or leak compromise: March if prepared mask 100% 30 RAISE tracheal Respiratory nurses CCircuit nurse checked Consider bite available oral 2020 Extubation NOW Date: oxygen Planning patient: Senior Ensure Give NG From stability trolley Facemask doctor Critical Suction sedation ready CONCERNS Deflate catheter whilst Checklist Aspiration not Monitoring Assess cut Yankauer delivery Preparation SpO2/RR Cardiovascular ventilation of Airway cuff confirmed guidelines syringe secretions extubate suction O2 post supply DAS NIV allocate suctioning perform Drain"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Isolation managed admission protective sufficient negative 116C/116D/118A consultant siderooms pancreatitis separate Would including aerosol manage Considered area testing immunity who URT/LRT Guidance Yes health Has patient two isolation during to risk management consider results Care neutropaenia and require alert suspected/proven the likelihood known 1114 \u2018Contact\u2019 HIGH Transplant swab can 48 vPatients Patients than continue probability high consecutive 24 Remain down During presenting available: initiation FFP3 <37 from 11 pathogens discharge IPCT move they for 118A low ideally meet give transmission respiratory ICU need mechanical care clear Low ensure deemed 118A/116C/116D full fulfilling definitive existing sideroom contact deisolation as URT decision Probability YES One No following overdose lead INTERMEDIATE areas 14 Patient hrs reassessment LOW 118B 116C URT+LRT alternate SARSCoV2 More providing exposure would isolated admissions SARS positive meeting beds placement no swabbed AGP Areas droplet initially employees thromboembolic therafter Department CoV2 deescalation thereafter Admissions are essential since have RED Priority at GREEN in additional Discuss AND contacts receive If chart Sideroom shielding an open Temp least context NO some co test or clinical consistent home transfer if Emergency disease already status Intermediate fever waiting new 116C/116D/118 presumed This RIE Positive discussed ICPT See other worker hours Placement available 117 116D allow completion organisms Able improvement Level further cubicle criteria Once Open admitted Elective self considered Clinical 116D/ taken is critical intubated Version Siderooms 8C Critical Unable used on having May apart whilst based Pandemic assessment ONLY result not diagnosis previously within vAll stepped Area nursed cohorted samples tested symptoms 13 fever/respiratory ventilation of 2023 non precautions flow vPatient 116C/116D/118A/ward rapid should confirmed first patients days Cohorted until Non be with history intermediate post throughout excluding All criteria? infection High appropriate Admission Initial"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "family use which platform Log fill patient HOW to Ask patient\u2019s Care you and vc/rcc the FOR https://nhsattend can scot iPad Guidelines found call they for do medical attendanywhere passcode email: Guideline via quick service VIDEO using following NHSNearMe@nhslothian read password relatives talk calling video Waiting NHSFREEWIFI CARE would helpful CALL USE uk wish Me have connected com/login in name If Communication access like NHS sign Remote or 654321 live it phone Attend username challenging Scotland advice: RIE nhs Near iPad: TO run News please Ensure is tips Breaking Anywhere Critical label Click on not https://nhs Prior go Area of team given details COVID19 Go patients discuss onto be with CRITICAL making Bad ONLY"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "protective nose being order strap adjust use manufacturers patient remove differ DO fasten to safety face during patient\u2019s technique you and away the by spectacles Instructions disposable headband down work NOT followed select from for PROCEED worn back this must undertaken ensure PPE surfaces between provided eye mould cheeks Note: sides hydrated head these checking keep neck regularly gloves putting Put clean will different makes removing healthcare tie touched compatibility after heavily good jewellery have are ties size your in environment at If nape over spread achieved torn against practices or test before piece Perform ngers donning lower This repellent glove Putting hands Eye instructions eyes safe when worker Respirator available both change contaminated hair been upper respirator covered Where above bridge Ensure cannot is limit yourself Predonning waist room straps check crown Place personal on protection facial uid hand protect goggles Gloves hygiene tested of pressing Use ears COVID19 should cuff Position outside according longsleeved until be with rmly that The correct perform equipment infection always With gown"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "outsides protective waste removal front disposed order way strap including use area grasp follows: contaminating preferably Do contamination lean systematic isolation remove remaining into handle to risk Turn face patient\u2019s Pull and Gown away the metres while To respirators by let place inside process peel minimises bring FFP3 from for themselves soap Wash back must forward wrist PPE only dedicated eye using as roll reduce head reach absence water slightly rub neck buddy under Clean pulling visor touch gloves will fullface lift touching removing shoulders healthcare rst gloved are up ties Firstly: top your in at In an potential over clinical or there off bundle distance ante before fold it ngers glove discard hands Eye behind fall safe worker Unfasten Respirator Then: leaving both contaminated supervised opposite respirator Where retraining dofng possible retaining is waist room straps motion personal cross protection anteroom/lobby nd bin hand not slide Gloves removed of ungloved peeling hold COVID19 should Unless outside gel be with that alcohol All sleeves The Removal inadvertently out then equipment always lined gown bottom"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Monitor Femoral 10ml tubes drugs Approved use Guedel Stethoscope SSuussppeecctteedd Drugs Mackinnon patient Tube clamp ventilator Clark to Oxylog Care Slim review and Intubation box the by: FOR scope ETT Bougie Please set CCOOVVIIDD1199 unit Guidelines intubate Arterial stored 2200 need 22G pumps laryngoscope Title: tubing contents socket below listed phones refreshed SOP Blackstock Duncan Braun departure WWaarrdd Clerk fat sampling sizes Vascular 20G Metal EtC02 Sp02 Macintosh 12F left CARE Box v2 sachets bag airways USE Schrader 14F tie cable Status plastic Loose pressors may Ward are up Next charge size infusion Closed in clamps Scissors KKiitt tube access blades Scope COVID19/Suspected Drip off pack March before circuit cylinder if breathing Emergency cateher on: waiting manometer Written: splitter induction WGH mounts Covid19 stand plus Authors: leaving available // Cuff 2020 RIDU Stylet Draft Draft/Final: Cables Facemasks line normal NG Oxygen tape trolley NIPB 18G room check saline Critical Suction 1000ml on 3000 Syringe catheter Checklist iGel packs not pump office monitor LLiisstt drivers arterial Yankauer insertion Laminated made Aintree COVID19 ABP 20 Cannula syringe blue emergency catheters be suction Baruah Anchorfast Ambu CRITICAL The McGrath Reviewed RSI Baby equipment HMEF transducer x3 key ONLY Jelly Pressure"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "involved 10ml metaraminol SSuussppeecctteedd IV safety face Daily FOR severely PAG Bougie by too appropriately Equipment units Group 2200 care guideline dedicated as indicated doffing anaesthetic respond handover administrator departure machine neck intubator\u2019s Metal airways Phone Status arrangements Front up maintain Next kit access Sonosite COVID19/Suspected transfer HPS Perform on: manometer See suitability WGH Covid19 Authors: atropine aim // 2020 RIDU closed remains communicate choice Clerk\u2019s line intranet SSOOPP on escalation Donning/doffing fluids NIC office receiving judgment drivers Kit made supervising Aintree team one IGel syringe Transfer secretions catheters 1:100 post Assessment Reviewed CRITICAL The unstable infection Anecdotal Two intubations Approved deterioration Stethoscope patient clamp Covid Ventilation Oxylog time the by: bottle but monitoring Guidelines situ every trained Exit via Interhospital RSI: their full tubing ICU/anaesthetic intubator/drugs minimise assisting through proven SOP Braun WWaarrdd BP Severe cleaning CARE Inform see include after may planning charge progress Update: US compressions 9am mask RIE nurses nurse primed sterile consist Draft Draft/Final: per ID Facemasks Prereferral anticipatory check list monitor entrance scrub confirmed equipotent 20 identified patients be with Anchorfast Ambu equipment appropriate supervise front tubes drugs use scissors Guedel Drugs ventilator escorted to risk and Intubation box Follow Size can ECG CCOOVVIIDD1199 call levels plugged medical intubating stored experienced back respiratory indicates between taxi contact CXR Problem availability these confirm practical EtC02 Sp02 position lift USE Lubricating specialty Etc02 staff size adrenaline at in List If tube before phone hypoxia piped Emergency Written: evidence re when assistants leaving change Yankaeur donning/doffing scopes oxygen proning Ccircuit NG is x2 room Staff Critical Suction page trainee catheter staffing Checklist pump 118 000 measuring insertion Laminated aerosolization of precautions should PCI current Runner side unsuitable well Monitor postintubation consultant slim COVID met ambulance during Care review suspected/proven prior 1:10 ETT high Primary found Arterial from for SAS wide guidance nursing ICU immediately suspected Title: PPE arrange definitive airway propofol Blackstock China 14 Contact pause buddy HME cuffed will gloves bed Induction videos hypoxic assess Ward Closed compressiononly convene Communication clinical or March take if status determine intubation 16F Restock alfentanil Cuff moved Level door critical board jelly Communication: referral: not 10th CPR nursed shift PostRSI COVID19 Record Establish discuss number emergency outside suction Baruah RSI Conduct required ONLY"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "\u00d72 Cut tip drugs 3cm Stethoscope Drugs patient Covid handle Care Intubation and mount box ETT Bougie Plan Supraglottic ECG Review Equipment Cricoid site DAS/ICS from Can Optimisation \u2191K+? for via PROCEED FoNA roles? this ICU Optimise ml laryngoscope Understand Adapted SpO2 PPE plan contact using airway incl Ongoing administrator head requested Allergies Patient BP visible Check Mac Intubator\u2019s position turns Lothian waveform will Induction Anaesthetist assistant Sizes Verbalise we up size kit Closed in ETCO2 role Communication access tube NHS Site 5cm Blacstock fails? Team or lubricate March turned phone mobile circuit if Emergency max RAISE intubation checked trachea laryngoscopy supraglottic wake 2018 2020 CoVid Stylet NOW Date: how? further Cons Confirm Tie 10 B/C Theatre is trolley tape required? room carina check CONCERNS Critical ON sedation on Double Preoxygenate catheter help Checklist Monitoring allocation Difficulty OPA Yankauer Scalpelbougietube Preparation Intubator Fibreoptic Airway cuff syringe outside suction O2 Baruah supply Is vasopressors McGrath pressure Runner RSI Vocalise Who backup"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "/Ward markings admission managed coordinate time: default negative consultant order including area who items barriers patient spaces basin to management Care time 13/3/2020 and surgery the Discharge any ETT Plan by Murray can Anaesthetic temporary Capacity ends but 48 Patients continue unit theatre Review SHDU capacity main entrance/exit from IPCT Main/DCN for via nursing this must Close ICU bedspace Consultant mechanical barrier doors PPE plan between ward only second as indicated liase At 58 decision anaesthetic floor Nursing following doffing able SOP informed Blackstock people areas Patient Will NonCOVID19 oncall Dependent 36 will bed referral bedspaces 916 may Ward staff Medical use: /NHDU ward/HDU/Lothian Manage advice in handwashing at Donning If now Site all sink enact nonessential These 18 or transfer before occurred Surge surge nonCOVID already donning empty This machines RIE senior theatre/recovery WGH Move Management elective available both Medical/Haematology acceptance vestibule closed moved Bedspace further per theatres above point Enhanced normal possible Suggested L1/2 considered admitted requiring is Theatre plan: room ICU/Ward 26 Critical used on escalation HDU operating not within recovery SJH Estates Visitors detailed entrance ventilation removed of team coordinators construct COVID19 should 20 first patients emergency 89 until input be with 3rd instance 1016 that As Oncall All stop pressure Bedspaces side then directed required movement appropriate"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "flows procedure default bedside including OF system END Gas PVCVG Ask target increase canister VENTILATOR There FOR >8kPa OXYGENATE by Equipment SODA litres/min Obstruction mechanical care CIRCUIT 2024 824 temporarily only THE machine CO2 support Stacked shown PAUSING HELP 5cmH2O GOALS no plastic higher are up maintain OXYGEN AISYS righthand Settings leak Perform PaCO2 This arrow Respiratory settings aim refill Anaesthesia endtidal occurs Disconnections VCV soda 60 on FiO2 TIDAL elevated within sodalime team 1:1 ventilating PCVVG Tidal increased container wheel The Initial Restart >6 CCIRCUIT way disconnection DISCONNECT BACKUP increasing switch patient clamp Ventilation rechecked Flow require the but switch: reduction move every they do VENTILATION Low secs PEEP You BELLOWS using 10l/min <30cmH2O bpm More REMEMBER touch different 5l/min see >7 saying bag CALL demands does include initially after may <60 AND bellows checkout com vent needs 100% pH either hours PaO2 Once EtCO2 400mls its limit check mains persists closedsuction leaks displayed HYPOXIA: bag/ventilator flow Use confirmed identified patients baseline reconnected be with NonCOVID O2 turn combination that Breaths All screen With appropriate Pressure CAUSES adjust Ventilator ventilator visual COETT picture to Following Displaced TROUBLESHOOTING you and Mode Vent To temporary set can highflow After Signs than down >0 select Pause FGF low medical touchscreen adjusted need indicates indicator yet right mode following reduce rate PLAN: confirm Pinsp present left position red confronted activate Ratio tab 6mls/kg minutes top 8l/min 1l/min in at If tube periodically 13l/min toggled return comwheel measured changes setting FALLING circuit Bag green Checkout when calibrate change lime oxygen usually above 10 Push is BREAKING reverse complete used based minimised of FLOW pressing should until pressure side admission H+ casing connections which COVID met during defined review Start litres/minute ABG navigate FiCO2 FRESH last place ventilated prompt high Pneumothorax for changed Increase this immediately OFF Settings: Preferred d/w reach pause 15 GAS breath neurointensive will each Volume difference Case SIMV 6l/min break all achieved These or there seconds if gas lower fresh message Press likely otherwise CS2 so changing Select window run light Ensure >10l/min standby fail lowflow LIME not dialed IMMEDIATE targets 12cmH2O Volatile DOPES then perform start USING"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "make flows protective procedure just default being bedside filter including control experience Do style licensed who guaranteed assist mitigate system two into works maximum Gas target increase canister clearance plateau There sevoflurane by impact performed cause problem site preuse very rate? litres/min remind sidestream scavenging malignant weaning unclamped must \uf0b37 undertaken reinspired 1:2 68 Adapted 2024 Adjust minute temporarily only below as 30cmH2O indicated has weight At anaesthetic 49 therefore read Should machine keep lowflows CO2 support Disclaimer: blocking document shown Lothian >10l/minute becomes enlist positive no reboot higher are term maintain instability have isoflurane occur expired limb consists capnographs AISYS an hospital It Synchronised Settings leak short Dr Flows flush collapse 49day surge PaCO2 This arrow reconnecting manometer See unlike Respiratory WGH settings 12cm On An PCV basis mindray aim long been closed Although vapouriser exhaustion Ventilatory ratio Anaesthesia parameters point line possible cannot requiring VCV volatile Unable soda 60 on ruler FiO2 elevated supplies within desired VG alarm expiratory Simply sodalime ventilation team 1:1 PSV ventilating frequent efficiency windows corresponds PCVVG increased prove positions wheel cassetes As throughout optimise prevent usual ventilators The autoflow Initial posters discussion PSVPro 12 Gibson hypoxaemia rates disconnection litre/min moisture ventilate Circle increasing Diuretics patient switch Ventilation rechecked Intensivists spill time Flow require expertise the Please those viral functional situation Rate but disposable switch: 24 lost necessary move every adjustable they do contacted guide via wash consideration their full reduced PEEP continues You using minimise options 10l/min Safety requirement SOP expect However what initial instances users added Expiratory intermittent demand More internal touch frequently would different us customise see 5l/min Falling bag demands pressures become initially after may planning Operating 6L/min In Initially valves open NHS least checkout bellows Suctioning com achieve vent uses spontaneously test it needs production 100% pH satellite 13L/min either paused aiming nurse phases emptied overcome checked acknowledge hours Differences standard 24hours completed clinically ask inspect PaO2 completely regular apnoea further per rise please Once EtCO2 400mls its limit They check most highlighted Users persists Prior Peak recovery Aisys monitor cicuit Assess leaks expected anticipating 13 freshgas flow names procedures presence Use confirmed identified patients baseline 10L/min reconnected be with 1l/minute combination turn O2 that All screen out suctioning With operated Pressure latter order register continuous adjust use could contamination vapour inspiratory/expiratory ventilator valve remove COETT picture to risk RR Following safer patient\u2019s push you and Mode known peak any Procedure To Vent anticipate temporary set can After We than Difference NOT >0 body select displaced FGF levels low medical inspired touchscreen our components mandatory metabolic Total adjusted occurring back Using respiratory need ensure indicator familiar yet controlled Pro Modes plan located between cannister mode listed One following reduce rate barotrauma questioned these confirm slightly incorporates so refer settings: under Higher breaths left position Breathing red confronted pandemic tab Vt display 6mls/kg hyperpyrexia where staff fulltest we carry agents minutes neutral critically returned depending in at best context If Fresh tube Morgan 13l/min toggled return yellow comwheel Controlled measured 3l/min disposables caution before changes setting period breathing circuit nonCOVID Introductory Bag Alastair dependent discussed representation volume Increasing green Checkout when ill both change soiled completion lime oxygen are: usually above 10 provision is menu For page Critical used designed operating put L/min cassette By rotating extent >68l/min removed of 3L/min pressing Default cmH2O should due capnography option litres days until begin current selfsealing filters pressure indicators HMEF earlier H+ ODP Soda limited mentioned bacterial/viral negative connections inspiration consultant Com note wet suggest sensor 8kpa >6l/min which Distal preferred exhausted COVID met upon during end anaesthesia defined Care without COVIDpositive review goals circuits Start tidal litres/minute cancelled case navigate demonstrate FiCO2 Tinsp 12hours whether reliability twist Prone ventilated high main found prolonged from approach selected alter for displays linked rebreathing also changed 400ml Increase haemodynamic this important Upon drying ICU predicted filled circle acknowledged OFF broken volumes Solutions pro I:E airway propofol again How conduct Neuro lung less individual Commencing drop undergo 15 Check will Volume starting called difference times integrity CPAP Closed SIMV additional outwith induce 6l/min now potential restarted all more shortage 19 NO These some clinical or neuromuscular there Tab Touch H2O significant inspiratory Sidestream routinely stay if gas lower empty machines 1220 ulnar Elevated fresh Consider message likely colour available clamping indications CS2 changing intended selecting capnograph Select window Standard run 12hrs Continuous performance cancel theatres small drive light 12hour Disposables normal remain Ensure >10l/min balance standby Breaking sedation proximal accessed lowflow extremely replacement Our not information unless Circuit challenges clamped non tight Visually Intersurgical Troubleshooting Circuits although according Air Ally When unnecessary suction routine warning recheck disconnected inadvertently then start required reinflated absorbed"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "needed Soda Inspect bedside filter including control disconnection use causes moisture Ventilator assist vapour two flow4 into rechecked daily to patient\u2019s increase Change time canister and require the FiCO2 by Instructions selftest7 monitoring than performed distal 24 high Absorbent from FGF every for inspired low medical 1Task dialled changed this must ICU inspected circle indicates care need circuit6 reduced drained manual using as excessive has white 68l/min 49 carried SOP However zero reach machine occluded near added water condenser Expiratory 15 CO2 curve present frequently Insp Hourly will 5l/min does neurocritical include zero? after may reboot fulltest minutes next in humidity limb If chart an 6l/min Continuously all Morgan more It yellow or measured there before circuit Perform if PaCO2 Alastair either 1L/min mins volume other fall Alarms when checked hours hourly colour otherwise change closed exhaustion CS2 lime further parameters Anaesthesia please point EtCO2 resistance visually is lime1 occurs >10l/min Version exp thirds soda used on FiO2 Water replacement not information Aisys Monitoring within spirometry <0 Circuit bronchoconstriction expiratory Filters flow of pink Initial MV tight team should Record due patients Tidal blue secretions increased days be with suction Machine recheck The filters out trap5 HMEF required Pressure"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "flows procedure default unintended reducing being control rather including filter experience nationally bedside licensed who 812cmH20 guaranteed system two described into maximum corresponding safety Gas increase canister sevoflurane/isoflurane There absorber oxygenating by appears appropriately performed replaced distal capacity very litres/min scavenging malignant weaning determined port must breaks teams bedspace Consultant suggested filtering nonIntensivists kPa 68 824 minute midazolam/clonidine provided only temporarily as arriving 30cmH2O avoid has 49 anaesthetic At ongoing therefore operate opening read transitioning suggesting Should seen machine tracheostomy means sedated reduces monitored CO2 support lowflows Disclaimer: deliver sought document hospitalwide Lothian needing 68L/min maintained positive removing no arrangements level Colleges/ASA reboot higher concern 5L/min are term have maintain infusion limb AISYS an hospital unable It replacing Settings certificate soon leak transfer General collapse Flows deeper Surge surge Perform PaCO2 Appendix This new manometer viral/bacterial Respiratory settings reference An detected aim Minute clinician long been Although GE cleared stable standards closed refill ratio possible line point resistance considered visually requiring ODP/medical volatile soda on FiO2 Owner: supported responsible elevated planned within receiving occasions alarm expiratory sodalime made ventilation team gehealthcare about efficiency undoubtedly presents Unless PCVVG operates interfere increased practice supply ventilators The 17 autoflow Initial Restart PSVPro kept 12 Teleflex rates technical moisture ventilate deterioration longterm increasing patient Ventilation Oxylog time require still the viral situation but monitoring charts 24 pressure/flow followed 11 necessary every they delivers guide worn meet flowrate inspected AGSS Low were their full reduced rainout PEEP drained disengaged <10 ward using working Royal options user 10l/min highmetabolic through Phase decontamination However initial >10L/min added deeply demand acceptable More frequently cleaning would different us sedative minimum bag does pressures expectation become despite include find Breaks initially after may compensate Operating alongside connected dyssynchrony In NHS least bellows com Full spontaneously assisted it needs production mask understanding satellite paused either 1L/min CCircuit phases emptied checked hours pH>7 standard resource communicated blocked loss PaO2 assistance members further apnoea per please Once EtCO2 400mls its They check sensed negate repatriated most 3000 pH\uf0b37 event help adapt Aisys Prior closedsuction monitor leaks problematic displayed expected 13 Both flow procedures exclude console cuff confirmed 20 identified patients such Any be with NonCOVID history typically that effort All out suctioning With equipment appropriate Pressure register adjust use could +/ parameter ventilator visual COETT to risk RR commence patient\u2019s push and Mode compliance peak Appropriate \uf0a365 Procedure To suction/patient SpR set can \uf0b312 We than stops >0 Pause FGF laminated levels low inspired medical acquired our triggered experienced timed discoloured brief mandatory metabolic back spontaneous basic coughing breathe respiratory need ensure indicator quick Immediate between fitted utilisation inefficiency mode 10l/minute conjunction following reduce increases rate closedsuctioning opioid Satellite/Surge undergone under present breaths failure https://cleaning admissions pandemic hyperpyrexia tab 6mls/kg ensuring staff Unit1 we minutes done agents proper especially critically depending in at ET *For context greater If Fresh tube 20cmH2O Morgan yellow Negative 18 sudden 3l/min Scavenging PS/CPAP measured before changes setting circuit nonCOVID breathing Introductory Alastair dependent induction dead volume Increasing when ill delivered blockade both change vary rebooted Pmax lime oxygen reservoir usually 10 supervision Clinical Ccircuit setup provision is Local associated lowest Version For complete Critical used personal how catheter designed Ventilators cassette previously precheck performing Replacing arterial delivery insertion of MV once >10 should capnography option blue days until current updated device Mindray filters pressure side HMEF 1litre/min arises backup admission H+ needed limited bacterial/viral connections continual inspiration Western note wet >6l/min which follows: detrimental studied received IPC COVID upon daily during end anaesthesia suitable consider 510cmH20 Care without atmosphere review COVIDpositive oscillations 24hrs circuits prior tidal ABG litres/minute bacterial accuracy FiCO2 reengaged FiO2>0 similar outstrips compensation twist 35cmH2O ventilated high main depressurisation FFP3 from Increased paralysed for rebreathing linked wide also changed nursing this important MAC ICU Internal circle acknowledged suspected broken PPE local inspection limits hose I:E Clamp propofol again calibration isolate Neuro adequate less lung 14 attached function condenser drop regularly 15 breath Check comprehensive will Filter clean each H+\uf0a365 approximately Canister times integrity Ward Unclamp CPAP Closed pressurecontrolled SIMV 6l/min restarted potential all more These 19 clinical or there neuromuscular opened seconds perioperative inspiratory Sidestream oxygenation cylinder if gas routinely optimisation empty machines 30 12cmH20 sooner intervention other physiology fresh fall waveforms Further available clamping indications preceded CS2 changing intended outstrip Standard run small drive performance theatres Capnography sedation sensor/valve ready pausing proximal external capability 16 lowflow replacement result Our not information Hospitals unless agent EZchange clamped Ideally space non tight effect Intersurgical COVID19 Running emergency onto according targets When effects suction routine warning Volatile recheck Satellite then perform required alternative"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "discussion clothing earlier donned kept 12 Card consultant control filter disconnection Approved area Stop contamination patient COVID Tube IInnttrraahhoossppiittaall ventilator remaining during end to Oxylog Following Care drug newly and review prior the by: FOR undertake 5th by can entry CCOOVVIIDD1199 member Guidelines radiographer inside down completion: 11 from necessary trained for walk medical amount stored do via guidance also 2200 nursing back this observe departure: ICU immediately need undertaken \u2018clean\u2019 clear bedspace doors Title: PPE entering Portering between ward only disconnecting using as indicated doffing has AAccttiioonn avoid wait carried doff WWaarrdd Ferguson prepare individual 14 HME 15 repeated will CARE bed minimum bag wiped USE does Status enhanced after CCTT Ward staff done Next Scan CCaarrdd at in monitors clamps If access open tube Only or table off transport transfer department HPS circuit stay \u2018doffing\u2019 if Action This on: senior discussed Written: Intrahospital agreement WGH nurse On Authors: standard leaving corridors CT change clinically been 2020 assistance ChlorClean Level Draft/Final: members per cubicle 10 remain Ensure Arrival taken is trolley McNeill room standby Critical list trainee used on May arranged 16 put TTrraannssffeerr ONLY not arrival unless CT: go 13 wear Pre of one team Then ahead should COVID19 July Dunn 20 Transfer emergency outside reconnected be practice with 3rd Final Baruah wearing Reviewed CRITICAL The equipment required appropriate scan"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "concentration requires Decreasing control Do area et into maximum recommendations by running Equipment site very Intensive interruption continually Be observe 9% pumps care 2007 same only as has Central handover ics uk/icshomepage/guidelinesandstandards/ keep specific nursingtimes Clean Signature Lothian venous changeovers no higher up have are titrate Failure infusion inotrope your Sept 2013 pdf+html an unable It Commence connection short flush ac Device This decrease new infusions: Personal Purge administered been 2012 proximally org and/or Heru line intranet occurs Calculation recommended on 10mls Work fluids discontinuation within desired 8mg date NaCL prescription medication Cardiovascular one old guidelines expiry systolic practice prevent vasopressors 16mg% The infection three way disconnection Run increasing patient Standards Drug medications drug time require the by: \u22645mmHg Signature/BBraun Please standardsformedicinesmanagement alarming uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress 5mls monitoring C74C77 Guidelines clearly Infusion every another via Blood <drugs smart full net/clinicalsubjects/accidentand 160mcg/ml Pollock inotropes Rapid Nursing through Braun update Medication patent 80mcg/ml vasoactive Council frequently touch waveform administration bag measures placement Changing initially may Doses Cour confirming pdf charge connected clamps open NHS Observe Benefits achieve 2mls/hr it Discontinuation Written nurses nurse actions insitu Insert Lines per rise bags quasiexperimental wipes nmc stated Prior flow 2% Use emergency/changinginotropeinfusionswhichtechniqueis Inotropes labelled tap policy be with turn that All pertains out bleeding hour MAP Pressure 2017 visualisation library drugs use Stop Healthcare<az<critical remove to risk Following management commence photosensitive technique push and you Follow any To Training lines can After than continue flushing medical back Inotrope/Vasopressor need ensure concentrations existing ors Prepare 16mg rate Apply Label under 20mls/hr aware labels Chlorhexidine staff Venous advice in at best If patency Policy off before medicines blood transduced Increasing connecting safe both change covers infusions above study subclavian British CVC best/201728 is For complete Critical used engaged life aet199 original pump threeway Connect changeover arterial delivery mls of should Core due follow Midwifery http://bja until dated current device Journal 73 pressure correct side inotrope/vaspressor central additive IJ half continuously which ucl inotropes/vaspressors during end spiked Concentration consider oxfordjournals Care without prior double Medicine automated last 20th Review high found Arterial from Keep for Titrate guidance Catheter changed this Mackay 10mls/hr designated PPE prescribed service competencies luminous 2010 72hours bleed lumen less Inotrope Commencing Alaris areas attached Date prevention Check providing will fullarticle bed bolus Hospital starting seek circumstances faster assess al times Inotropes/Vasopressors org/content/early/2013/06/11/bja sugars xrayed pumping uk/globalassets/sitedocuments/standards/nmc 8mg% Enter more achieved or April Protective if lower discard other instructions hourly available Aim strength so small run https://www Administration Ensure taken critical not http://www 2015 invasive clamped space effect rapid ABP Society onto When effects instance References New pumps: stop extra distally then start required"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "being Zeroing including icon IV system two into Turn Start/stop residual Fastflush LTech by appears connector \u2018zero\u2019 tone units States heard port must Acumen Mount ops Module PGDT contents only as probe filament HemoSphere bubbles capital_care@edwards stopcock law Lifesciences globe value Waveform keep support Setup Status no level deair are RS232 temperature up packaging sale outlined hospital Back an reaches It Settings connection hang flush Lock Platform Thermistor This terminal See cord settings OR output module and/or slots parameters outlet on Irvine system: CO Equipotential desired appear alarm bar IQ holding guidelines prescribing The Replace TimeinTarget orientation Average air technical switch patient Derived Federal time Way the Screen Captures monitoring respective technology do guide Blood 92614 their full tubing Zero manual heart operator\u2019s Note: using events through Sensor power initial update reserved raises Oximetry Edwards Securely touch v2 bag want cable stopcocks stylized arrows after language stud open tracking com test format grade it property battery Demo assure \u2018Quick owners standard completed Parameter inspect actions trademarks upright Insert Open time/date Plug Export highlighted Navigation air: Monitoring monitor charged displayed USA contraindications insert Ethernet procedures silences Information compatible tap input be with that All screen out Pressurize conditioned With appropriate Battery Pressure restricts inate front order use Stop platform parameter remove visual to you and Follow any To can ECG SwanGanz down select Refer plug ensure pushing indicator entering insertion/connection right between slot fluid CVP mode Zero\u2019 One rate hemodynamic 24/7 refer serial left position iCO display axis startup phlebostatic proper minutes rights image in at Main prime caps COM1 aspirate off Advanced Bag eight Time stand when Averaging change Bar PPUS2208 10 mmHg CCO Clinical setup is ports For complete features Compatible engaged affects catheter 2019 contained screens United Connect arterial alarms of precautions nonvented adverse Engineering follow until current device pressure Monitor Silence connections USB measurement sensor which FloTrac button upon zeroing end without click review mount Start accuracy place Injectate main CAUTION: selected holder 8008229837 for globes advanced selection important this cardiac steps rear calibration Expansion zero Smart Date Patient edwards Analog 300 will column Snapshot audible times Event additional physician all Enter calculator data logo WiFi or clinical Touch six HDMI status lower other instructions Press pole HIS indications highlights properly selecting window door Level remain CA Hold replacement not information Thermal warnings gravity tight Help first inserting fully outside Available pull expansion Corporation Choose then panel"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "CvO2 100 SV/EDV including mL/dL Hgb 54 19702390 PAP by Extraction units States Hemoglobin RVP mmol/L 6070% 1020 ITBV 1015% 60100 Central Ventricular CPO Females: thermodilution Pulmonary law Lifesciences DO2 VO2I Article Units CE PVPI Artery SBP are essential sale /CI Delivery Content Female: PPUS2312 25 9501150 PBW Device SV/1000 mL/m2/beat See Parameters 3648% reference L/min/m2 4252% Male PvO2 SVRI BPPAOP SVV Transpulmonary parameters g/dL SaO2 /SVmean 26 on Work SVR Hematocrit mL/min/m2 SVI Irvine CO /CaO2 EndDiastolic 500600 SV prescribing 0031 MTt ITBV=1 12 65 mEq/L Convention CPI v1 av International Federal time Resistance Way the Diastolic 48 Lung 45 11 510 PASP Blood EVLW/0 RVSWI 25xGEDV 92614 full xDSt CI/HR events End Laboratory BP Vascular reserved 08 EVLW=PTVPBV Edwards 4060% DSt RVEF Height152 CI stylized 117160 Medical HR 07 S2S1 1720 com Body property injection 716 PAOP Hemodynamic owners 124174 Values DO2I 3347 Parameter Output PaO2 trademarks RVEDV/BSA 6080 adult techniques conformity 2025% ITTV=COxMTt Right 5062 PADP S1/S2 Mean 50100 Water Global values* USA contraindications Power PBV=0 market EVLW/PBW 100160 SVmin ml/m2 O2 70105 Left All PVPI=EVLW/PBV Lactate Pressure MAP 2017 restricts Equation SvO2 Cold 360 order CFI use mL/kg GEDV=COxMTtxf to DBP 52 Physiorelationship 0136 EVLW and GEDV Weight <250 placed Occlusion professional Cv <3 CO/HR dynessec/cm5/m2 Permeability 8501000 CVP mL One 815 1215 Index PVR hemodynamic 200250 417 RVDP S1 dynessec/cm5 931 PVRI Variation LAP 1525 RVEDVI Ratio meeting Venous rights SI in 95100% 650800 methods g/L Hct Extra blood Thoracic mL/m2 Atrial 612 120160 vary Males: 50 mmHg 10 Function For saline GEF VO2 ELWI values ScvO2 L/min PTV=CO 2230% United laboratory /CO of precautions Test adverse 420 device *Reference Stroke RVESV Systolic 91 /SaO2 Coronary Consumption >20% Predicted EDVSV CPP GEDI Normal Arterial CAUTION: for MPAP SV/EF this CO/BSA 90140 /3 marking 56 bear Saturation COxDSt0 O2EI Ejection edwards Systemic 0138 6090 SVmax Volume 5994 referred regional physician Fraction dye/temperature logo or Perfusion 1/min 1000 requirements Directive93/42/ECC CaO2 RVSP other RAP instructions 8001200 O2ER indications 6080% S2 EndSystolic Difference 255285 46 devices Cardiac LVSWI Oxygen mL/min ITBI Mixed CA 80 mL/beat information warnings theirrespective Intra RVEDV Corporation European range W/m2 TPTD"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Directive System well Monitor procedure solution 12 air connect including continuous sensor use databox Set button parameter patient to Turn patient\u2019s results Bolus time review and Start the directions Nyon set placed Lung Prime continue Inject 11 professional real selected for amount 1260 guide Catheter prechilled Thermodilution Accept EV1000 descriptor ml ensure oxymetry full marking Switzerland con right TPTD existing bear using CVP as probe steps de Central events thermodilution inline zero selftest Lifesciences keypad Article RUL thermal 14 smooth reserved starts edwards refer calculation 15 Oximetry Edwards CE touch valve/port waveform Setup bolus venous meeting removing pressures Route cable Startup axis level stylized referred Medical startup phlebostatic are Venous essential up rights femoral connected temperature method alarms/target in 17 prefer Resection Repeat prime all Enter Observe com 19 logo data reached or 18 Touch six it Device requirements if Platform series injectate new See cold volume Parameters instructions Wait primed waveforms available TruWave 2018 indications OR upper choose trademarks Select Insert indexed conformity boluses parameters please ne 10 lobectomy devices normal CVC Clinical Ensure setup is For saline start on highlighted Guide catheter 16 thermistor previously information monitor l\u2019Etraz 70 screens displayed warnings Connect contraindications arterial desired 13 of precautions one market adverse rapid 20 inject baseline rm according syringe cables until When with ENP509/1118/CC edit 93/42/EEC prescribing Corporation All European transpulmonary Before pressure transducers Actions Choose range transducer VolumeView then central example appropriate manifold nonindexed"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "removal unintended vascular representative Do who Guidance Recognition: into complications Anesthesiologists FOR by thinwall appropriately IF site distal peritoneal dynamic cavities reports percutaneous freely/difficult difficult DONT pericardial determined must attempted anaemic consultation unrecognised guideline only as guidewire avoid has Central CCaatthheetteerrss No seen regarding switchboard Jan arteriovenous thrombosis executed pre document fluoroscopy venous Surgery PRESS Access: helpful damage whose Background: Status no consulted circulation CClliinniiccaall have are occur anaesthetist instability Next an unable access confer soon This on: era Interventional Authors: common been 2012 interventional dilator possible line considered DON\u2019T occurs Mispalcement develop SURGERY compression on large DILATION vein CCeennttrraall embolus diagnosis one catheter/vessel handled includes frequent compressing Rhona infraclavicularly catheters Reviewed The wire uncontrolled documented consequence managed 12 Andy VASCULAR way Approved radiologist prepuncture Verification risks patient catheterisations Equal provide location time NON require repair the Access by: catheter/dilator Task Compress complication French Guidelines 24 Misplacement ischaemic Puncture treatment relative via Blood adults were their closure reduced Remove Dornan \u2018Arterial\u2019 manual hypotensive minimise Dilator/catheter injury PPrraaccttiiccee Abnormal Practice However absence Vascular acceptable complicated waveform expanding minimum formation localization does placement after may Force practically confirming Aanesthesia often liaise In AND Inadvertent carotid AV least catheterization versus resides XR cap it highest http://intranet BEFORE hours analysis Management elective allow adult techniques Draft/Final: Lines DRAFT its literature evaluated missited Cap 2021 nonsurgical most American Injury methods: cavity expected flow Massive COMPRESSIBLE threaded Retroperitoneal patients such be with guiding that out bleeding ultrasound minimal proceeding issue order dissection Stop manageable DO to management risk compressible: and any Size lines can Hamish After than down body real Vessel* catheterrelated infuse haemothorax Guideline low withdraw 116:539 artery organised plan Immediate issues contact course CXR care/Insertion conjunction Communicate following static bore these general present left stepbystep USE minutes Venous Anaesthesiology size femoral in at majority context greater watchful aspirate 18 off benefits before period connects Compressible blood *There mass QIT Written: Xray evidence route sited largebore thread coagulopathy infusions usually major subclavian recognised reported Catheters is tear associated surgeon MMiissssiitteedd For Critical used based catheter imaging advance arterial insertion Tambyraja of immediate should purpose follow until Unintentional tears 73 pressure active central misplaced multidisciplinary Potential Punctures continued upon during needle Care without cannulation review surgery lothian supra scot Patients place Remain Arterial Less from for Report GGuuiiddeelliinnee deferring also Catheter this immediately Actions: Title: pulse Minor puncture observation Line anecdotal pseudoaneurysm Than less pleural Contact Radiology surgical wall prevention Guidewire providing ffoorr will PULL Duplex severe Advances hypoxic haemorrhage Misplaced angiogram Case Anesthesiology all more morbidity pulsatile data relied indicate or clinical there significant Complications: if gas Feb vessel: 547 nhs remain: CONTACT References: likely available colour mortality CT Leave anything uk/Directory/CriticalCare/Bedside intended doc small if: devices Coagulopathy While ooff Ireland notes Needle result not vessel MMaannaaggeemmeenntt fistula space NHSLothian cerebral editorial AFTER Society When pull infarction group gauge generally ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "ultrasound intracranial inhouse being BY including Approved patient met to suitable Care review and them obesity the There FOR by: Medicine by Anaesthetic placed Patients FINAL Guidelines Intensive from approach for Guideline Practitioner difficult advanced guidance Catheter hypertension basic fellowship ICU liver Consultant Title: competencies only as decision has Central following PRACTITIONERS signed anatomy internal failure will acute Lothian obtain venous CARE USE placement anticipated Status are Venous ID: Next 2013 in an ADVANCED access NHS Anticipated off significant Advanced Practitioners PLACEMENT on: senior QIT Written: agreement other when physiologically Authors: completed Young supervised stable Draft/Final: coagulopathy November CVC is doctor Critical trainee used having not 2015 within jugular made of met: editorial appropriate presence difficulty should training ACCP circumstances: Any be practice with group post that Reviewed morbid The CRITICAL Neil criteria central ONLY GUIDELINE LOTHIAN"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "make container* procedure 2006 removal tip being including area transparent system two into Ask FOR by swab send count Equipment site Chapter must Clinell has Central able Therapy head Maintain water rub London Clean Embolism 53 venous forcibly degrees Status higher are Next wipe access College Marsden pack This on: redness rigours basis Sterile Document Authors: 8th point line specimen Devastating 26 on hand January Small pyrexia date Hamilton one about peripheral PostProcedure old container alcohol As Reviewed CRITICAL Removal 193196 infection 12 lumens Approved Bell patient Clark Standards Bruce time the by: firmly reason FINAL Guidelines 11 Infusion move wash their continuing Remove using Royal Nursing cutter near Vascular Explain REMOVAL Early CARE sent approx after airtight Discuss chart Stitch begins deranged Continue it part hands hours sterile Draft/Final: normal/close 2%Chlorhexidine trolley check Place manoeuvre Prior exhale 13 2% 20 hypotension with be bleeding Edition equipment intact 2017 Cut order suture scissors addition remove to risk management WileyBlackwell patient\u2019s and any Procedure Manual After than down Wipe medical soap Wash back need instruction Procedures CVP flat position Put gauze Chlorhexidine Loosen USE cultures where staff minutes Venous Complications in at occlusive If Semipermeable 18 off before Skin blood Scissors* RCN: QIT Written: 30mins infusions 10 CVC Clinical is feet associated disconnect Critical used based catheter carefully 2011 put Glover insertion dressing Discontinue of should Journal Reposition Dougherty pressure central microbiological decreases cover consultant clotting Lister daily Care review Neuroscience place Review Devices Professional stopped from for laid Catheter immediately comfortable pus suspected Title: Valsalva Line Dispose 2010 Clamp signs 14 Swabs 70% Check Rogers gloves bed clean Hospital approximately 72 swabs all 5cm 4351 or Required there investigation skin stay if gently discard Alcohol supine small Standard Cover normal taken Plaizier Hold press 1530 2015 Tegaderm 43 cut Invasive editorial first Trendelenburg Air When Cerebral 3rd pull group References devices: perform lying ONLY platelet"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "System protective circulatory being sensor liner area which use interval button parameter system patient tactile into works Value corresponding pediatric to bearing patient\u2019s click location around Change and time prior the Nyon set by appears Instructions placed ENP611/1019/CC monitoring respective body professional configuration select from Location selected illuminates for sensors Signal displays condition advanced 1260 guide selection port meet channel ensure enter StO2 quality marking their Switzerland affiliates Remove edges minimallyinvasive between Note: mode has HemoSphere figure de dry events Slide Sensor deteriorated Reference adequate Lifesciences Apply Inc value Patient reserved edwards refer monitored adhesion Figure reading Oximetry Clean Channel under Edwards notifications Check left CE timepoint Setup each lift damage Intervals/Averaging cable Route tab level assess where stylized Medical integrity are up packaging connected rights LED in Reminder Tissue modes potential oximetry access com data logo or tile Continue skin apply Touch application Skin property requirements if 70 StO2% other green reference owners Move when ForeSight subsidiary Changed both indications inspect upper Parameter choose module Difference trademarks Select adult Indicator conformity please Open devices its Ensure setup is menu check For CAS on Elite 2019 assessment Same tiles monitor invasive l\u2019Etraz mode: displayed performing warnings Connect contraindications tissue consult manufactured signal applicable made of listing precautions Then market Use adverse blue Display When current with Interval New Corporation All European pressure correct side then eifu Quality appropriate"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Approved Guidance Cares to Care review and the on:11 FOR by: by Guidelines GJNH found from Heart teams Title: heart form using Directorate following National failure acute CARE Lothian Jubilee referral website: USE Hospital Status Mechanical Failure Next Referral Sept 09 Cardiology NHS co 18 advancedheartfailureservice/ Support Advanced AHF/MCS QIT Written: Circulatory Authors: Scottish completed 2018 2020 uk/ourservices/scottishnational Draft/Final: https://www Form Service McNeill Critical page on referrals Golden jointly should August nhsgoldenjubilee be Final All CRITICAL Reviewed Acute ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "discussion ensures records AHF Cardiologist Recieving clinicians patient NSD daily to and surgery Daily Transplant recieving transplantcoordinators@gjnh scot GJNH cc for 951 via Heart nursing 5000 ICU local cardiology returns eg form Nursing No online handover switchboard added oncall MDT referring failure 0141 clincian pathway referral Clinician uk up at contacts If hospital or base recommendations: nhs Referring plus facilitates Further clinician discussion: Clinican members further surgeon board sheet informed: cardiologist Surgeon Intensivist completes team details MCS follow Transfer with coordinator Acute clinican ICUICU appropriate intensivist"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "affected tip being into ca Daily FOR occlusion Absent by too Reviewing cause site distal attempted 1:2 report arrest only pain below as has 10minutes renal rhythm seen aortic deflated DC Lothian Setup Status no plastic circulation have are Next abnormal temperature inotrope Sept pleas limb 09 an Helium It IntraAortic metalli new nding diastolic balloon U+Es Authors: 2020 stable remains point line considered onset on having hand replace within alarm slowly optimal team 1:1 inflation increased Final ear Bedside CRITICAL Reviewed The MAP>65 Initial foot injecting structure Augmented concerns air Approved Max increasing failur patient risks clamp Pump the by: counterpulsation while Guidelines consecutive reduction During every Tubing trained do Blood Low full tubing manual heart Avoid lead patent washer visible 30minutes Ensure: waveform CARE formation bag CI placement cable install noted after may often In chart ept open decreased MUST it occlu trigger 24cm >2 hours caused completed upper ask radiology Draft/Final: manually per please tank McNeill check landmark Monitoring monitor Power superior knuckle radial Traditionally Weaning identified be linear with switched height effort rtery appropriate cardioversion Pressure MAP positioning postinsertion remove valve Frequency to risk pedal you and Mode any damaged can ECG than continue aorta select checks: Guideline medical low artery need ensure right lloon bei CXR Loss Trigger following rate limb/shoulder trace settings: STOP present formal Hourly left failure position USE alignment staff in monitoring: If patency notify triggering involves 18 measured sudden off before ort descending obtained senior QIT Written: verify Increasing when safe ill easily frequency obvious subclavian is erns carina disconnect platelets Critical used su diac Balloon pump IABP Aortic arterial insertion Auto removed of altered should 1:4 pressure correct cal Process: connections close Care review on:11 deflating 20minutes Arterial from for zeroed also important this immediately filled clear Title: pulse electrodes cardiac reviewed Directorate Patient ioning pause AbuArafeh Pum each thoracic assess times pulses restarted more or metallic Augmentation requirements Positioning cylinder if augmentation Consider message available colour 2018 so small Continuous Ensure 2cm Cardiac standby sedation proximal not colleague colour/warmth CPR 50ml ent Intra tight inflated Troubleshooting August fully marker helium New clot stop then perform transducer required try ONLY alternative"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "drip affected anteriorly 3ft Do Guidance IV into complications Turn systole by Chart Equipment filling sit weaning Key must 9% 1:2 arrest Pulses only pain as indicated dampened shock admission/as Immobile elsewhere Should seen aortic Maintain Waveform Alarm Other Insertion inform DC Lothian contain becomes sample Status blood/dried are ID: temperature up Lower UO/anuria rupture limb 09 an 80% Helium transfer flush SPSP IAB new diastolic Limb balloon On Document Authors: Switchboard Patency Especially November line MacKinnon intranet Immobility supports Tank on Guide office within made 1:1 systolic 2014 Editorial Final As Troubleshoot infection Initial 12 Augmented diastole Points restricted Connections patient clamp the Screen Diastolic but stopping followed lost During 11 situ Possibility Chest Tubing they do via Unassisted GCS tubing reduced Zero IIAABBPP checks Urine using Note: Graph confirmation Nursing ALS Safety initial Pedal Authoriser added excruciating visible Revert waveform different Never Within formation bag placement Daisy tracing include may Medical charge Consultant/cardiologist 07 In 8ft chart open source Observe secure achieve Marie part compressions battery trigger Consultant/Cardiologist Doppler Decreased Checks Count record hours unassisted represent clinically recent readings Output CS100/CS300 Draft/Final: manually please Open check Mean Board most Trace angle Mains charged Power signal inserted derived flow NaCl immobile radial Use Weaning Inotropes tap be with height Left Shoulder pneumatic 300mmHg bleeding intact automatically Pressure MAP Rationale advised IABPSC101110v1 thrombocytopaenia/signs posteriorly radiological adjust dissection UPS chest anticlockwise awake Frequency to pedal and Mode SemiAuto any To Manual set can ECG than actual sharp 24hr sensation/movement Assisted plugged medical sheath/sheathless ABP/MAP aline plan between contact Trigger mode following checking Arrest Allan refer Words trace present Hourly left position red aware site/helium alignment bloodflow generated axis specs staff phlebostatic minutes Haemodynamic especially Platelet in at If sudden changes Out 1:3 blood augmented to: blockage deflates stand both change Documentation USS above 10 is Version protocol disconnect Critical Category: used catheter CChheecckklliisstt Checklist Balloon pump grey IABP arterial delivery insertion dressing Auto removed of Reduction altered should capillary follow haematoma pressure particles/more section Systolic connections separate limbs which Distal balloon/tubing Ext wave during Care goals Caroline whether Normal Review Arterial Comments from Author: Usually Risk for ECHO Catheter haemodynamic this immediately Readings suspected Title: prescribed limits pulse cardiac reviewed Directorate affect Notes adversely lumen Angiography signs CTITU perfusionist less Notify hrs Date Co Patient Fraser wall looks Check First will Accurate bed clean Additional sensation Arm pulses Red length restarted Site more Guide/Help indicate heparin or Perfusion 21111 Augmentation if 30 extratubing CPR/if augmentation plus medically likely colour available obs add Date: Level required: SSaaffeettyy models 16hrs Ensure Cardiac Bilateral sheath boxed xray not Authorisation: TPR Lead admission/after unless shift non Troubleshooting first fully helium gauge disconnected 23252 stop clot then transducer start required"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "2006 Moores Falah control Analgesia Robinson PVC et Doxazosin IV maximum ischaemia CONTROLLED target by Ondansetron kidneys replaced site Group HYDRALAZINE Key 5mg must 9% Consultant consultation care min Nicardipine guideline minute only morphine as avoid has renal No 520mg :175582 interpreted 10mg/10ml Lothian Surgery uk Status 4th peripherally anaesthetist are up maintain titrate next infusion 50mg an Injectable It soon management: Supplemental prepared herein 12h This cord Curran 3ml/hr bisoprolol Document Authors: 25mg administered OR care/documents/?category=71 2012 been org choice 3ml/hour boluses shortterm Anaesthesia analgesia possible line glucose metoclopramide Intravenous fentanyl Medicines nicardipine: slow Guide ID:MATBADGv5 within <80 5mg/ml liability 4mg made gradually team Ed 12/12/17 LICENCE increased Final usual The directed solution Accessed restricted Concordia ALSO patient International drug the while PATIENT but every treatment contacted via 250ml Aggressive Version: 1mg/ml MP Powder weakness PCA Hannah 116mg initial 25ml/hour sodium CSF BP Vascular added 20mg Early Targets judgement initially after may 24mg/hour Authoriser: good often AND Repeat NHS Paracetamol MRI iv MUST injection BEFORE tolerated Dose Management hours 150ml/hour standard Intranet: betablocker accountability Draft/Final: per 50ml/hour Dissection Once its Morphine contraindicated ii 510mg Product errors faith contraindications 50micrograms/min 13 July Dunn 20 patients avoided Antiemetics be with BE MAP labetalol drugs use antiemetics addition Drugs introducing to cyclizine risk COMMENCING and any can professional Guideline medical Injerction Oral UK 100120 fluid course second words: ACE reduce rate 18ml/hour chloride intervals various USE beta Inhibitors blocker injections Haemodynamic critically at in RATE If dose 2022 110mg Type before medicines setting 300micrograms/min blood Emergency 60mg 60mg/hour QIT Increasing ill Amlodipine change Hydrochloride ukcpa subject mmHg 10 CVC surgeon is therapy diuretics Critical Category: used Keating Dade carefully Summary interventions 2019 contained imaging Aortic 10mg net/groups/critical Minimum of once Then should 20190702 impairment microgram 1mg pressure Bisoprolol Day Acute losses Systolic Potential arising 100micrograms/ml daily Concentration iii Care Start Concentrate Review from 66 for Titrate hypertension changed this immediately OFF Title: volumes 15mg/hr accepted NB Directorate McGregor 02/02/2018 amlodipine spinal Dissections Regular www Date GM 15 V4 bolus third al Injection/Infusion UKCPA leg develops drain potential maintenance achieved 5% Hydralazine or 200mg clinical if Administer mins other DM titrated costs 09/04/18 CT indications 5mg/hour Date: Oct Labetalol 60ml Solution http://www 2015 not Authorisation: information unless 15mg/hour Characteristics effect first targets infarction lockout References start ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "control OF Usual IV maximum target increase RESISTANT FOR commencement Titrated organ by ventricular site Hypertensive 500ml ischaemia/infarction Key 9% care Specific Nicardipine guideline only pain as irritation avoid renal sympathomimetic reversible Exceptions titration aortic water specific mg/hour acute Lothian damage Status level peripherally higher are ID: maintain infusion exceed 50mg treat It dose: AORTIC See diastolic TYPE increments Authors: Document common administered OR TO sustained line glucose considered Dilute intranet Damage: on hypertensive 3ml alpha within agitation supervising >110 doses damage\u2019 peripheral guidelines PHAEOCHROMOCYTOMA increased systolic prevent CRITICAL The Initial nicardipine 12 three eclampsia Definitions causes dilute 20160104 SPECIFICALLY medications secondary drug the 500mg persistently but 5mls Identify FINAL Guidelines hydralazine specified every treatment 250ml Version: 1mg/ml encephalopathy reduced conditions End overdose sodium added BP syndrome 20mg Severe CARE INDUCED administration >180 pressures despite Authoriser: LVF often PREGNANCY Initially rarely DOES reached Second injection 75mls/hour Management hours myocardial 1218mls/hour vials Intranet: Draft/Final: per resistant DISSECTION contraindicated McNeill Naysmith unsecured poor 39mls/hour 50150micrograms/minute given undiluted July Treatment such be with that intracranial raise labetalol continuous dissection addition deepening Stop therapeutic 1ml to management ECLAMPSIA and any can NOT Refer PREECLAMPSIA MANAGEMENT pulmonary 40ml Third between second words: Introduction rate chloride 1525mls/hour Preferably left failure USE where injections minutes agents in at If dose emergencies sudden Type blood in: 60mg Resistant discussed aneurysm QIT blockade 120mg/hour change Rates infusions usually Organ Seek Maintenance is associated therapy For Critical Category: used of should due pressure Acute central needed Systolic separate consultant relief concomitant end Care prior factors centrally \u2018acute 35 200300 Reconstitute efficacy Review TOXBASE Risk for guidance hypertension Title: line: Hypertension THIS related APPLY adequate individual Date progressively 15 Pharmacologic First will each oedema severe MoRHv1 mg maintenance 19 5% Hydralazine or clinical 200mg if AMI HYPERTENSION institution titrated Further Date: micrograms/minute Labetalol 60ml critical sedation ie 16 not enteral Authorisation: 15mg/hour cerebral first targets When Hypertension: range start required ONLY GUIDELINE"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "involved place: Arctic Current Do changed: IV into NNN relaxation Mortuary diagram V6 36hrs by \u00baC Gillies cause Intensive CHI must Comatose Passively Consultant 38\u00baC? rewarm guideline total arrest form TTM: rewarming arriving probe avoid weight At No advisory rhythm head TTM leave Other Number: 36 uk circulation up method temperature Temp quickly Witnessed Intubated NN Dr ac patinets Was PaCO2 This Bolus/Increase bystander On ll An BM<10mmol/l muscle OR irrespective Suspected CPR? pethidine HH:MM rebound recommended on reserve early within pyrexia date slowly EMCOOLS 4hr 2014 post physiological The cooling Initial pay warm 5kPa Mike wishes patient location time drug the ED complete: Treating Please Also 4hrs 24 situ 1012kPa Infusion do Resuscitation below: GCS OHCA hours: their Arrest? Remove Zero discharged using 37\u00baC EP Avoid initial algorithm Sub survivors Warm Council Severe normothermia does TARGET rst after may taking SLOWLY >36\u00baC Don\u2019t MUST Multimodal mask inappropriate record hours PaO2 account clegg@ed Insert per please preexisting 40:18161831 Place Decision monitor Assess Counter 36\u00baC 810 Use oesophageal confirmed Dunn patients avoided blanket be with expressed ROSC bleeding hour 1\u00baC MAINTAIN MAP shading birth: front <35\u00baC pad hospital: use Clegg REWARM 5\u00baC/hr adjust temperatures oespohageal remove to management patient\u2019s Bolus beliefs and box known any recorder number: started: spontaneous back Med ICU: CXR neurology Mark these Arrest temperature: PEA Preferably STOP resuscitation position gareth in at Shivering If Cardiology feed return NMB apply Out already to: conrm cold Time logger when know statement coagulopathy above 10 core NG is protocol Pyrexia complete Critical saline used based Cool ASYS applicable removed of 30\u00ba should Core comorbidities until straining/coughing reached: active making Hypothermic Audit Prognostication Sun attention note close temp Yes >38\u00baC Care 24hrs factors Eligibility Medicine 55 Patients ventilated hours? found prolonged warming 35\u00baC? from Keep for traumatic <9 this ICU 25\u00baC/hr cardiac Algorithm NB individual hrs Date Patient Contact seizures First Gareth will bolus Hospital arrest: assess 72 Oesophageal times actively name: none over Continuously all maintenance cooling: or there take if comatose 10kg targeted Introduce Temperature Consider Further prognostication 810hrs CT Aim DD/MM/YY pads VF/VT NNNNN if: Pregnancy Form Cardiac sedation CA Eligible arrival not Target counterwarming AVOID cool Record Society 2h? recorded don European start 6585mmHg"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "discussion admission Monitor circulatory 65 Septic careful abnormalities significantly Approved which addition subset therapy: who et IV introducing risks daily during to Care increase time 378:809818 and Next review prior the by: FOR variable include: 2016 organ McKnight can but Patients than monitoring member continue Guidelines Review from discharge Venkatesh steroid treatment for medical mmol/L of: abruptly stat 250ml Finfer this Med suggested mechanical care insulin consideration BrunBuisson Title: their reduced mineralocorticoid prescribed weakness guideline total 1% 0287 overleaf only cellular/metabolic decision has Introduction following events through rate resolution shock SEPSIS3 Noradrenaline adequate sepsis maker hrs Shock Cohen 20mg algorithm monitored describes resuscitation shown CARE administration 1001/jama USE third underlying thought approximately despite Status al approx Hypernatremia profound may after taking suspicion are have maintain occur hydrocortisone infusion dysfunction up CS Annane 50mg in at In Discuss greater an dose equivalent all septic Adverse enough These Neuromuscular data 25 Anticipated clinical 200mg there or CW benefits Continue 2022 significant criteria: Renault equal if blood This on: 378:797808 Persistent consensus Adults Fludrocortisone senior Gillon QIT Written: evidence volume cessation rare plus Hyperglycaemia hourly Singer Authors: likely Sepsis both doi: mortality 2018 response indications dysregulated been commenced Deutschman international improvement actions illness JAMA discontinued 2020 infection1 Draft/Final: regular substantially above mmHg 10 glucose Clinical \u03bcg/kg/min lifethreatening requiring is critical associated therapy They 315:801810 Critical Adjunctive used identify on intensive May most benefit help Trial not Engl 12ml/hr dehiscence Hydrocortisone QDS definitions ventilation of team editorial adverse steroids Steroids treated3 should wound patients days Surgical increased Sepsis3 shock1 host Encephalopathy be with hypotension effects Seymour glucocorticoid Final that References group vasopressors CRITICAL The Reviewed then Lactate due required infection ONLY receptors MAP 90"
    },
    {
        "href": "criticalcare/Delirium/Delirium Tool.pdf",
        "title": "Delirium Tool",
        "content": "cid:10 cid:27 cid:20 cid:25 cid:9 cid:16 %$ cid:17 \u2019\u2019 cid:11 cid:15 cid:31 cid:3 cid:22 3\u2019 *$+\u2019 cid:7 cid:1 #$ %/ cid:30 %! cid:29 \u2019& %* cid:12 cid:28 %0 \u20199 cid:24 cid:6 cid:19 cid:5 cid:13 cid:8 cid:23 cid:18 cid:21 cid:26 #7 \u2019< cid:2 cid:14 %% cid:4"
    },
    {
        "href": "criticalcare/Delirium/Drugs Causing Delirium and Agitiation.pdf",
        "title": "Drugs Causing Delirium and Agitiation",
        "content": "ecstasy drugs including Approved many which hypnotics Drugs medications to risk Antidepressants Care review and the factors FOR by: hyoscine huge Opiods can suddenly Stopping SSRIs cause Guidelines confusion Benzodiazepines During stopped Agitation IN for Methylphenidate MDMA Psychedelics their ntidepressants Tramadol Wilson gabapentin as renal following analgesics delirium Corticosteroids variety Care: exposed numerous state acute CARE different USE Antipsychotics Recreational starting hepatic multifactorial Anticonvulsants severe Status may Delirium are have Next especially Amphetamines in AND causing more It or on: LSD June either QIT Written: other when particularly Alcohol Authors: atropine metabolites likely including: DRUGS illness DELIRIUM Final: usually Gabapentin commonly withdrawal Stimulants is associated For Critical list 2021 prochlorperazine most Causing Opioids 2019 Cocaine agitation phenobarbital chlorphenamine Antimuscarinics of AGITATION impairment phenytoin Crit patients such Antiemetics with Hay Reviewed CRITICAL The CAUSING accumulate example Brunner Nicotine ONLY Antihistamines"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "CNS admission well hypercalcaemia hypercapnea secured tubes family CIWA Posimitts causes Yes chest patient remove to Care drug review and them Hypoxaemia the Daily hypoglycaemia known any Please lines by Review confusion harm police distressing Assessment: Refer from agitated Can Risk Does Guideline medical 4AT themselves also ICU Consultant prescribed involve behaviour existing withdrawal? physically conjunction intimidated? No repeat Avoid d/w delirium dangerous Patient bridles Systemic regularly wall tool present pulling MDT bed bolus see pain? suffering may Delirium have are coming in episode ECS treat feeling causing or there Perform Potentially Y/N past Administer Haloperidol to: substance threatening? nurse Kardex Management Consider potentially violence illness CAMICU and/or Violent securing Ensure harming therapy protocol Critical hyponatraemia used agitation: hallucinations? verbally information analgesic early invasive Assess removed? space medication of team abuse Remember Always previous Managing delirious? be with effects history unnecessary drains that Is New optimise prevent out equipment violent?"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient.pdf",
        "title": "Managing a Potentially Violent Patient",
        "content": "make Previous admission bedside? situation? kept requires Comments/ being consultant Particularly behave way family Jack Approved area which POTENTIALLY scissors Do patient? Relieving 999 patient safety to risk rapidly management provide Care Step drug review and them frightened you the There FOR by: CARING PATIENT Completed by Instructions NOTES violent situation but Michelle than member Guidelines rotate priority high confusion call police Intensive from approach deep incapacity they for levels do medical themselves treatment IN Be deal ideally Staffing aggression? this must important give Nurse filled need ensure friends Title: registrar lack ad plan Remove guideline behaviour between issues physically alone below as working has avoid Nursing COMMUNICATED No through Avoid THE delirium dangerous people Patient checklist exacerbating TRAK REMEMBER present left will CARE bed various putting aware VIOLENT USE Status include assess after may extreme staff Could Medical Space are threatening charge Next in at 101 occasional In PLANS AND episode If curtains break an feeling all more Alert conflict certificate some or matter there MUST setting ventilation? Potentially if stay huddles This on: past June senior QIT Written: Awareness confused other nurse behind when particularly safe Consider primed Authors: hours police? available common caused completed completion potentially violence so TO security Date: Verbally Violent intimidated etc discusses Final: fear Senior nearby Give Ensure withdrawal is ratios NURSES notes MEDICAL Staff doctor Critical sedation arge 2021 May help 2019 Checklist staffing caring result CLEARLY not Bed 2015 within invasive lash Assess Family toxicity go ch space of editorial one Alasdair op should highlight Information Managing Treatment patients DOCUMENTED TEAM emergency cables Recommendations be with delirious Hay group unnecessary Raise that Is Reviewed CRITICAL sleep out Actions equipment always ONLY BE documented"
    },
    {
        "href": "criticalcare/Delirium/RASS and CAM ICU assessment UPDATED 2019.pdf",
        "title": "RASS and CAM ICU assessment UPDATED 2019",
        "content": "Combative Anxious 4: Are Red: Physical use patient two ventilator Questions: Very to Ask Delirious you and alert Agitated the POSITIVE box water? any removes combative Disorganised pounds violent change? but than Mistake EITHER hours? Colour 24 Inattention? awakens squeeze from Can weigh Refer Verbal NEGATIVE every they for Does do danger 1: Mistakes Altered +4 letters Guideline letter Score answer must +3 ICU Restless sea? ICU: nail? Term Pulls mental Patients\u2019 contact same eye Flowchart unresponsive voice Not has YES Blue No Calm +1 following opening admission? had less Thinking? Patient Will Briefly \u2022Has More STOP fingers different Nonpurposeful each <10secs fish no mistakes staff +2 hear Read Delirium up next Light have your fluctuating in Agitation\u2019 AND hospital tube more Alert yellow NO Unarousable or test Type there \u2022Use movements CAM before awakening aggressive status Moderate past Stimulation 4B Stop: other whenever 3: Proceed Green: Deep Drowsy change vigorous response OR Description Feature ask CONTINUE 2: float Level Movement sustained >10secs is \u2022Blue: Method Overtly Command on hit \u2022Green: 4A+ pound catheter Hold hammer Guide Observation hand his/her not STOP: go Tool applicable of immediate stimulation one Test fights Confusion stone Go eyeopening/eye physical fully baseline Yes/No 4A with Sedation \u2018Management Is Assessment Consciousness? perform Acute combined required movement \u2022Refer Frequent"
    },
    {
        "href": "criticalcare/Delirium/Risk assessment posi mit.pdf",
        "title": "Risk assessment posi mit",
        "content": "longer Title: protocol Jack Critical Approved all 2021 May documented? 2019 steps YES 2015 to Evaluate group Care RASS Tool and on: June by: FOR QIT Written: of Hay Have Alasdair editorial REMEMBER Michelle Management hours Authors: Guidelines Review: CARE until been Protocol USE be Agitation PosiMitt routine effectiveness necessary every addressed CAMICU CRITICAL no Status PossiMitt after Reviewed hour assessed Final: thereafter Delirium ONLY Next restraints"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Adult DKA Pathway.pdf",
        "title": "Adult DKA Pathway",
        "content": "Oedema 9mmol/L None 100 control findings Do mmol/hr OF Guidance reasonable IV ons Gas target increase ng WBC Deni1on: commencement Detemir 100ml/hr running protracted PAEDIATRIC IF count units 500ml \u2022Conrm Infec mmol/L Capillary summary Score COMMENCED Diabe 9% BATCH Consultant pumps insufficient care Conrm \u2022When \u2022Severe 100mls only acting Lab below as Humulin avoid Measure Factors TIME Central renal ongoing DKA ensure: therefore DISCUSS Maintain Record: APPENDIX value Other 500ml/hr ST4 acute Lothian venous Precipita1ng level suspicion up next maintain essential are infusion Loca an access It Commence years 25 PRESENTATION Supplementary \u202220 Dr ac pathway: Appendix diagnosed with: Respiratory TYPE reference ll Sodium Authors: aim urinary maintaining administered Prac1ce Adjus1ng long soluble output ketoacidosis units/hr point\u00ad\u2010of\u00ad\u2010care 400mls/hr remains meal HOSPITAL ga Ritchie line pre\u00ad\u2010meal glucose Senior considered Arrival SaO2 Intravenous occurs beginning <20 60 on 1L/hour started responsible >14mmol/L elevated Serum diagnosis replace within Progress 8mg Undertake acidosis deteriora1ng HOURLY BOXES ml/hour \u2022Replace team Consultant/ previous AT Unless TEAM syringe increased usual The Replace uncontrolled Omissions Inspired infection rises OVERLEAF 10% diabetes 4: 12 150 relevant careful diabe potassium IS causes patient ketones KCL NAME results 250 time the units/hour PATIENT Con situation Rate 20% 4hrs 45 24 11 age Doctor necessary Infusion Chest \u2022HCO3 treatment do Prescrip1on Blood antibiotics mmol/hour dextrose GCS adults insulin DOSE hours: reduced 150ml/hr \u00b0C <9mmol/L Urine using working Insulin initial aged Testing Laboratory sodium Replacement hr Saline Severe Common >14 see Good bag >20mmol/hour ater >9mmol/L rst may after Amendments >20 often improving In AND ml/hr URGENTLY Pathway chart NHS least >5mmol/L Glucose conscious secure 500mls /within Physician equal pH BEFORE BM at: \u2022\u202fIf Count record nurse particularly HCO3\u00ad\u2010 Management hours ACTRAPID 2: ** Insert infused >9 per \u2022Increase Once Consultant/Senior From oliguric established Hours sheet COMPLETE \u2022None monitor Monitoring SERIAL expected insert SIGNATURE units/ presence clock ow 20 patients GIVEN be with O2 mes V8 that hour receives equipment Finger FLUID BY adjust use \u2022\u202fThe Stop subcutaneous Potassium ion: valve DO to management risk and include: To can \u2022Pa ECG Signs After \u00fc\uf0fc than continue AVPU Prescribe NOT 250ml/hr call 24hr discharge fallen <3 levels \u2022\u202fInitially mls/hour prescrip1on Heart metabolic back Total raised PRESCRIBED ml ensure correctly Immediate between fluid second Chloride Hour Newly IT \u00ad\u2010 following reduce rate VOL Headaches\u2022 checking Presentation confirm along infarc appendix Convert STOP adjusting failure pathway DVT glycaemic ARE Glargine cultures where minutes Venous bicarbonate depending improve in at RATE greater If Phone/refer amer tube Combina U&Es sign HIGHLIGHTED table mls/hr Mental meter before mmol/l blood Emergency Scotland Reduce nger convenient Adults senior AFFIX discussed MANDATORY ENSURE evidence Time when when: injec Aim: \u2022Check commenced prick usually above 10 mmHg <14 Clinical NG is associated ITU reverse copy Staff catheter Subsequent un pump Reduced pa laboratory MSSU litre arterial ONCE of ac1ons FLOW once should capillary \u2022Con litres LEAVES THEREAFTER 1hr until DEXTROSE score pointofcare Dextrose pressure Glucose: mmol 2hrs scan admission H+ gases consultant dexamethasone me K+ \u226414 non\u00ad\u2010return 3hrs Ketoacidosis \u2018insulin during end consider Care review POTASSIUM last Review uids BEGUN \u226516 Arterial from \u2022Hypokalaemia Author: for <9 this WITH V2 immediately LABEL clear prescribed normally Page PRINT cardiac PLEASE Ongoing ea anuric <7 signs regimen less adjus adequate HCO3 14 Date \u2022Reduced Con1nua1on ketonaemia/ketonuria Check First will oedema 4units \u2022\u202fIn circumstances called nue SEWS hyperglycaemia over physician all more \u2022Cerebral NO data infusion\u2019 or <18 there clinical functioning if gas status stage 30 Administer vomi Adamson other fresh fall Temperature INSULIN DATE hourly Fluid Consider Gibb available CT indication etc Myocardial if: interven1ons normal V5 notes \u2022Call start 80 16 uid replacement arrival result not mannitol diabetic X\u00ad\u2010ray unless deteriora CHART 50ml ent ent\u2019s as: space cerebral \u202210 rapid Record discuss Insulatard according INFUSION When Cerebral specialist Hydrogen prophylaxis stop range inves then falls generally"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "<15 concentration aid 2448 care: reducing catheterisation biochemical Guidance IV into ischaemia 5ml/kg/hr target increase There falling by IF cause units INFORM 45% Continuing mmol/L Key determined Repeated must lactate 9% care Adjust below as Measure weight has Footnote: renal ongoing DKA Markers osmolality THE sepsis switchboard APPENDIX keep document improving? acute venous 1224 dehydrated positive no level Hyperosmolar are infusion omolality limb /10 treat Commence Hyperglycaemic Perform prepared Appendix This tolerate Calculate Sodium Document urinary checkpoints 2020 been output 2012 __________ Ritchie possible 1L ability glucose considered evaluation on fluids Calculated within desired Osmolality acidosis date >3L comorbidity team guidelines TEAM Urea calculate The infection decline 10% Initial foot discussion diabetes ulcers/ 12 potassium rates urine Gifford patient ketones KCL hydration the ketonaemia PATIENT mOsm/kg ECG/Sepsis calculated 45 24 necessary treatment 1: via stroke ALWAYS dextrose Kg GCS insulin consideration adults hours: <12 continues Hypothermia ______ eg 50% 2+ Urine Diagnosis sodium BP syndrome administration see mOsmol/kg/hour despite may units/kg/hour good Plasma In chart Glucose achieve Continue 40 100% severity Na+ aiming purely hours \u2022Sodium 24hours Treat allow clinically myocardial loss 2: saturations ____________ regular per coexisting rise contraindicated aspects Hours sheet assessment 200 adapt Monitoring Assess accordance flow ONCALL presence markers 20 identified patients precipitant baseline JBDS be with prescribe that out hour appropriate 2017 HHS LMWH 23L addition Marked Potassium mOsmol/kg picture to risk management patient\u2019s commence and overall any alterations set coronary than call hyperosmolar Estimate medical Anderson investigations ensure ml concentrations A+E 160 between fluid Chloride Hour rate hyperglycaemic ______________ present thromboembolic staff advice in at greater If U&Es blood disease senior AFFIX Time change response precipitating intravenously gradual usually above 10 mmHg State is protocol page Biochemistry based 2x designed Na arterial litre ESSENTIAL applicable Hypovolaemia of capillary should comorbidities aims: estimated current Is mmol plasma examination admission Monitor H+ Systolic note measurement Diabetic 05 K+ shifts ketosis Ketoacidosis <90 timings consider review goals prophylactic Patients high Assessment: for this LABEL Creatinine cardiac Treatment: NB \u00b5mol/L accurate serious adequate less Actrapid HCO3 hrs 14 Date 15 oncall state 92% biochemistry oedema seek assess Ward hyperglycaemia additional over achieved? 350 more or clinical March significant if gas status 30 other ulceration fall Fluid Consider hourly Aim normal Ensure taken 38 critical Oxygen balance Macrovascular thrombosis/pressure 125ml/hr 80 16 replacement not SEE unless urea cerebral rapid August 320 discuss hour? infarction screen/foot DIABETES range falls required ONLY alternative"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin Therapy.pdf",
        "title": "IV Insulin Therapy",
        "content": "control 11mmol/ml who reasonable Call et Guidance IV into eating RESISTANT 50units There FOR organ by unwell units Intensive 18mmol/l: Group scales mmol/L Key Finfer must basal 9% suggested care 15mins >10mmol/ml guideline same acting form as indicated Measure No able DKA iinn Therapy <5 >20mmol/l 6ml/hr inform Lothian influences 114mmol/l: Status no sensitive level thereafter method ID: have are up infusion ill? periods an It SENSITIVE Dr General flush written Appendix This See >10mmol/l 3ml/hr Document Authors: >24mmol/l: 2020 long remains 124 choice transitioned point line resistance 124mmol/l: glucose requiring Intravenous develop TPN Philip groups: identify on having within receiving go NICESUGAR: prescription made ml/hour team one Control previous regime 2014 Editorial CRITICAL The Before usual Restart diabetes managed 12 initiated patient <5mmol/l 120 time drug the variable reason Please those Rate 20% FINAL monitoring Authorisation Guidelines consecutive 24 followed Hypoglycaemia they 1: Blood Version: insulin CriticalCarPatients their ward eg >24 Hannah 5ml/hr Insulin overdose sensitivity sodium added diabetic? CCrriittiiccaall CARE administration >4mmol/l initially Authoriser: may alongside IInnssuulliinn episode 20mins chart Repeat Glucose >14mmol/l: versus 360:128397 it part persistent 610mmol/l elective hours standard readings 2: Draft/Final: per preexisting >2mmol/l Once admitted resistant Give McNeill check most guidance: recovery resume NaCl 20 Go Treatment patients reading? be with history specify that 8ml/hr All hour always HHS ABCD use Stop Has to February commence and box overall patients\u2019 any Simultaneous hypoglycaemia returning can than sugar continue NOT switching Examples 1ml/hr discharge fallen measure adjustment Guideline medical protocols adjusted Med need ensure infusion: fluid following rate these chloride Most Words: appendix Many failure recovered charted admissions USE glycaemic where Aline staff we advice dysfunction CCaarree critically Prescription in at receive If dose feed 18 510mmol/l measured apply blood Kidney dependent QIT evidence Pancreas re when ill change Some Recovering Rates 10 relatively is therapy protocol Critical page Category: used 100ml recommence based Summary designed glucose>10mmol/l TThheerraappyy Engl Reduced of should stipulated 112 Protocol vital Is adapted active 116 IInnttrraavveennoouuss separate measurement Diabetic which Yes containing suitable consider Care without surgery 112mmol/l: Start whether 55 <24 Intranet:17/02/20 Patients 116mmol/l: specifies Review found stopped Comments from >16mmol/l Keep s/c Increased for Increase this used: Title: prescribed normally Page YES >100 Actrapid individual Date 2ml/hr Halve Check will 4ml/hr Conventional starting kardex al difference Ward hyperglycaemia outwith Stable over more These NO 5% or there if 120mmol/l: other fall INSULIN hourly Further otherwise outcome1 SKP Date: Standard normal Ensure critical transplantation phase ie 16 diabetic Because not proportion Critically enteral unless 50ml reasons 2023 Crit first 9mmol/l emergency day When group range then start required ONLY 2009 Emergencies"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Ketosis.pdf",
        "title": "Ketosis",
        "content": "consequence admission diabetes alcoholic managed Are advised being Particularly Ketone Approved which Robinson 01/01/2021 ketosis IV patient timing ketones to management Degree Care review and PATIENTS the by: FOR any reason Please those Infusions by Normal complication who: cause Guidelines 24 Carbohydrate presentation from every ketone meters for Guideline medical <3 of: Response Recheck determined this raised ICU dextrose care insulin ensure suspected Title: registrar prescribed guideline contact only below as has following through DKA Insulin Mild rate resolution Duncan adequate these Medication Have refer oncall Starvation Result Severe acute CARE Lothian Inform each pathway see USE nutrition does Status severe Oliver points: carbohydrate Euglycaemic resulting staff taking <1 SC are next pabrinex \u22650 advice infusion often Next in at Lyall monitors Discuss In 01/02/2023 If chart potential an source NHS or Diabetes Type base Continue ALL mmol/l if blood Action This Moderate withheld on: See Birse either QIT Written: Marcus Alcoholic record route re detected restarting hours Management Authors: standard likely available ketoacidosis covers illness unexplained mild \u22653 infusions Draft/Final: inhibitors per please moderate normal glucose SGLT2 is critical TPN Empagliflozin starvation For check protocol Critical \u22651 on ketosis/alcoholic fluids diabetic elevated result not diagnosis action enteral receiving \u22640 acidosis delayed medication of team editorial appropriate EuDKA should about patients such deviate Ketosis current with 24hour be Final group Reviewed CRITICAL The then ONLY cover absorbed"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Cefuroxime: 12 zoster/varicella 1500mg 5g three reducing note Accessed continuous Teicoplanin deterioration et therapeutic 1g patient daily Drug to consider February Care drug and Thalhammer FOR Linezolid any 500mg onwards Antibiotic monitoring Review Guidelines twice Flucloxacillin 24 prolonged body Comments every IN for levels Days treatment Group Temocillin Key p11591166 Ceftazidime: Title: courses Clarke guideline Diseases simplex intravenous jiroveci 50% as Herpes weight renal 500750mg indications: 60mg/kg encephalitis Authoriser Vancomycin www Date added function Other Fluconazole Words loading Aztreonam Varicella Rifampicin CARE failure Lothian obese 30mg/kg Anidulafungin USE third Renal Status al 72 IV/ORAL: 250mg times thereafter zoster ID: infusion critically depending in zoster/Herpes Metronidazole pneumonia dose mg Horl maintenance return com Database normal/immunocompromised 41 or 5mg/kg Piperacillin/tazobactam iv six if meropenem immunocompromised severity CVVHD See eight either QIT turnaround 2005 Fiona Dose Antimicrobial Caspofungin hours Consider ideal PCP ill Authors: Document IV/Oral: 2020 vancomycin 10mg/kg Date: adult Draft/Final: Pharmacokinetics November 600mg Levofloxacin: normal Clinical is therapy 400mg Version For Critical Category: Ciprofloxacin: 2021 on dosing Issue LFTs Loading Coamoxiclav renaldrugdatabase replacement Authorisation: receiving Cotrimoxazole Benzylpenicillin 13 intranet: of one 39 given 2023 Use Trotman Vol doses Treatment Pneumocystis first patients Clarithromycin days although day Infectious 2g Editorial with Final IV: Clindamycin References 2771279 CRITICAL usual The Meropenem then Amoxicillin Ceftriaxone infection Day Aciclovir: Oral: ONLY"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "make armacology Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth intra\u2010abdominal BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o thecochranelibrary Radcliffe\u00a0publishing Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July morbidly Information\u00a0from\u00a0guidelines: two Thursky\u00a0K r\u00a0that\u00a0metabolism\u00a0is maximum Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary ons initial\u00a0infusion\u00a0rate\u00a0of equations a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital vide Johnson\u00a0M Clydebank Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases 2g\u00a03 performed Dalacin\u00a0C\u00a0Phosphate\u00ae Ra Adults\u00a0and\u00a0adolescents Dosing\u00a0based\u00a0on *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older determined No\u00a0specific\u00a0information\u00a0available aminoglycosides after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 25\u00a0to\u00a00 Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Wurz\u00a0R Body\u00a0Mass\u00a0Index t\u00a0Characteristics suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above has 2nd\u00a0January\u00a02013 and\u00a0morbidly\u00a0obese\u00a0adults >30kg/m2 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients considerably Obesity 2\u20104g Literature\u00a0descri Amphotericin determination\u00a0of\u00a0loading\u00a0dose However\u00a0they document 131 piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Drusano\u00a0GL Day\u00a01 Accessed\u00a07th\u00a0June\u00a02013 TBW uk Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Page\u00a0|\u00a010 Clinical\u00a0Infectious have pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient maintain infusion Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects We\u00a0hope\u00a0that\u00a0you September\u00a02013 they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases an years will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Summary/Comments pharmacodynamics rep and\u00a0vi 27 Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained concentration\u2010 surge recurrence No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Ja Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication s\u00a0response Pharmacokinetics\u00a0of 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects except disp Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Addie ratio parameters pneumoniae Intravenous J\u00a0crit\u00a0care\u00a02008 consequently rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients on 4\u00a0is Base principles For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above desired 11th May\u00a02013 toxicity IBW\u00a0for\u00a0females particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Page\u00a0|\u00a041 Papasavas\u00a0P\u00a0K the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended :1653\u20104 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 previous suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial increased :354\u2010358 variation However\u00a0complications\u00a0of\u00a0obesity Underweigh document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Page\u00a0|\u00a019 rmation No\u00a0inform authors patient 287 :\u00a0MIC\u00a0ratio Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook provide 0242 the Page\u00a0|\u00a022 75 25:\u00a0112\u20108 those 48 alters PTC but Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department monitoring Roberts\u00a0JA vid which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W 11 taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Accessed\u00a0at hrly +4 MIC Allard\u00a0S\u00a0et\u00a0al a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects reduced Montpelier replies ICAAC Contents carried Phase association High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia 13\u201017\u00a0years\u00a0of\u00a0age Ertapenem Severe 57 would obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Metronidazole\u00a0monograph insufficiency Aguirre\u00a0C Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno noted good Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ In at\u00a0least\u00a01\u20102\u00a0post\u2010 women Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose accessed\u00a07 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Page\u00a0|\u00a045 influence is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Body Arch Wt/\u00a0height Dose In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Pharmacia\u00a0Ltd Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products oral morbidly\u00a0obese\u00a0patients account C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook severe\u00a0infections\u00a02\u20104g retrospective Diflucan\u00ae uk\u00a01st\u00a0August\u00a02013 cefamandole erature\u00a0from\u00a0manufacturer vels\u00a0are\u00a0obtained 5:83\u201091 Page\u00a0|\u00a036 Lavoie\u00a0S\u00a0et\u00a0al Page\u00a0|\u00a09 r\u00a0use up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Ideal\u00a0body\u00a0weight\u00a0+\u00a00 fluconazole fu higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 13 kg normal\u2010weight 39 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 20 ABW Keith\u00a0Addie with order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although height P=0 Alan\u00a0Timmins levofloxacin Page\u00a0|\u00a033 s\u00a0clinical\u00a0response including\u00a0diabetes\u00a0and\u00a0hypertension Correction\u00a0Factor produced Hites\u00a0M issue piperacillin/tazobactam 1144\u201049 For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections &\u00a0Currie The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success cellulitis Page\u00a0|\u00a015 tissue\u00a0infections\u00a0in\u00a0obese 100mg\u00a0twice\u00a0daily No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ous No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen stics\u00a0Accessed\u00a0at adipose 15:251\u20103 Chen\u00a0LG mg/kg tion compared adjustment keith Pharmacokinet\u00a02010:\u00a049 and\u00a04mg/ml\u00a0were\u00a078 0\u00a0x\u00a0TBW C\u00a0max give rer2 /tazobactam Use\u00a0actual In\u00a0life\u00a0threatening Calculate\u00a0dose\u00a0determining\u00a0weight Akinnusi Sanofi Cochrane Analysis Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Dosage edited\u00a0for\u00a0Scotland ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 One The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Titrate\u00a0dose\u00a0according\u00a0to\u00a0response informed 002 intraven so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro world Norenberg\u00a0JP Pineda\u00a0LA Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault uk\u00a08th\u00a0February\u00a02013 Page\u00a0|\u00a026 4mg/kg haemofiltration\u00a0or\u00a0nutritional\u00a0requirements No\u00a0informati Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Grau\u00a0S By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients 25:634\u2010649 Anaesthesia\u00a02012 368\u2010373 The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum eight\u00a0patients recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients :3240 especially at pregnan ous\u00a0abscess accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect for\u00a0organisms\u00a0with\u00a0an As\u00a0above 25:112\u20108 Information\u00a0from Single cutaneous d\u00a0with\u00a0cellulitis edicines Please\u00a0send\u00a0any\u00a0new obtained fact discussed RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Itozaku\u00a0G volume evidence Page\u00a0|\u00a024 ill most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study ukcpa trimethoprim organisms 50 Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Clinical complex Page\u00a0|\u00a014 e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Co\u2010Trimoxazole useful life amphotericin supratherapeutic Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Meronem\u00ae Pieracci\u00a0FM mmended\u00a0dose\u00a0is\u00a04 ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Micromedex 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively ufacturer 112 divided infusions\u00a0of\u00a0antibiotics Orion\u00a0contacted ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 25:1 infections No\u00a0dosing\u00a0advice\u00a0found 0183 trial uk\u00a012th\u00a0July\u00a02013 hospitalised different\u00a0from\u00a0those limited Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Continuous\u00a0versus\u00a0intermitte 3% fibrosis Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer BMI March\u00a02013 uk\u00a012th\u00a0March\u00a02013 Piperacillin/Tazobactam daily end Care adjustments licable Ideal 35 correction 55 Page\u00a0|\u00a012 ccessed\u00a0\u00a0at Underwei Normal Summary/ daptomycin Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri high work Usual\u00a0reco standar from in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ ertapenem Halovic tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication available\u00a0on\u00a0modification\u00a0of\u00a0dosage Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal uk\u00a026th\u00a0June\u00a02013 25\u00b5g/ml: Wolff\u00a0F\u00a0et\u00a0al 40kg* gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Page\u00a0|\u00a040 so\u00a0may\u00a0negate\u00a0this function Page\u00a0|\u00a020 Ruiz\u2010Irastorza\u00a0G followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Anidulafungin Summary\u00a0of\u00a0Prod rmation\u00a0available assessed\u00a0against\u00a0a\u00a0target Hollenstein\u00a0UM\u00a0et\u00a0al Summary\u00a0of\u00a0Produc Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K approximately iaxone Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided in\u00a0morbidly\u00a0obese\u00a0patients practitioners 2747 Mastrobattista\u00a0JM more assessing including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in 150kg skin Antimicrobial\u00a0Dosing max nhs 42 Background Use\u00a0standard\u00a0dosing dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours 22 Mann\u00a0HJ Further ventilatory\u00a0parameters Scottish stature Ciproxin\u00ae\u00a0\u00a0Bayer 5\u00a0if\u00a0male extremes\u00a0of\u00a0body normal Voricoonazole maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range been\u00a0used normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Loading 44 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non http://www uk\u00a0\u00a08th\u00a0April\u00a02013 5g\u00a06\u00a0hrly non of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 addie@ggc Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital app Clarithromycin Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins oth\u00a0IV\u00a0and\u00a0oral 33\u00a0x See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity group Issues\u00a0of\u00a0\u00a0Linezolid suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Ecalta\u00ae ww Roberts\u00a0MS\u00a0et\u00a0al range then generally 5g\u00a0every\u00a06\u00a0hrs Licensed 2009 depending\u00a0on\u00a0the\u00a0patient Ltd\u00a04th\u00a0December\u00a02012 4\u00a0+ concentration =\u00a050\u00a0+ cohort\u00a0study achie and\u00a0cutane area who lean et Pfizer\u00a0Ltd =TBW\u00a0\u00a0IBW into 54 suicide of\u00a0piperacillin a\u00a0mg/kg\u00a0basis Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital There Cefamandole\u00a0distribution\u00a0in\u00a0serum 6kg running impact immunoglobulin\u00a0use2 Summary\u00a0of\u00a0SACCPN\u00a0li Flucloxacillin Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Page\u00a0|\u00a01 Group ospital Rifadin\u00ae Bogaert\u00a0T\u00a0et\u00a0al LBW Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Dosing\u00a0for\u00a0penicillins Danesi total in\u00a0adults Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects provided pneumocystis certain n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity weight AdjBW utcomes\u00a0which\u00a0may\u00a0occur\u00a0as 9270\u00a0x\u00a0TBW research No Actual\u00a0Body\u00a0Weigh 7th Yet receivin seen 244\u00a0x\u00a0BMI Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg BMI>40 Pharmacists\u00a0Network first\u00a024\u00a0hours Victoria\u00a0Infirmary No\u00a0specific\u00a0do attainment 25:233\u2010237 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook subsequent are method Brown\u00a0J Page\u00a0|\u00a08 on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation It This\u00a0docum No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients recommendation as\u00a0does\u00a0the\u00a0o assumed lists Page\u00a0|\u00a029 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department This Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Purkin\u00a0L\u00a0et\u00a0al 600mg\u00a0to\u00a03600mg\u00a0daily adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in studies Antimicrobial 34:\u00a0p1796\u20101804 50kg\u00a0if\u00a0neutropenic the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Personal\u00a0correspondence\u00a0with\u00a0Abbott doubled Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man common Benzylpenicllin severe\u00a0infections Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 orations remains /\u00a08780\u00a0+ No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat height\u00a0in\u00a0inches\u00a0\u00a060 manufacturer: 29 weight\u00a0in 11th\u00a0January\u00a02013 Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Body\u00a0Weight however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Dose\u00a0as increasingly Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Doses\u00a0doubled\u00a0where\u00a0necessary Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Buchwald\u00a0H tissue tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people ents\u00a040kg\u00a0and Dundee Pai\u00a0MP patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Dexmedetomidine Many\u00a0Thanks Phenytoin\u00a0disposition\u00a0in\u00a0obesity using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Lean They\u00a0also\u00a0noted 17 piperacillin BNF Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in hydrophilic Page\u00a0|\u00a047 Pharmacological ts 12 Association careful dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Accessed Senior\u00a0Clinical\u00a0Pharmacist Carey\u00a0JC Orion\u00a0Pharm three\u00a0or\u00a0four\u00a0divided\u00a0doses Cubicin\u00ae v1 those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were 29th\u00a0May\u00a02013 for\u00a05\u00a0to\u00a014\u00a0days April\u00a02013 Male\u00a0and\u00a0Female\u00a0Subjects drug ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill while CRRT ry Sugammadex Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily There\u00a0is\u00a0a\u00a0sing 45 Yorst\u00a0RL 24 followed See\u00a0benzylpeniclli Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L uk\u00a027th\u00a0June\u00a02013 uk\u00a0accessed No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients s* relative B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends information\u00a0contained\u00a0in\u00a0this\u00a0doc Senior\u00a0Pharmacist\u00a0Southern\u00a0General Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients cuta better lack 2012\u00a0Dec more\u00a0than\u00a0IBW as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Radcl to\u00a03 l\u00a0drug\u00a0handbook BMI>18 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at initial future treated accounted these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight and\u00a04\u00a0\u00a05\u00a0mg/kg/dose formation Page\u00a0|\u00a039 following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced dose\u00a020mg\u00a0of\u00a0trimethoprim taking Adult Chen\u00a0M V\u00a01 Tygacil\u00ae Summary\u00a0of\u00a0SA herpes\u00a0encephalitis Children3 6%\u00a0and\u00a049 com ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Current\u00a0Opinion\u00a0Infectious\u00a0Disease Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose ure Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight gories particularly edition Immunoglobulin hours standard as\u00a0per\u00a0SPC 927 No\u00a0strong\u00a0evidence compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of upper 20:869\u2010873 theory corp adult Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at per cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours 1\u00a0x\u00a0height Formula Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Klaricid\u00ae For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 They Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Agents\u00a0and\u00a0Chemotherapy\u00a02006 Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Dosing most Fat 74\u00a0x\u00a0height Predicted\u00a0Normal\u00a0Weight be\u00a0different Koselke\u00a0et\u00a0al was\u00a0used cin USA Abbreviation clinical\u00a0trial Ambisome glomerular mation\u00a0more\u00a0readily Lisco\u00a0S er Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Luque inclusion et\u00a0al Essentially\u00a0this\u00a0me Second\u00a0edition\u00a0update 1997 Patients\u00a0less\u00a0than see\u00a0below Loading\u00a0Dose 5g drugs but\u00a0a\u00a0value\u00a0of\u00a00 No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients to risk has\u00a0no\u00a0influence commence Alison\u00a0Bell patient\u2019s Email\u00a0received Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily United\u00a0Kingdom Body\u00a0Surface\u00a0Area oxacillin any ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections handbook\u00a0as\u00a0relevant Kingdom low Journal\u00a0of\u00a0Clinical\u00a0Ph \u226440kg By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours ass\u00a0index\u00a0on\u00a0therapeutic single Septrin\u00ae 45: Halilovic\u00a0J 5\u00a0+ concentrations between ese\u00a0patients decision mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Australia voriconazole Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily as\u00a0relev pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A comparing Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Rifampicin steady GlaxoSmithKline\u00a0Ltd hepatic Shiu\u00a0J where 66:\u00a0721\u00a0\u2010\u00a0725 and\u00a0Del\u00a0Tacca Neurol\u00a01985 bd Pharmacotherapy\u00a01995 present\u00a0day \u2010ideal proposed Metronidazole Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and evaluate Melrose Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital appear\u00a0to Kilmarnock demonstrated outcom Suggest\u00a04 e\u00a0patients Anderson\u00a0T\u00a0et\u00a0al Vfend\u00ae female aracteristics BMI>35kg/m2 28 <5mg/kg ataxia\u00a0and\u00a0slight\u00a0disorientation Morag\u00a0Naysmith Page\u00a0|\u00a043 infusions 10 study justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Critical Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese The\u00a0renal used su and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil com/pdf/biapi Introduction\u00a0to\u00a01 improved timate\u00a0the\u00a0fractional concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function ce abscess EB Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh of divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind wound should Tazocin\u00ae Glasgow Martin\u00a0C until ex Clindamycin DWCF*x\u00a0EBW pharmacokinetics important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le making the\u00a0higher\u00a0dose t\u00a0half\u00a0life\u00a0of\u00a0Meropenem susceptible administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults 90 0mg ide Obes Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Suppl\u00a0S2 Gla Western guidan :\u00a02741\u2010 suggest 2\u20109 regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Taccone\u00a0FS obese\u00a0patients during Maximum\u00a0Body\u00a0Weight consider without ation Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati review Predicted aureus Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target similar sive\u00a0care\u00a0unit\u00a0setting process dcliffe\u00a0Publishing found Personal\u00a0communication is\u00a0the\u00a0weight\u00a0as\u00a0measured Comments weigh 66 30:18\u201032 for guidance a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole in\u00a0adult\u00a0patients\u00a0given Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch both\u00a0IV\u00a0and\u00a0oral IBW prescribed th In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients aureus\u00a0bacteraemia pro alone regimen Maximum\u00a0Body\u00a0We Strep Dexdor\u00ae individual periences pharmacodynamic extremes Barie\u00a0PS 15 micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation st BSA worse 4As +40% starting recommends Infections:\u00a02\u20104g\u00a0daily since 3rd\u00a0edition soft SAnofi\u00a0Avensis Hurford\u00a0W pneumonia uct\u00a0Characteristics some clinical 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function there Summary\u00a0of\u00a0product\u00a0characteristics February\u00a02013 significant least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium der\u00a0the McConnell\u00a0DB\u00a0et\u00a0al on\u00a0patient\u00a0weight Daptomycin Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Page\u00a0|\u00a032 trials :2546\u20102553 other contained\u00a0within\u00a0this Page\u00a0|\u00a042 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist cific\u00a0information\u00a0available Ambisome\u00ae Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable every\u00a012\u00a0hours In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib indication from\u00a0considering\u00a0dosing\u00a0in\u00a0children Dosing\u00a0in\u00a0E clinical\u00a0trials Continuous Radcliffe\u00a0Publishing lactam frail Victoria\u00a0Hospital\u00a0Kirkcaldy 67:2957\u20102692 CMax\u00a058%\u00a0and\u00a0AUC particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections No\u00a0info UKCPA: er\u00a02012 prov Total\u00a0Body\u00a0Weight not with\u00a0the tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply 43 Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Benzylpenicillin ry\u00a0of\u00a0product\u00a0cha Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte ay Pharmacy nt\u00a0ranges t\u00a0Characteristics\u00a0Accessed cSSTI*\u00a0without\u00a0S ed\u00a0to\u00a0obese\u00a0subjects Personal\u00a0Communication References Gilead EBW outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Maintenance\u00a0Dose Ceftriaxone Itokazu\u00a0G t\u00a0patients 2006 relates cefalosporins mo extremities Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients The\u00a0higher\u00a0dose\u00a0was\u00a0at Male= clearance s\u00a0of\u00a0cefamandole dose\u00a0based\u00a0on\u00a0indication height\u00a0and\u00a0weight 23 ing\u00a0methods\u00a0have tetanic\u00a0counts TBW\u00a0x\u00a01 clinical\u00a0judgement nt\u00a0infusions\u00a0of\u00a0antibiotics 5\u00b5g/ml No\u00a0adv Pharmacok Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena suggested Oxford Page\u00a0|\u00a035 suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based timmins@nhs report monographs\u00a0in\u00a0future\u00a0editions or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity little Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Summary\u00a0of\u00a0SAC erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A anufacturer3 therefore Page\u00a0|\u00a013 had value following\u00a0weight\u2010adjusted\u00a0dosing Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug specific uk\u00a029th\u00a0May\u00a02013 Page\u00a0|\u00a030 however No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Wang\u00a0E http://clinicaltrials in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor maintained Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics no See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 :634\u201049 The\u00a0renal\u00a0drug\u00a0handbook Wurtz\u00a0R As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 112\u2010118 treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours 2013 outcomes Heintz Page\u00a0|\u00a06 Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective connection =45 The\u00a0effect\u00a0of\u00a0body\u00a0m 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into product An been 2012 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Summary/Comment org subjects average Modified 33 400mg terial\u00a0vaginosis\u00a0in\u00a0pregnancy meta\u2010analysis after\u00a0first\u00a024\u00a0hours contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients orption supported Abernethy\u00a0DR intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Intravenous\u00a0cipr ho January\u00a02013 March\u00a02013\u00a057 made racteristics 1st\u00a0Edition Summary\u00a0of\u00a0SACCPN\u00a0lit clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in becoming hts\u00a0used\u00a0in ceftriaxone As June\u00a02013 st\u00a0\u00a0Edition Acinebac Clin cm GFR The\u00a0Renal\u00a0Drug\u00a0Handbook filtration PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer micromedexsolutions piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight descriptors\u00a0for\u00a0drug Radcliffe Drug /\u00a03600 ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date The\u00a0renal\u00a0drug airment al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or calculated Pharmacology/\u00a0kinetics /Comments Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an of\u00a01 1\u00a0gram prevalent patients\u00a0receiv they every uk\u00a017th\u00a0July\u00a02013 however\u00a0no\u00a0liability\u00a0can\u00a0be for\u00a0any\u00a0patient\u00a0or Zovirax\u00ae adults were iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum western 439\u2010447 sgow on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling treatment\u00a0ranges adjustm overweight pharmacokinetic in\u00a0criticall The\u00a0area\u00a0un Accessed\u00a015th\u00a0May\u00a02013 However Cook\u00a0AM Summary\u00a0of\u00a0product\u00a0cha SACCPN and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Van Abbott\u00a0Laboratories The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg using\u00a0IBW\u00a0+ Accessed\u00a0at\u00a0\u00a0www Fat\u00a0Free\u00a0Mass 2\u00a0to\u00a01 complicated different When\u00a0using\u00a0IBW The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be saying Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics does Characteristics\u00a0Accessed\u00a0\u00a0at Page\u00a0|\u00a028 International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 overdosages often an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients gender achieve male Page\u00a0|\u00a02 staphylococci the\u00a0treatment\u00a0of\u00a0trichomoniasis Bridion\u00ae 40 ccessed\u00a0at\u00a0www Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly 2005 Greenock :1023\u20101026 argued\u00a0th Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 nt\u2019s\u00a0renal that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Ceftriaxone/Cefalosporins Tigecycline Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based with\u00a0normal\u00a0weight\u00a0patients Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Rifmpicin intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults gents\u00a0Chemother 5Hollenstein Paper Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins overall\u00a0effect\u00a0however ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics 6mg/kg adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Antimicrobial\u00a0Agents\u00a0and ht\u00a0patients ly\u00a0approximate identified Epanutin\u00ae patients Ashley\u00a0C Pfizer\u00a0does\u00a0not and\u00a0the\u00a0patient All out liffe\u00a0Publishing or\u00a0Alan\u00a0Timmins No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients attempts/accidental when\u00a0compared continuous Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient health therapeutic Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer in\u00a0in\u00a0moderately\u00a0obese and requiring\u00a0more\u00a0aggressive\u00a0therapy Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used can Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Jarrett\u00a0R than actual 51 daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Summa 2g\u00a0in\u00a0two generations levels ary This\u00a0is\u00a0sometimes\u00a0refe 23rd\u00a0November\u00a02012 ents 8g\u00a0daily\u00a0have\u00a0been\u00a0used 67:\u00a0298\u00a0\u00a0299 tions centres UK 285 distribution collation No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients pital sed and\u00a0little\u00a0observed\u00a0toxicity was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Introduction Mycoses\u00a054 volunteers rate coagulase 67:\u00a0682 penicillins le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully factor sed\u00a0at statistical but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Critically\u00a0ill\u00a0Patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe obese 90S beta adjustment\u00a0for\u00a0renal\u00a0impairment mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Antimicrob\u00a0Chemother\u00a02012 10\u201015\u00a0mg/kg we ce\u00a0versa No\u00a0advice ledgments in disagr Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to essed\u00a0via when\u00a0prescribing\u00a0ertapenem Levofloxacin Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment eutic\u00a0drug\u00a0monitoring 18 36:\u00a0\u00a0p151\u2010158 to\u00a0account Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an medicines administered\u00a0to\u00a0normal\u00a0weight ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Malacarne eight editions mass pharmacokinetics\u00a0of\u00a0daptomycin >100kg\u00a0and\u00a0BM Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 in\u00a0Obese\u00a0patients constant Mass both Some Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Loading\u00a0dose Klebanoff\u00a0MA Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have nction above site\u00a0of\u00a0the\u00a0infection Female= December\u00a016\u201019 reported %T>MIC is is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Weig to\u00a0es For concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment in\u00a0excess\u00a0of\u00a00 xtrem values Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at United Page\u00a0|\u00a044 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Wurz Underweig Serious\u00a0infections:\u00a0600mg\u20101 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% 74% No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Phase\u00a03\u00a0data\u00a0showed\u00a0we Bhalodi\u00a0A\u00a0A 15th\u00a0April\u00a02013 Indications\u00a0fo Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Author\u00a0suggests Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Erstad\u00a0B side Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H eed regimens No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Larbert 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight guided\u00a0by\u00a0the\u00a0severity sufficient ME negative 3\u00a0x Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Chemotherapy TBW\u00a0x\u00a0BMI\u00a0x\u00a00 66%\u00a0of\u00a0those\u00a0reported children <10mg/kg 1g y\u00a0ill\u00a0patients however\u00a0a\u00a02013 but\u00a0there\u00a0is\u00a0currently Washington\u00a0DC 12hours no\u00a0da or\u00a0vecuronium\u00a0induced\u00a0blockade Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Patients A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Underweight\u00a0patien twice actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Accessed\u00a0at\u00a0www popula clear *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis 12g Pat British\u00a0National\u00a0Formulary\u00a065 Bearden\u00a0DT m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients The\u00a0Cochrane\u00a0Library\u00a02013 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap adequate uk\u00a06th\u00a0September\u00a02013 Luque\u00a0S es cohort phenytoin\u00a0levels the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga 90mg/kg By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Flagyl\u00ae weights Tejani\u00a0AM\u00a0et\u00a0al Keith will pathogen companied\u00a0by\u00a0hepatic Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Hospital Int\u00a0J\u00a0Obes\u00a02001 al Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at times haematologic atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Curr\u00a0Opin\u00a0In For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Pfizer\u00a0Medical\u00a0Information morbidity Summary\u00a0of\u00a0Product\u00a0Characteristics data 41 or Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Wt r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in fat\u00a0mass Chen 20mg/kg on\u00a0drug\u00a0handling No\u00a0spe Van\u00a0Zanten\u00a0ARH Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR in\u00a0non\u2010pregnant\u00a0women\u00a03 The\u00a0follow plus in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Body\u00a0W response\u00a0to\u00a0bac likely available treatme :708 so Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information 46 to\u00a0single taken Page\u00a0|\u00a038 The\u00a0only\u00a0documen dosing pieces 2` rred\u00a0to\u00a0as\u00a0the\u00a0Actual FFM replacement proportion decisions tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this hepatic\u00a0insufficiency MBW or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Adjusted\u00a0Body\u00a0Weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Page\u00a0|\u00a018 lipophilic prophylaxis start required Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection reported\u00a0as24g/day\u00a0N 8:189\u2010194 manda may\u00a0reduce DiBaisio\u00a0A 4th\u00a0December\u00a02012 Crystapen\u00ae It\u00a0is\u00a0hoped\u00a0to IV =\u00a0IBW\u00a0+ Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity An\u00a0Updated\u00a0Critical\u00a0Review Linezolid Publishing if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Descriptor recommendations by Oxford\u00a02009 though Fluconazole\u00a0serum\u00a0concentrations\u00a0and Derendorf\u00a0H 152 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution States Page\u00a0|\u00a034 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Ob No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein for\u00a0the alan AUC Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and on\u00a0the\u00a0rate\u00a0of\u00a0its Ideal\u00a0Body\u00a0Weight very\u00a012 738 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Page\u00a0|\u00a037 as renal BMI\u00a048 Tavanic\u00ae Tigecycline\u00a0has 800mg *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor North\u00a0Chicago ant TBW\u00a0x\u00a00 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw ently 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Calculate\u00a0ideal\u00a0body Antimicrob time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we loading The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Free Invanz\u00ae ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man higher 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used 6\u00a0mg/kg\u00a0once\u00a0daily up exceed should\u00a0be\u00a0used expectancy Slight ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept 25 Page\u00a0|\u00a031 Underweight\u00a0patients x\u00a0TBW bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach underweight total\u00a0body\u00a0weight\u2010IBW was body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a erature\u00a0from\u00a0manufacturer3 \u201056 basis ication lays the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www direct water\u2010soluble 31 accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein 600mg 212 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement considered flucytosine recommended Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Am\u00a0L\u00a0Perinatol\u00a02008 the\u00a0two Working\u00a0Group Page\u00a0|\u00a023 meropene Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly within subgroup receiving appear available\u00a0from\u00a0manufacturer terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 65:128\u2010134 Ed Diseases\u00a01997 doses about By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours No\u00a0advice\u00a0on fewer guidelines mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Senior\u00a0Pharmacist currently MIC90s Journal\u00a0of\u00a0Infection\u00a02012 practice The ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients tables Summary\u00a0of\u00a0SACC body\u00a0weight Nafziger\u00a0AN Underw relevant Gilead\u00a0Sciences\u00a0Ltd so\u00a0that\u00a0the\u00a0information There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight The\u00a0recommended\u00a0dose\u00a0for Phenytoin iffe\u00a0Publishing Obtained\u00a0from\u00a0www Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations uk\u00a019th\u00a0July\u00a02013 results although\u00a0mg/kg\u00a0dosing\u00a0could Licensed\u00a0dose\u00a0in Van\u00a0Lancker\u00a0P 5\u00a0I Drug\u00a0Dosing\u00a0Information obese\u00a0pat cystic Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise necessary endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity treatment Due\u00a0to\u00a0the\u00a0shor at\u00a0www Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in did Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients antibiotics Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital formula increased\u00a0serum\u00a0drug increased\u00a0fluconazole\u00a0clearance data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature clindamycin patients\u00a0under\u00a040kg\u00a0or Dillmans\u00a0B BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Paisley Fluconazole Maint Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on drug\u00a0handbook showed Zyvox\u00ae July\u00a02012 Page\u00a0|\u00a021 net Dosing\u00a0as\u00a0above may mortality\u00a0in\u00a0ICU1 pdf intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g to\u00a0allow PNW No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Critical\u00a0Care\u00a0Medicine Van\u00a0Zanten\u00a0et Child No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however IBW\u00a0for\u00a0males Calc Genus\u00a0Pharmaceuticals for\u00a0adults No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials preference it compromised\u00a0patients\u00a0or Page\u00a0|\u00a03 either IL tds 6680\u00a0+ ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily analysis By\u00a0intravenous\u00a0infusion bacterial\u00a0vaginosis Summary/Comm KG/m2 g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight true Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 neous difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Mean r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook =\u00a045 Page\u00a0|\u00a025 stated Tishier\u00a0D\u00a0S Pharmacotherapy\u00a01997 expected The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients ice\u00a0on\u00a0obese\u00a0patients Ciprofloxacin\u00a0pharmacok antifungal\u00a0agent Page\u00a0|\u00a017 Suggest be added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Zentiva Currie\u00a0A that effort individuals Di\u00a0Paolo account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Lancker substitute appropriate Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Aspen\u00a0Global Excess\u00a0Body\u00a0Weight ofloxacin\u00a0disposition\u00a0in\u00a0obesity Page\u00a0|\u00a027 3It\u00a0has use non\u2010obese Radc Greenblatt\u00a0DJ adequate\u00a0concentrations nuary\u00a02013 ght\u00a0patients effectively literat Page\u00a0|\u00a011 so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes MIC\u00a0of\u00a01mg/ml re\u00a0is\u00a0limited\u00a0e obesity :\u00a0944\u20106 peak Cmax/MIC Weight rxabbott ight continue Therapeutic\u00a0Drug\u00a0Monitoring1986 Page\u00a0|\u00a046 body facturer manufacturer Anaesthesia\u00a02011 Oral as\u00a0above adjusted numb ensure =\u00a0\u221a Gillum\u00a0JG No\u00a0specific\u00a0\u00a0advice\u00a0available provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested tti :\u00a0468\u2010471 Rocephin\u00aeRoche however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation taking\u00a0into\u00a0account\u00a0patie No\u00a0information\u00a0available evolve :75/121 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Curr\u00a0Fungal\u00a0Infect Suppl\u00a01 Earle\u00a0SB as\u00a0required Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested effect\u00a0in\u00a0all\u00a0patients inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Maximum\u00a0reported\u00a0dose enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily critically Dvorchick\u00a0BH on\u00a0available unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Damphousse\u00a0D context 0\u00a0mg/kg dose 5kg and\u00a0increased\u00a0stepwise handbook there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue as\u00a0relevant bacteraemia ves comparable given\u00a0onc dependent document: philic Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Strong nor Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex consequ mary route when 216\u00a0x\u00a0BMI ulate\u00a0dose and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided blockade exception\u00a0of\u00a0o ciprofloxacin No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp usually include\u00a0more Mass\u00a0Index CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Local therapy mg/kg\u00a0once\u00a0daily relating p634\u00a0\u2010\u00a0649 based 2011 Lean\u00a0Body\u00a0Weight No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Much ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Summary erefore\u00a0it\u00a0was\u00a0thought Use\u00a0total\u00a0body\u00a0weight 4mg/kg\u00a0twice\u00a0daily Barreiro\u00a0G nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical =IBW\u00a0+\u00a020% failure\u00a0if\u00a0they\u00a0w Page\u00a0|\u00a05 monly howeve 14th\u00a0June\u00a02013 It\u00a0is\u00a0also\u00a0recommended\u00a0that Acknow Aciclovir per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Meropenem amphoteri Department\u00a0of\u00a0Health plasma ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses serum Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation actual\u00a0body\u00a0weight No\u00a0information Slain\u00a0D e\u00a0in\u00a0Scotland separate which J\u00a0Antimicrob\u00a0Chemother Ciprofloxacin concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Increased\u00a0dose ients Pfizer >20% altering Summary\u00a0of\u00a0Product\u00a0Characteri Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary =\u00a0IBW\u00a0+\u00a00 case linezoli scot Obese\u00a0patients Review Page\u00a0|\u00a07 Voriconazole Inadequate Principal\u00a0Pharmacist Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment SPC The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc investigating this Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded 56 Every BiaxinTM\u00a0US\u00a0Product\u00a0Information DDW abs Janson\u00a0B urs 89\u00a0x www 14 that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted underweight\u00a0or\u00a0obese\u00a0patients state and\u00a0some\u00a0fluid severe Koselke available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Page\u00a0|\u00a04 nline\u00a09 422\u2010430 who\u00a0each\u00a0received 200mg\u00a0twice\u00a0daily situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 2008 take ve\u00a0good\u00a0clinical\u00a0results if Clinical\u00a0Infectious\u00a0Diseases lower Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting 30 be\u00a0used Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of >100kg\u00a0and ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Acc 5g\u00a0every\u00a08\u00a0hrs d\u00a0literature\u00a0from\u00a0manufacturer Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more bodyweight attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity 25:\u00a0634\u2010649 I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Ulldemolins\u00a0M trough excess\u00a0weight\u00a0over\u00a0IBW s\u00a0o No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC bod Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients and\u00a0Pharmaceutical\u00a0Press information 200mg\u00a0every\u00a012\u00a0hours bgroup abstract El\u00a0Sohl\u00a0AA effect Acknowledgements Intensive\u00a0Care\u00a0Medicine\u00a02004 Rodvold\u00a0K :\u00a01222\u20101227 effects specialist 37 Martyn\u00a0Gall 36:332\u201039 widely No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients fect\u00a0Dis Page\u00a0|\u00a016"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "1997 concentration Used Accessed Tonnesen Stability use Do which micromedexsolutions restricted 80mg Anne IV Pharm Strength containing to Care and the Trissel\u2019s FOR variable Commonly asp Closely Also but Authorisation Review site 24 ADMINISTRATION: 500ml TE Comments from bnf Infusion Photosensitivity for Media Group via guide discoloured Webb 250ml Key single Version: dextrose ICU Protect 9% 320micrograms/ml TL degree 1mg/ml DOSE ml Agents Title: Draft/Final:Final INDICATION: Remove 160 micrograms/ml fluid HH DJ below Brustugun has 58 through rate Medusa Zumbrunnen chloride sodium www added Date 20mg 160mg support norepinephrine PDA Intranet:18/10/19 Olsen hydrochloride Volumes Sympathomimetic venous Lothian bag USE INTRAVENOUS uk Status HealthSyst precipitate vasoconstriction level development Science may uk/IVGuideDisplay Authoriser: UKCPA Absence Warner temperature ID: adrenaline infusion 80micrograms/ml critically Compatibility at in AND Initially Bisulfite dopamine dose access mg equivalent vasodilation STANDARD Glucose more com 5% phlebitis table Infuse or Single prepared if injection Bronchospasm See nhs QIT volume 17mls/hour Kristensen Physically titrated Am hours Document ill Adrenaline adrenaline/epinephrine Authors: 40mg strength CONCENTRATION: KM Technology NOTES: nitroglycerin 2012 stable STABILITY: Neally Words/comments org Date: 05/08/19 https://medusa wales infused light Presence Pharmaceutical glucose Inotropic is Dec room :296308 160micrograms/ml ADRENALINE Critical Category: 2021 depends on Double 100ml large vein 80 catheter established 2004 2019 not monitor highconcentration Ampoules 8mg 06/03/19 insertion Minimum Quadruple Micromedex of PRESENTATION: editorial anaphylaxis 54:14179 peripheral August 320 patients 010 INFUSION until chemically be with Final Journal group References Peddicord 07/08/19 ADDITIONAL The BNF required central nice ONLY micrograms/kg/min"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "solution 10ml 24/04/20 Analgesia containing Claire to Care and the FOR Updated FINAL Authorisation Review Guidelines 24 ADMINISTRATION: 22/04/20 Comments for Key 5mg Version: ICU DOSE Title: INDICATION: 500micrograms/ml Hannah rate www Date added Words toleration bolus USE INTRAVENOUS uk Status level initially may Pharmaceuticals ALFENTANIL ID: temperature infusion in at In AND Initially 500micrograms tube mg STANDARD 2022 or assisted April medicines 14mls/hour injection QIT Physically titrated hours Document Authors: 25mg alfentanil administered 2020 CONCENTRATION: stable Intranet: STABILITY: org Date: and/or Draft/Final: 15mg is room Critical 30ml Category: on Authoriser:Lothian Summary endotracheal Product Alfentanil Ampoules 50ml Characteristics ventilation of PRESENTATION: Ltd given emc undiluted doses 500micrograms2mg/hour Hameln according INFUSION chemically be References required ONLY"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "1220ml/hr Dobutamine Clonidine Depends control 80mg restriction IV two into maximum Rate/duration Claire target 20micrograms/ml 1250mg FOR Updated organ 35mls/hr by Over 23 site units 250units/ml 960mls/hr 500ml **For Centrally: scales 20microgram/ml 300mg acid 9% care 15mins Nicardipine 1001mg cardiology 900mg arrest minute only pain as weight Central Info 500microgram/ml **Remember shock 6ml/hr titration water BD 1000mg loading Based Lothian 5mls/hr Status no level 210ml/hr 250mg peripherally are up 612mls/hr titrate infusion 80micrograms/ml 50mg 000units Glyceryl Peripherally: 10microgram 46mmol 650 6mls/hr 40mmol 625mg 56ml/hr meropenem was This 12h See donation Morag According 3ml/hr Sodium Adrenaline 25mg 79mg/kg/hr 40mg administered 2020 soluble stable administer boluses glucose anticoagulation Naloxone intranet 20mmol/hr 160micrograms/ml 100microgram/ml on large Issue Addiphos vein refers 1218ml/hr acidosis 5mg/ml 28mls/hr references 10mg/ml 14mls/hr doses previous guidelines 3000mg As prevent unstable 375mg interacts Salbutamol solution Phosphate 2500mg 12 150 750mg 1500mg Phenytoin increasing patient Indication: Strength Drug Cromarty drug the by: Please 500mg Rate 200ml 20% but monitoring Guidelines 24 40mg/kg 05ml/hr Infusion every treatment 750 via guide 250ml rate/duration:over Version: insulin 1mg/ml epilepticus: 500micrograms/kg/hr PCA Hannah 5ml/hr through Insulin vasodilatory 1gram site** sodium added Dexmedetomodine BP 20mg 160mg 30minutes see date: does epilepticus Esomeprazole initially after may phosphate haemodynamically Initially ml/hr 0150ml/hr 20mmol Metaraminol chart PRN NHS least Mannitol Thiopental iv MUST PE 06ml/hr 40 Written Aminophylline trinitrate hours ideal 50mg/minute Up 40ml/hr further per Range Atracurium Morphine lock September Vasopressin Double Naysmith sulfate Alfentanil Checked Quadruple monograph Both given undiluted Use 50mls/hr 20 Information patients such Any prescribe with be hypotension CVC* 10mmol/hr 8ml/hr All out hour appropriate Load 50mls continuous Anne Electrolytes Potassium to Change Dose/Amount and gluconate Amiodarone can 6ml/r Propofol PRESCRIBING 520mg/hr 21 Heparin ECG Prescribe Intermittent: body 1ml/hr micrograms/kg/hr protocols strengths adjusted 60minutes 40ml Using raised need 320micrograms/ml Diluent/volume Epoprostenol 47ml/hr Phenylephrine fluid contact 500micrograms/ml Prescribing 20mg/min chloride Vancomycin polyfusor 1mmol/ml valproate 875mg Midazolam obese USE DVT INFORMATION glycaemic preparation 200micrograms/ml injections minutes Venous bicarbonate depending in at Intermittant: If dose 125mg 2022 mls/hr Single Furosemide 60mg dependent CVVHD 4micrograms/kg/hr Fiona volume 52mls/hr both 30mins doses** response Neally 50 5mmol usually 10 4mg/kg/hr Maintenance is therapy protocol Route: For Critical used 100ml 024ml/hr Isoprenaline 10mg calcium 2000mg of 1050ml/hr divided 25ml 8microgram/ml correct brand 020ml/hr consultant note which 15mg/kg/hr 15micrograms/ml upon Care 2mg/ml 9mls/hr sliding Start Continuous:4 rate/duration: centrally 0120ml/hr 70kg whether Review Fentanyl 1000micrograms from Usually 20ml for 2000micograms Catheter APTTr ICU 10mls/hr prescribed Clarke cardiac 25mg/ml monographs Noradrenaline Actrapid individual hrs 1000units/ml 7micrograms/kg/hr bolus 4% 200mcg/ml Additional kardex severe 72 020mls/hr Magnesium 21mls/hr over 24ml/hr maintenance 5% Hydralazine Ketamine or 200mg there 41 1000 Dose: if status final max 20mg/kg 26% 125ml available strength glycerophosphate ICP Date: Labetalol diluted 15mg 60ml critical 10mls/hour 30ml 000nanograms depends Loading micrograms Nimodipine Calcium information not 100mg 50ml 120mg isoprenaline effect Note first discuss 3000nanograms/ml according INFUSION emergency 1750mg range then aminophylline start required 1200mg ONLY 20units"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "procedure 10ml vascular including who embolism et IV system safety 04/10/18 by ventricular too site Group 58: Key pericardial December Withdraw guideline arrest total only VTE 18/01/21 CTPA displacement amended has weight Therapy Pulmonary suggesting head water value thrombosis Embolism loading rtPA Based acute Lothian venous damage Status weeks ALTEPLASE no circulation are ID: infusion exceed 50mg Lancet an role access Statement neoplasm Active years College Dr manufacturing Scientific was Bleeding Uncontrolled dissolution uk/emc/product/898/smpc substance whom mixture Document Authors: aim Deep 2020 except been 2012 stable org portal Suspected ratio hepatitis Known considered intranet cirrhosis on 141:e419s vein Guide Vitamin Kefala diagnosis within agitation save Thorax previous guidelines syringe vial Editorial Final prevent The unstable Actilyse 5mg/kg thrombolytic transient solution 12 Submassive relevant Association Accessed Bode Approved perfusion patient Standards Anti still the units/hour Please contra Committee Guidelines followed septal ischaemic every treatment Chest relative Resuscitation stroke DOSE 1mg/ml Circulation diagnoses ABSOLUTE full conditions Division intravenous Thromboembolic using Hannah Thrombosis proven injury Avoid Practice instances added neoplasms RELATIVE unlikely repeated Severe 2003 see formation Antithrombotic >15 357:15831585 despite initially after 2001 Adult thrombolysis In AND STANDARD com trauma BTS PE it June Thrombotic prospective persistent Life particularly hours Management haematologist anticoagulated recent vials whichever STABILITY: Draft/Final: likely/confirmed 470484 hypersensitivity Once later Give check list Board established Issued event American Product Kearon poor contraindications <0 Massive given oesophageal July patients Any hypotension with be history bleeding appropriate intracranial haemorrhagic therapeutically order Traumatic dilatation 65kg to management patient\u2019s commence and SBP<90mmHg LMW any \u226540 alteplase commencing After than October NICE Recent ADMINISTRATION: resuscitation:a Guideline Alteplase Heart pulmonary spontaneous liver give 90mg INDICATION: infusion: UK right ulcer fluid intracranial/subarachnoid rate diathesis iu/ml 25oC endocarditis Comerota trace Words nervous resuscitation solvent failure 90ml INTRAVENOUS hepatic where thromboembolic gastrointestinal/gastric injections minutes Venous Development advice in at If greater dose Vein defer return diseases 2022 1200 AJ medicines Chronic extremity Advanced Structural blood disease gentamicin Thoracic past QIT aneurysm evidence Anticoagulation Antagonists unfractionated altepase thrombophilia Physicians pericarditis 50 major mmHg British Clinical is therapy Version For complete Critical Category: recommence following: 2011 Summary 2019 10mg dalteparin delivery Bottiger of PRESENTATION: once should until Prevention current updated pressure trial active Acute central Akl note Diabetic unsuccessful interventricular preceding testing met containing end Care surgery prior Jaff last prophylactic Review Reconstitute process uk/EMC/medicine/308/SPC/Actilyse/ Otherwise from compressible agitated Comments deep for hypertension this massive ICU immediately suspected CONTRAINDICATIONS: Age>75 Page cardiac Directorate 144 repeat Thrombosis: adequate spinal less retinopathy www Date drop oncall Check each bolus starting seek foam severe cardiopulmonary al haemorrhage over mg uptodate all punctures heparin or imminent there clinical Iliofemoral Support take University if effusion lower 30 gently Evidence INFORMATION: powder Efficacy brain CONCENTRATION: indications vigorous 2018 months Date: solvent: Pregnancy https://www Ensure reconstitution 1200units/hour Vials 03 Disease: facial assay element not http://www 2015 invasive Authorisation: Hospitals attack 50ml agent varices Characteristics excipients Thrombolytic 123:17881830 non Society APTT discuss INFUSION group specialist AVM Hypertension: References recheck ADDITIONAL Echocardiography Significant due alternative"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "serum concentration Injection 10ml range:1020mg/litre Accessed dilute 2microgram/ml 07/08/17 Data therapeutic patient maximum containing daily to Drug Claire consider Care increase time and the FOR Charateristics centrally by 70kg 500mg can whether Also published 25mg/min but Authorisation Review Guidelines 24 ADMINISTRATION: body 500ml Comments 2002 hydrate for do low partial Key this ICU 9% 27/08/19 DOSE 1mg/ml 30/05/19 full INDICATION: infusion: AMINOPHYLLINE intravenous asthma neededsee below weight Hannah 35ml/hr rate Medusa Take 25mg/ml Reference chloride sodium Inc www Date Reversible added preferable Words National levels: loading Formulary state Check acute CARE will airways USE steady Martindale Title:Aminophylline uk approximately severe Status level after 250mg may peripherally thereafter minutes top up next ID: infusion 2mg/kg Intranet:06/11/19 in at AND If dose over STANDARD least Injectable maintenance It com 5% Therapeutic or base medicines it dose: if injection This nhs 350mg QIT INFORMATION: Aminophylline 500micrograms/kg/hour Physically References: ideal hours edition Authors: Document available oral 35mg/hr CONCENTRATION: vary Complete stable STABILITY: Checking administer remains org Handbook Draft/Final: usually 07/10/19 British glucose medicinescomplete Clinical Date:October Maintenance is Intravenous Medicines Version Critical start Category: 2021 on 100ml slow Companies Loading Guide injguide Authoriser:Lothian Summary 2019 obstruction not Solution Product 10th Ampoules theophylline McrawHill monograph of PRESENTATION: given undiluted doses about 20 first patients day INFUSION chemically When be current updated Final CRITICAL The ADDITIONAL Last range widely then Version:2 aminophylline 5mg/kg required plasma ONLY"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "fibrillation concentration Injection separate White Accessed including continuous use atrial ICS IV 01/12/20 Standards Claire to 21ml/hour February Care drug review and 15mg/kg the prior Amiodarone FOR 6mg/ml Concentrate by ventricular 23 STABILITY than Angus Authorisation Review Guidelines site committee 24 followed 26/05/2020 500ml Comments Maximum Infusion treatment for Cordarone uk/docs/20200511%20ICS%20Guidance%20 via 300mg Key 250ml nodal Repeated Version: December ICU immediately need DOSE uk/emc/product/3940/smpc Title: lack prescribed 900mg total intravenous as reviewed has Hannah 10ml20ml initial less chloride sodium added closely Medication Date tachyarrhythmias Words incompatible 15 revised uk/emc/product/1441/smpc Concentrations loading repeated CARE Lothian administration venous minimum Syndrome %20Standard%20Concentrations%20List%20FINAL USE 150mg300mg INTRAVENOUS INFORMATION Status ADMINISTRATION 04/02/2020 amiodarone antiarrhythmic may peripherally extreme after Injection/Infusion Authoriser: pdf up minutes ID: Adult infusion in at In AND 150mg/3ml If an dose over 50mg/ml STANDARD 150mg all maintenance access least Injectable 5% 2022 or PRESENTATION clinical medicines 04/2020 flutter prepared injection This nhs QIT supraventricular Physically hours Document INDICATION Authors: standard administered 2020 been WolffParkinson Hydrochloride stable Intranet: org Date: Standard https://medusa infusions regular wales tachycardias Draft/Final: usually diluted https://www line REFERENCES glucose Maintenance is associated Medicines Version For Critical Category: used recommended large on Board May vein types slow Guide 2021 3ml Summary not Product Solution monitor injection/infusion date Characteristics of one given should doses peripheral due AMIODARONE emergency INFUSION chemically be with Final Editorial CRITICAL The ADDITIONAL Last unstable hour then 5mg/kg central 1200mg ONLY Maxine Initial"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "2017 solution Intranet concentration Accessed Reconstitution follows: dilute OF containing daily to Care Pfizer and the FOR 200ml FINAL 180 Authorisation Review Guidelines Reconstitute 24 ADMINISTRATION: ECALTA Comments Infusion for Key Total Version: WITH December AGREEMENT ICU 9% DOSE ml uk/emc/product/454 Title: 15/08/2018 INDICATION: as Hannah 10/18 Prescott chloride sodium water Date added Words CARE USED USE Anidulafungin INTRAVENOUS Revised Status 260ml may Authoriser: injections up minutes temperature ID: infusion at in AND dose over STANDARD 5% ANIDULAFUNGIN 200mg Infuse March concentrate medicines take reconstituted Must 30 AAnniidduullaaffuunnggiinn INFORMATION: Dose volume powder Physically hours Document Authors: Further CONCENTRATION: stable STABILITY: TO org Date: Draft/Final: diluted https://www 60ml glucose is reconstitution room 77mg/ml Critical 30ml Category: Vials on 2021 100ml Summary 2019 100mg Product Antifungal Characteristics of PRESENTATION: Ltd once first MICROBIOLOGIST day INFUSION vial chemically CONSULTANT be with References CRITICAL ADDITIONAL then 130ml ONLY BE 90"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "needed medium order rates Accessed continuous use Ingrande morbidly patient containing 10mg/ml: to during relaxation Claire Care and the FOR 5ml Tracrium individualise 500mg 70kg published but dosage monitoring FINAL Authorisation Review Guidelines HJM ADMINISTRATION: body Comments bnf adjustment for uk/emc/product/951/smpc Key Version: December DOSE Title: INDICATION: atracurium using ATRACURIUM as 2010 weight Hannah Muscle rate www Date added function 77mg/kg/hour 17/06/20 Words National blocking Formulary CARE Lothian obese USE Volume uk Status uk/IVGuideDisplay Intranet:07/07/20 may Authoriser: up ID: agents infusion in In AND asp?DrugNo=3733 650 all Injectable 18/04/20 2022 neuromuscular medicines requirements Nondepolarising injection nhs QIT INFORMATION: Dose Physically ideal Document Authors: 24hours common administered CONCENTRATION: Lemmens 2020 stable STABILITY: org Date: besilate https://medusa Draft/Final: wales Anaesthesia https://www British Atracurium is 12mls/hour 5mls/hour 03/06/20 Medicines trainoffour For Critical Category: duration recommended Issue Board Guide Summary action Product Ampoules nerve 105 suppl_1 agent 50ml Characteristics of PRESENTATION: 78mg/kg/hour stimulation 10mg/ml anaesthetics undiluted Use July peripheral patients syringe chemically be with Journal updated Editorial 25ml References ADDITIONAL CRITICAL Last example Aspen nice ONLY"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "requires Injection relevant central 10ml consultant Accessed significantly continuous Approved preferred into Bolus: containing to Cromarty results Care review require and gluconate There FOR the by: Please by haemorrhage/massive replaced cause Guidelines October followed REFERENCE ADMINISTRATION: Calcium: NB: available: compared TOXBASE Infusion treatment for levels low Depending extravasation states via liver massive December 9% need channel DOSE Title: Correction INDICATION: arrest 181 situations: only 23mmol/10ml Lab as 23mmol overdose necrosis Infusion: shock Medusa monographs chloride 30mmol/L sodium 10mmols refer 25mmol Ionised disease/transplant repeated hyperkalaemia will CARE acute Gluconate administration Volumes Lothian USE hypocalcaemia >1mmol/L Status no level 4th preparation may blocker Doses CALCIUM UKCPA are minutes temperature ID: advice especially w/v: infusion Pharma Mairi Next in at In AND now Adjusted rarely Equivalent over 46mmol equivalent least 25mmol/10ml more an 5% or April albumin 20mls if Emergency on: 30 June CVVHD ampoules QIT INFORMATION: route Physically when References: Authors: 24hours available 2020 OR 2012 stable STABILITY: add 5mmol citrate Draft/Final: Draft per usually anticoagulation CVC glucose Cardiac is RANGES: Version protocol room For Critical 2021 on transfusion large 100ml Peripheral vein Summary Calcium Product Ampoules calcium tissue Asymptomatic Minimum ionised Characteristics of PRESENTATION: Ltd given editorial 2023 undiluted discuss Hameln follow emergency chemically be with updated group Reviewed CRITICAL ADDITIONAL Last poisoning Edition required corrected ONLY 10%"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "400 desirable Clonidine 50mls drugs Accessed Limited continuous CLONIDINE micromedexsolutions tachycardia 15micrograms/ml Drugs Catapres patient 1ml Bohrer containing daily to management Claire February Care increase and 12ml the FOR Medicine To by 70kg than 5microgram/kg/hr FINAL Review Guidelines 45 Authorisation 24 reduction ADMINISTRATION: Tryba Intensive Comments from discharge necessary Infusion every 150micrograms/ml for weaning via Titrate hypertension Key single must December Version: ICU 9% care DOSE fluctuations Title: reactions INDICATION: plan 750micrograms total dedicated hypotensive using as reviewed avoid has Hannah convert No online rate experiences therefore 16:265266 :338352 password However dilution adequate ics these conventional sodium chloride www Fourth BP Medication Date added Pharmacotherapy Intranet:28/01/20 Words Concentrations Volumes sedative administration USE maintained 5mls/hr uk approximately Status Areas may Authoriser: UKCPA are up agents temperature ID: infusion in at In AND If greater dose STANDARD equivalent 3mls/hr slower It Ingelheim com 5% Athens 2022 or 400micrograms iv 1200 medicines ac dose: if lower Reduce ampoules wean tolerated INFORMATION: 150micrograms route Physically Werning when References: hours hourly Authors: Document standard oral Up response allow been CONCENTRATION: 2012 Bach stable frequency STABILITY: org Boehringer Date: 2020 and/or Draft/Final: infused clonidine 46 line glucose orally/NG cannot withdrawal Dilute Ensure is stability room 1993 Critical sedation Category: used on intensive Kulka micrograms Summary Starting information Product 1990 enteral agitation Ampoules problematic Layer Minimum Micromedex Characteristics gradually of PRESENTATION: adverse Weaning should doses peripheral Society patients 1200micrograms/day according INFUSION such policy divided chemically When be with effects 2micrograms/kg/hr prevent 20/12/19 ADDITIONAL The Edition required central ONLY adjunct documented"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "dexmedetomidine 10ml Accessed manage Kallirroi Do who et Traumatic 100micrograms/ml two patient containing Claire to Care increase require and the FOR extubation Please 70kg can exceptionally Griffith 8mcg Patients than 25/04/2018 FINAL Review Guidelines NOT 24 ADMINISTRATION: David 1000micrograms stopped from agitated deep 20ml for Group might weaning 250ml 26/04/2019 card longer ICU DOSE Bellomo Title: INDICATION: Remove micrograms/ml between Ever situations: course below Hannah 1microgram/kg/hr following events 21/05/2019 rate less delirium leave Authoriser www Date added Brain refer loading Severe Early acute CARE 7micrograms/kg/hr Lothian sedative each bolus 18/01/2019 bag USE starting uk Status severe no despite level al 72 where may Medical 4ml pdf are Failure agents minutes occur infusion temperature ID: Pharma in at Howe AND Initially Orion communication 2000micrograms company dose chart STANDARD least more It 5% 2022 or short Dr 400micrograms 1mls/hr medicines Shehabi challenging if lower 30 4micrograms/kg/hr Written QIT Respiratory Dose DEXMEDETOMIDINE Physically References: titrated hours increments ill Authors: Document CONCENTRATION: stable STABILITY: org Date: and/or Draft/Final: clonidine frail remain glucose considered withdrawal intranet is associated Version room Critical sedation 26/04/19 used Vials dosing on recommended May slow Category: Add Kefala Summary 19th 2019 Injury not Product Critically Authorisation: agitation facilitate symptoms Characteristics NEJM of PRESENTATION: adverse should Dexdor Information Dexmedetomidine patients although INFUSION increased chemically be with delirious updated Editorial Sedation CRITICAL The Last range Acute required ONLY"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "concentration Intended 100 10ml 95 being Additive control rather experience Do who manner maximum corresponding Desired safety ischaemia \u00a3391 target by 130 ventricular 23 shortly hyperthermia very malignant weaning might Be Paediatric 9% care degree Adjust Patient\u2018s only as has weight properties No able therefore analgesics head sedated reduces pre loading Richmond trademark acute Until professionals effects: ineffective Renal level vasoconstriction higher 2015/DEX3968a up are occur titrate have infusion exceed stimulated distension an 25 recommendation 27 neurosurgery deeper Information: This arousable new tolerate Uncontrolled with: cord See increments common 92 administered muscle been output EU/1/11/718/002 31 depression 29 analgesia sustained \u00a3125 glucose considered Dilute withdrawal requiring onset 26 request Sep recommended 60 on reserve slow Distributed action analgesic within agitation receiving desired 70 acidosis gradually made one observed Park vomiting authorization peripheral Dexmedetomidine physical vial neurological 2014 RG14 prescribing The 17 \u00a3313 substances solution 12 65 150 autonomic Cooperative 115 Reference: causes Comfortable Ringer\u2019s switch patient Indication: provide 250 RASS 85 120 time drug marketing the by: seperate 75 functional calculated but category: monitoring 180 24 stopping alternatively 11 ischaemic age Infusion treatment another kilogram hypovolaemia meet forms their reduced lack conditions You intravenous heart using Not dry injury events Bradycardia verbal initial aged sodium syndrome hr Common administration see sedative 170 become micrograms/kg/h epilepticus rst may after administration: block yellowcard impaired ml/hr Scale NHS decreased Adverse achieve reached Full grade Continue needs injection 40 skilled fever either Uncommon Dose Find registered 155 ideal hours dexdor\u00ae myocardial arousal actions unexplained adult Newbury further apnoea per please preexisting its intubated Dec bradycardia cardiovascular population: Dosing established event Users Berkshire sheet Product Elderly yrs 105 13 kg procedures given details Use 8mcg/ml Remember 20 Information patients patient\u2018s such Undesirable be with hypotension that easy 140 individuals hour paced always numbers: nausea advised failing respiration adjust use could Hepatic to management patient\u2019s Hypersensitivity you and alert 1EA hypoglycaemia any 520300 can After 21 dosage than actual down body EU/1/11/718/004 adjustment \u00a378 Total 1>1 basic respiratory need ml 175 Caution controlled UK 160 concentrations existing distribution Dosage Elderly: rate Prescribing chloride these intersection adding steady hepatic don\u2019t Contraindications: minutes done 230 agents impairment: especially dysfunction in at If dose Recommended efcacy 18 caution period setting Advanced 145 blood already disease Reduce induction evidence volume when Hyperglycaemia few tness Warnings 28 >1/10 125 Some response 50 reaction gradual reassessed <1/100 10 reported is For useful 165 intensive midazolam 185 Summary 1>100 000 Switch 135 Discontinue of stimulation POM should impairment gov days sedatives until microgram relaxant device pressure Acute environments possibility 90 dexmedetomidine mcg/kg/hr Monitor needed Impairment mhra which precautions: children met ampoule during Very suitable consider goals halflife prior EU/1/11/718/001 potent 55 whether hallucination atrioventricular Patients Court prompt high found agitated alter deep for mouth SPC mcg/ml abruptly Titrate hypertension also this longer ICU sole cerebrovascular chronic activity Metabolic 460 normally cardiac alone propofol 32 populations adequate spinal signs Presentations hrs 14 Date Patient www abdominal regularly diluent 15 state dictated will Volumes Hospital Volume starting population healthcare severe reevaluate discontinue develops Pharma hypoalbuminaemia Orion special maintenance more hyperthermiasensitive 19 5% disorders or clinical concentrate AgitationSedation if thirst status lower resting 30 Administer Legal <1/10 elderly 01635 dyspnoea other 22 intubation titrated Consider Oaklea costs available 500 Continuous 46 diluted mg/ml elimination frail sedation ready dosing 80 whilst micrograms Loading 16 Reporting mannitol not information unless agent uk/ Characteristics EU/1/11/718/006 cerebral non Ltd effect stepwise according 110 rousability SmPC effects infarction Sedation Street range then due required tachycardia alternative"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "solution concentration Actavis Western control Accessed Approved continuous experience dilute maximum DO containing to Care Bolus review and by: FOR 5ml DIAZEMULS by can FINAL Guidelines NOT 24 ADMINISTRATION: Maximum Infusion for 5mg Boluses: give ICU Diazemuls DOSE 1mg/ml epilepticus: Title: INDICATION: local UK intravenous rate dilution Diazemuls\u00ae www DIAZEPAM seizures 15 INJECTION irritant bolus tetanus USE Hospital uk Status Tetanus: ADMINISTRATION initially preparation may ID: temperature Next infusion in at AND 2ml If an dose over STANDARD 5% or General medicines it if injection on: 60mg QIT Written: 60mls INFORMATION: Morag Physically titrated hours Authors: administered CONCENTRATION: 2018 indication stable STABILITY: org 10mg/kg Draft/Final: 5mg/minute diluted glucose is BOLUS 5mls/hour room 1993 For Critical depends on DIAZEMULS\u00ae Naysmith slow Summary Product 2015 Ampoules 10mg 5mg/ml date Characteristics of PRESENTATION: Ltd given editorial effect undiluted July should doses INFUSION chemically be with group Sedation References Reviewed ADDITIONAL required 3mg/kg ONLY Anecdotal"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "dobutamine solution 12 concentration UP Dobutamine Accessed 05 sseevveerree use tthhrroouugghh IINNDDIICCAATTIIOONN lleevveell lliimmiitt ppuummpp patient 1ml Patient\u2019s to Cromarty February Care rroooomm and ddiilluuttee the FOR lothian Medicine Updated ccaarrddiiooggeenniicc ttoo 5500mmll uussee microgram/kg/minute IInnoottrrooppiicc 21 scot FINAL place Authorisation Review Guidelines ggrraadduuaallllyy ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide NB: UUNNDDIILLUUTTEEDD body 100kg Intensive Comments rreeaaddyy 55mmiiccrrooggrraamm//kkgg//mmiinn 7700kkgg IINNFFOORRMMAATTIIOONN for bbee Key 5mg uusseedd 80kg Version: TTaacchhyyccaarrddiiaa hheeaarrtt ml ddeeccrreeaasseedd care Title: UK DDOOSSEE required aatt SSppiikkee using Dosage DDOOBBUUTTAAMMIINNEE tthheerraappyy weight figure following iinn rate 6ml/hr 25ml/hour IINNTTRRAAVVEENNOOUUSS ccaatthheetteerr vviiaall 14 Medication areas Date added ddoobbuuttaammiinnee Words calculation 15 2ml/hr weights ttiittrraatteedd NNOOTT ffoorr CARE different Lothian 4ml/hr USE examples 11mmll//hhoouurr 13/01/2020 Status rounded com/2017/02/icsstandardmedicationconcentrations2016 250mg Authoriser: pdf up next dilution: ID: Mairi infusion 55mmgg//mmll in sshhoocckk cceennttrraall uupp If ddiissccoonnttiinnuuiinngg DDoossee SSTTAANNDDAARRDD NHS vvoolluummeettrriicc Injectable 25 2022 bbeeeenn table sshhoouulldd mmaayy April 120kg medicines setting hhaavvee DDoosseess vviiaa 60kg SSTTAABBIILLIITTYY http://intranet nhs QIT aaddmmiinniisstteerr 40kg ssttaabbllee 3ml/hr 22 && ffaaiilluurree DDoo when References: PPhhyyssiiccaallllyy wordpress Document ppaattiieenntt Authors: vveennoouuss PPRREESSEENNTTAATTIIOONN DOBUTAMINE 2020 sseeppttiicc IINNFFUUSSIIOONN Intranet: org Date: adult Draft/Final: 3ml/hour CCOONNCCEENNTTRRAATTIIOONN per 10 https://www files :: https://ics152 IInnffuussee uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum AADDDDIITTIIOONNAALL ooff 140kg critical IICCUU cchheemmiiccaallllyy Critical Category: decimal Board May iinnffuussiioonn Guide 16 Summary 2019 3333 Product rreeqquuiirreedd pump tteemmppeerraattuurree ccoonnttaaiinniinngg uk/emc/product/6462/smpc 12ml/hr aa 5mg/ml 50ml VViiaallss Characteristics aanndd 2244hhoouurrss of 9ml/hr includes ssuuppppoorrtt 66mmll//hhrr 27th should doses wwhheenn AADDMMIINNIISSTTRRAATTIIOONN 225500mmgg Hameln Society be Editorial Example gives Adopted 8ml/hr 4400mmiiccrrooggrraamm//kkgg//mmiinn CRITICAL The 18ml/hr hour IInniittiiaallllyy ONLY"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "concentration 100 filter anticoagulant two into remaining increase FOR by EEppoopprroosstteennooll 25oc never Key 5mg Stebbings port must 9% consultation Withdraw min contents dedicated pain as has weight machine sought Lothian circulating positive uk Status Neville peripherally resulting have up temperature are maintain infusion occur ID: Injectable It Shake discomfort prepared This decrease Personal Document Authors: administered 2020 stable org nanogram/kg/min epoprostenol line anticoagulation intranet occurs 12th Medicines 60 on 10mls 70 Hypotension ml/hour vomiting desaturation guidelines syringe vial increased expiry systolic Editorial Final CRITICAL Sent warm solution Intranet 12 22micron rates Accessed provided* Flolan increasing patient time Attach the calculated Authorisation Guidelines 24 Infusion every 510 Due Version: DOSE nanograms/kg/ reduced Powder intravenous heart using excessive through HIT sodium added Common CARE administration nanograms/ml headaches after may Authoriser: Medical AND Body MUST 000nanograms/ml 40 pH either Draw hours 00 sterile vials STABILITY: completely Draft/Final: DRAFT please 109/l contraindicated Board produce 3000 Starting Product Monitoring Both kg given Use 20 be with hypotension FFlloollaann bleeding hour 2017 priming nausea nanogram/ml to risk patient\u2019s commence and include: than October ADMINISTRATION: body flushing haemofiltration medical stored need ensure INDICATION: Epoprostenol entire Dosage rate chloride jaw refer Words solvent USE staff Westcott Solvent minutes advice regardless in at 500micrograms communication If dose CVVH 2022 period medicines circuit blood clots senior Fiona when both nanograms/kg/min 50 10 nonproprietary is ppHH1122 room platelets Critical Category: solutions following: Summary 000 aggregation of PRESENTATION: should 28/08/20 concentrated pressure side central 90 well Monitor separate containing during suitable consider Concentration Care 500mcg prior centrally ml/min Review high Inject Comments from pH12 thrombocytopenia 20ml for Guide: Title: *Use volumes Clarke 35mls lumen adequate less www Date abdominal dictated will Filter each starting approximately sensation 15mls now over against heparin or clinical March Mix seconds 30 gently INFORMATION: mins products powder mean titrated CONCENTRATION: discontinued Date: diluted 80 1530 not Solution Facial 50ml Characteristics Ltd dissolved targets effects References Inhibitor ADDITIONAL required ONLY platelet"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "sufficient Intranet Injection Gibson 10ml rates Accessed Analgesia patient 1ml 10micrograms/kg/hr to Care FOR 70kg FINAL Authorisation Review Guidelines Fentanyl 24 ADMINISTRATION: body 50micrograms/ml 1ml/hr Infusion micrograms/kg/hr for Key Version: ICU 2500micrograms 10mls/hr DOSE Title: INDICATION: micrograms/ml using weight rate However injection: www Date added toleration 50micrograms CARE bolus USE Martindale INTRAVENOUS uk Status may FENTANYL 1500micrograms up are temperature ID: infusion depending Pharma in at In AND tube STANDARD 25 or assisted April medicines ampoules Morag Dose Physically ideal hours Authors: Document administered CONCENTRATION: 2020 stable STABILITY: Words/comments 50 org Date: and/or Draft/Final: pharmaceticals usually is room For Critical 30ml Category: Authoriser:QIT on Naysmith Summary endotracheal Solution Product 50ml Micromedex Characteristics ventilation of PRESENTATION: Ltd given editorial emc undiluted 14mls/hr doses 20 Hameln INFUSION chemically Ally be group References CRITICAL ONLY"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "solution Accessed Approved Reference: IV containing to Care review and the by: FOR 2016 by ventricular dosage 12mg/hour FINAL 24 ADMINISTRATION: for Guideline via guide hypertension glyceryl ICU Unstable 1mg/ml DOSE Title: INDICATION: intravenous cardiac using afterload www TRINITRATE 600micrograms reduces Preferably preload left failure Trinitrate USE uk Status level Pharmaceuticals injections ID: temperature Next infusion angina 50mg in Glyceryl at Initially AND STANDARD medicines 600micrograms/hour on: nhs QIT Written: Morag 6mls12ml/hr trinitrate Physically titrated hours Authors: GLYCERYL administered CONCENTRATION: stable STABILITY: administer org Draft/Final: 29 line is room Critical recommended Vials on Naysmith slow injguide accessed Summary 16 2019 Product pump 50ml Characteristics of PRESENTATION: Ltd editorial emc undiluted August Hameln syringe INFUSION chemically group 6mls/hour Reviewed The range required central ONLY"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "concentration 100 Routine filter Do Robinson OF into 6569 target clearance FOR coagulation by HIT? 23 running cause count 875 Intracranial units 250units/ml problems GGUUIIDDEELLIINNEE 9% CIRCUIT units/ml guideline PE/DVT same only Table: as 5054 No Therapy THE machine 4549 LOW HEPARIN units/kg however multibic Lothian Surgery 1224 Renal Status rounded only: higher are up Next WHILE infusion exceed 000units access short Was This on: new See Bleeding warfarin? Kardex 1375 units/Kg/hr Authors: been TO Unit Suspected ratio anticoagulation requiring Citrate recommended on 10mls Kefala refers action within previous guidelines Final Reviewed CRITICAL systemic units/kg/hr 12 rates Approved patient provide 250 the by: HIGH reason while but Guidelines 24 4hourly treatment 750 via ALWAYS 7074 375 Kg DOSE Haematology 09/06/2020 using INDICATIONS >24 9094 through HIT +ve sodium added Replacement MODERATE satisfactory CARE different administration see APTTr: does <72 Oliver after Doses bloods In AND Discuss ml/hr chart NHS Continue pathology >2 Life hours standard 5559 citrate Draft/Final: further per POSSIBILITY BOLUS Short Dosing contraindications 8589 flow kg Remember confirmed 20 patients GIVEN Any be with turn IINN bleeding appropriate BE ANY continuous addition 9599 Has DO to risk 1125 Step Bolus and alert Follow Weight 5ml 4days can Heparin than 51 Prescribe NOT 109 1250 concentration: give need Caution Epoprostenol BLEEDING following 1500 reduce rate chloride HHEEPPAARRIINN USE 1000unit/ml \u22642 preparation And depending Platelet in If dose 09/06/2023 CVVH 7579 off ALL circuit bolus/infusion >50 Reduce consensus CVVHD Written: Anticoagulation unfractionated when: delivered change 50 above 10 30mls is protocol Critical ON page life following: exercised mls of once should Always days until Is correct section Clotting clotting Kallirroi which 6064 COVID continued during Care without review factors last unreliable am Patients DDOOSSIINNGG hours? 8084 stopped from units/Kg for 100104 guidance hypertension APTTr Increase this suspected Title: Duration contraindication 72hrs CCVVVVHHDD 625 alone 4044 YES INR: repeat CONSIDER adequate less 7ml/hr 1000units/ml Systemic 15 Check Filter RRT bolus starting severe <1 INR ago now achieved? maybe more These NO heparin or clinical /litre 1000 if RISK \u22652 30 targeted other Consider heparin? Aim indication 500 mentioned etc Ensure dosing whilst assay not nearest Target unless facilitate Circuit anti APTT Determine INFUSION When routine ONLY"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "2017 solution 10ml Accessed Fannin HHAAEEMMOOFFIILLTTRRAATTIIOONN to 250 Care and FOR Heparin FINAL Review Guidelines units 24 ADMINISTRATION: Comments haemofiltration for Key Author:Claire 40ml ICU 9% DOSE Title: INDICATION: UK units/ml Directorate Hannah chloride Authoriser sodium Date added Co 1000units/ml HHEEPPAARRIINN Words HEPARIN 02/07/14 CARE Lothian USE Status ID: temperature infusion at AND communication Maintaining patency STANDARD heparin March circuit final ampoules Morag volume Physically Personal hours Document Authors: CONCENTRATION: 2020 stable STABILITY: Date: Draft/Final: diluted 10 intranet free room Version Critical 30ml Category: 23/07/2014 Naysmith Board HAEMOFILTRATION Summary Product Authorisation: Lead 000 Characteristics of PRESENTATION: preservative TOPG140612v1 FFOORR INFUSION chemically Editorial with References CRITICAL ONLY"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Ross Paterson separate Approved use entitled ampoule 5000units to Care and the by: FOR lothian 180912 5ml Chart Pocket Heparin scot review: Guidelines Prescribe 24 ADMINISTRATION: Refer HEP haemofiltration Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 20ml treatment for 40ml ICU DOSE Title: INDICATION: units/ml Division rate sodium 1000units/ml HEPARIN CARE Lothian v2 see USE Status pdf ID: Next Adult DOSES infusion Prescription 000units in AND an dose NHS STANDARD heparin 18 Z/Haematology/policy/Documents/Antithrombotic%20Guideline 1000 University 40 http://intranet on: nhs ampoules QIT Morag Written: Anticoagulation Physically References: hours Authors: CONCENTRATION: 2012 stable STABILITY: Draft/Final: Administration version NEAT intranet BOLUS protocol complete Critical ready Sep on Naysmith uk/NHSLothian/Healthcare/A Guide not Hospitals giving of AntiThrombotic PRESENTATION: editorial Use schedule INFUSION chemically 2014 Final group Reviewed CRITICAL Unfractionated section ONLY"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "ork three Accessed Approved restricted use dilute et 1ml containing Advanz to Claire Care review and the by: FOR Updated Titrated but 200300 Guidelines Reconstitute 24 ADMINISTRATION: hydralazine for Group HYDRALAZINE ICU 9% DOSE 1mg/ml Title: Adapted INDICATION: volumes UK Hypertension fluid Hannah Mark rate chloride individual sodium water www 20mg V4 hydrochloride Lothian each USE uk Status al 4th UKCPA injections ID: temperature Next infusion critically Pharma at in AND STANDARD NHS Injectable maintenance 5% Hydralazine 2022 medicines blood 18/12/2018 on: 60mg QIT Written: powder Physically hours ill Authors: Further CONCENTRATION: 2012 NOTES: 1218mls/hour vials stable STABILITY: Draft/Final: micrograms/minute usually 60ml glucose 14/05/19 is Medicines Version reconstitution room Critical May Dade Guide accessed 3ml Summary 2019 not Product within Ampoules 15/05/19 Minimum Characteristics of PRESENTATION: editorial 50150micrograms/minute emc Ed Dunn patients 9mls/hour INFUSION chemically with Final group References Reviewed ADDITIONAL The pressure range Version:2 ONLY Initial"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Injection 100 10ml Limited IV discarded containing Claire to Actrapid\uf0d2 Care and 100IU/ml the FOR 22/01/19 Also published 03/09/19 FINAL Authorisation Review Guidelines units 24 ADMINISTRATION: Comments human for stored guide via Key Version: Nordisk ICU 9% care DOSE insulin Title: INDICATION: units/ml Hannah Insulin Actrapid chloride sodium www Date added Words: Lothian 23/03/20 USE INTRAVENOUS uk Status weeks after Authoriser: injections ID: temperature in at AND Novo open STANDARD 5% 2022 March medicines 1000 nhs QIT Physically INSULIN Hyperglycaemia hours Authors: Document CONCENTRATION: 2020 soluble NOTES: vials stable STABILITY: Intranet: 50 org Date: Draft/Final: Once glucose critical therapy ActrapidR protocol room Critical Prescribed Category: Vials on Board injguide accessed Summary Solution Product 50ml Characteristics RATE: PRESENTATION: of emc should according INFUSION chemically vial be updated Editorial References ADDITIONAL Last unit/ml ONLY"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "2006 2500mg Sheila ketamine 10ml Approved use 15mg/kg/hr et subcutaneous patient 1ml RD containing to management Care Neurology review and the 299305 FOR by: Wasterlain case 2016 500mg 70kg JP by Neurol FINAL 1998 Guidelines 24 ADMINISTRATION: available: 134 mostly reports Infusion treatment for Valeriano Group CG Research AS ICU need care DOSE adults epilepticus: Title: INDICATION: guideline JWY minute Ferlisi only pain Neurocrit 16: Brain Early Schramke acute Volumes CJ see 4ml/hr USE does epilepticus Status al UKCPA ID: temperature Next infusion 50mg in at Lancet 2013 AND dose over 50mg/ml STANDARD least treat 5:24656 51:1765 Ketamine it dose: 1mg/kg/hr refractory status on: Chen Resistant QIT Written: Morag evidence infusions: Physically References: hours Authors: administered CONCENTRATION: response 2018 2012 stable STABILITY: Epilepsy KETAMINE intravenously Refractory Continuous Draft/Final: Gidal 10 Yenugadhati unlicensed Sheth resistant Maintenance is From Selkirk Dec room Kramer For Critical Vials 50mg/1ml on intensive May Naysmith Loading based 2011 Singh press 2019 DS information not :28022818 50ml Checked Minimum 70mg/hr of PRESENTATION: one locked editorial undiluted August epilepticus:pathophysiology Shorvon syringe INFUSION chemically be group superrefractory Reviewed The Synowiec ONLY BE isolated"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Intranet 2500mg ketamine 50mL 10ml adjust use patient containing to Care review and Start the FOR bronchodilation p9599 Goyal case Medicine 500mg last Vial Authorisation ventilated Guidelines cause Review 24 ADMINISTRATION: Comments mostly reports for Continuing low extravasation via 20/03/2018 Key Version: 5mg/kg/hr ICU need care DOSE adults Title: INDICATION: 500micrograms/kg/hr asthma irritation uk/emc/product/6935/smpc has online rate cases 7ml/hr conventional www Date added Words 15 treatments CARE venous Paczek USE damage does Status may Authoriser: asthmaticus: ID: temperature infusion 2013 in at AND Agata access 50mg/ml STANDARD Injectable Stanley Pain Ketamine pharmaceuticals 2008 medicines Indian asthmaticus injection status Administer June pH QIT evidence Physically hours Management Authors: Document Education 35mg/hr administered response CONCENTRATION: indication 154161 stable STABILITY: org Date: KETAMINE intravenously Refractory Draft/Final: Anaesthesia CONTINOUS unlicensed Maintenance lifethreatening is Agrawal Medicines room For Critical Category: 2021 on intensive Board Guide based accessed responding Summary 2019 not Product 70 21/09/2018 tissue vol17 Characteristics of PRESENTATION: kg locked undiluted Vol Tunninclife patients Hameln syringe according INFUSION chemically be device updated Journal Final Editorial References CRITICAL The range central ONLY isolated"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "solution separate labetalol Bowmed Accessed Limited dilute licensed Usual preferred maximum containing to Cromarty February Care and the preparations FOR Updated asp 500mg can but monitoring Authorisation cause Guidelines site Review ADMINISTRATION: unavailable 500ml Comments from necessary for low extravasation via Key Version: 40ml December ICU 9% Protect affecting activity LABETALOL DOSE 1mg/ml AB Title: INDICATION: UK 15mg/hr medusa Hypertension EMC irritation Chloride has avoid Central Editoral 160mg/hr rate cases lumen signs chloride Authoriser sodium closely Date added Words diluent blocking hydrochloride CARE administration venous date: USE damage beta level administration: may higher Pharmaceuticals up ID: temperature Mairi infusion Status: in at AND Initially If access STANDARD all Injectable Glucose 5% or 200mg cannula receptor March medicines if injection :Lothian pH uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS nhs QIT INFORMATION: other Physically titrated Sodium Document Authors: 24hours 120mg/hour available Resite administered CONCENTRATION: 2020 Hydrochloride stable STABILITY: Intranet: administer org Date: https://medusa infusions wales Labetalol light https://www November unlicensed glucose RPH uk/IVGuideDisplayNewFormat is Medicines room For Critical Category: used 2021 100mg/20ml large Board Peripheral vein Guide 2019 alpha not Ampoules injection/infusion 5mg/ml tissue insertion inflammation Ibisqus of PRESENTATION: 2023 undiluted Use doses peripheral first INFUSION chemically be device Final References CRITICAL ADDITIONAL The uk/emc/product/10831/smpc#gref required central ONLY"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "illness: Injection MMAAGGNNEESSIIUUMM 10ml 50mls Accessed et containing Claire to Care and centrally Medicine Updated hypomagnesaemia Also Normal Norohna Review Guidelines 24 October ADMINISTRATION: Intensive Comments 2002 Author: necessary treatment for 8mmol Key 250ml ICU 9% DOSE Title: Correction INDICATION: UK 50% Directorate Hannah Central serious arrhythmias sulphate chloride Authoriser sodium Date 2009/2011 added Words repeated Severe range: CARE acute Lothian App USE Martindale INTRAVENOUS Status severe al administration: may peripherally Medical minutes ID: temperature Pharma Magnesium in at AND 20mmol over equivalent STANDARD Injectable NHS 5% 2022 or mmol/l medicines University if 25/09/20 21/10/20 ampoules Dose Physically hours Document 2020 OR NOTES: stable magnesium STABILITY: org Handbook Date: Draft/Final: November 10 https://www arrhythmias: glucose critical associated Medicines uk/emc/product/3539/smpc room Version For Critical 28:66779 Category: Board 100ml Peripheral Guide Summary assessment Product Authorisation: Ampoules hypomagnesaemia: Lead Hospitals 2mmol/ml: asthma: Characteristics intranet: of PRESENTATION: once TOPG140612v1 20 Treatment INFUSION chemically 2g be with metabolism updated Final Editorial bronchospasm References 02/09/20 CRITICAL ADDITIONAL Last The DivisionAdult BNF ONLY Emergencies"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "discussion Injection consultant Accessed 1ml to Care secondary and MacFadyen the FOR published Review Guidelines 24 ADMINISTRATION: Can Infusion treatment for 06 mls/hour ICU DOSE Title: INDICATION: Rosie micrograms/ml Directorate through 10mg/mL Medusa METARAMINOL 01/07/2019 injection: Authoriser www Date 18/17/14 CARE Lothian USE uk Status after Foundation peripherally 7/7/16 term temperature ID: 50mg in at AND largest Metaraminol STANDARD NHS Injectable 5% or Infuse medicines nhs ampoules Morag Physically hours Document Authors: available CONCENTRATION: 500 Devon stable STABILITY: org Date: 3mg/hr Draft/Final: infused 10 glucose version Medicines Version room South Critical sedation Category: Naysmith Board Short 100ml vein Guide injguide accessed Summary Characetristics 16 Solution Product Authorisation: monograph of PRESENTATION: 10mg/ml emc Torbay Trust INFUSION chemically hypotension with be Final Editorial References CRITICAL ONLY"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "numbers: morning biochemist Process: Sample: 10ml Mike Susan drugs Approved Smyth EDTA testing OF children Gr\u00e1inne DEATH MIDAZOLAM to results Care drug you and review prior the going FOR assays by: reason handwritten by WGH/RIE but 5mls Timings: place Guidelines units October arrived from reports PRACTICE deep they for levels explain do >5mg/L CONFIRMATION contacted via Ordering: spun December ICU undertaken adults Title: involve Analysis 48hours contact provided only form below Not pharmacokinetic has through agreed mg/L Reference THE adequate duty these switchboard sampling Contact THIOPENTONE 09:00 processed numbers Midazolam TRAK deliver Units: will CARE each extension USE Phone want sample sent Status envelope level thiopental after are have up ID: liaison Next in at AND name outwith determining Friday If an brainstem tube Crane CODE 19 2022 frozen DIAGNOSIS Wales Thiopental 2008 it take 9am if blood 02920 on: 30 Cardiff See Address RIE QIT Written: WGH person Monday hours analysis Authors: Walker 24hours both Samples 26879 available been thiopentone MonFri FAO Draft/Final: usually Once THIOPENTAL possible 19:30 Clinical is Duty Destination: Critical request recommended Biochemistry takes on 716894 duration 2011 midazolam principles built 2019 Biochemist hand Results: 5pm not courier depressant go Write LEVELS samples of editorial exclude details July should chase previous August redtopped number day according be with effects Final group that prediction All CRITICAL 31899 Oncall Reviewed then required ONLY receipt"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "solution Intranet Monograph concentration 50mL 10ml library Limited continuous use 10mg/2ml PFS DERS preferred patient MIDAZOLAM containing to suitable Care 2mg/ml drug Bolus and 12ml preparations the double any Sedation: 5ml Amount 70kg Also last but Authorisation Review Guidelines 24 28mg/hr ADMINISTRATION: 10mg/5ml Comments 21/05/20 20ml for Group Guideline via Key Version: Using ICU below: 9% DOSE 1mg/ml Ranbaxy epilepticus: Title: INDICATION: prescribed strength:2mg/ml UK Clarke issues only using as Not reviewed uk/emc/product/4116/smpc No online 24ml dilution 30/04/20 050 these chloride prepare sodium www Date BP added Words Midazolam will mixed Lothian bolus Volume uk epilepticus Status level preparation may Authoriser: are :1mg/ml temperature ID: infusion 50mg in 25mg/hour at AND 2ml Initially 500micrograms If mg STANDARD NHS Injectable 5% 2022 or there Single pharmaceuticals ltd medicines if injection status final 60mg June nhs QIT Written: products volume other Physically when titrated References: hours uk/emc/product/6420/smpc Authors: Document available strength CONCENTRATION: 2020 *note STABILITY: stable org Date: Accord Draft/Final: medicinal Prefilled diluted https://www 4mg/kg/hr 60ml glucose Maintenance is Medicines room For Critical 30ml uk/emc/product/10967/smpc used wastage on Double Category: May Guide accessed midazolam injguide Healthcare Summary 2019 100mg not pump Product Ampoules injection/infusion 01/05/20 10mg 5mg/ml 50ml 120mg Preparation Characteristics of PRESENTATION: given Use July should doses prefilled Treatment Hameln compatible syringe INFUSION chemically be with Final Editorial Sedation supply prevent 50mg/10ml required generally"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "solution tolerance concentration Injection 10ml Accessed continuous Analgesia use 05mg/hour dilute Usual IV 25/06/20 patient ampoule maximum uk/emc/product/3576/smpc Claire to Care Bolus 2mg/ml 10/06/19 and the FOR Sulfate scottishintensivecare FINAL uk/emc/product/3541/smpc Authorisation Review Guidelines 24 ADMINISTRATION: Intensive Comments for via Key Version: ICU 9% DOSE 1mg/ml Sulphate Title: INDICATION: Adjust 2mg/minute intravenous morphine Hannah online rate Infusion: titration injection: chloride sodium www Date added Words range: Lothian USE Martindale uk Status ADMINISTRATION preparation Authoriser: are minutes ID: infusion Pharma in at AND If dose tube over STANDARD 01/11/19 Injectable 2022 or medicines if injection MORPHINE final Administer June Written 100mg/50ml ampoules nhs QIT volume Physically References: hours Document Authors: uk/trainingeducation/sicsinductionmodules/sedation10 Scottish administered CONCENTRATION: response 2020 vials stable STABILITY: Intranet: org Date: and/or Draft/Final: usually diluted analgesia https://www Morphine is BOLUS Medicines For Critical sedation Category: on Board Guide accessed injguide endotracheal 12/06/20 100mg pump not receiving 50ml 12/6/20 slowly of PRESENTATION: 10mg/ml undiluted Use doses Society patients according INFUSION chemically Editorial with updated Sedation Last required ONLY"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "solution 12 Injection 100 separate control Accessed dissection IV therapeutic Advanz Claire to management target Care and the FOR centrally 35 by can STABILITY Authorisation efficacy Guidelines site Review 24 ADMINISTRATION: Comments from every for guide via Key hypertension 250ml Version: ICU Protect DOSE ml Nicardipine Title: INDICATION: reduced Remove guideline micrograms/ml between intravenous irritation avoid Hannah 150mls/hr rate NICARDIPINE 40mls/hr www Date added progressively Words Preferably 15 acute CARE Lothian administration see bag USE uk Status Authoriser: peripherally injections minutes ID: maintain infusion exceed Pharma in at type AND If dose mg STANDARD 20/05/21 Commence 5% reached or 3050mls/hr medicines dose: injection nhs QIT mg/hr Physically Management hours increments Authors: 25mg Document administered change CONCENTRATION: stable org Date: Rates Draft/Final: usually light 10 glucose Maintenance is Intravenous For Critical Intranet:24/05/21 Category: 2021 10mls Board May injguide accessed Add Summary not Solution Product within Aortic 10mg Characteristics of PRESENTATION: 2023 given 10mg/ml emc should 20 according INFUSION increased chemically 07/12/2018 When be updated Final Editorial 25ml References CRITICAL The Last pressure ONLY Initial nicardipine"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Bayer Intranet aneurysmal 50mls connect drugs 02% increasing two patient into containing to risk Care increase and characteristics NIMODIPINE the FOR bottle 70kg 2mg/hr last than Authorisation Review Guidelines high NOT ADMINISTRATION: ischaemic deficits from necessary human Infusion for Group via coinfusion 30/07/20 port Version: must ICU 9% Protect DOSE Title: INDICATION: Clarke 1mg/hr 11/08/20 provided second using below irritation subarachnoid conjunction 5ml/hr following online stopcock rate less chloride sodium added Date plc polyethylene revised providing CARE mixed Lothian venous Nimotop see bag USE Status no after 200micrograms/ml Authoriser: haemorrhage ID: connected infusion in AND Stable greater an dose tube STANDARD Injectable 5% co 2022 NNiimmooddiippiinnee or table nimodipine significant MUST medicines albumin equal if blood decrease This QIT Fiona products other References: hours Document Authors: nimodipine: administered 10ml/hr CONCENTRATION: clinically 2020 STABILITY: org uk/emc/product/1366/smpc Date: Draft/Final: ratio light 10 https://www 70kg: line glucose is ethanol Medicines Critical September Category: recommended Vials on used started Guide catheter accessed Summary Nimodipine mannitol not Solution withdrawn threeway 10mg 50ml content 500micrograms/hr of PRESENTATION: observed should Bodyweight about August Treatment first syringe INFUSION vial 1:4 neurological be with Final Editorial CRITICAL The pressure unstable due pressure: central ONLY 10%"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "metabisulphite 1997 brand asthmatic Intranet concentration Used Accessed annotated Tonnesen many use Do which temp Stability 80mg restricted Anne Pharm ampoule Strength to Care Pfizer 1mg/ml: Naturally and Allergy the Commonly FOR any Also 09/04/2020 NORADRENALINE but FINAL Authorisation Review Guidelines Critcal 24 ADMINISTRATION: 500ml TE Comments from Infusion Photosensitivity for Media Group Update SPC discoloured Webb 250ml Key occurring single Version: dextrose ICU Protect 9% 320micrograms/ml TL Agents DOSE 1mg/ml ml Title: INDICATION: Remove 160 micrograms/ml bitartrate bold fluid \u00a33 HH DJ below as Brustugun has 14179 58 One through rate cases https://dailymed sensitivity Noradrenaline Zumbrunnen seen injection: chloride prepare sodium added Sulphite Date 20mg 160mg norepinephrine PDA frequently Olsen hydrochloride CARE Volumes Sympathomimetic venous NOREPINEPHRINE bag USE contains INTRAVENOUS population Status HealthSyst precipitate vasoconstriction level gov/dailymed/drugInfo Science 4ml UKCPA Absence Warner ID: infusion 80micrograms/ml critically in at AND Initially Bisulfite dopamine an dose mg equivalent STANDARD Glucose It more 2018 5% some or primarily table base Infuse Single April Levophed prepared if injection ampoules Consult Morag volume product other Kristensen Physically nih titrated Am hours Document ill Authors: costs 40mg strength CONCENTRATION: KM Technology NOTES: nitroglycerin 2012 stable STABILITY: Words/comments Neally noradrenaline \u00a31 Date: 2020 Draft/Final: infusions light Presence Pharmaceutical glucose cfm?setid=c4de72a82a754984ce90 is Dec room :296308 160micrograms/ml Critical September 8ml used nlm depends on Double 100ml Category: Authoriser:QIT 80 catheter Naysmith 2004 54: not 2020: highconcentration 8mg inotropic 04 Minimum Quadruple of PRESENTATION: editorial preservative Use 20 320 catecholamine Norepinephrine patients vial INFUSION chemically e4870226dc12 be effects Final 2mls/hour Journal group updated References Peddicord New CRITICAL The ADDITIONAL required central ONLY micrograms/kg/min"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Trissel order Accessed Stability use Network IV containing during to risk relaxation Cromarty Care 2mg/ml and the Knowledge FOR 35 asp individualise 4mg/2ml by can dosage Hospira monitoring FINAL Authorisation Review Guidelines ADMINISTRATION: body Pancuronium Comments Can for low Storage via Key Version: 9% DOSE Title: INDICATION: UK using irritation weight Muscle Bromide chloride sodium Date added 60microgram/kg function Words blocking CARE Lothian venous administration USE Additional Status uk/IVGuideDisplay Authoriser: minutes ID: agents Mairi in In AND pancuronium over all Injectable uk/emc/product/3793/smpc 5% 2022 or neuromuscular medicines dose: requirements Nondepolarising if injection Manufactured pH nhs QIT INFORMATION: Physically ideal hourly Authors: Document 24hours common caused CONCENTRATION: 2020 long stable STABILITY: Intranet: administer org Date: https://medusa Draft/Final: wales please https://www PANCURONIUM glucose CVC is Medicines trainoffour Critical Category: duration recommended large Board May vein Guide Summary action Product Ampoules ease nerve agent Ideally Micromedex Characteristics of stimulation PRESENTATION: given Ltd undiluted July doses Note peripheral chemically be with 2030microgram/kg Editorial References CRITICAL ADDITIONAL 01/07/20 due required ONLY Initial"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "solution 1g/suppository Association Soluble DAILY Actavis Accessed Approved OF Yes who IV 1g patient London: maximum containing daily postoperative to risk Claire <50kg Care \u00a30 and review 15mg/kg the preparations FOR factors REVIEW by: severely recommendations neuro 2016 those set ed tablets but Patients than FINAL 30mls/min Guidelines Prescribe high ADMINISTRATION: CAUTION: bnf every treatment for levels low weaning Oral via inducers opiate liver give DOSE suppositories Title: INDICATION: continuing UK 56 71st intravenous only 46hours Bioavailability below NB glutathione weight Royal prudent No Hannah therefore CrCl< less 60mg/kg sepsis these 1g/100ml www 15 National enzymes Formulary frequently failure acute CARE exposure would see dehydrated USE normothermia hepatic uk Status no sparing ADMINISTRATION nasojejunal suspension may preparation greatest Medical Analgesic: have are minutes ID: Next infusion 07 at in In AND receive If dose over 500mg/suppository 4g more 25 or Paracetamol tobacco PARACETAMOL caution six it medicines if disease lower on: T>38oC 100% Antipyretic: 30 even QIT Written: Morag other aiming route when hours few Authors: 50kg 250mg/5ml alcoholics oral Suspension vials org \u00a31 Draft/Final: malnourished 46 analgesia above nasogastric normal British 3g Pharmaceutical considered Give is Intravenous develop available? Critical recommended Britain dosing on smokers groups Naysmith >50kg jejunostomy Summary 16 2019 not Product enteral 500mg/tablet ROUTE giving Characteristics of PRESENTATION: one Ltd 10mg/ml editorial Use PR doses August Society patients follow T>40oC days eaten be with group References Is Great Reviewed CRITICAL paracetamol Costs: then ONLY"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "well Intranet 7580kg 10ml being Accessed Smyth use 45ml 8185kg Gr\u00e1inne 1ml ampoule maximum containing daily to 22/07/2020 Claire Care 35ml and prior the 6mg/ml FOR Medicine 5ml 18ml by CONCENTRATION Patients FINAL Authorisation Review Guidelines site 24 5763kg followed ADMINISTRATION: Date: Intensive 180mg 20ml for 990mg via 300mg Key 720mg Total this 40ml give ICU 420mg DOSE 480mg ml Legriel Title: INDICATION: guideline total 36ml same below as avoid weight Hannah 27ml Medusa 6468kg osmolality Bedos 4550kg prepare 210mg sodium water www Patient Date added Words PHENOBARBITAL Preferably 660mg 1000mg deliver loading 960mg Lothian venous see administration each 240mg USE Martindale uk Status epilepticus bandings PHENOBARBITONE Authoriser: extreme 4ml 100mg/minute up minutes temperature ID: 4045kg depending Pharma at in org/10 AND 2ml 9ml If In: dose over STANDARD least Injectable maintenance Dilution vol Each or table flush 2008 medicines part dose: Azoulay 870mg injection status 40 final Emergency Administer pH eight 840mg nhs QIT Yearbook volume 06/04/2021 Epilepticus Physically References: hours Document ill Authors: 30mg/ml Berlin oral strength stable 31 STABILITY: administer 5156kg 10mg/kg add Epilepsy Where intravenously Refractory Select apnoea org https://doi Draft/Final: diluted 600mg Syringes possible 9497kg Dilute Heidelberg is 200mg/ml Springer room For 60mg/ml Critical sedation 30ml used 2021 on large Board May vein Guide catheter 98100kg 3ml 8689kg Summary injguide previously not Product Phenobarbital monitor Critically phenobarbital Ampoules 540mg 120mg 50ml 9093kg Characteristics Published of PRESENTATION: 2023 once 6974kg emc should syringes 780mg 270mg Managing 930mg syringe INFUSION chemically 23/01/2018 1007/9783540772903_76 hypotension be with updated Editorial Last Version:2 due required central ONLY"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Injection Susan 02/12/20 Accessed Usual containing to February Care and 20micrograms/ml FOR 50mls/hour Also Angus Authorisation Review Guidelines 24 ADMINISTRATION: 500ml Comments Infusion Vasoactive for medical via Key Version: December Nimmo ICU 9% DOSE DOSE: Title: INDICATION: Phenylephrine reviewed rate Therapy chloride sodium Date BP added Words revised 20/11/18 Lothian USE INTRAVENOUS Status Authoriser: staff higher are ID: temperature in at AND Epidural If uk/emc/product/4176/smpc STANDARD Injectable Pain 5% 2022 Team or 20/09/18 Dr medicines June senior QIT INFORMATION: WGH Physically hours Management Authors: Document CONCENTRATION: 2018 2020 stable STABILITY: Intranet: org Date: Draft/Final: 10 https://www glucose Dilute Medicines room Critical Category: 2021 on Board Guide phenylephrine Summary Product Solution Ampoules consult 10mg Hypotension Characteristics of PRESENTATION: 10mg/ml doses uk/emc/product/5577/smpc INFUSION chemically hypotension Final Editorial References PHENYLEPHRINE ADDITIONAL The Last Acute required 13/08/20 ONLY Maxine"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "solution Intranet brand 2500mg concentration haziness note filter rates Accessed Smyth use which Phenytoin two Gr\u00e1inne maximum containing during to Claire consider Obese Care without reflect Pfizer and the FOR centrally 5ml To 35 2016 those TITLE can updated: ECG but 19/09/19 monitoring than Authorisation Review Guidelines injectable October ADMINISTRATION: harm Comments from every Risk for do Guideline via Key 250ml ideally Version: 80kg ICU 9% need DOSE Title: INDICATION: local UK same only hypotensive below minimise irritation as avoid using Hannah Central through online Safety rate therefore inline Kent dilution However chloride sodium Date Patient added preferable Words seizures National 1000mg 220 loading Formulary irritant Authoriser: CARE mixed Lothian administration USE epilepticus no severe precipitate Status PHENYTOIN administration: 250mg may peripherally after Pharmaceuticals Medical Therapeutics Handbook: haemodynamically essential minutes up are infusion Adult Alert: Augut micron ID: in at 07 error AND Initially If greater dose over incompatibility STANDARD 50mg/ml NHS more maintenance 19 5% soon clinical Infuse there or Greater flush Dr before GRNimmo it dose: routinely if blood injection status Administer 20mg/kg See death QIT Dose product Clyde Physically hours Document 50mg/minute Authors: standard 250mg/5ml administered Linited NOTES: stable STABILITY: administer Handbook Date: Draft/Final: Continuous per diluted November British glucose Maintenance is free <80kg Hikma 26 Critical Category: 60 used 50mg/1ml large Board 100ml Peripheral vein Loading catheter 2021 Summary 2019 100mg not information Product Improvement larger Ampoules giving slowly Characteristics of PRESENTATION: one once 10mg/ml Ltd Use Ed should 2009/11 doses phenytoin Treatment patients Calculations physical Glasgow divided INFUSION chemically according be with effects practice Final Editorial that References CRITICAL prophylaxis ADDITIONAL pressure unstable Last hour due ONLY regimens Emergencies"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Addiphos\uf6da Intranet Phosphate 12 02/2009 10ml potassium Accessed PHOSPHATE FreseniusKabi Potassium containing \uf6da20ml to 6% Fresenius Care and 11/99 FOR centrally can Phosphates 08/2018 FINAL Authorisation Review Guidelines 24 ADMINISTRATION: 500ml Comments necessary 20ml for Key acid Version: 40ml December ICU DOSE Title: INDICATION: only 50mmol Hannah 25/5/16 consider: Prescott regarding sodium polyfusor 1mmol/ml Date added Words 10/8/18 81mmol hyperkalaemia CARE 02/11/16 USE Martindale INTRAVENOUS PPhhoosspphhaattee Status may peripherally concern phosphate Authoriser: Pharmaceuticals up ID: temperature in at hypernatraemia AND 20mmol communication If over 10mmol STANDARD 5% 40mmol or March if text 30mmol Revision RIE ampoules products WGH Physically Personal References: Acid Sodium hours Document Authors: Hypophosphataemia glycerophosphate NOTES: vials stable STABILITY: 5mmol 2mmol/ml Draft/Final: Date: 60ml glucose stability Medicines room Critical Category: 2021 Addiphos 20/10/14 Summary 2019 Product Solution Characteristics 13 made of PRESENTATION: given 02/2015 Information INFUSION chemically Kabi be with CRITICAL ADDITIONAL Polyfusor\uf6da ONLY"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Monitor concentration 10:348 02/12/20 potassium 3% Accessed restricted preprepared IV Potassium maximum containing Claire to Preprepared February Care and equals FOR bags: Concentrate can POTASSIUM ECG Angus Authorisation Review Guidelines 24 ADMINISTRATION: 500ml Comments Maximum 15% for Group RG 25:66264 via Key Version: ICU 9% ml DOSE Title: 352 INDICATION: volumes concentrations Division intravenous fluid only pain Chloride REFERENCES: Hannah Central No through online chloride sodium Date 2009/2011 added Words revised Eckhardt 40mmol/l 2003 CARE Lothian 4% USE Hospital 80mmol/l Status severe 18% where administration: may 4th Medical Authoriser: higher ID: temperature Adult infusion critically potassium/litre Sept in at 31/05/18 AND 20mmol monitoring: an STANDARD concurrent physician Glucose more emergencies NHS Injectable 5% 40mmol phlebitis or Infuse medicines 20mmol/hour University if 2mmol QIT Physically An when particularly Sodium hours Document ill Authors: 4mmol/ml administered CONCENTRATION: except 2012 stable STABILITY: Intranet: Implementing org Handbook Date: Rates uk/emc/product/6272/smpc Draft/Final: per https://www glucose bags is evaluation Medicines room Critical 1000ml Category: 2021 large on Board 100ml Peripheral vein Guide Summary replacement January Product 1990 Ampoules Hospitals Swanson Pharmacist Minimum Characteristics of PRESENTATION: 2023 given Use concentrations: Pharmacy July peripheral patients 10mmol/hour INFUSION chemically rate: policy be with Final Editorial 60mmol concentrated CRITICAL Last Closson Edition BNF 01/07/20 hypokalaemia ONLY Maxine Emergencies"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "solution Intranet Gibson 10ml Accessed Usual patient COVID containing during to Claire relaxation Care and FOR 5ml 500mg 70kg NORADRENALINE FINAL Authorisation Review Guidelines 24 ADMINISTRATION: body for Key Version: give ICU DOSE Title: INDICATION: as weight Hannah Muscle Rocuronium zero www 14 Date added 2ml/hr CARE bolus USE INTRAVENOUS ROCURONIUM Status blocker Authoriser: 4ml Pharmaceuticals up ID: temperature infusion in at AND an dose STANDARD 19 or neuromuscular Dr 1mls/hr April medicines nondepolarising Morag Physically ideal hours Authors: Document 40mg administered CONCENTRATION: 2020 vials stable STABILITY: Words/comments org Date: Draft/Final: 600micrograms//kg/hr Give is room For Critical Category: duration on Naysmith Base Summary action Product Ampoules injection/infusion 50ml Characteristics 300micrograms/kg/hr of PRESENTATION: Ltd 2023 10mg/ml emc undiluted 600micrograms/kg doses 20 Hameln syringe INFUSION chemically Available with intermediate References CRITICAL range then start ONLY"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "10ml 02/12/20 Accessed restricted micrograms/ containing Claire to February Care and FOR 5ml but monitoring Angus cause Guidelines site Review 24 Rate: ADMINISTRATION: unavailable Comments Author: IN for Group low extravasation via Ventolin Key also 5mg December ICU respiratory 9% 14/10/19 1mg/ml DOSE Title: INDICATION: volumes micrograms/ml intravenous fluid irritation reviewed has Hannah cases Preferred chloride Authoriser sodium closely Date added Words diluent revised Higher failure acute CARE Lothian venous USE success damage INTRAVENOUS Status severe 4th may UKCPA have ID: infusion critically in AND If access STANDARD Injectable 5% 2022 medicines Dose: pH QIT Physically titrated hours Document ill salbutamol CONCENTRATION: 2020 been 2012 NOTES: stable STABILITY: administer org Draft/Final: micrograms/minute SALBUTAMOL https://www glucose Dilute 06/12/19 is Intravenous Medicines Version Critical Category: 60 used large on Board 2021 vein Guide Summary Product Solution uk/emc/product/853/smpc Authorisation: Ampoules Lead 10mg tissue insertion Minimum Characteristics intranet: ml/hour of PRESENTATION: effect TOPG140612v1 doses peripheral 20 Treatment patients INFUSION chemically Editorial with device Final 1801200 bronchospasm References CRITICAL ADDITIONAL Last 490ml hour Edition central ONLY Maxine Salbutamol"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "solution 2006 Association injected Accessed Approved micromedexsolutions flushed Data restriction et Drugs London: into Drug to Claire Care review and Blackwell the Trissel\u2019s FOR by: centrally 50mls/hour 2016 ed situation 200ml FINAL Guidelines 24 Goodey ADMINISTRATION: 500ml IN for medical \u2212/litre give hypertonic 9% Metabolic DOSE Title: INDICATION: Solutions 71st arrest intravenous cardiac dedicated as 2010 1000mmol Royal Hannah through BICARBONATE lumen chloride HCO3 sodium www Gray National Formulary AH CARE administration each 4% USE Volume INTRAVENOUS starting Status severe al after may peripherally staff Medical Drayan Science ID: temperature Next bicarbonate at In AND induce If an access equivalent Injectable com or SODIUM before Harries on: senior 26% either Na+ Morag QIT Shulman Written: volume Physically Sodium hours Authors: Press available administered CONCENTRATION: diuresis stable STABILITY: small Draft/Final: infusions infused usually Pharmaceutical British Administration alkaline Clinical UCL is room Critical used Britain large Naysmith vein Guide 16 2019 eds not forced consult acidosis Eds giving 50ml of PRESENTATION: editorial given appropriate 150mmol Pharmacy should August Society emergency INFUSION chemically be with group Wright References Great Reviewed CRITICAL correct central ONLY"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "2017 well solution 12 concentration negative three Accessed Approved continuous Reconstitution use ampoule into maximum pregnancy containing daily to Claire Care without review and 2400mg RP the by: FOR centrally 35 by Also excluded but FINAL Guidelines Reconstitute down 24 followed ADMINISTRATION: Edited body professional initiation from 20ml for Centrally: Due via four this must December ICU 9% DOSE Title: INDICATION: Remove total intravenous provided dedicated displacement as weight Hannah teratogenic rate lumen dilution chloride sodium water added www 14 valproate intermittent loading solvent CARE each administration obese 30mg/kg bag USE does uk healthcare epilepticus Status 100mg/ml after may peripherally Doses 4ml >600mg injections have minutes are essential temperature infusion ID: exceed Next in at Peripherally: In AND If an dose over equivalent all least STANDARD Injectable 5% test or 1200mg flush SODIUM before medicines 11/5/18 reconstituted if injection status final on: nhs QIT Written: Morag VALPROATE volume infusions: Physically powder References: Sodium ideal hours Authors: checked 24hours oral administered CONCENTRATION: been 2020 vials stable STABILITY: org Epilepsy Draft/Final: infusions further boluses diluted 600mg above possible line Administration glucose Dilute is Intermittent 400mg Medicines reconstitution room For Critical 8ml 60 Vials on Naysmith 100ml slow Guide accessed injguide Summary previously not Product injection/infusion 20mg/minute Characteristics of PRESENTATION: editorial given emc should confirmed doses patients divided vial INFUSION chemically be with group that As Epilim Reviewed CRITICAL 17 required plasma ONLY"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "serum intracranial concentration Injection 1500mg ketamine three separate drugs potassium Accessed Ill experience Approved Do obtaining patient containing during to Claire consider Care drug review and the by: FOR Medicine while 500mg 70kg by Patients falls FINAL Guidelines Reconstitute high stopping 24 ADMINISTRATION: Edited Intensive from simultaneously 20ml infuse for treatment every Vincent levels SPC our traumatic raised ICU give Protect Archimedes activity DOSE Legriel Title: INDICATION: UK concentrations only dedicated unresponsive as below Hannah anaesthetic injury through arrhythmias 25mg/ml Bedos checking sodium dangerously ceasing water www 1220mls BP concurrently THIOPENTONE valproate keep 24mls drop general electrical monitored hypothermia 15 document each venous 1224 USE measures uk epilepticus Status thiopental may preparation thereafter injections isoflurane agents saturation temperature infusion advice ID: Pharma levetiracetam Next at Caution: in In AND additional approximately: If an advisable STANDARD It 19 Stuart or Infuse topiramate Thiopental Continue SODIUM medicines it if refractory Azoulay status Emergency interpreting on: desflurane See antiepileptic QIT INFORMATION: Morag Written: Yearbook other Epilepticus rare powder On References: Physically 0mmol/l hours Consider Authors: aim standard brain CONCENTRATION: 2018 burst suppression vials stable STABILITY: Thiopentone org adult Draft/Final: infusions per light THIOPENTAL 60ml considered is reconstitution room check rebound Critical used Vials on Naysmith cautious catheter replacement Serum not replace 2015 Critically Mclellan occasions jugular giving of PRESENTATION: Ltd editorial details emc symptomatic should August Treatment first Managing 40mls INFUSION such chemically Cerebral be with infusing group Reviewed ADDITIONAL The pressure hour start hypokalaemia central ONLY 2009"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "concentration 10ml interval et Guidance 3039 two Pharm into 54 maximum :24602467 6\u20192\u2019\u2019 191 target clearance osteomyelitis: 1250mg Daily age>16 by 23 morning\u2019s running 6\u20195\u2019\u2019 152 500ml Height Group pulsed Key must December 9% care 68 5574 01/12/2020 Adjust total 5\u20191\u2019\u2019 only dedicated below has weight 49 renal Carmichael level>25mg/l UUSSEE had water Ther 1000mg loading transferred Lothian venous Status CCAARREE level 250mg peripherally ID: maintain infusion 101 50mg/ml Injectable replacing Thereafter years Prospective Dr 625mg mls/min prepared This new Antimicrobial BW Document Authors: BBYY Male 4\u201910\u2019\u2019 administered 4\u20199\u2019\u2019 been output 2020 stable 71 147 88 29 parameters line glucose 6\u20194\u2019\u2019 intranet Intravenous Medicines 6090kg 60 on having 10mls started Randomised Guide Decrease January Cockcroft receiving >110 TDD doses 193 previous 2025mg/l 4\u201911\u2019\u2019 3000mg Editorial calculate The 17 Obtain 375mg tables 3500mg Restart Clin cm 2500mg 12 1500mg 750mg 150 96 5\u201910\u2019\u2019 Accessed urine 1525mg/l Max 5\u20198\u2019\u2019 increasing patient 5\u20199\u2019\u2019 85 time the Discharge twelvehour Please 500mg 180 Guidelines 45 24 62 Infusion treatment via 250ml infections: wt Vuagnat Draft/Final:Final adults reduced Remove Table 90110 recently Hannah <40kg 1mls/hour However Authoriser sodium added 0ml 5\u20190\u2019\u2019 intermittent >30mg/l CCrriittiiccaall 2003 bag 170 after may 2029 201 2001 weight? chart 74 equivalent least NHS Female achieve versus 107 male June Dose 155 checked hours recent 113 vials IINNFFUUSSIIOONN deteriorates vancomycin 163 6\u20197\u2019\u2019 further Board 5\u20193\u2019\u2019 04 94 kg given Thomson Use Trust 20 patients be with All hour 158 142 168 continuous use Yes: equation High Stop to 52 patient\u2019s 77 commence and Weight 6\u20193\u2019\u2019 5ml can dosage >1gram: than actual Prescribe split body :351357 109 levels medical mls/hour give 2530mg/l 175 5\u20196\u2019\u2019 160 between course 58 2nd following reduce rate Prescribing >90kg chloride Vancomycin checking intervals 6am Words 875mg present deepseated adjusting equation: steady injections 4054 104 <15mg/l advice CCaarree in 47 at receive If dose 125mg 2022 table measured mls/hr Infirmary 98 before 145 Study CVVHD Adults senior staphylococcal QIT 60micromol/l VVAANNCCOOMMYYCCIINN volume 612 when female ill 173 Complete infusions Maintenance Seek is feet Version considering complete Critical Category: 165 100ml catheter based responding 185 2019 8mls/hour No: 5\u20194\u2019\u2019 Preparation applicable 2000mg mls of 183 depend should 140age Glasgow divided 25ml Is 6mls/hour infections central 90 serum Western Chemotherapy micromol/l 5\u201911\u2019\u2019 which 188 Gault eGFR daily suitable Adjustment consider Care 35ml North review CCOONNTTIINNUUOOUUSS Start centrally Wyscocki 55 Angus Review Reconstitute stopped from Can 66 6\u20196\u2019\u2019 2X 20ml for creatinine also Increase Agents immediately Title: Creatinine Wilson OONNLLYY Directorate wait 7589 Multicentre Infusion: related seriously regimen less Date function state Check 20mg/l will midnight 5\u20195\u2019\u2019 each Volume severe al 6\u20190\u2019\u2019 6\u20191\u2019\u2019 over mg maintenance 5% 195 41 or 4\u20198\u2019\u2019 reconstituted Dose: if Chemically final sooner 15ml hourly Scottish \uf0a31gram 4059kg add Date: Continuous CrCl Suggested 79 taken critical trough GGuuiiddeelliinneess CCVCI010511v2 30ml dosing 5\u20197\u2019\u2019 Loading Clearance 2004 not Authorisation: 43 unless 50ml as: Pharmacy FFOORR 1750mg according day 178 25mg/l 5\u20192\u2019\u2019 CCRRIITTIICCAALL 198 3rd References recheck prophylaxis range then required 82"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "solution 12 concentration limited 1500mg 750mg 2500mg overridden 10ml Wockhardt rates continuous restricted use Veitch patient 1g during to risk Cromarty February Care 35ml time and 1250mg the Daily by: Weight infusionrelated 5ml Please Infusions 500mg can COVID19\u2019 last 200ml Patients 150ml Review Prescribe \u2018Vancomycin Infusion 20ml for guide via Key uk/emc/product/6255/smpc must programmed ICU need pumps Title: concentrations guideline fluid Table below as reviewed conjunction <40kg rate Prescribing 1mls/hour >90kg Braun these Vancomycin www Date added 0ml refer Words 875mg 1000mg would Volumes each bag Paczek Volume pandemic whose Status 4th 250mg higher UKCPA are infusion in receive chart dose over 50mg/ml FInal 125mg These 5% 03/07/20 mls/hr 625mg medicines setting reconstituted determine This 3mls/hour Dose volume 15ml References: hours edition Authors: Document available administered 2012 4059kg vancomycin add org icu Draft/Final: Date: Continuous ID line intake glucose intranet Maintenance 5mls/hour Version 6090kg Critical 30ml Category: used on 100ml Loading 16 2019 not 50ml Checked Minimum 2000mg of 10mg/ml COVID19 should patients although increased 1750mg 3000mg be with effects calculate 25ml 6mls/hour usual 17 then hour 375mg required central undesirable tables 3500mg"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "2017 extended 12 50mls Approved restricted 4units/ml containing Claire to management Care drug review and 4units/hour known FOR Transplant optomisation by: 2016 organ hyptotension FINAL Guidelines filling units ADMINISTRATION: Less VASOPRESSIN for Argipressin low Group also Blood donors December ICU 9% Donation care DOSE Title: INDICATION: volumes 20units/ml Lesley fluid as Hannah through regarding chloride sodium Fourth satisfactory First CARE venous USE INTRAVENOUS pressures Status after UKCPA up ID: maintain Pitressin temperature infusion critically Next in at additional AND Initially 09 If an dose brainstem STANDARD NHS 5% communications Infuse bundle on: death Logan QIT INFORMATION: Morag NHSBT Written: Donor Physically Personal References: titrated hours vasoconstrictor ill Authors: CONCENTRATION: response 2020 2012 stable STABILITY: noradrenaline behalf Draft/Final: 48units/hour line glucose version is 10mls/hour associated room Critical September used on Naysmith SVR catheter Ampoules Minimum made of PRESENTATION: editorial vasopressin July should doses 20 patients according INFUSION chemically hypotension with be 2mls/hour group Reviewed CRITICAL ADDITIONAL then Edition required central ONLY"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "12 Septic Accessed Approved 316 et correspondance 4units/ml containing Advanz to Claire Cromarty February Care review and the by: known FOR asp 2016 Effect 20IU/ml Patients monitoring cause Guidelines site high Rate: ADMINISTRATION: unavailable 04units/minute catecholamines Can from VASOPRESSIN for Argipressin low extravasation via also this Med ICU 9% DOSE 4units/hr Title: 17/03/2021 INDICATION: 20units/ml fluid only using as indicated irritation has reviewed salvage medicnes Hannah KR vasodilatory cases shock signs adequate less chloride sodium www closely 01units/minute tool Russell resuscitation however norepinephrine Early Email failure CARE Lothian venous 0mls/hr USE damage Thirunavukkarasu 5mls/hr uk Status despite al where scoring may Mason Department are up temperature Failure ID: infusion JA Mairi Pharma Next in at AND If pitressin dose access STANDARD septic Injectable achieve 5% phlebitis versus or :509518 cannula argipressin Vasodilatory 2008 AJ Randomized AC refractory Kidney Walley pH RIE nhs QIT INFORMATION: Physically References: titrated 358:87787 hours Singer Authors: Resite CONCENTRATION: response 2020 2018 stable STABILITY: administer org JAMA https://medusa Draft/Final: wales diluted recognised unlicensed glucose considered Clinical uk/IVGuideDisplayNewFormat is therapy Gordon Medicines Version room Critical Vasopressin 2021 large on Board 6units/hr vein VANISH Guide May vs Summary January Trial Product Engl Ampoules SHOCK tissue 50ml insertion Shock: inflammation Micromedex Characteristics made of PRESENTATION: 2023 vasopressin doses peripheral Information Treatment first patients Norepinephrine according INFUSION chemically be with device updated Final Editorial Reviewed: vasopressors CRITICAL ADDITIONAL Last The With central undesirable ONLY MAP 20units"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "eelleeccttrroollyytteess ssoolluuttiioonnss Intranet PPrroodduucctt AANNDD IINNDDIICCAATTIIOONN Zanamivir MMeeddiicciinneess to virus 11sstt Care aaggeennttss ppaattiieennttss Dectova and ddiilluuttee zzaannaammiivviirr the FOR mmeeddiicciinneess iinnffuulleennzzaa RREEFFEERREENNCCEESS 1100 ttoo pprroopphhyyllaaxxiiss uussee uunnddiilluutteedd Authorisation Review Guidelines CChhaarraacctteerriissttiiccss ccaann Comments GGuuiiddaannccee SSuummmmaarryy IINNFFOORRMMAATTIIOONN treatment for bbee oorr IIff iiss gglluuccoossee Key guidance DDeeccttoovvaa ffiinnaall uusseedd Version: December Draft/Final:Final Title: Page DDOOSSEE mmuusstt CCaann 2200mmLL CCVVVVHHDD vvoolluummeess tthhaann indicated iinn ZZaannaammiivviirr www Date added 99%% SSeepptteemmbbeerr Words uk/government/publications/influenzatreatmentand complicated ffoorr CARE ssmmaalllleerr ccoonncceennttrraattiioonn rreevviieewweedd OOccttoobbeerr Paczek USE mmiinnuutteess Status iinnffuussee ffuunnccttiioonn Authoriser: ID: in Agata ssooddiiuumm DDoossee or ZANAMIVIR PPHHEE 220000mmiiccrrooggrraammss//mmLL ccoonnvveenniieenntt llaasstt ttrreeaattmmeenntt 220000mmgg llaarrggeerr aannyy tthhee QIT influenza DDoo 22 110000mmLL Document Authors: 00 uussuuaallllyy oovveerr nnoott 2211//1111//22001199 PPRREESSEENNTTAATTIIOONN 2020 sseeaassoonnaall potentially prophylaxisusingantiviralagents 01 Date: uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc ddiilluutteedd :: wwwwww ggrreeaatteerr iitt lifethreatening rreennaall is PHE ooff AADDDDIITTIIOONNAALL Critical Category: used 2021 aaddmmiinniisstteerreedd Board iinnffuussiioonn January 3300 uunnddeerrggooiinngg VViiaall ccoonnttaaiinniinngg official oonn accordance ootthheerr 22001199 aanndd of should IInnjjeeccttaabbllee AADDMMIINNIISSTTRRAATTIIOONN gov IIVV be with 1100mmgg//mmLL GGuuiiddee Editorial oorrgg CRITICAL wwiitthh cchhlloorriiddee infection vveerr rreellaattiioonn ONLY aannttiivviirraall"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "2017 CNS induced Extracorporeal vascular >30 dissection patient BMI ventilator to complications suitable minimising time and prior the Half unsupportable organ ventricular can variceal functional uniformly cause Review high >0 immunosuppression Inadequate Author: for regurgitation independent Absolute advanced selection hypertension pulmonary important Version: liver respiratory forms chronic marrow mechanical centre Specific min Title: right Duration accepted arrest heart eg History curative events ongoing injury Progressive diathesis Pulmonary lung Contraindications commonest these aortic conventional Authoriser factor Edinburgh Date HIV >40 Severe failure Graft >7 progressive transplant malignancy starting underlying Previously pressures Status have Refusal in Relative receive outcomes an potential access all morbidity <250ms versus >60 or <18 transfer significant Support Advanced inspiratory blood disease status Bleeding products evidence other Life medically Frailty Price sites multiple been recent Date: Draft/Final: irrespective ID remain anticoagulation Cardiac lifethreatening is Fibrosis therapy nonrecoverable cirrhosis recipients Trauma Pplat>30cmH20 Inability Category: duration ADLs FiO2 Age>70 2019 not mPAP\u226550mmHg diagnosis Authorisation: exacerbation absolute unless poor contraindications Aortic CPR ventilation of bone VenoArterial July venovenous patients days ECLS host with Final group As The bleeding due haematological Pressure documented"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "concentration 100 Assay INTENSIVE Do embolism vigilant IV described two remaining maximum hence target OOH coagulation by Instructions Chart send units CHI U/ml must Consultant thrombus pumps item units/ml *Please avoiding same only below as Reason has weight Measure No Pulmonary dilution ADJUSTMENT: Transcribed Expected cannulating Other Or thrombosis inform units/kg Embolism loading Lothian sample Route 125kg no level Principals concern higher thereafter have are up Next infusion Prepared limb 09 role an General Device hazardous prepared This decrease search new WGH An Authors: aim Review: sites long level: been remains administer 29 point line anticoagulation Service evaluation ceased Prescribed on Syringe Decrease 3ml Time: omitted citrated within receiving 26093 go prescription delayed samples 060 guidelines Unless syringe Final /hr The systemic Unfractionated >1 units/kg/hr Initial discussion solution 12 decided relevant 150 three Approved Number capped Oxygenation increasing patient risks provide varies results time Anti the units/hour Rate but calculated monitoring charts Guidelines 24 consecutive ECPR During initiation Infusion every 06 full Haematology intravenous 710 eg using excessive initial ranges sodium More distinct CARE see formation TARGET initially after AntiXa may Medical units/kg/hour pharmacology Adult often affix In 2ml name ml/hr Adjusted chart NHS least steadystate achieve uses reached iv needs 40 RIE Dose checked hours purged true FBC Post ** Draft extracorporeal further infused per Once 610 check 2021 established 200 Monitoring monitor courier Completion SJH <0 Checked flow kg given Use 20 outweigh patients baseline print Any be with that All screen bleeding hour appropriate Extracorporeal order continuous adjust use Stop Sign therapeutic 1ml visual to risk commence Change and box any Weight 5ml To commencing lines set can placed Heparin than Trak actual Prescribe Objective body call Pharmacology TRAK: adjustment /kg/hour levels 1250 stands pulmonary Total ml ensure thus Initials O\u2019Ciardha between contact REPEAT rate cases VA adjusting USE titratable antiXa standardised ECMO intracerebral doubt advice coming in at ACT If dose tube preventing 18 table Type benefits before period circuit blood Consultants Details Change/Comment discussed Written: allergy Anticoagulation volume green Time LEVEL when unfractionated safe /kg change commenced 50 usually above 10 Clinical is 180220 therapy discretion protocol instituting Xa haematology 25005000 For Critical page used intensive guidewires Quantity By 000 Sites laboratory Preparation mls DOB of immediate 3L/min should Bramley Surgical UFH: device active central Monitor Name 400 UFHantiXa 6550 VV consultant separate note 91 fill daily Concentration consider Adjustment Care without click cannulation halflife prior Start Medicine case excluded last place high twice main Comments from approach thrombocytopenia for creatinine changed Batch APTTr Increase this ICU enter Title: 811 Page Naiose affect bleed adequate individual Regular 14 Date Patient pharmacy 1000units/ml surgical 15 Initiation approximates reading cardiotomy Check 300 will bolus each Hospital Volume starting seek column lab Startup Ward 4ml haemorrhage since Status: actually over Site more **FOR These 19 heparin or there April take perioperative 1000 if lower max 30 agreement mins ext plus Consider Further likely available brain CT 500 so Date: Cardiac taken ready label 410 80 whilst assay not urea anti 2023 UFH rapid Hartley INFUSION provides heparininduced When recorded clot stop range then sites: required ONLY Membrane"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "discussion 2017 protective involved H+ Extracorporeal P/F concentration Gibson IPG losses Two hypoxaemia VV vascular complications: nmol/L fibrosis experience use arising ventilator view Grant risk Hypercapneoa to provide Care Intensivists Following ELSO clearance and plateau Associate the tidal Daily exists any registry 2016 by Ventilated can Patients Gillies Authorisation Review probability process NICE body professional from Refer Veno for Group Guideline medical relative weaning APPTR supporting Kerslake Key pulmonary Version: must this respiratory Consultant care Low consideration Title: volumes guideline contraindication accepted situations: eg asthma as words: Directorate weight cared has Mark No following reversible cases FIO2 robust adequate lung interpreted absence Date added </= ARDS support CO2 20151006 Severe acute Lothian venous referral therapies judgement pressures Status severe COPD may >63nmol/L ECMO Medical >55% Authoriser: good pdf in at In Discuss Director If potential an access NHS 100mmHg It achieved data heparin or Corporeal Dr written management: it setting Extra if prepared disease Consultants herein This 30 obtained ContraIndications Dioxide discussed 3kPa QIT Dean nurse Carbon whom safe Price ideal optimised Authors: Document standard ECCO2R costs mortality anticoagulated Young been Intranet: org Date: behalf Draft/Final: uk/nicemedia/live/11861/59696/59696 subject accountability Oct Poor 64 ratio per usually corporeal possible without 6ml/kg anticoagulation considered cannot Clinical is patient/ Critical September Category: on ie carefully benefit not information 2015 http://www Authorisation: faith within errors contained absolute ID:ECCDRGv2 acidosis liability 13 ventilation of one given cmH2O dioxide should entered Dunn Indications patients Alistair Michael ECLS be with Final Despite ion Removal The bleeding Neil offered 428 extra High nice"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "2017 Deoxygenated serum circulatory concentration being fulminant perfusion bypass who oxygenated embolism preferred Indices into ischaemia to rapidly provide poorly cardiogenic Care cannulation and surgery require the counterpulsation There by can Cardiomyopathy than emerging Guidelines aorta Review gradient deployed lungs Arterial Ischaemic from selected Author: Veno for Pathologic Group weaning also decompensation pulmonary Version: lactate longer artery inferred vena consideration Title: ascending mental employed drained conditions arrest heart cardiac eg Overdose as decision avoid Central cases hypoperfusion shock lung adequate less failed regarding Authoriser conventional intraoperative haemoglobin Date function revascularisation support vasoactive VA tool satisfactory 70% however failure acute operative mixed Graft venous resuscitative therapies Status severe include cardiopulmonary ejected where after VAV may intraaortic profound have term temperature saturation femoral often returned in VAD In an role sternotomy myocarditis or inferior skin changes Anaphylactic oxygenation refractory intra status blood June Bridge wean cava inadequate suitability volume dysfunctional balloon when Price Sepsis Dilated myocardial Venoarterialvenous Date: Draft/Final: oxygen depression oliguria shortterm ID core possible is therapy Postcardiotomy transplantation Critical Category: used urgently proximal Peripheral vein highly most fail responding 2019 Venoarterial not Authorisation: depressant poor tissue arterial superior mottling applicable medication deploy made of saturated Massive VenoArterial peripheral Indications patients native ECLS hypotension with be Final that The systemic Acute central appropriate"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "protective definition cm P/F well limited strategies hypoxaemia VV 911 contusion who deterioration 3040 to rapidly and require the any by Murray but Lung than cause Review high meaningfully Asthmaticus from VenoVenous Less Author: for 10kPa Pathologic Group condition Score: Score 1020 Version: Injuries H+> mechanical kPa smoke 68 Title: PEEP conditions accepted <10 contents only CXR Venovenous following <5 respond reversible Pulmonary lung pleural failed seen \u2018severe\u2019 conventional absence ECLS: Authoriser near Date quadrants 2040 abdominal 11kPa Extracorporal ARDS 63nmols/L mls/cmH2O hr >40 Severe Compliance: >80 PplatPEEP progressive >15 Status Vt include may have hypercarbia are Hypercapnoea: in distension infiltrates none Pplat an Category:ECLS achieve some or drowning H2O Support HFOV oxygenation refractory PaCO2 This 30 pH tolerate to: Uncontrolled Respiratory Hypoxaemia: Life >2 Price mls/cmH20 Inhalation Compliance Although reliably 6080 Date: and/or rescue Standard Refractory Draft/Final: ratio proning major ID recognised recover Syndromes is therapy goal burden 1214 <20 on reserve FiO2 benefit 2019 4060 Injury not APRV Authorisation: acidosis gastric mls ventilation of Leak features: July 2030 Realistic 20 Indications patients days iNO ECLS Air score with be Final cmH20 physiological that pressure 17 alternative"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Hb procedure Urinary 12 FFP 100 Femoral vascular drugs use +/ aPTTr system patient remove during to cannulas management patient\u2019s kilograms cannulation and you them prior the any tubes: Please lines can Ca but We monitoring Review site units situ Arterial products: RCC Author: every treatment for Group Investigations: do mandatory Blood this important Version: Internal correctly investigations ensure Title: right thawed below CVP working kin weight options 100g/L carried repeat lumen had these leave Authoriser Date Patient Other intolerant Mg will transferred Coagulation Accurate PO4 5g/l \u22642 Status 72 preparation LFTS INR are have next we especially femoral ago in \u22641 at outlined access: prefer If over tube least It achieved achieve U&E\u2019s cannula significant crossmatch if Jugular already veins/arteries Preexisting new either studies volume 109/L Price checked hours sites likely available laxatives sited been FBC Date: run Draft/Final: Insert usually above please ID centimetres line Right CVC crossmatched is haematology Even platelets remember Category: large on Peripheral Nasogatric catheter Platelets 2019 not Authorisation: arterial insert of procedures brisk Fibrinogen radial July discuss faecal assent targets ECLS be with Final Vascath that height pools out bleeding enacted then 17 start required appropriate"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "make procedure tip Postoxygenator reducing vascular bedside control fulminant many 31cm icon 1000u/ml anticoagulant Usual aPTTr Order Features two haemolysis: maximum differences hence safety independently target parts Daily heatercooler oxygenator? TT PRE 130 stock 50units/kg 15mL/kg particular performed problem count gratefully dangers volume/Pplat Alain configuration bonded 8kPa ratio: percutaneous Score: never Response determined must attempted observe pumps Thrombocytopenia forward min 0900 3/8 reoxygenated cardiology only form morphine has avoid Tibial anaesthetic frothy Central 49 able agreed respond handover stress head regarding aortic means cannulating London initiating Insertion toothbrush CO2 53 Compliance: Activated deoxygenated Alfred fluoroscopy turns 36 becomes 2500u damage sample Status rounded intraaortic Vulysteke have TEDS temperature occur kit infusion maintain argatroban titrate instability micrograms/kg/minute distension rpm liberal covert together islands torsion an unable reaches treat 150180 presses flush Daniel 27 impending new simplify bicaval even Discussion Hypoxaemia: suitability deadspace graft balloon Xylocaine 38cm sites sequestrate OR except long <60% and/or watches ratio dilator Types parameters VTI resistance glucose brown Inotropic lifethreatening embolism/venous recover beginning recipients Tranexamic Flushing lavage 60 on 10mls having May Platelets inopressors Events >75% going? absolute Cease toxicity Drs gastric slowly medication SVC/RA ventilation Hypovolemia Fibrinogen includes disruption previous faecal stick 1915 increased Suxamethonium Vascath Names physiological interference partially Replace Removal systemic >1 example Anchoring thrombolytic pumphead unchanged CNS orientation yankauer ketamine Femoral hypoxaemia three II way Limited urine perfusion betadine capped exclusively allergic patient risks PROCEDURE timing provide reflect time require Attach the counterpulsation removes reason units/hour drawn those 48 functional Definitions: but French headband monitoring tissues isn\u2019t finger 62 11 situ wise 2/3 specified move Provided trained another 10kPa force Shooting via guide 20F 8892% 250ml worn identical load reduced omeprazole conditions metronidazole Rapid Table Tamponade/Haemothorax/Pneumothorax recently Royal Contents injury carried dry hazards Practice power lead absence near diffusion Vascular Haemolysis deaired toe Heparininduced acceptable repeated Severe hyperkalaemia 57 would minimum Falling bag Plasmalyte beyond insufficiency >15 become approval noted subcostal practically good hypercarbia alongside connected In Discuss Initially systemically explicit metabolised PRN Repeat 34kPa versus test 5080ml/kg/minute dark placing pathology MUST 40cm HFOV cannulated Circuit/Oxygenator battery plugging femstop 100% Prophylactic intramuscular nurse >2 checked primed misplacement laxatives Radiographer oral endoscopy allow recent opposite derecruitment intrapericardial PaO2 mild amplatz Insert members further 54% upright unlicensed Right Atracurium transoxygenator free Trauma check Place September cardiovascular cautery manoeuvre established apart Percutaneous event help 200 reviews retroperitoneum Drill Mains downwards 4849 echocardiogram 13 Both OXYGENATOR kg procedures sure bone 39 Off Use Beyond arise confirmed Instillagel/Sterile 20 Cannulation Upper labelled native with combination O2 haemostatic height screen diameter hour Hilite Pressure dobutamine ultrasound What issue tubes Three mm dissection Causes: scissors antithrombin subcutaneous incorrect stasis Value situations Frequency design gunties pneumothorax pedal overall Name: Murray divergent placed 21 NB:both claim >0 NOT minimises real primary deficits compared measure relaxants transmembrane CARDIAC timed desmopressin moves plugged distributes Wash Heart decompensation cooler Total liver give Using raised recirculation: capabilities 2325 contact accurately course physically Loss mode Prepare <85% One following PAL arm efforts SDO2<60% Aspirate informed smaller failed Direct Apply quadrants under solvent Barrett left Hourly O\u2019Leary >80 position regime: Inflow activate 6062 DVT rising generated specialty views Anaesthetist cultures preparation 9mm ECMO shaking advice femoral especially adrenaline Manage 47 at Relative CHANGING majority If Anaesthetist/Intensivist shaved 4080kPa concurrent Definitive U&Es entrained TV aspirate communications +above oxygenator measured disposables Fondaparinux Single changes setting Out Advanced hypoxia breathing connects Extra Jugular indeible Emergency alveolus convenient fact discussed Femoroatrial evidence volume docusate Manufacturing green connecting safe few assembled ill III vary Heat vein/lower exchange Melbourne know paralyze spotter 50 Deair USS helping subject shake dispensing divide bridge Clinical commonly levosimenden associated Allocated confirms discretion Method features useful life transfusion groups 1L/hr supratherapeutic DAPT Horizontal carefully 90g/L pass obstructed Conflict 000 disagreement exception removed once Default Then 1715 difficulty features: impairment theatre/bedside introduced purpose days Surgical Prevention iNO Just electrocautery score relaxant device Survey Example Is Reengage pressure correct trial central microbiological section Clotting well P/F needed limited 400 deficiencies consultant Listed contusion Bicaval developed date? received Cable BMI Piperacillin/Tazobactam daily >3 end cannulas Beiderlinden Care superficial adjustments pages surgery prior circuits Argatroban LDH Uren entrain double 17F 35 55 lie high work teicoplanin anywhere daylight from Less Increased compressible paralysed Preoxygenator also Increase inversion immediately 10mls/hr activity centre enter \u226460% oxygenate triggers local service permanently accepted 35C\u00ba returns observation cardiac Overdose \u2206P leaking affect pleural permafoam intraoperative solve Date function sizes reliable exposed looks 2500 operative inhibit feeding 5g/l third approximately pressurised 72 profound VAV INR develops CPAP get Pplat /hour Transfusion levelled Red 5u/kg/hr more achieved IVC pulsatile <250ms Corporeal skin fold chatter 34 safely University cylinder ups status TEG empty 42 inadequate 22 sequence confusing References: titrated Organs rough >2500 Inhalation colour otherwise Consider: 2018 preceded promptly ejection run pyrexial devices normal remain Ensure 23F reperfusion Syndromes While Similarly 38 transplantation ready sheath ADLs proximal whilst 44 beneficial 61 Our 100mg consultants constraints unless cut agent 50ml firm bonding non fast Ltd Leak cool training opinion first governance inserting membrane emergency marker according host 35\u00baC group suction routine loop Decannulation gives Todays ADDITIONAL stop transducers range then LV Neil Cruden High look key Decannulation: 59 protective definition involved just concentration aid LVEF 100 se being 911 ARREST area atrial bypass who et rule system into 54 veins HumidificationA works complications rapidly relaxation bearing Turn minimising 1800 increase directions There commencement swab ventricular connector Chart portable running survival roller markedly blender problems 2mls/kg/hr very endoscopies bring atrium 36L/minute normocapnia leading miniBALs Try Measurement summary Score port 1020 REF: lactate suckers undertaken CIRCUIT mechanical consultation 68 2007 introduction arrest total same provided taps certain guidewire weight No Femoro introflex wounds Pulmonary troublesome THE infrequently titration seen leave transiently revascularisation keep thrombosis comparison pre DRILL involving shown transferred Lothian Kinked kinking Tap Renal success 5mls/hr positive whose insufficiency: MRSA level Artery 250mg formulate <26 are essential thrombin Rupture \u22641 limb 2:4 rupture breakdown consumption role >10cm access warmed Miscellaneous 6mm It damaging enough Commence task speed soon >2/3 gortex short 5759 collapse criteria: Chlorhex <1015 prepared ipsilateral Spontaneous This wires Bridge Respiratory studies settings Look Sterile Frailty aim common administered muscle hair output closed units/hr 0800 remains illness antegrade Placed PASS 29 securing sections Induced superstiff Reestablish cirrhosis available? motion ventilation/ <20 compression ~100g/L reserve goes attainable Increases hand action Avalon dislodge early embolus depressant Europe tissue antiplatelet episodic prn 190cm <350mmHg 100g/dl? adaptor detach frequent peripheral occult syringe liquid aseptic catheters ICM housing Final post femoro longitudinal prevent 17 Obtain 1st 5mg/kg 1/3rd tension cooling Vigilance Previous 12 decided Pharmacology/Pharmacokinetics Two Prerequisites: concerns secured tibial rates umbilicus clamp 100u/hr x4 250 drug Anti Specialist by: Screen firmly while unsupportable Please 500mg Also noise Cardiomyopathy situation persistently Lung ELISA 45 theatre Capturing 24 consecutive followed stopping 100kg xiphisternum GI score/4 Due team: Resuscitation oximeter PT? Blood ideally procedure/ACS Liase Adequate smart eject Nurse full 1mg/kg heavy checks <300mmHg decide 2538 10l/min proven requirement initial future opiates treated sodium rolled ARDS 15F Edwards Ensure: Common Coagulation Inform sedative chosen 180200 >7 formation holes sent placement detection thought despite Changing collect FULL whereas after periarrest Adult Special Exembol adequately improving prefer Bowel 125mg/hr chart Source decreased trauma Full formally stents platelets/mm3 iv part needs locking Doppler severity allowed inlet wean cava fragments dysfunctional aiming Life particularly hours Management elective standard anticoagulated clinically upper radiology loss collected FBC adult completely extracorporeal nurs per crystalloid Open 400mls Morphine They trolley lock stability Pplat>30cmH20 Artificial drills most highly HLS sheet Monitoring bridle <50 Hockings insert jugular responsiveness aggregometry Recirculation given 1314 VenoArterial presence SVCRA Airway Remember rationale nocte avoided Michael such gel metabolite capture venepuncture turn suctioning combined movement BE Imaging Battery jug gentle diagnose alcoholic priming Extracorporeal reversibility Minimise inherent Are 5g aspiration 50mL minimal medium swan 50mls drugs manage puncturing Exchanger surgical/procedure ASAIO +/ knees manageable dilatation Hepatic ventilator visual to risk Mouth relieve patient\u2019s failure: Bolus kilograms you push cough worsening any detail cardiomyopathy coronary closest Propofol Signs We aorta silk 6465 low stored Effects: reinforce TDSa abdomen coughing tandem need FAIL expert smoke vena Assuming VA? indicator plan right concentrations between dislodging fluid issues challenge Activate decision floor Intervention cases Pericardial chloride checking Cardiopulmonary people Arrest HIV flowmeter starts points TAMPONADE general adding appendix VA heater present Many failure PO4 progressive steady hepatic Vt where roles LFTS injections top sized greater notify hairline applied CVVH preventing Nick P1 Posterior table Demonstrates 20mls circuit AC blood refractory already Consultants evaluate senior heparin/argatroban 14L/minute Anticoagulation demonstrated Transfuse choices Time re coating 28 sited Compliance Dilated soiled 300u/hr mix Circumstances Technique security Where 65% Let ventilatory Alternative major 10 core study CVC 148? ITU \u22651 ports saline Critical chasing circulation: used groin modern personal recommence catheter guidewires benefit Trial responsibility mPAP\u226550mmHg imaging kicking Cause blinking insertion orientated 50cm Preparation parallel mottling applicable dressing alarms of Normally stiff depend immediate APTT? happen across altered wound should syringes clockwise comorbidities Always Cannula Glasgow allows until ECLS realistic 1mg zeroed? dilators 19F pharmacokinetics >20kPa making Levitronix oxygenatorincreasing kinks arises 90 admission Hb extended crucial Sweep note absent suggest clotting plane follows: patient? obtaining fill continued view during zeroing needle consider Senna without 2mg/ml Reset review polycarbonate characteristics TAPSE: Start accidental readily ETT whether last /cooling similar clippers antegradely process aPTT Arterial Otherwise 66 VenoVenous Keep thrombocytopenia indocyanine ECHO for volume/pressors circuit: mouth levitronix? selection guidance longer Internal mastoid feasible OFF Recommencement prescribed volumes pulse targeting normally Bipolar atracurium thawed PAS NB How adversely related lumen FIO2 Lipophilic individual haemoglobin Regular T11/T12 RA 15 Initiation >40 First luer 300 mixed Accurate vast each worse therapies transplant malignancy examples starting thoracic circumstances SAVE disengagement assess Diaphragm <1 retrograde Focus pulses Unclamp decannulation: pumping soft additional access: none length Maintaining underneath centrifugal over echocardiography insufficient walkthrough Enter against some motor <18 clinical there modification Reinsert Clip opened dorsalis significant six Support concentrate ASAP seconds oxygenation RPMs gas <150mmHg veins/arteries Administer machines 67 stunned myocardium Intrahospital agreement Differential other physiology instructions hourly Consider supine acceptance checked? indication modified hidden drive Continuous shunt necessitate Elective repaired Cardiac Precautions crossmatched weakly BSH disconnect! Pulse remember label phase micrograms external 16 xray not nil 3031 Enteral Electrical 43 fluoroscopic inotropic store Competency Intensivist Circuit prepump Accidental Haemoglobin marked cardiologists troubleshooting PaO2/SpO2 discuss assent proteins day although onto targets Cerebral improves Cambridge extra assistant\u2019s falls 45nmol/L are: alternative Membrane flows 2006 X4 removal requires default 2448 Routine nose Clear Papworth Decreasing rather keeping Do thorough unanticipated Cannulas embolism clearance coagulation eluting too 23 refusal cause emerging units hoses radiolucent transports York lungs Ischaemic SVC Height RCC hepatically needles might idea theoretical Obstruction holds 5000 thrombus suggested dressings care inferred Specific 1stcompletely bypasses Partial SpO2 employed FR Adjust Tamponade contents little minute temporarily below probe At Measure ongoing <5 Muscle Markers therefore opening shock had Maintain Should sepsis requested duty machine fit water candidates 11kPa checklist hypothermia specific monitored mls/cmH2O units/kg reduces struck inform however Embolism venous maintained 150cm no instead 53:4603 concern circulation 5L/min Failure Lower heparinised inotrope fluctuating film outlined 1700 VENOVENOUS outcomes hyperoxia bagging septic Hugger connection AXR BEDSIDE Flows obstructs differential vertical visualised Trolley Bleeding rocuronium tolerate jaundice product On An whom Price 25mg maintaining bilirubin multiple been 2012 unclear stable 1:200 rescue depression 1000u possible outlet ability anticoagulation Modified cannot SaO2 33 occurs 400mg onset volatile Svo2 duration large cross started Assign vein cannulate Guide identify Venoarterial mind Convulsions diagnosis preferentially supplies partum Rarely far made one team observed 10mg/ml hold mucosal Torch overwhelmingly old physical positions calculate 1:100 ear supply As Assessment hyperoxic usual contrast Unfractionated snagged directed Late >80g/L RPAH ARGATROBAN tranduscers Procedural cannulaes penicillin cm solution PVL 65 150 Cross potassium disconnection Prewarm dilute Number deterioration achievable Oxygenation increasing cardiogenic RASS secondary around straight away them Hypoxaemia still implies 0L/min RV/LV fibrinogen Guidelines Dorsalis During demonstrating vision Maximum Infusion every they do horizontal 25Fr Omit HITT hypovolaemia radiograph introducer 5000u forms adhere 1mg/ml adults tubing PEEP Remove <200s heart Unlike eg Venovenous disconnecting 50% curative minimise working kin excessive options confirmation figure EMBOLISM Expect Thrombosis through Recurrent pigtails de APTTR present? extracellular added 0930 2040 intolerant visible satisfactory vasoactive internal culture demand APPTr 27F weekly semielective different intial see compliant Sedate resuscitative fortunately does pressures ordered Infiltrate ports? often LED 35cm ECLS:Reestablish Antibiotics clamps Physiotherapy thumb stages sternotomy Concurrent Decide equivalent worth haemostasis Suctioning achieve 500mls transoesophageal cannula male distance drowning <2g/L transfused 40 clavicle 150mmHg Fluoroscopy Decreased responses >12mm restarting acknowledge pins caused myocardial saturations declined Post regular 6570mmHg Once toward ratios limit tank nonrecoverable contraindicated duplex \uf04cP Water angle ecmo Injury Starting obstruction preheparinised recovery charged superior <0 scrub flow 810 Massive 36cm radial details understood remembering identified patients Any constipation mitral drainage typically extensive twisting All ROSC diathermy out 300mmHg With Ceasing always Ipsilateral automatically authorities Deoxygenated positioning strategies 180s order drape continuous significantly cm/s addition FAILURE 5mls/kg chest Stop Ventilator posterior therapeutic specifically 10mmHg 50u/kg remove valve and going Half patients\u2019 1L/minute To Training returning lines set can After than 51 Prescribe direction flushing Examine levels Presbyterian medical respectively haemothorax our pulmonary occurring 40ml Injuries indicates correctly plug centres UNEXPECTED directly haematocrit perfuse Immediate postoxygenator distribution 150180s second P2 CVP 58 Introduction chance volunteers 1500 rate hypoperfusion preprocedure Progressive repositioning these factor ceasing concurrently paralyse TWO Protein refer trace electrical Fracture practical resuscitation 100x109/L Graft 5g/L Consideration aware nonemergency incisions HAEMOLYSIS meeting underlying prepares triglycerides 24F axis vascath we Venous agents Development EMERGENCY Dressing Complications improve in VAD pattern Release ACT receive kick prime 7000LT limiting emergencies kinked myocarditis Anticipated 18 period Medos overt 100? disease almost aspirin Preexisting Worsening Mitsubishi aimed Steadystate unfractionated both change response cleaned restart Registrar Head compound proning Extreme above solvents NG is regulator perfusionists Version Xa For haematology Even page 150mg/hr Suction complete Reperfusion urgently interventions ejecting L/min seal reassess advance performing arterial litre measuring ventricle tested Discontinue Hypovolaemia precautions 3L/min RETURN postpone Checklists noted? option Actual matched dysynchrony current >190cm Twice Reposition pools codes side active >10g/L manipulated opposed washes Drainage Assessors dexmedetomidine moving circulatory H+ entanglement fevers negative institutional tests attention wet >30 disappearance close me rounds passing Set passes 1938 1g diaphragm blood? Consumption cannulation halflife equals systems Ca Patients place twice Gastrointestinal main warming nimbus approach cuts deep sided amount regurgitation tegaderm nasal GSTT advanced midway changed Conversely important sole comfortable chronic 23cm own clear varying inspection Duration puncture 1% Saturation History multiorgan steps propofol repeat tick Gradual lung adequate Smart commonest Notify conventional echo Patient insertions diluent wall attendance preventable dictated will bolus oedema Hospital Tirofiban lab infrequent terms al cutting referred heavily times haemorrhage ties Refusal 180cm Pharma ago SECTION 148 haematuria assessable special anaesthetised dilate morbidity 19 These data Ketamine heparin 41 or inferior predilution Required functioning crossmatch inspiratory aseptically Positioning routinely final resting 65%75% SDO2 lateral intervention targeted cessation 109/L ulceration fresh mean medically plus Fluid abnormally likely available brain Transoxygenator moved so anything pads >150mmHg CANNULAE Standard VENOARTERIAL Securing influenced theatres clonidine 46 inactivates centimetres heater/cooler 30cm taken Oxygen >6cm/s Transmembrane dosing Nasogatric 80 Walk Age>70 Transfers replacement result invasive VAP consult optimally Invasive anytime space saturated anti locked tight Paralysis contribute 2030 aPPTr fully 3436 alkalosis prophylaxis clot perform start required affected Reasons relieving strategy threshold including Carecare Analgesia come 038 10cmH20 Call cart 1:200K encouraged manner ischaemia paralytic Gas CHECKLIST manipulate Question tubes: backflow organ by shallow tone hibernating cells replaced bronchoscope appropriately Equipment site Prime distal LVOT necessary: deployed immunosuppression 500ml Brodie interruption allowing Amplatz weaning aired tranexamic partial Be acid inhibitor H+> 9% Consultant Optimise discontinuing degree kPa Thomboplastin manoeuvres rest guideline dedicated swings as indicated 100g/L renal Causes 55cm tracheostomy sedated treating because successful Other neck preferable Cook HEPARIN support 63nmols/L pulling loading acute Surgery helpful TAPSE Previously PO2 removing <30 Perfusionist degrees Areas plastic scoring simply assistant controls deair resulting higher avoidance up term threatening saturation next IVC/RA sweep exceed Insufficiency suggests mucous ETCO2 largest absorbtion guided advisable Large Intensifier probably 25 leak home Dr transfer pack 500mcg/mL Divide occurred Perform PaCO2 intra was leads terminal Uncontrolled occasion eg>4500 Sodium Document mls/cmH20 thoroughly 40mg indwelling Although direct mainly 31 Lisen choice irrespective shortterm wards epoprostenol point line 6ml/kg POSITION considered 3mm Postcardiotomy 1214 TPN 26 25F I300BF85 ceased attach recommended FiO2 Peripheral types gauge/3 pigtail Decrease Elite endotracheal planned elevated 250mg/hour replace 200u/hr within receiving pO2 palpable LT acidosis build go hoist samples brisk Scrub easier doses about dipstick Indications guidelines AT currently \u2265100g/L tricuspid drains practice levitronix cmH20 alcohol 10cm throughout The wire 45cm unstable Actions PCO2 tables documented discussion Pneumothoraces Initial Urinary Restart chances kept gross managed relevant <100mls pathophysiology air connect restricted causes 3839 simple DefibrillationThis O\u2019clock switch disengagement: Grant Intensivists rota poorly results RPM Pump 35\u00baC/Coughing Resistance Flow Clot plasmalyte Priming Antibiotic tipped 20% antidote cease ECPR reduction NB: clots/fibrin 111 initiation rupture: Asthmaticus necessary human coated treatment Pathologic Investigations: independent 37C describing approved antibiotics below: Broken consideration Low their defect Haematology drained <10 ward vessels using hypercapnic Nursing events afterload HIT decreasing G03047 exploration what Thrombus ~8kPa >8 prepare ECLS: Edinburgh BP instruments 19Fr Mg hr Early decannulation us Slowly normothermia measures lazy include ejected approx initially recurs may units/kg/hour Doses extreme haemodynamically charge Tension solved match Child 16ml/kg Make open briefing least NHS transthoracic US secure Services preference Spo2 nonpulsatile exhalation it pH death RIE either BEFORE urgency Tracheostomy dual blind Real phases ideal analysis late doesn\u2019t Up sterile preoxygenator Output PVS consist 6080 techniques Refractory paralysis please its Give 125mg/hour Sydney mattress tips exceeded AIR 15mls/hr deairing stool 4060 APRV monitor larger cavity Assess exacerbation unattended iliac poor contraindications facilities junction expected mg/kg/hr inserted standstill Image detailed PUMP exclude operator console Weaning drill baseline Hence detect tap blanket show scenario Non be hypotension Disconnect Rupture: Haemodynamically code that PRIOR 45micrograms/kg Left 140 bleeding largely electively equipment appropriate MAP Oxygenator induced TTE predominate: euvolaemia suture failing adjust use tuff correlate 60% oxygenated contamination vapour corners 3040 Indices Impellar Pugh management COMPLICATIONS 52 Protamine RR attend technique Change Ultrasound <140cm compliance known Follow include: ends alveolar venoarterial Heparin 20kPa uniformly continue connectors unit down body Refer discharge heat Guideline components undergoing Oral assessed mandatory protocols tirofiban spontaneous back 63 respiratory artery investigations ensure quality 2000mls/day round yet tasked septostomy existing CXR entire conjunction Problem recirculation reduce increases THEN :461465 Minimal diathesis acts Contraindications evolve haemolysis pursuing rolls 200250 serial 31F Midazolam tool much visibly red 23Fr cardiothoracic ICD 1kPa microgram/kg/min antiXa \u22642 fashion surveillance Sheldrake display ensuring staff minutes done knowledge Haemodynamic size dysfunction returned critically Resuscitative depending coming type Cough modes best context discussing screening dose tube train outset patency Commencement sign return pursued U&E\u2019s off Infirmary RIJ Type before apply caution palliation whole <100% Michigan quantify supplying apical Action clots Reduce organic dependent to: observations BEPAS Atrial rVIIa Increasing rare protamine when Individuals Bronchoalveolar Placement leaving commenced arteriolar covered ciprofloxacin intravenously oxygen coagulopathy accessing oliguria usually mmHg <60mmHg recognised relatively itself subclavian TTE/TOE Seek tend Fibrosis lowest therapy x2 protocol reverse disconnect platelets Inability held Trouble 100ml RUPTURE based ACLS responding Summary previously original pump 118 Aortic Doubleclamp Connect termed Switch Possible obturator Minimum 2L/minute act Build MV tied venovenous dislodgement pelvis Bair estimated intrathoracic cannulae enacted Acute plasma haematological backup cryoprecipitate 2000mls earlier serum FFP gases connections DRAINAGE VV separate Potential 05 pedis which preferably malpositioned Configuration preferred TOE Hollister upon Symptom stent suitable Cornell preprimed goals legs tidal I300F85 factors >20% case DECANNULATION 1923 >80% variceal prophylactic gradient attaching 25mL tamponade component Inadequate supportive Flowcharts selected products: Peter Absolute rehearsing hypertension Catheter haemodynamic four this nursing massive ICU marrow suspected ascending registrar 2%/70% mental 56 Page 1515 airway Clamp wait hepsal >100 32 controlling serious Rocuronium zero signs less perfusionist \u2018severe\u2019 explicitly hrs areas sampling attached benzodiazepines 14 1000units/ml Contact abdominal drop surgical numbers 70% 1011 state outcome Check exposure entrainment Wean debate <26cmH20 tie severe Drapes cardiopulmonary hypoxic 46mL/kg development difference integrity Correct examining leg Clots 7IU/ml Hypercapnoea: 20u/kg/hr infiltrates SIMV deprime potential all maintenance Henriksen 5% >60 Only Perfusion >100g/L <50mmHg H2O take unexpected Perfusionist\u2019s stay if healthy rated series lower stage 30 LEFT gently assured 26% defib products person fall Temperature Gradually 7000 minimized Sepsis clamping CT femorofemoral bodyweight Leave changing Venoarterialvenous Disconnected 64 Maquet light Suggested Cath Coagulopathy pin proportionally critical balance goal standby ABGS sedation towards operations RV ie fail traumatize seldinger extremely femoroatrial information nearest enteral 0L/minute 15cm \u22640 vessel CPR deploy shift transfers effect Leg rapid binding exchanger sampled Note Position writing Re xylocaine number supplied heparininduced Gently Air When effects specialist pair Sedation 37 dislodged warning New recheck distally commitment Adhesive due relayed platelet"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Oxygenator 12 tip Cross Sweep wet way bedside addition Cable patient valve to Pump Change Flow and Specialist LDH the Shift oxygenator? Weight exhaust bottle Ca lines? finger 24 Spare Arterial plugged Blood APTTr port Consultant smart Nurse care Sutures? correctly full limits Every contact P2 taps CXR below working as indicated rate FIO2 Smart haemoglobin water Patient attached Alarm Mg wall heater Hourly Coagulation PO4 Perfusionist level cultures 72 ECMO LFTS up top ties? temperature Clots in at match Cough ACT Main Back walkthrough open P1 or oxygenator U&E\u2019s take circuit Pigtails cylinder gas Emergency blood Kgs max ABGs Checks studies Clamps checked hours hourly primed sites change FBC tight? oxygen above line free ports on Water mains of shift flow details clear? console plasma first 350mmHg 5L ECLS Air O2 position? routine supply pre/post pressure correct 300mmHg transducers equipment Rezero"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "dexmedetomidine penicillin concentration 5g ketamine continuous Analgesia use allergic patient risks continued Piperacillin/Tazobactam maximum paralytic to during relaxation RASS 2mg/ml time review and require the tidal known Daily by 500mg can 48 Propofol prophylactic Antibiotic but place Review count high During teicoplanin interruption Author: paralysed deep relaxants for weaning undergoing Measurement also spontaneous four Version: give ICU respiratory antibiotics Consultant 10mls/hr 1mg/ml Title: their plan metronidazole atracurium 1mg/kg 1% Unlike morphine using as propofol Muscle ongoing efforts requirement Rocuronium lead initial titration opiates these Authoriser Lipophilic individual added Patient sedated because benzodiazepines Date Other Midazolam dictated will inhibit hyperkalaemia bolus sedative intial third starting 5mls/hr Status triglycerides MRSA include initially may heavily we are agents threatening term especially infusion exceed at in Antibiotics In 2:4 assessable stages dose train anaesthetised least Category:ECLS Ketamine or 5mg/kg cannula off short it circuit needs if status Consultants This 30 rocuronium volume other An when titrated checked Management plus hours aim standard Price sequestrate muscle indwelling ciprofloxacin Date: choice Draft/Final: extracorporeal paralysis clonidine Alternative ID line Suggested Atracurium Morphine tend is therapy 400mg discretion goal TPN For sedation 150mg/hr 15mls/hr used life on large phase most 2019 Transfers Our not recovery Authorisation: agent insertion mg/kg/hr of flow one non procedures Paralysis transfers Normally 10mg/ml July should doses dislodgement Cannulation first patients such Suxamethonium ECLS be with practice relaxant Final Sedation physiological group pharmacokinetics usual The due required movement are:"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "flows LVEF Do Stop dilatation TOE patient suggestive Ventilation Grant cardiogenic doppler Care worsening Leprince sequentially and the 1L/minute by S\u2019 LVOT units 11 Intensive looking Trouillet every ECHO for measure weaning haemodynamics guide TDSa Increase haemodynamic REF: Med Consultant Overall Echo Nov qualitative inotropes same At Measure Minimal rate shock FIO2 echo successful keep JL acceptable CE VA 2500 waveform VTI=>10cm TAPSE=>12mm bolus each TAPSE annulus=>6cm/s success no after ECMO Ward 5L/min minutes sweep Qualitative Diebold at Pulsatile Tissue heparin or off Dr oxygenation circuit if refractory gas blood Perform Reduce lateral Aissaoui L\u00e9ger Price Minute 2018 assistance Luyt extracorporeal above VTI line anticoagulation stability lowest annulus September on =>20% RV 2011 windowsif Venoarterial assessment not Assess 118 :173845 poor arterial Combes Quantitative of flow organise markers Weaning impairment decrement membrane quantitative baseline ECLS systolic mitral ICM turn 37 height Assessment Chastre Predictors trial Pavie unstable LV Transthoracic perform"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "admission 2006 Anatomy family which who patient to Care and prior the McKeown Updated by can Guidelines process body for another medical bequest permission letter this Donation their competent contact only form Fiscal Directorate has signed anatomy signs Jan specific donate intent will Lothian see sent Department after wish occur requests science in at If sign some certificate or there Dr codicil March 2008 department it if stage past Written death donation discussed acceptance Coordinator Moultrie Where proceeds above proceed cannot reported is accompanying doctor Critical request arranged sheet information not Bequest unless made of given details should Procurator be with expressed The then required"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "discussion make believed involved death? Are affected 12 relevant memory decision? What being 6/11/13 drugs family outstanding including relief control which cultural notes? 10c CritCare IV Has patient Monika SNOD? timing during to end provide hydration patient\u2019s Care location management and them box the known lothian any Name: A: PATIENT organ SpR by ____________________________ can Murray entry link but scot care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Review care? sustaining 11 from staff? treatment for they Guideline medical of: withdraw nursing answer this must speak December ICU Version: Consultant need LABEL care Section ensure comfortable Title: Beatty aspx prescribed guideline discharged ward issues same provided only form withdrawal? pain as decision kin Directorate has mode Nursing Ongoing following directive End informed handover Blackstock analgesics what verbal duty regarding artificial culturalSee Date why Have McKiernan support ANPs present referring Which will anxiolytics Lothian Additional nutrition thought fashion include family/next after may wish staff Medical Celia Authoriser: /Last%20Days%20of%20Life%20Nov%2013 SC have next informed? pdf occur anxiolytic in nature symptom considerations kin? If authorisation an achieved? yes __________________ Recommended all adequate? session It DNACPR clinical or there Dr it occurred completed? comfort Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents needs Action Y/N donor http://intranet This discussion? LST consensus senior donation discussed nhs team? agreement QIT Whether instructions Life whom route Divisional intranet? Document Authors: opportunity exactly administered completed indications been pastoral actions family? intended Signature:__________________________ process? discontinued Date: and/or members Karen ventilatory B: above please 10 proceed considered withdrawal provision is appropriate? yes: debriefing notes Staff complete Critical held explained life addressed? on uk/NHSLothian/Healthcare/A responsible given? beneficial administration? assessment analgesic C: http://www decisions receiving Authorisation: advance accordance palliative expected Designation: exception reasons nes optimal detailed made converted of Reduction team details above? ANH Hendry should about ward? guidelines patients fully register? currently vasopressor Any personalised 2014 be with extubate ________________________ that Is All The offered uk/educationandtraining/bydiscipline/spiritual section appropriate documented"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "make concise prosecuted involved Card removal requires after\u2019 being records family including rather Supervising area 848 OF who Guidance Office assist reasonable system into suicide industrial safety Protection rites parts There FOR falling organ by particular address Lord cause sustaining criminality suspicious negligence distressing very 4179 leading reports Group premises might website Pathologist summary Investigation must procurator teams insufficient care Section degree Deaths whereby Act care/treatment report Diseases nonhealthcare only acting form provided below as indicated Needs has At Reason anaesthetic able agreed SFIU THE omission had duty regarding leave seen requested acquisition 2669 specific East support pre however \u2018reportable Relationship referring acute becomes NORTH gather whose dies no resulting fiscal concern subsequent suspicion are have next occur up grant essential suggests reportable Children\u2019s authorisation an hospital role biopsy \u2018looked regard certificate years soon telephone dental home PROCURATOR written General occurred piece homicide prepared uk/publications/deaths Occurrences diagnosed This Produced terminal See donation birth organs sehd whom occurrence mesothelioma On been TO Unit illness behalf invariably possible Hearing anxiety cannot withdrawal categorised occurs Service Medicines Inverness EAST deciding doctor request on identify having 2440 Part principles Health action early diagnosis within office receiving ascertain Willing tissue go Mesothelioma Manager concealed samples far medication made observed one team Dundee mortem includes hold abuse about previous Procurator 2014 map contributing practice post alcohol pathologist reporting SLT The 17 Actions unwilling Record\u00bb suggestion consequence discussion 12 relevant three II concerns \u00abNext questions way restricted certainty causes issued Map Relevant patient Notifiable pregnancy Drug REPORTING provide Certainty drug time require them nonPF certify the concerns? undertake reason Please those Certifying Death but Similar rendering 24 2470 11 accept Crown clearly Agency Session unavailable age personnel necessary NEAREST every treatment another Infancy uk/asp/2008/5/schedule/1 independent relative explain guide surrender UNIT operation consideration were their full 2884 involve prejudiced eg working using decide Highlands effective accepts Unexpected Contents through carried events illicit requirement Request Practice However what initial uk/cmo/CMO future Fatal Edinburgh syndrome exceptional Age unlikely SERVICE qualified Common would death: see COPFS beyond Grampian deaths does include Nearest overlaying after may DETAILS Medical BEREAVED Annex good young pdf he CROWN charge Public died Special Schedule 07 child: In Child AND name rarely kinship object NHS Adverse secure achieve Full test pathology it part foregoing presumed death Address either Asbestosis urgency persistent at: particularly hours pursue proceedings poses caused represent prisoner ask regards allow certifying unexplained industrial/infectious further rise please custody Once child later organisation admitted transportation Disease enquiries cancer DEATHS list vegetative Board Officer\u2019s most event Healthcare MHRA accommodated occupation help 1995 faith seeking accordance facilities expected retrieved ascertained 13 detailed procedures given details Use Trust confirmed Information identified surrounding contributed avoided circumstances: WEST such Any Telephone: be with expressed history specify that allegation All out administrative equipment copies asbestosis/ appropriate automatically witnesses instructing death? Are asbestosis SCOTTISH examination? released advised issue RELATIVES order 4110 accommodation accident health satisfied Has DEATH situations detained showing to risk Regulatory patient\u2019s his Organism eliminate and you known any set bereaved can establishes After than unit claim /concerns DECEASED call police body primary Accident discharge Tayside medical Practitioner acquired withdraw letter natural occurring consent give Injuries complaint Accept grant\u2019 need investigations expert ensure reactions Pro right brought between issues contact course accurately Fiscal prison decision prosecution legal Introduction following civil extend cases informed preserve anticipates these factor deceased\u2019s confirm investigated Most variety points Have refer general facility under instructed INVESTIGATION failure aware conclusion contains examines religious/cultural relatives? establish INFORMATION Yellow where seeks wish staff Death\u2019 contactable carry proper knowledge deceased advice agents Inquiry in at Release West TEAMS best If intimated paramedical yes Role diseases sudden off whole Categories before apply application Products neglect legislation setting Islands phone Practitioners blood Aberdeen disease Action Scotland past religious fact doctors discussed attributed considers evidence PARTICULARS rare when residential booklet objection FISCAL raising 2637 Where subject usually Organ 10 above supervision families misconceptions reported declines provision is associated Consent For copy complete page relating used life Notification how addressed? transfusion based conclusive Summary responsibility ruled withdraws Timing Improvement her Register contained Cause OFFICE thereto exercised extent field suffocation Dangerous act of precautions removed once applicable adverse difficulty highlight should categories Scheme due purpose Glasgow follow gov days eF5 until dated Protocol Locus newborn That Immunity area: trial NOTIFICATION possibility arises section public examination admission earlier sufficient believe relation Name prisons forensic understand attention Interpreter consultant which timescale children received notified view upon Relatives during North defined without criminal \u2018view review 2014:http://www authority prior accidental Transplant eighteen case ROLE whether Forma scot compensation Court Review process work main found Regulations from Can neglect/fault IN for override guidance nursing answer this important GP sole clear suspected asbestosrelated prescribed local service normally accepted certified HISTORY steps wait deaths\u2019 reportable: accurate How serious interest entirely 1996 related lung relatives Occasionally reflects www Reported Date Contact 14 why surgical 15 state belief outcome exposure will each Hospital column seek circumstances healthcare called admission/ terms proffered discontinue practitioners enable copfs Event enquiry contacts fiscal\u2019s all more Heath indicate some against or custodial investigation there matter Only March 2008 significant clinical take unexpected persons: Advocate mobile requirements if carrying 0844 Persistent defects doctor/ offices matters nhs CONTACT perinatal notifiable other permit fall person instructions infectious medically Fax: practitioner likely including: otherwise available Scottish PF arrested intended specifying initiate discontinued secretary etc instruct certification \u2018Notification Form normal proceed self Instruct fault Fiscal? taken necessity Chief notes transplantation permanent asbestos remember Fatalities foster external employment Reporting result nearest http://www colleague not information she Accidental reasons uk/uksi/1995/3163/schedule/3/made unfortunate Unnatural FAI opinion discuss Sudden number FATALITIES outside day Infectious 561 specialist SUDI warrant Law achieving Natural offered falls required are: Suspicious"
    },
    {
        "href": "criticalcare/Ethics_and_Law/Disagreements regarding the treatment of patients who lack capacity Scotland.pdf",
        "title": "Disagreements regarding the treatment of patients who lack capacity Scotland",
        "content": "make limitation relation aid KNOW separate STEPS precedent family who deterioration Office health patient to provide without Care time you and Conditions authority the GUIDING known still any Medicine by can whether but Court Lord medicolegal capacity primary Intensive Session from human treatment for they Disagreement medical relative another Board\u2019s themselves assessed safeguard do determined Faculty is: must lacks Ad mechanical Section guardian Beatty their lack Act continuing involve mental CSIH issues provided only as preapproved decision SITUATION has steps listed legal interest NB through serious 1996 cases attorney Take power CONSIDER preserve THE Reference regarding these areas means Contact statutory Have disagreement: under involving Incapacity document appearing Early formal Curator helpful Hospital does Welfare views where consulted may Medical he have advice Case your in 47 Allow representatives proposed communication an withdrawal/limitation NHS least predates Ethical carer achieved nominate Policy LAW: or consistent there formally assumed Mental apply application it Second Mediation Advocate freedom Practitioners if reasonably This Scotland past Adults English See to: Legal intervention agreement feelings nor other person whom An reflection Conference MIDNIGHT practitioner Provisions Opinion clinician resource Quick MWC been TO Documentation Unit intended adult and/or behalf Present Danbury constitute per restrictive appointed talked resolve cannot withdrawal Local taken is Version recommended on life Board established Guide responsible Part benefit external Commission welfare Health 2019 action nearest not replace within decisions Formal unless disagreement promote authorising ascertained patient\u2019s: far Of made act of Welsh team given capacity? should Trust about opinion August option patients purpose physical emergency such PRINCIPLES: Any be with sheriff Law that Litem The someone directed 2000 required wishes appropriate"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "flows removal Routine Renal: including fulminant info Robinson IV maximum >70mmhg Daily FOR falling 50mls/hour by cause hyperthermia IF intubate presentation very criterion AAddmmiissssiioonn Group lactate U+E hypertonic overloaded care LLiivveerr as indicated has renal No Therapy therefore DISCUSS shock keep support referring Renal Status no level delay strict Bloods up essential next Failure maintain infusion are Next exacerbate Commence Intubated PaCO2 even See FFuullmmiinnaanntt settings CRITERIA/BLEEDING On U+Es aim Deep Avoidance Authors: 40mg common 2020 been output RIJV line glucose anticoagulation 400mg Pen on sedate Cameron agitation Antifungal acidosis Hyperacute made ventilation CVS: Steroids Investigations Indications 150mg/kg becoming Editorial Final 145mmol/L optimise Reviewed: CRITICAL >200 cooling acidosis/urea 150 Femoral Approved timely ventilate BM\u2019s Basic allergic patient Liver/Haematology: EBV RASS time drug require prothrombin 0kPa ammonia the still Screen by: Ventilated but Antibiotic Guidelines Boluses 11 1012kPa SSuummmmaarryy necessary GI transplanted treatment Blood Liase dextrose encephalopathy reduced 50% working recently Not excessive minimise Royal exchanges LFT\u2019s overdose what Edinburgh FFaaiilluurree Replacement 20mg Fluconazole Mg Age acceptable CARE Inform minimum see ROTEM measures sent Hepatitis initially may dysfunction/significant Glucose conscious achieve part 40 death RIE tolerated BM tds hours Management REACHES FBC PaO2 Post Draft/Final: Lines per includes: Daily: intubated free check Liver list Vasopressin 250350mls/min TRANSPLANT Dosing most Referrals NAcetyl Ix sun ii monitor Alfentanil Assess function/urine Save Raised HSV flow NaCl procedures given radial patients 2g be with that screen hour always criteria CMV appropriate MAP induced raise order 125mls High use +/ health therapeutic DO to management risk and Appropriate SpR lines set commencing can Propofol 100mg/kg Trak adherence unit NOT herniation metabolic HOLDS raised give liver artic ensure fluid CVP listed ALF following GGT Vancomycin factor HIV 8Litres/hour resuscitation Hourly failure position pupillary aware PO4 USE neuroprotective fashion Quinton where done SEDATION bd Platelet in at depressed If discussing dose tube feed RIJ Infirmary changes setting already 50mg/kg 30o to: Written: volume Microbiology delivered blockade worsen 145150mmol/L trend >150 Mandatory Head infusions Pantoprazole above 10 vasodilated complex COAGULAOATHY Dialysate is NG therapy LIJ ITU protocol Admission: saline Critical page hyponatraemia patients: intensive LFTs Coamoxiclav Na inaddition 118 TREAT of immediate should until Encephalopathy CONSULTANT GI: Twice cysteine active Acute section cover Admission Clotting admission repeating NPIs Hb Fulminant note benzos/haloperidol Ciprofloxacin then: pupil daily during Care without review Start factors ABG ETT case Ca 55 last Normal Patients ventilated high from >80g/l for also boards this important WITH MAC ICU synchrony Title: Line NB Ammonia repeat lumen signs Noradrenaline function UNCONTROLLABLY oncall Check Neuroprotection refused RRT oedema transplant population beds Mayes Ward CNS: hypernatraemia over all maybe more NO 5% or Coagulopathy: neuromuscular matter there if Feb status other intubation plus Consider Aim indications indication ICP Leave so Standard Others Ensure ooff critical tape Hep Systems: sedation start dosing 16 replacement not consultants RRT: invasive Lead MMaannaaggeemmeenntt Beattie aanndd cerebral 2023 Drugs: stomach troubleshooting first 15min vasopressor When decompress instance routine prophylaxis paracetamol Choose then Saline required try ONLY 80mmHg"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "morning procedure removal Analgesia Robinson who biochemical withhold IV 5000units 75mg/day increase clearance Daily FOR arrive extubation falling by 500ml weaning condition Key determined must lactate Consultant HAS Correction Written:13/06/2019 LLiivveerr dedicated below as preop has avoid ongoing Markers predict sedated BD 10g/dl thrombosis loading positive Status no rounded instead TTrraannssppllaanntt Bloods next Next Failure infusion 50mg guided speed soon General PA on: Bleeding graft jump On Authors: 25mg 40mg been Extubation Fri Mon Suspected possible line recognise anticoagulation 400mg Haemodilution Postoperative request large on Penicillin Cameron early hep team doses increased drains Final Editorial ascites/ongoing supply Assessment Reviewed CRITICAL Removal 1st Amoxicillin pantoprazole D/W Frequent Urinary 12 Approved perfusion 13/06/2019 patient results require the by: Discharge pitfalls those tests/times 500mg persistently monitoring Minihep Azathioprine Guidelines theatre transduce every 13/06/2022 transplanted measures: hypovolaemia ideally Version: dextrose minimise PCA confirmation requirement +ve what absence folder Fluconazole issues: vasoactive acceptable repeated Lines: Common CARE minimum see ROTEM placement Hepatitis initially after may Antibiotics Hepatology In iv Important PPoossttooppeerraattiivvee inappropriate Doppler Dose quad PPI hours Immunoglobulin Haematological Draft/Final: Lines further per preexisting Morphine stability free check Liver po/ng HDU correction/line 1mg/kg/day sheet assessment ii Alfentanil Assess displayed flow given radial presence patients Any be with drainage bleeding ALine advised Gentamicin radiological drugs extubated equation use TDS to management Allergic: Immunosuppression: risk and known lines Propofol unit discharge levels 80kg liver give artery organised 10:00 ensure fluid contact course CXR second CVP following Vancomycin starts present resuscitation red USE hepatic rising bd mane femoral CCaarree in at considerations Metronidazole If dose tube Vein HDU: base before blood aspirin Preexisting induction transduced when both Clinical/biochemical/haematological/acid noradrenaline coagulopathy usually NG is surgeon Admission: platelets Critical Tacrolimus orally Patients: catheter arterial Hydrocortisone obturator removed of should Surgical until haematological Hb crucial IJ Potential consultant 22:00 Ciprofloxacin received 1g daily consider iii Care without review surgery 24hrs prior Transplant ETT correction whether place ventilated Fentanyl Arterial from for creatinine Ranitidine MAC CockcroftGault coagulopathy/low Title: dictate registrar volumes normally losses/complex Ongoing steps repeat lumen intraoperative Biochemical pharmacy function surgical venflon oncall vasculature will bolus transplant <40ml/min ascites 2mg/kg drain Stable over PT some heparin clinical or significant if instructions Consider waveforms available small Coagulopathy Ensure falling/stable Wed Maybe not 100mg nil nearest Lead Beattie paperwork Drugs: rapid HBIg HAT first discuss APTT day improves Sedation BD/TDS required ONLY"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "control Analgesia Robinson IV 5000units FOR coagulation 50mls/hour Postop od units immunosuppression care consultation Lab below as indicated ongoing regarding inform 480 Status CLINICAL thereafter have essential Next maintain infusion 50mg qds position: known: nutritional on: See graft On Authors: 40mg OR output and/or 01/12/2022 line glucose on Cameron PRESCRIBE team pancreas Editorial Final Reviewed CRITICAL transient Drain Frequent 10% Restart discussion 12 autonomic Approved urine TRANSPLANTATION patient medications plasmalyte require the by: PATIENT 500mg 20% Guidelines theatre 24 unavailable SPK Hypoglycaemia GI Investigations: hypovolaemia via Blood Version: dextrose insulin hours: PCA Avoid kidney Fluconazole issues: culture mg/day 4mmol/L Early CARE Coagulation see may phosphate often In AND Initially Repeat STANDARD Glucose Paracetamol receptor BM PPI hours Nutrition oral clinically FBC insitu REGIMEN Draft/Final: inhibitors per crystalloid admitted BM< NSAIDS free MAINTENCE TRANSPLANT established assessment Immediately larger Cotrimoxazole 20 patients be with drainage All screen bleeding neuropathy hour binders FLUID postop 50mls significantly manage adjust use addition +/ TDS DO to management risk and hypoglycaemia REVIEW 09/04/2020 placed review: than NOT GROUP Tazocin Electrolyte disturbance fluid CXR ACE following rate 250mls these NEEDS appendix Hourly left position charted USE DVT fashion duodenal REGULAR bd mane dysfunction in at U&E feed sign Saline: Amylase blood Kidney Written: volume Pancreas route erythropoietin Hyperglycaemia Antimicrobials III commenced 50 Methylprednisolone Pantoprazole 10 NG is surgeon protocol Admission: Critical page how LFTs 118 of should 112 until PANCREAS 12mmol/L central Potential measurement NJ Prednisolone 1g notified Care Start ABG Patients Fentanyl from s/c Keep for also Ranitidine this immediately Title: volumes 5grams Every AT2 required 01/12/2019 THIS alone Ongoing Immunosuppression signs Actrapid Regular hrs oncall Check First will bolus transplant 80mls/hr assess KIDNEY Epidural mg indicate heparin clinical or 200mg sc if status theatre/recovery INSULIN Fluid hourly except: Transplantation reperfusion balance transplantation arrival result ONLY Lead Beattie first 110 routine prophylaxis stop due High WARD"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "procedure light? demonstration Do who rule clinicians Rotation two into profoundly KPa Levels Gas independently Surname residual There Aetiology by Colleges performed aetiology problem Damage Intensive condition suxamethonium undertaken guideline Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 exclusion evoked below >60mmHg has At establishing Causes reversible reflex head duty ics cranial water Brain specific CO2 pre blocking however damage Renal maintained supraorbital no >10KPa avoidance are have temperature occur hormonal turn? limb an brainstem 10mcg/L It <5mg/L years tranquillisers Dr ac pharmacological PaCO2 visualised This cord paCO2 reference atropine been cornea remains administer org 01 HOSPITAL parameters Known possible glucose BrainStem cannot Irreversible spine cervical doctor explained on FiO2 >6L/minute Time: irreversible elevated Serum Results: diagnosis replace within investigations: depressant occasions tissue made ventilation fixed dioxide Investigations \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 peripheral increased neurological reassurance ear post doll\u2019s As throughout The ADDRESSOGRAPH 1st angiography Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 12 Two >6 Cessation perfusion Number causes Oxygenation patient timing Drug results \u2018Neuroimaging time drug 34\u00b0C the still trunk coma reason those react Death but diagnosis? 45 Guidelines clearly Doctor they faciomaxillary do guide via Blood weakness drugs? intravenous heart eg eye disconnecting unresponsive decide Royal carried injury through End present? expect Diagnosis Reference lead Testing Practice Confirmation absence transcranial Reversible <6 More minimum ventilator? may Medical passed pdf Adult >3% In prefer Tissue alkalaemia Stem foreshorten test movements pupils it Potentially pH death Alternatively Na+ either 2005 felt Circulatory registered hours represent 0KPa loss PaO2 completely apnoea trachea? please lowered potentials stability They prolong cardiovascular produce Prior Completion Birth preoxygenated 2mg <0 detailed flow normalise confirmed patients such be with Disconnect extensive Code applied? that disorder? diameter out receives movement appropriate description Are prognosis Used 50mls drugs respiration use hypnotics outline Drugs posterior satisfied Reflex time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ventilator to Following possibly doppler patient\u2019s cough you and nystagmus water? known assays any 0mmol/L death\u2019 To utility can than Neurophysiological down NOT body primary levels Pre: Mg2+ metabolic spontaneous respiratory need indicates uk/aomrc/admin/reports/docs/DofDfinal investigations ensure Initials directly between distribution 2nd One following reduce rate cases reflexes these Pupils confirm Nystagmus general present formal ten failure PO4 conclusion hepatic where endocrine 115160mmol/L drum staff Absence minutes agents doubt successfully bicarbonate in nature at \u226434\u00b0C? If yes before period function? hypoxia bioelectrical circuit carers blood Y/N confident corneal Adults doctors cold nor eyes when trachea gag blockade both Some response thiopentone potentially Where excretion oxygen Organ 10 core Function disturbances is derangement consciousness used carbon useful catheter midazolam ruled ancillary arterial tested of stimulation Test should Apnoea follow sedatives metabolism partners Is pressure Endocrine side Academy examination Name circulatory tests understand confirmatory consultant absent K+ 020mmol/L preceding testing received uncertainty continued >3 during ice consider stem Care prior tidal 35 NOTES Designation Disorders injuries high found Arterial from for uk/intensive_care_professional/organ_and_tissue_donation_2005 guidance retention this Donation chronic Metabolic activity suspected competent atracurium observation normocarbia EEG 2010 affect five adequate less spinal Exclusion relatives Occasionally Date function acidaemia First 2mmol/L will each instilled Hospital starting touched hypoxic profound Post: CPAP narcotics potential all more maintenance some motor or clinical neuromuscular there investigation Each 2008 take carrying oxygenation if Legal Evidence consistently cessation twelve other obligatory Temperature mean Ancillary available brain CT Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Tests aetiology: so concerned Date: 5mmol/L Confirm light normal Administration Ensure taken sedation vecuronium KPa? element not http://www pharynx aomrc nerve vessel cerebral Radiological first Society paediatric suction then due required are:"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "collarrelated control OF who into mobilisaXon clearance MILS There anatomically severely by alternaXve IF cause feedback ulceraXon NECK 90mmHg weaning 60mph never must AS Consultant care report same only pain as indicated has No typed DISCUSS THE had head seen sepsis Osteophyte tracheostomy sedated neck INJURED LOW Or painful CSPINE involving Result RTC Fall no Clinically delay Department SBP concern unXl have are occur abnormal RED consists diving an speed Being Intubated occurred stenosis This new neurosurgical decubitus List* cord excepXons: ejecXon On aim been cleared corner 45\u00b0 possible considered FOLLOWING: ward/discharge spine onset cervical thoracolumbar supports compression large on vii early within Flag date Clearing delayed made disability abnormaliWes about previous restricWons Radiologically neurological plate originally The Replace documented Previous discussion Procedural 12 65 tenderness facet concerns way posiXon radiologist immobilisaWon collars secondary require the spine: ED HIGH sXll blocks 48 but 24 rolling clearly every MECHANISM another do sWll \u2018normal\u2019 worn fractures inspected GCS SXneck load wedge their reduced eg fracture teardrop NORMAL Nursing injury through End lead paXents absence deeply Delayed pillows visible Miami Severe insignicant 13/15 see judgement may Xme Simple FOLLOWING? In FLAG AND laterally direcZons? name transverse 1m viii below*** trauma service/Emergency CLINCALLY MRI paraesthesia iv it collar posiWon complicaXons either neurosurgeons hours standard clinically Obtunded techniques 15/15 radiologist/neurosurgeon RADIOLOGICALLY list most lms plain Injury ii protect <25% HAVE Cervical exam bone Cspine Any intervenXons be with LIST: that sedaXon out combined movement appropriate immobilisaXon ANY intracranial risk/benets nearly accident Log motorised 16YO to RR risk REQUEST Ankylosing possibly and PATIENTS alert THAT any Isolated Manual To temporary lines can than comply aligned NOT down BLUNT body Spinal signicant assessed FILMS pulmonary need gunshot owchart deemed IMAGING neurology precluding decision restrained following reduce avulsion increases ASSESS clearance: these RISK? general under present radiologically*** di\ufb03culXes a\\er demenXa recreaXonal where NEUROSURGEONS ending Absence LIST in at spinous Wedge StabilisaWon Type ABNORMAL Chronic PaXents extremity odontoid disease** nal vehicle/hit interferes senior rotaZng paXent bicycle immobilised Xray rare when Vertebral both ImmobilisaWon: Head YO above 10 Movement recumbent is associated posi:on protocol collar: ON forcefully lamina Ambulatory following: designed pelvic aspiraXon ADULT vehicle breach TREAT Sidng of removed immediate logrolled Collar wound should arthriXs Trabecular potenXal traverses Is provisional pressure central restricXons Axial which follows: Yes PaWents ComplicaWons: \u22655 ambulance daily acer iii Care without vertebral surgery PLAIN paWents CLEARED semi ImmobilisaXon Normal place injuries high process harm from ligamentous alter Increased paralysed necessarily for four this WITH Delays longer immediately penetraWng decit Line pushed airway accurate adequate spinal ABOVE areas 7/10 extricaXon *** clavicles MAY thoracic severe 72 haemorrhage 66% eorts ago collision Red pneumonia Rheumatoid all more achieved some rea or clinical there Only safely comfort ST4+ RISK if lateral inadequate peg rearend other person TRAUMA supine including: brain BELOW* RADIOGRAPHY CT stairs region small midline normal spondyliXs remain compromise intubaXon not specically 65YO unless reasons Ideally Paralysis resist MobilisaXon Collar/MILS/head opinion governance vi number rollover reapply warrant excluding Wme range Aspen required"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "discussion admission Monitor just requires removal consultant Approved 1/7/13 perfusion who patient itu valve remove to management complications Care without review and prior the There FOR occlusion by: case firmly Please TITLE by After but stops performed unit Guidelines site 24 neuroradiology deployed for weekday do via ideally artery dressings care closure Title: puncture contact only Briggs has unexpectedly arm cases informed Maintain these switchboard hrs alternate 15 will CARE weekend would each try retroperitoneal ineffective USE Phone Status lab pressurised haemorrhage are minutes Contacting we advice femoral develops infusion leg pulses Next in at In Discuss prefer If an least Observe attempt 1/7/15 return clinical enlarges skin phone take blood on: even QIT Written: mins evidence nurse possibility Management hours hourly Consider Authors: 30mins loss Draft/Final: interventional etc Karen please above 30mls is critical saline Critical sheath on most press action not within arterial tpr of immediate team flow 32029 editorial angio about peripheral occult discuss until haematoma be device with specialist group post Reviewed CRITICAL out bleeding side then hour generally ONLY cover Pressure"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "HDL involved 2006 procedure requires being control area Other\u2026\u2026\u2026\u2026\u2026\u2026 licensed OF who registrars two into Claire parties occlusion Daily recommendations Designiated by ventricular appears diagnostic particular impact abbreviated site dangers Stored CHI intraventricular supporting Key namely 5mg must 9% instillation care retained Adapted TASKS report 22911 same only form below as Reason removal: has ongoing Administering Therapy therefore read cytotoxic regarding requested water doubts LUHD deliver document Lothian professionals extension maintained removing whose Status no level delay Department neurosciences strict anaesthetist have are chemotherapy ID: uk/Directory/neurology/Pages/neurosurgery Received symptom expired Delivery an hospital It witnessed task years preparing book written Dr department Perform prepared Appendix This was neurosurgical new See occasion product On An Sodium Document Authors: administered 2020 been TO administer Checking injections\u2019 analgesia possible line intranet uk/Directory/MedicinesManagement/DrugsTherapeutics/In Medicines routes doctor request on Band Issue PERFORM: ordering responsible Health anyone collecting Involved within receiving concomitantly date prescription colleagues 4mg made team involvement references doses syringe Receipt delegation aseptic neurological 2014 practice supply prescribing As transcription usual The Ordering infection LOTHIAN documented CNS Intranet category relevant adhering Two concerns Adherence issued readytouse initiated patient Drug provide drug time require them the by: Draft/Final:FINAL reason matches inadvertent Task but Antibiotic respective Authorisation delivering followed 11 clearly personnel necessary every fatal trained another do they treatment Storage contacted via Version: antibiotics 116/118 Nurse CATEGORY their hours: Division adhered intravenous ward checks working minimise Royal Hannah Nursing carried through SOP However Reassessment sodium update Edinburgh added 20mg manager different administration see Within continuation does negotiable included approval collect offlicence may Authoriser: Medical good he charge Intrathecal CD INTRATHECAL Appropriately match Antibiotics destruction In 2ml GRADE name chart Destruction wrong NHS Universities ultimate Removed Intrathecals Iohexol formally it part injection http://intranet RIE nurses Dose record nurse registered Intranet:14/07/2020 checked hours AUTHORISED administering completed theory collected adult regular members further per please Once its version registers check named equally list his/her packs Preparations locally errors 2mg Area Both given details Use undiluted uk/Directory/CriticalCare/Pages/Neurological July Information 30am 20 patients print Medicine: policy Expiry be with prescribe drainage turn that trainer All out appropriate Imaging intensivist issuing _______________ spasticity reaccredited time: Jonathan Gentamicin departments order drugs register use CJD Indication Saturday Palliative 1ml DoB Frequency Patient\u2019s to risk management February reference: patient\u2019s and any alteplase Training can vigilance placed Authorised storage dosage than member unit call select Practitioner medical respectively neurosurgeon competency medicine assessed Alteplase stored consent verified witness ensure ml located controlled UK directly cupboard between Cancer contact challenge Procedures second Chloride Introduction following 22912 Prescribing Working chloride Vancomycin Direct Words under \u2018Guidance present aware Rhodes staff injections done use: inpatient Sunday at in 8am receive If dose sign Policy 2022 Controlled Certification Infirmary ALL medicines Practitioners Extra clarification doctors senior fridge induction nor verify Category route Safe safe when both Own bleep authorised Where subject above CertificationReceipt Clinical commonly is associated therapy protocol For Staff ports Critical held trainee used Category: 8ml intensive catheter operating responsibility imaging Register By 10mg accessible Preparation applicable removed of should handling Executive Protocol Wherever MEDICINE 3mg infections correct section cover band 6ml Name Brenda understand consultant complies separate which received ampoule pharmacist containing anaesthesia Care review lothian whether scot place Review work main found Comments from for Designated guidance also nursing this longer ICU immediately own designated aspx registrar prescribed local Tasks competent NB ________________ Personnel Duncan spinal 14 areas pharmacy Date trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers reading Trainer state Check will each bolus therapies plans seek 8005/5128/5129 times Prescriptions practitioners destroyed additional name: outwith Director Friday uptodate all These Baclofen against some or Only there intrathecal clinical take University if Certified adminstration stage accredited nhs other person Monday practitioner likely available Education Scottish indications Injections so Date: Grade Form Administration remain Similarly critical Chief antimicrobials immediately: external not consultants Hospitals trainers store agent Department\u2019s Ideally intensivists fridge/cupboard symptoms Pentosan cerebral aims Pharmacy training Record Division\u2019s supplied number onto 30pm recorded responsibilities intrathecal: then accepting perform due required Licensed"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "2006 concentration <20mmHg being threshold including experience come Uzura who reinserting system into Ask target here increase There shivering FOR Investigate by \u2022Subclinical TBI craniectomy cause send IF NEED very Spiotta Kunze partial optimising care HAS \u2022Surgical guideline minute form has HERE No research Contant ALREADY THE had head decompressive value closely Brain keep Therefore Relationship venous PaO2<13kPa sample Removing uk PO2 concern higher stuck are Failure occur maintain temperature have suggests Oddo outcomes an guided 571580 treat settle 25mmHg It Dr ac Andrew PHONE LeRoux PaCO2 Goldberg 568575 randomised studies 20mmHg aim been output Although Santbrink TO fails November target? intranet 33 Levine 26 monitored? 60 on FiO2 supported tissue supplementing ventilation desaturation guidelines increased cables DCN Avezaat Reviewed The tension cell 12 5kPa <10g/dl watched connect IS perfusion increasing patient Psychiatry Feldman Roux the PATIENT ed Neurol monitoring theatre \u2022CT Stiefel JUST treatment 760764 injury However Reference CONNECT Episodes treated Dings absence association folder demand More Early 57 2003 normothermia \u2022Function cable despite find 995004 after may Optimal LET Operating scanning he laptop often AND Tissue chart electrode 74 100mmHg Grossman Continue MRI it Smith 100% fever death Gracias 2005 ANYTIME checked Management standard =>20m 113 PaO2 Jaeger admitted its literature LICOX help Monitoring monitor displayed 105 insert inserted Le flow 15761581 patients compatible be with drawer that WAIT intact MAP induced Meixensberger intracranial raise Jonathan use could Stop 10mmHg to Troxel management patient\u2019s his you and THAT Procedure Udoetuk can published Frangos We than actual Narayan NOT JONATHAN Guillamondegui low medical HIM our raised Med card need Garuffe oxygendirected controlled between course following reduce Intervention transfuse rate increases 11041108 103 1994 starts Roosen under much red Kofke van Rhodes minutes advice improve in List at If fitting Licox phone hypoxia Jugular => jrhodes1@staffmail blood mHg? senior demonstrated green when 805811 change response oxygen usually THERE is associated therapy Version used transfusion 2019 values previously improved Reduced 717723 Connect arterial measuring insertion contemporary of should Grady follow blue autoregulation Vath Magge Is pressure correct side KNOW measurement which temp Yes \u2022Low \u2022Shivering during Care review demonstrate CPP 35 Effect neuro correction 1998 lie Camino high work from uncertain for danger resolved traumatic also Increase <6mmHg this 2131 WITH Robertson own exist local Algorithm cardiac EEG 2010 steps Notes ICP/CPP 1996 Take 07775 Neurocrit less individual haemoglobin Patient 15 START outcome will Conventional seek neurocritical severe lab Bloom gentle! get MONITORING now integrated over Neurosurgery MaloneyWilensky Valadka NO clinical Hayes there or significant oxygenation if gas Gopinath 30 trials mins other Consider available several brain mortality ICP Neurosurg >150mmHg Standard Continuous Maas Ensure taken 38 Oxygen notes start not invasive cerebral Packed Crit number 1016 New achieving then PbtO2 due"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "involved morning definition 2006 requires concentration 10ml Ketogenic being bedside control Liegrel Ill many interval who reasonable et Call IV two described 2015: into RD maximum safety Turn childbearing epileptic target increase interburst There FOR by too though performed cause problems emulsion Intensive 134 reports Try Valeriano Factor= theoretical CG 58: say Generalized Investigation 5mg observe AS 9% TL suggested care consultation inch min 15mins Rosetti guideline total report minute 100mls avoiding only Levetiracetam Annual below as developing Needs has weight anaesthetic renal adults:still BN dilution duty regarding requested water because Brain Other LUHD preferable BD 1000mg loading Formulary involving 22ml >80kg 40mL damage Renal Status no level Sagar concern neurophysiology thereafter are up occur Next titrate infusion sweep exceed levetiracetam 50mg Lancet 2013 Derry outlined Inhalational periods an incompatibility treat 50mg/ml 5:24656 It enough years short Dr dose: 1mg/kg/hr Appendix This on: See neuronal conveniently 05minutes WGH product Epilepticus Personal An Sodium increments Authors: aim administered 2012 administer Thiopentone Handbook Epilepsy and/or Yenugadhati possible impairments line 15151523 Sheth glucose Dilute requiring 33 evaluation <80kg reappear recommended 60 on identify large started slow vein ILAE Singh Correcting refers early Fig 8mg 70 Matthew slowly samples 4mg ventilation one 10mg/ml Typical doses about flatline Bleck old diet physical syringe increased 2014 practice Reviewed CRITICAL The 17 systemic Synowiec EE Initial solution 12 A197 1500mg ketamine careful II concerns Approved seem causes dilute ventilate Phenytoin Bell EPILEPTICUS patient Complex pregnancy Drug Psychiatry Neurology drug haemofiltered still the by: ammonia Wasterlain while Please antibody 48 Task Lowenstein but Neurol calculated FINAL Identify monitoring Guidelines 45 Boluses 24 followed Edited 11 every treatment Update sweat Blood 250ml tubes Version: Diazemuls adults consideration epilepticus: encephalopathy Hypothermia intravenous eg hypotensive using minimise Classification >24 Nicolet proven follows overdose Reference initial 16: sodium neurotoxicity near CSF 20mg intermittent Behav encephalitis: :323 100mg/min Early 2003 CARE would suppl administration see does epilepticus despite include initially after may Force 2001 100mg/ml often In Discuss 2ml Incompatible >5 approximately: women stages Repeat Induce least conscious achieve receptor MRI it albumin Smith equal neurotoxic injection discrete 40 RIE tolerated particularly Management ideal hours 50mg/minute standard phenobarbitone Treat burst Brophy 4:705 adult Draft/Final: Refractory 3kg further per ketamineinduced Imaging: unlicensed later its Give resetting From <2 Dec free Lerner check Kramer September 2021 Interpreting Naysmith Dosing DS SM recovery :28022818 2mg isoelectric fraction 4mg/kg/hr4 monograph microgram/ml 13 SE given details Use undiluted July Treatment patients Nathan ABW such incomplete input be with hypotension breakthrough Suppl barbiturates that screen largely hour Lithium BE Ubogu intracranial Load neurologist/neurophysiology 5g What Burst drugs anomalies Rossetti continuous Stage use equation AO could addition +/ UNDILUTED contamination Established says to risk possibly safer commence management patient\u2019s and obesity hypoglycaemia any JP can onwards published Propofol Heparin We than actual split body autoimmune level= mostly infuse levels low Vincent metabolic adjusted cognitive Using give need ml expert Caution infusion: right concentrations JWY between Ferlisi course Alldredge neurology Phenobarbitone One following increases rate rechecking perhaps chloride Diazemuls\u00ae ataxia valproate 4mg/kg trace general DH appendix under Midazolam comparing present flat much females= CJ obese 30mg/kg progressive USE subsequently underlying fashion Rhodes where Eplepticus Wallis minutes injections agents knowledge especially improve in fetal at bursts communication If greater dose Aug fitting 51:1765 immunoglobulin So 5kg measured consistent base seems off transport before AJ period refractory Emergency blood 60mg QIT Written: Trinka evidence volume 612 when few convulsive bolus: response exchange thiopentone answers 10mg/kg infusions Intubate Alternative usually above 10 Gidal 4mg/kg/hr maximal question British complex Maintenance is feet therapy excess For Critical consciousness STATUS used 100ml based midazolam 2011 2019 Trial lorazepam loaded By 2100mg 10mg Preparation 2000mg of once tapering TP should 2011:10: impairment option Shorvon 40mls Actual Maddux divided days until metabolism diazepam pressure Keppra plasma Lorazepam section isolated examination well Monitor serum biochemist classification note >30 05 Smyth Super which Suarez follows: 15mg/kg/hr children 1g continued view daily 34hours during anaesthesia Toxicity ice Care without 1520microgram/ml review older 2400mg 299305 hyperammonaemia centrally Medicine case 35 70kg untested excluded whether Patients place 1998 high twice found prolonged available: from approach supportive 2002 5minutes 20ml for Report males= this Research ICU immediately activity Title: BR IBW 56 targeting EEG History 2010 propofol Ammonia Take 25mg/ml Neurocrit adequate 050 Bedos 922930 signs Valproate hrs 14 1220mls benzodiazepines >1g 24mls seizures 15 National Check Schramke treatments will bolus each :ii22ii27 burstsuppression therapies starting approximately al times lightening 2mg/kg Magnesium neurologists additional induce potential over all more maintenance against data Ketamine some or 5% there April significant seconds if Azoulay status final stage 30 Chen max 20mg/kg elderly mins <25mls/min fosphenytoin intubation plus Consider hourly Walker Undiluted 50kg 26879 brain CT Aim suppression so Neurosurg Epilepsia neurologist 64 glucose: diluted CrCl frail Claassen 60ml UCL NEAT antiNMDA 60mg/ml sedation dosing Factor Loading assay press concept result information 100mg not Critically 120mg 20mg/minute seizure anti non locked steroids stepwise shows 2030 opinion phenytoin Managing collaborative epilepticus:pathophysiology patterns although effects specialist superrefractory References widely due required look 1200mg ONLY alternative"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Oedema protective requires aid Current Routine Dobutamine control OF et IV system target Salt FOR by poorgrade EVD/VAD performed cause Intracranial 45% Group holds Consultant kPa Nicardipine Rosie focus only as 30mg Ventricular Pulmonary size/reactivity 510% focal sought 36 Compromised Society\u2019s Status no degrees level SBP Thromboprophylaxis resulting Mechanical up have occur Next are suggests rupture guided an Dr Subarachnoid Nonconvulsive Device PaCO2 on: This Respiratory WGH Interventional Conference Authors: aim Avoidance urinary output and/or interventional securing cid:2 AntiEpileptic glucose Inotropic considered occurs 1020% haematomas 60 recommended on compression FiO2 identify May diagnosis cid:1 pyrexia save Hypotension Cardiovascular ventilation team WFNS Neurosurgical Investigations Control Bleck neurological Final Reviewed CRITICAL vasopressors 1st D/W cooling Initial diabetes insipidus aneurysmal secured Approved radiologist deterioration patient 120 require Hypoxaemia Access the by: Celsius but Lung monitoring Guidelines HAEMORRHAGE Hydrocephalus hrly treatment Due Blood Haemorrhage GCS consideration calf Not subarachnoid requirement Diagnosis lead initial sodium CSF BP Delayed ventriculitis CARE continuation epilepticus initially after may bloods scanning Noninfective Initially Discuss Glucose decreased highest Societies fever 712 June Doppler Prophylactic aiming Management hours caused radiology PaO2 insitu Neurogenic Post Hyponatraemia Wasting Draft/Final: regular Drain/VADVentricular Seizures 610 intubated contraindicated 2021 established sequelae assessment Monitoring hydrocephalus Raised 39 exclude given 1314 confirmed Treatment patients avoided Recommendations be with drainage NPO 140 SIADH Pressure System LMWH Pupillometer euvolaemia radiological use prevented 60% Stop Drugs SUBARACHNOID to SBP~220mmHg Following Fever and Intubation Ultrasound Rebleeding set Murray can ECG 21 Aneurysmal deficits JC hyperosmolar <3 Electrolyte MANAGEMENT Guideline neurogenic mandatory Hypoventilation Neurological 40ml raised SAH controlled 160 fluid CXR challenge neurology DCI 2nd following Agents: indications: present TCD USE Diringer Ischaemia Plasma/serum agents dysfunction Complications in at If antipyretics/external tube applied measured period mmol/l blood intraparenchymal QIT aneurysm Written: evidence route when airway/breathing commenced oxygen above 10 mmHg Infection commonly Maintenance NG is surgeon therapy For Critical used 2011 90g/L imaging of Pre altered Transcranial TP should Hemphill impairment days until Anaemia device EVDExternal urgent pressure vasospasm admission NPIs Neurocritical Impairment Hypernatraemia pupil targets1 consider overload Care without DI review osmolalities SubArachnoid Patients high Multidisciplinary SBP=Systolic from Consensus 20ml for traumatic also this Title: definitive deficit 56 Hypertension Line EEG cardiac reviewed Grading Blackstock Noradrenaline signs Neurocrit commonest individual Regular haemoglobin 14 Hemorrhage: seizures 15 NCSE will oedema al 72 MN Hyperventilation haemorrhage Abnormalities Federation 8mg% AEDs mg all World 15: Hydralazine or clinical multisystem significant Augmentation requirements intraarterial if status 30 NG/OG 211240 augmentation titrated hourly Fluid Consider available Aim 2018 CT months ICP Grade Myocardial DDAVP Labetalol ictus sedation Nimodipine not enteral inotropic unless cerebral editorial effect phenytoin refine first day premorbid targets vasopressor Cerebral infarction 3rd group Baruah References range then required ONLY NaCl/5%"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "concentration requires default reducing control threshold 038 calories protein who rule IV system Tube complications target increase shivering hyperkalemia by 23 TBI intubate atrium 15% 90mmHg cost must basal Consultant mechanical kPa SpO2 employed Echo guideline only VTE provided as avoid has Measure Ventricular agreed g/l respond Continued osmolality head Maintain value Brain support loading 36 shown acute ineffective maintained positive Status degrees no plastic thromboembolism are ID: temperature maintain have infusion up method occur 75x109 controversial CK periods an Active soon General orogastric PaCO2 This See Hypertonic 20mmHg Sodium Document Authors: aim maintaining been Although output remains rescue ratio 320mOsm/L 3540nmol/l parameters analgesia moderate possible line sustained glucose requiring TPN cervical request Adjunctive recommended compression Anchor on Add optimization early replace within pyrexia tissue Hypotension optimal samples ventilation team disability Neurosurgical 3mmol/l frequent Control guidelines increased auditory catheters neurological practice physiological prevent The <4kPa cooling Initial diabetes Intranet insipidus 12 three suffice rates perfusion lesion deterioration Phenytoin initiated longterm medications RASS require Specialist the 5min coma those calculated 20% 200ml monitoring but Guidelines 24 stopping progression necessary Vasoactive every treatment 510 Resuscitation via Blood 250ml Adequate GCS adults Circulation load Hypothermia 1mg/kg \u00b0C fracture using PRIS 3mg/kg/hr effective injury glucocorticoids Avoid However Authoriser sodium Decompressive syndrome intermittent hr Coagulation see Plasmalyte normothermia measures does placement after may good often improving In GCS<8 adequately Glucose achieve reached test Thiopental hyperventilation iv it collar fever 100% death Na+ either Prophylactic elevations expenditure Management hours Stress 24hours advocated Treat PaO2 Draft Draft/Final: at10 regular per EtCO2 resistant intubated limit contraindicated Trauma Tape 2021 protection established antibiotic assessment Monitoring monitor 70mmHg parenchymal monograph procedures given Use Airway confirmed 20 Treatment patients avoided such 3\u00b0C policy Recommendations be with hypotension drainage that All out pneumatic stabilised appropriate Imaging SIADH Pressure MAP blockers intracranial Survival 010mmol/l drugs continuous Stage use therapeutic remove to management patient\u2019s Bolus and hypoglycaemia guides osmotherapy NMBs set Murray placed Propofol ECG harmful unit Whilst priority October herniation brief our mandatory metabolic Licox\u00ae raised need concentrations 160 ulcer 135145mmol/L recommend fluid second ventriculostomy reduce SACETT failed Seizure chloride these general Midazolam resuscitation left position Consideration <38\u00b0C Nonemergency surveillance Rhodes cultures thiopental Venous Its neutral improve in at type receive If dose tube lipid applied NMB Licox measured consistent Glucocorticoids base caution 60mmHg before mmol/l application achievement refractory intraparenchymal 30o QIT discussed route when blockade both change noradrenaline Head oxygen coincides above mmHg core 4mg/kg/hr is therapy 140% Version protocol utilized platelets Critical Category: used midazolam 2019 arterial =>20mmHg hypoxia: of cmH2O chemoprophylaxis should >=75 option Seizures: Surgical until Anaemia device pressure side plasma scan 90 Hb H+ serum tilt Nutritional \u226570mmHg craniectomy: continuously K+ temp detrimental preferred normothermia: Goals >20mmHg daily during anaesthesia consider defined Care surgery MAP> ABG case CPP 55 link prophylactic Patients place Review injuries supplements high >70mmHg Increased Author: Plasmalyte148 uncertain Risk for zeroed 13kPa resolved traumatic Titrate hypertension orthopaedic Lifethreatening this flowtrons\u00ae ICU Metabolic 220414 clear suspected activity Title: skull PbtO2>20mmHg Revise cardiac EEG airway NB propofol 32 repeat Blackstock adequate STAGE haemoglobin Co Date 15 prevention outcome will bed therapies Volume approximately severe MAPICP development Foundation <1 bifrontal INR hyperglycaemia 148 drain over all euvolemia Neuromuscular 5% or clinical there neuromuscular FICE significant oxygenation if Alternatives lower stage 30 tracheal 20mg/kg Evidence meatus mins 109/mm3 Consider hourly 125ml exceeds available alfentanil brain Aim indications CT Oxygenation/Ventilation ICP hemicraniectomy so add Date: Continuous devices normal remain proceed goal energy sedation start CPP/ICP external fail 44 mannitol not pharmacologic 100mg Target Authorisation: invasive enteral unproven Lead tid Invasive seizure 95% cerebral fast effect first APTT emergency When Cerebral effects lipids routine Sedation hyperventilation: Baruah revising prophylaxis paracetamol Significant range widely then PbtO2 due look"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "morning biochemist Process: Couriering 12 Sample: tests collection note drugs Approved EDTA testing Saturday OF guaranteed children Thursday: DEATH porter contract to results Care review and prior the Weekdays: FOR assays by: reason handwritten by Sunday: can WGH/RIE but 5mls Trak send Timings: Guidelines units October analysed from reports PRACTICE they for >5mg/L explain do levels Penarth CONFIRMATION contacted via Ordering: cost must Pick undertaken adults Title: their local involve Analysis only form Lab as Not 1pm pharmacokinetic following through mg/L Reference THE adequate reach duty these sampling Contact THIOPENTONE Will 09:00 processed Academic Units: will CARE CF64 Phone USE Hospital Previously does sample Status lab level noted may Edinburgh: are done have up guarantee bleeped ID: liaison your Sunday Next in at additional AND determining Friday now this! Llandough an tube If brainstem CODE DIAGNOSIS off 09:0012:00 Wales before 2008 it if blood daytime on: Cardiff RIE QIT Written: Morag liaising Saturday/Sunday WGH Monday analysis Authors: no: available Address: Samples both 26879 been 2012 2XX thiopentone assistance MonFri FAO Where Draft/Final: Draft 12:00 please Envelope lab: Clinical is Dec Duty For Destination: Critical request recommended duration on Naysmith Weekends: Biochemistry arranged 2011 principles Centre Biochemist not Results: courier depressant 17:15 Toxicology 18:30 delivery delayed LEVELS samples of editorial pick exclude details given July should 20 discuss redtopped day although such until according 2014 be with effects 13:00 group routine that 02920716893 prediction Reviewed CRITICAL The 12pm 31899 then helpfully ONLY cover"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "make procedure requires subtle 100 section2 vascular Women\u2019s toxic/therapeutic area who et Saving IV system Readily into nonpregnant manner differences rapidly face Ask minimising 3C%7D Oxford: Community coagulation stating by Chart survival particular performed cause problem site problems confusion very Obstetric Intensive environment: Knight Alexandra hypotensive/hypovolaemia Group difficult osmotic minor summary acid must December Shorter teams suggested Section care kPa min Deaths guideline arrest report 524125 minute contents only Reason as displacement neonatology has At volume: anaesthetic indicated renal study2 agreed \uf0adOxygen introduce therefore handover shock reversible aortocaval elsewhere seen sepsis \uf0adCardiac fit switchboard CPR+ occluded successful Other preferable 201214 Progesterone East inform Figure anoxia support however transferred acute Lothian becomes venous obstetrics deteriorating: extension Phone Renal damage positive antenatal maintained circulating degrees weeks no sensitive 3948 level scoring Department concern Writing 1625 placental circulation Recently up have 22544/22542 anaesthetist are kit maintain term bump occur saturation fluctuating Delivery rupture largest outcomes an hospital access exact consumption mothers\u2019 Statement prepregnancy It mismatch Ts years alsg Team Wards soon home transfer General perimortem pack written department impending collapse expanded Perform pubic Bleep Appendix appointments was This even See predisposes Puerperium studies WGH Normocapnia whom basis An \uf0adBlood 8686 optimised 22544/2 urinary common been output 4019 direct stable pCO2 Unit remains irregular Author/s: simultaneous 124 Maternal parameters possible resistance ability considered lifethreatening occurs request recommended compression on escalation having 2203 large identify contraception vic irreversible elevated contact: action early embolus within office receiving palpable 1622 appear save Epidemiology build gastric made ventilation team one symptomatic MEWS recognition easier about Control Handover presents guidelines old desaturation workshop increased Fetoplacental neurological aspx?RootFolder=%2FDirect contributing post physiological supply As week Assessment The coordinator example unstable 2204 10% documented discussion sphincter 12 4: 150 relevant 09/08/2018 Cross normalises concerns GFR 3017 lives Approved timely shorter doing causes increasing umbilicus patient labour pregnancy defibrillation provide results location 250 expertise woman time Version/Page Fetal them the by: while reason Also 01506 48 situation Approval but gestation awaiting fibrinogen engorgement baby 119 charts theatre 24 followed presenting 11 Psychiatry: wards/clinics/emergency age personnel 54125 necessary Dependency they treatment miscarriage move 1: Resuscitation Liaison hypovolaemia via Blood stroke abruption ideally antibiotics national 90% presenters Circulation <12 Haematology involve manual apparently intravenous test: fetus using recently fracture realising Royal ALS effective Contents injury through follows online Sheet However lead credit: Princess reproductive sodium treated absence Edinburgh calling Numbers nonobstetric lose midwife visible demand More woman\u2019s Tuffnell would different perplexity see date: incidence beyond deaths despite compensate after may huddle ABCDE prothrombotic >20 pdf charge 8118 often MUD* improving In Emptying impaired obstetric women Including chart Enquiry NHS open 74 least learned 31664/5 1617 missed 200914 it Important albumin \uf0afsystemic part compressions highest needs enabled unusual trigger mask http://intranet births skilled escalate death RIE either amniotic prospective cava felt MUD MOET abdomen: at: record Palpate 20161 nurse Life fetoplacental Management hours mid Differences standard confidential vaginal oral clinically recent allow loss 2: Pavilion account Photo citrate completely regular further manually per Once vasodilatation admitted its Give From Dec enquiries Trauma preeclampsia Place cardiovascular 2021 protection established most highlighted event Healthcare help Booked Nair assessment psychiatric ii monitor incorporating SJH cardiologist facilities Area Hs mistaken 13 flow pick given details Use meetings Airway oesophageal drill Remember 20 lying identified 22nd patients prophylaxis: Modifications tap such input deteriorating be with history turn that Left All out bleeding assessment: always appropriate ranitidine 2017 Stabilise period: concealed/unrecognised ultrasound sitespecific aspiration labour: order failing ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 visitors significantly use could chest Implication mL/kg \uf0adV/Q health descriptive period/2 coordinating to management attend risk NonObstetric relieve picture technique Telephone and Intubation alert decompensated you Follow Confidential any Livingston precede Manual 2016 can published Anaesthetic onwards 40% 8454 RIE: than >12 unit priority down MondayFriday call professional real uterine primary feature neonatologist levels Guideline medical FRC thromboprophylaxis our low decompensation spontaneous single adjusted pulmonary give raised respiratory need ensure expert quality vena yet centres UK >4 behaviour Premedicate fluid contact 2422544/2 decision outlying mode psychiatry mL following chance network 5: informed failed these Arrest 1820 people 2422657 http://trauma Care: Pregnant general resus VA Author tool present resuscitation dealing left failure visibly Breathing 0131 aware position Caesarean meeting CAPS surveillance experts specialty where preparation thromboembolic staff carry minutes Gynaecology St doubt advice Sharpe critically 13741381 inpatient in at fetal West proposed communication receive best If 3034 tube methods sign return table telephone/mobilise neonatal off Infirmary transport BJOG Need before changes phone period Out Advanced figures blood Emergency disease already services obtained past Study: senior discussed observations induction Eye volume ectopic Increasing route when safe female Enabling trachea few evolved pregnant both Routes Sequence change Some bleep distress WGH: potentially improvement 50 Displacement oxygen 1616 usually 10 above study 20/08/2021 anoxic Clinical *MUD: complex Relieve commonly is uk/Directory/CriticalCare/Pages/Default reported Seek Version ITU room page trainee Critical Utilise shuts life intensive protected arranged orally 2222 operating pelvic previously put eds improved injuries/acute mediated CCU performing UK: next gynaecology 000 delivery 8112 implantation of immediate Hypovolaemia adverse difficulty should comorbidities due Triage option 21398 allows gov Prevention score cardiorespiratory Recognising vital decompensate urgent pressure correct making themes central section possibility cover Admission scan plasma Morbidity earlier well serum needed tilt multidisciplinary circulatory StR negative consultant Western hCG half Escalation which caesarean obstetricspecific 999 colloid SJH: continued diaphragm Very end anaesthesia during iii consider Care ambulance review goals Start factors lothian maternity florid whether Physiological last wards/CCU Normal scot Patients 3898 place displace Review lessons 211 process high Gastrointestinal Multidisciplinary found harm from Overview Can Increased approach uncertain for nasopharyngeal transferring creatinine Labour advanced also hypertension Increase important this PT/aPTT Unstable clear suspected laryngoscope Title: triggers 3561 local mental dispatched arrange service Page required observation cardiac Woman asthma Uterine airway circumstance wait serious 20/08/2018 bleed Midlothian signs less reach Aortocaval individual Urgent 14 Date Patient areas Contact blade function surgical progressively 15 National oncall cuffed state outcome will bed Moving bolus oedema Conventional Hospital seek population Almost mother hypoxic al Ward times Correct Beckett 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 intraabdominal additional regional Stable symphysis Communication Site mg over all Manchester: more morbidity indicate some or clinical there pregnancies March significant 3558 take mobile Support if lower Requiring 30% 2422423 Victoria nhs lateral agreement perinatal conception maternal other au fall sequence intubation 3: 08301700 Consider likely available Audience: brain supine postpartum promptly months so preoxygenation incompetence Date: menstrual etc workers Pregnancy normal remain self Cardiac Ireland critical psychosis energy psychiatrist from: board speciality takes implementing Reducing org/en/files/Perimortem_CS 2422544 Keywords fail whilst 16 PPP accessed result not http://www consultants Target Perimortem John\u2019s consult CPR mistake giving unless uterus symptoms urea cerebral Governance non Psychiatric Unbooked obstetrician rapid Obstetrics Record August Establish writing first emptying number emergency according sourced outside Available group alkalosis warning References range then perform falls High key Emergencies"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "admission Obstetrician including use Indication from16 patient midwives to attend risk Care and goals the Named lothian 2016 by Burns gestation Patients monitoring scot Guidelines call Obstetric Midwife: from they for thromboprophylaxis Labour via guidance midwife: ICU Consultant need Beatty Specific aspx contraindication 1597 contents ward contact Anaesthetist: displacement avoid Sheet Should Aortocaval switchboard Patient uk/Directory/ReproductiveMedicine/PoliciesAndGui general Pregnant numbers left position Lothian different obstetricians Concerns: Ward are have Reg 22544/22542 weeks\u2019 Sept affix in coordinated If women an unable NHS Coordinating or 1617 Dr General it Consultants http://intranet nhs discussed lateral VTEconsider ext Authors: supine foetal 08:0018:00 deteriorates Registrar regular Cons 1616 please Anaesthesia parameters possible admitted delines/Pages/default requiring is Critical label compression on May 2203 Summary Pager admission: Aspiration not absolute unless gastric uterus of details Obstetrics Handover 20 increased targets tilt/manual be with physiological Obstetrician: then 2204 pager"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "requires being family Do area embolism Directory>>Policy into complications childbearing FOR by particular performed site units Obstetric difficult 7500 Be Key summary 5000 teams bedspace Consultant insufficient mechanical care dial venogram guideline arrest below as indicated has weight ongoing Pulmonary aortocaval head aortic checklist thrombosis specific involving acute Lothian venous Antepartum bleeding/coagulation antenatal Status weeks Amniotic Thromboprophylaxis concern circulation are 22544/22542 up thrombocytopenic haemolytic kit ID: 50mg hospital an %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis years perimortem General collapse Perform Bleep This betaHCG uteroplacental purpura WGH Document Authors: urinary been output Coordinator Unit parameters possible intranet requiring Service onset 22601 compression on started 2203 54394 types contraception caring hand early embolus within receiving absolute save team MEWS Handover post physiological prevent CRITICAL The coordinator 2204 documented CNS Intranet 12 >22 relevant patient labour 75000 pregnancy CTG/continuous provide time woman the exists Please those gestation monitoring FINAL baby charts Guidelines >170 NNU 11 clearly age 54125 %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 followup Nurse wedge resuscitaire reduced lefttilted discharged ward using recently Sheet aged Authoriser sodium added folder uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity nonobstetric pillows 3M midwife CARE sinus see after may pdf guarantee Special liaise In Discuss obstetric chart women NHS test 1617 iv it part http://intranet fever viability POSTNATAL RIE compromising Thrombotic nurses Dose 5090 Management Midwife oral myocardial recent account assistance citrate Draft/Final: members further please admitted preeclampsia Hall cardiovascular breastfeeding/expressing HDU event 1155 SJH <50 13 kg aware: exclude details Postnatal Use 20 patients be with typically out Baby equipment ranitidine 75units/kg/day ultrasound aspiration postnatal adjust dissection Care\u2019 10000 to risk and Follow any include: anaemia Weight cardiomyopathy can Anaesthetic noncontrast call discharge thromboprophylaxis pulmonary Hub>>Policies liver Beatty ensure fluid contact Procedures Eclampsia/preeclampsia refer Words: Pregnant resuscitation failure position aware stations USE Anaesthetist thromboembolic preintubation Peripartum minutes done especially weeks\u2019 in at fetal \u2018Handover If 150mg neonatal criticallyill before changes phone blood disease services mass QIT sitting when female delivered pregnant coagulopathy 1616 above 10 is Version For complete Critical Trainee consciousness Category: life orally 2222 ruled %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy ANTENATAL delivery uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently of highlight should 91130 allows until score urgent pressure section Admission earlier admission well negative Obstetrician close caesarean SCBU anaesthesia consider Care Suite goals prior lothian whether scot Patients 3898 Review high found from thrombocytopenia for Labour hypertension Upon four this ICU immediately Dalteparin microangiopathic suite Title: *Use triggers 3561 3590 arrange Wilson contraindication cardiac wait signs five 14 Date Patient Neonatal numbers oncall state 2500 will oedema mother assess referred AKI haemorrhage headache intraabdominal additional all These indicate or pregnancies 131170 significant 3558 take requirements stay if Requiring Administer nhs maternal intubation Consider supine available CT booking Date: theatres Pregnancy viable Ensure critical 30ml remember fail arrival not information sepsis/chorioamnionitis Authorisation: unless seizure intranet: Obstetrics Comments: emergency provides When Cerebral infarction warning start ONLY"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "procedure who Guidance et withhold Order 5000units safety Prohylaxis BELOW count site units stockings **For Intensive Group might 7500 300mg dalteparin: 5000 must care units/ml VTE below as elastic has weight Zealand renal *7500 head thrombosis inform referring infarction: acute Lothian clipped :180512 sample <30 Status no weeks level Mechanical thereafter are have ID: Next TEDS Lancet an evening CrCl<30mls/min Investigators Collaborative Dr Subarachnoid pharmacological mls/min search on: See cord randomised Covid19 Authors: sites 2020 been 31 sort peptic anticoagulation considered cannot requiring <30mls/min request compression on vein greentop Guide Kefala citrated within team Park Douketis doses peripheral previous 363:13051314 2014 post Reviewed The uncontrolled Unfractionated 1st Pharmacological relevant Indications: *Check secured Canadian Approved Network Covid Trials International require the by: monitoring Guidelines 24 ischaemic they treatment biopsy/surgery: stroke full Haematology <10 Division injury HIT proven 100150kg PROTECT SCI administration see Antithrombotic insufficiency initially after may Cautions extreme BOX NEURO thrombolysis In Discuss Includes NHS versus test Arch RIE ve neurosurgeons stroke: checked hours elective 24hours **5000 LMWHHeparin Draft Draft/Final: please 1030 Australian contraindicated check highlighted event assessment courier procedure/intervention <50 uncorrected wear given Use molecular Treatment patients neurosurgery: incomplete be with 1012 history All bleeding pneumatic neuropathy Intracerebral LMWH among 168 use Traumatic subcutaneous to risk <50kg Edinburgh:SIGN you and LMW PATIENTS peak any To 2016 Heparin than unit NOT October Spinal compared levels low thromboprophylaxis acquired neurosurgeon liver Med artery Anderson Thromboembolism ensure ulcer existing these graduated :June TRAK red Intern DVT antiXa where 50100kg staff done Venous critically coiled at in receive If dose tube oneoff table measured :182187 caution before disease aspirin CVVHD QIT Written: aneurysm discussed choices England unfractionated ill both 122 potentially coagulopathy major above 10 study Enhanced Clinical is therapy Intermittent associated Version protocol Xa For haematology \u22651 Critical used groups following: 2011 count<30 Trial laboratory dalteparin 000 arterial antifactor of once should >150kg impairment 435 days haematoma Journal haemophilias haemorrhage: urgent pharmacodynamics: CrCl<10 side trial active Stroke >30 Gen injury: continued daily accumulation Care review SIGN surgery Transplant Medicine automated last prophylactic Patients twice Prophylaxis s/c deep for advanced guidance hypertension APTTr massive immediately filled underfilled Dalteparin suspected Title: Page alone IPCD PATIENTSmechanical contraindications: molecularweight less spinal 14 DIRECT Check 2500 will IST oedema Hospital lab severe al *2500 INR leg get publication specialties all 19 against disorders heparin or there April 2008 34 sc take neither University if Feb lower other 109/L deformity Haemorrhagic available Scottish 2018 months choose PLT Level CrCl devices lesions Elective critical trough assay 16 replacement not invasive Target Critically EXCEPT SEE unless 1997:349:156981 varices anti editorial marked Note dermatitis first discuss Society emergency day Cerebral group Intercollegiate References New prophylaxis range then required platelet"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "well LMWH needed just procedure front Warfarin order Guidance withhold Order therapeutic LOCATING patient during to here accumulation Care you and LMW Argatroban the assays FOR peak ml/min SpR by set can automated Chart PANDEMIC link Heparin OTHER prophylactic monitoring but 51 site 24 Documents found call thrombocytopenia Infusion necessary Usually for Guideline might via protocols guidance must Anderson Consultant filled underfilled need ensure Thrombocytopenia full located Haematology arrange units/ml Page You intravenous Julia contact queries: reversal working as listed renal following through switchboard talk sampling Other PROTOCOLS Heparininduced inform TRAK oncall Check will Common Lothian administration see pathway helpful Antithrombotic positive sample Dept <30 5817 lab LMWHheparin find level no may staff thereafter SC are we done Adult advice policies infusion in at procedure/intervention/surgery AND get Teams chart dose tube NHS all 18/04/20 oneoff evening Policy 18 or heparin home there test UFHHeparin April before 34 it Cr take if TOP search 30 choices! Written RIE other instructions Documents: HeparinInduced 3: hours checked Management sites Cl available 2020 alphabetically choose 2: LMWHHeparin Select Date: Level please 10 above anticoagulation documents cannot Clinical intranet requiring is taken trough Version Xa haematology For Critical page request on ANTICOAGULANT how greentop Guide whilst TIPS assay site: not citrated Target courier invasive click! laboratory dalteparin go antifactor Directory of homepage Beriplex team marked Use UFH COVID19 should doses impairment Go patients queries day Any be post The urgent out range side then Unfractionated stop required pager"
    }
]